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O1
The role of bubbles and cavitation in therapy ultrasound
Brian Fowlkes
Basic Radiological Sciences Division, Department of Radiology, University
of Michigan, Ann Arbor, Michigan, USA
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):O1
When exposed to sufficiently high ultrasound pressures, microbub-
bles can be generated spontaneously in tissue and undergo inertial
cavitation where collapses result in physical effects. These effects
range from petechial haemorrhage to complete cellular disruption,
termed Histotripsy, depending on ultrasound parameters. This pres-
entation will explore the mechanisms associated with histotripsy
along with the tissue effects and the wide range of potential applica-
tions for this mechanical disruption method.
O2
Challenges for clinical trials in therapeutic ultrasound, the need for
an evidence base, & trial design
Pejman Ghanouni
Stanford School of Medicine, Stanford, California, USA
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):O2
In this lecture, we will compare the design of clinical trials that led to
approval of MR guided focused ultrasound for the treatment of uter-
ine fibroids and osseous metastases. The impact of these trials on
the evidence base, and thus on adoption by users and coverage by
insurers will be compared. We will also review the process of expand-
ing approved FUS applications, either via investigator- or industry-
initiated studies or through off-label clinical use.
O3
Prostate HIFU – current status
Narendra Sanghvi
SonaCare Medical, Indianapolis, Indiana, USA
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):O3
In this lecture, present status of focused ultrasound for the treatment
of localized prostate cancer ablation will be discussed. High intensity
focused ultrasound (HIFU) has been used for the ablation of prostate
over two decades and has treated thousands of prostate cancer pa-
tients. Meanwhile, prostate cancer management is undergoing sig-
nificant improvements as molecular markers, targeted biopsy and
advanced multi-parametric MRI are routinely used to accurately
localize the prostate cancer. These advances offer a unique oppor-
tunity for focal ablation of localized prostate cancer with HIFU as it© The Author(s). 2017 Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeplays a significant role in reducing morbidity and treatment cost. This
presentation will focus on hardware design, software architecture
and HIFU features of the devices. Presentation will demonstrate
localization of prostate with ultrasound imaging, treatment planning
with 3D volumetric rendering of the prostate with ultrasound and
MRI fusion techniques for focal treatment and finally HIFU dose set-
ting with guidance using real time Tissue Change Monitoring (TCM)
with the Sonablate device. The presenter will encourage exchange of
ideas and discussion for research topics.
O4
Enhancement of drug delivery - clinical challenges and solutions
Constantin Coussios1, Paul C. Lyon1, Michael Gray1, Christophoros
Mannaris1, Marie de Saint Victor1, Eleanor Stride1, Robin Cleveland1,
Robert Carlisle1, Feng Wu4, Mark Middleton3, Fergus Gleeson2
1Institute of Biomedical Engineering, University of Oxford, Oxford, United
Kingdom; 2Department of Radiology, Churchill Hospital, Oxford, United
Kingdom; 3Department of Oncology, University of Oxford, Oxford,
United Kingdom; 4HIFU Unit, Churchill Hospital, Oxford, UK
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):O4
There are four key clinical challenges in optimizing drug based strat-
egies: (i) achieving prolonged blood circulation of the therapeutic to
enable active or passive accumulation in the target tissue; (ii) mediat-
ing triggered release or activation, or active accumulation of the
therapeutic, to maximize its concentration at the target site whilst re-
ducing off target side effects; (iii) enabling successful transport of the
therapeutic from the blood stream into the target tissue, and achiev-
ing a homogenous distribution in that target tissue and (iv) where
necessary, further enabling penetration of the therapeutic into the
cell. The potential of therapeutic ultrasound with, or without, sono-
sensitive microparticle or nanoparticle formulations to address these
challenges will be explored.
O5
Neuromodulation with ultrasound for beginners
Jean-Franҫois Aubry
Institut Langevin, Paris, France
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):O5
In this lecture, the use of transcranial low intensity focused ultra-
sound for neuromodulation will be discussed. A historical review will
be presented, with an emphasis on the experimental setups and the
acoustical parameters. Models ranging from slice cultures to intact
rodents and primates will be presented, together with recent trials
on humans. Potential mechanisms will be described. Based on our
own experience, exciting successful neuromodulation as well as dis-
appointing failures will be presented.le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 1 (abstract O8). Overcoming the resistant to change - is there
a strategy that could bring all the different stakeholders to combine
and align efforts?
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Thermometry in ultrasound fields, challenges & solutions in vivo,
ex vivo & everywhere else!
Kim Butts Pauly
Stanford School of Medicine, Stanford, California, USA
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):O6
This talk will cover image-based thermometry methods for guiding
focused ultrasound. MR Thermometry based on the proton reson-
ance frequency shift with temperature is linear and reversible in
aqueous tissues and is utilized in clinical practice with common
temperature resolutions of 1°C. Ultrasound based thermometry
based on the speed of sound change with temperature can be used
to 45°C in aqueous tissue. Both methods are sensitive to the pres-
ence of fat within the aqueous tissue, as well as motion. This talk will




Center for Imaging Sciences, Imaging Division, University Medical
Center, Utrecht, the Netherlands
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):O7
Motion leads to several challenges for HIFU treatment. In this lecture,
the effects of respiratory, cardiac, and peristalsis related motion on
MRI thermometry will be discussed. In addition, methods for tracking
the moving target with the HIFU will be described, as well as gating
strategies.
O8
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MRgFUS treatment is a disruptive, non-invasive, outpatient treatment
alternative that is capable to treat tumours and functional disorders
under real-time monitoring and control via MR thermometry.
Transforming this breakthrough technology from the lab to a main-
stream treatment alternative requires gaining the support and the
agreement to change by a whole array of stakeholders in different
areas some interrelated and some conflicting.
The stakeholders’ current position, changes they will need to go
through and possible changes engines are mentioned below:
▪ Physicians (surgeons) need to transform into image guided sur-
geons where knowledge and understanding of the disease play a
dominant role in the procedure outcome. The benefit is the confi-
dence in the safety and efficacy coupled with income that wouldn’t
decline. The change engine could be the patients and the payers.
▪ Payers should benefit from covering MRgFUS by saving cost and
addressing patients’ demands. The change engine in this case should
be the patients, governments and physicians.
▪ Governments should see the benefit of very fast recovery, very low
level of adverse events and productivity enhancement. In this case
patients and physicians should drive the change.
▪ Patients should benefit from safer treatment, fast recovery next day
back to your life, minimal trauma and morbidity. The significant
benefit to them should transform them to the dominant driver of
this change. They will need to influence physicians, payers and pro-
viders to adopt this new treatment.
▪ Providers should adopt the technology and provide this treatment
since the data exist proving safety and efficacy, proven cost savings
and physicians and patients demand.
The current Medical ecosystem is biased against new technologies
since the incumbent system/treatments are reimbursed while the
new technologies are not. Could governments perform economic
analysis and if found beneficial (example: saving money andimproving productivity) decide on limited 2 years reimbursement
during which RCT data will be collected based on which private in-
surance will decide to cover. This model should incentivize the phys-
ician, payers and providers to try the new technology.O9
MR guided focused ultrasound treatment of soft tissue tumours of
the extremities
Pejman Ghanouni
Stanford School of Medicine, Stanford, California, USA
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):O9
In this lecture, the use of MR guided focused ultrasound for the treat-
ment of soft tissue and osseous tumours will be discussed. Results of
treatment of these different types of tumours will be reviewed,
including lessons learned from challenging patient treatments. Tech-
nical aspects of all parts of a treatment, including patient prepar-
ation, positioning, imaging, planning, thermometry, and methods of
evaluation, will be described. The talk will also focus on methods de-
veloped to address these current challenges and opportunities for fu-
ture development.
O10
Non-invasive, non-destructive FUS-induced neuro-modulation
assessed by recording auditory evoked potentials – initial
experience in small/large animals
Shirley Sharabi1,2, Dianne Daniels1,2, David Last1, David Guez1, Yoav
Levy3, Alexander Volovick3, Javier Grinfeld3, Itay Rachmilevich3, Talia
Amar3, Zion Zibly1, Yael Mardor1,2, Sagi Harnof1,2
1Sheba Medical Center, Ramat-Gan, Israel; 2Tel-Aviv University, Tel-Aviv,
Israel, 3InSighTec, Haifa, Israel
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):O10
Objectives
MR guided focused ultrasound (MRgFUS) has been extensively stud-
ied in recent years as a non-invasive treatment modality. Initial clin-
ical trials have indicated promising treatment response to ablative
FUS treatments of patients with brain tumours, neuropathic pain, es-
sential tremor, obsessive compulsive disorder, and Parkinson’s dis-
ease. Apart from the ablative applications of FUS, this technology has
been extensively evaluated for less destructive applications such as
thrombolysis, blood–brain barrier disruption for increased drug deliv-
ery, and recently also neuro-modulation.
Fig. 2 (abstract O10). See text for description
Fig. 3 (abstract O10). See text for description
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invasive, non-destructive, reversible FUS-induced neuro-modulation
in small (rats) and large (pigs) animals by inducing temporary sup-
pression of auditory evoked potentials.
Methods
All animal experiments were performed under full anaesthesia. Rats
were anesthetized by Xylazine/Ktalar and pigs were anesthetized by
Propofol. Rat’s heads were shaved prior to treatment but they did
not undergo craniotomy. Pigs underwent craniotomy to avoid FUS
reflection/aberration by the skull. EEG was recorded using 3 small
cup-shaped electrodes attached to the skin/dura with metal
particles-containing gel for optimal sound conductivity (Fig. 2).
The audio stimulation system consisted of a pulse generator con-
nected to the EEG trigger input and to speakers placed near the
animal ears, producing a square-wave form at 10 KHz, resulting
in 150 “click” sounds per min (Fig. 2). Each measurement con-
sisted of 200 repetitions enabling acquisition of a full measure-
ment in 1’20” min.
The ExAblate Neuro system (InSightec, Tel Aviv, Israel) is a combin-
ation of a standard MRI scanner and a FUS delivery system. The FUS
device is in the shape of a helmet consisting of 1024 transducers
which deliver US energy in the form of “sonications”. The system is
designed to provide real-time therapy, planning, thermal dosimetry,
and closed loop therapy control. Treatment starts with conventional
MRI scans, displayed on the ExAblate computer, used to determine
regions of interest of the target volume. During the procedure, the
beam path is periodically reviewed to confirm the planned direction
through the tissue. The set of sonication volumes is sequentially ap-
plied to cover the entire planned volume. The current experiments
were performed with a modified ExAblate version developed for
neuro-modulation as part of the MAGNET programs supported by
the Israeli Ministry of Commerce.
Baseline auditory evoked potentials were recorded by EEG prior to
FUS treatment, with the animals in the prone position. The animals
were then placed in the supine position, with the skull dipped in de-
gassed water at the centre of the FUS system, for localization MRI
scanning followed by FUS treatment. The animals were then returned
to the prone position for continuous post-treatment EEG recordings.
Rats which did not show recovery of the auditory evoked potentials
30–60 min post treatment were monitored again 48 hours or 1 week
post treatment.
The animals were treated by FUS for 52 sec using the Exablate
Neuro system at 220 KHz, 12 W, and 100 ms on/ 2900 ms off
pulses. Two rats were treated in the thalamus region (targeted at
deep auditory tracks) and another two in the frontal cortex re-
gion (targeted at peripheral auditory tracks). Two sham rats
underwent a similar procedure without activation of the FUS sys-
tem. One pig was treated in the thalamus region and another in
the right motor cortex region.
Results
Auditory evoked potential EEG signals shapes varied from one animal
to the other but all were detected 2–10 ms after the trigger. The
maximal peak-to-peak height was calculated for each measurement.
The sham rats showed no significant change in the auditory evoked
potentials EEG signal.
The rats treated in the thalamus regions showed 50% and 65% sup-
pression of the baseline auditory evoked potentials EEG signal. The
first showed no recovery 2 hours post treatment with full recovery
measured 1 week post treatment. The second showed no recovery
for 1 hour post treatment and full recovery 48 hours post treatment.
The rats treated in the cortex regions showed 50% and 67% suppres-
sion of the baseline EEG signal. The first showed no recovery 30 min
post treatment with full recovery measured 1 week post treatment.
The second showed initial recovery 14 min post treatment reaching
full recovery within 28 min post treatment.
The pig treated in the thalamus region showed 90% suppression of
the baseline signal with no recovery 30 min post treatment. The sec-
ond pig, treated in the cortex region, showed complete suppression
of the baseline signal immediately post treatment with initial recov-
ery noted 18 min post treatment, reaching full recovery 63 min post
treatment (Fig. 3).Conclusions
Our preliminary results suggest that reversible neuro-modulation by
non-invasive FUS is feasible. Full recovery was noted in all 4 treated
rats and in 1 of the 2 treated pigs. Unfortunately we were not able
to monitor the first pig for more than 30 min post treatment.O11
Biophysical dissection of ultrasonic neuromodulation mechanisms
Michael Plaksin, Yoni Weissler, Shy Shoham, Eitan Kimmel
Faculty of Biomedical Engineering & Russell Berrie Nanotechnology
Institute, Technion – Israel Institute of Technology, Haifa, Israel
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):O11
Objectives
Low intensity US can noninvasively suppress or excite central ner-
vous system (CNS) activity using different combinations of stimula-
tion parameters. While applications are already emerging, the
underlying biophysics remains unclear regarding the relative contri-
bution of possible mechanisms: extracellular bubble cavitation,
thermal effects, acoustic radiation pressure and US-induced intra-
membrane cavitation within the bilayer membrane (the bilayer sono-
phore or BLS model). Interestingly, both radiation pressure and
intramembrane cavitation can induce plasma membrane capacitance
changes. Here, we use detailed predictive modelling and find that
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):15 Page 4 of 114only intramembrane cavitation can explain all the observed aspects
of ultrasonic neuromodulation.
Methods
We analyzed the relevant experimental literature using modified
Rayleigh–Plesset intramembrane cavitation BLS biomechanics and
acoustic radiation pressure gradients (RPG) - induced membrane dy-
namics. By coupling these biomechanical models to biophysical
membrane models we predict dynamical biophysical responses of
artificial bilayer membranes, and of three common neocortical single
cell Hodgkin-Huxley type models: i) Regular Spiking (RS) cortical pyr-
amidal neuron, ii) Fast Spiking (FS) cortical inhibitory neuron and iii)
Low Threshold Spiking (LTS) cortical inhibitory neuron, RS-FS-LTS
Hodgkin-Huxley based network model and CNS axon model. In
addition, live brain tissue RPG subjected areal strains were evaluated
in a viscoelastic brain model.
Results
Only the Neuronal Intramembrane Cavitation Excitation (NICE)
models were able to explain US-induced action potential generation
through BLS-type pulsating nano-bubbles inside the bilayer plasma
membrane: the leaflets' periodic vibrations induce US-frequency
membrane capacitance and potential oscillations, leading to slow
charge accumulation across the membrane (on a time scale of tens
of milliseconds), until action potentials are generated. In contrast, the
analysis of RPG-induced membrane capacitance variations associated
with membrane area changes explain artificial membrane results, but
were found to be highly unlikely sources for neural excitation, when
considering the areal strains expected to form in brain tissue during
normal sonication. Further, the NICE-LTS inhibitory neurons show a
much higher relative sensitivity to sparse ultrasonic stimulation com-
pared to the other neurons, resulting from their T-type voltage gated
calcium channels. This model-based prediction was found to explain
the results of a significant body of suppression and excitation experi-
mental studies, including in humans.
Conclusions
These results provide a unified theoretical framework for a large
body of experiments in multiple preparations across the field of US
neuromodulation, lending further support to the hypothesis that
intramembrane cavitation is responsible for ultrasonic neuromodula-
tion. They could thus pave the way towards new CNS therapeutic
protocols, using the only method that currently allows targeted non-
invasive neuromodulation with millimetre spatial resolution essen-
tially anywhere in the brain.
O12
Ultrasonic stimulation of mammalian retina in-vitro
Omer Naor1,2, Nairouz Farah3, Shy Shoham2
1ELSC Center for Brain Sciences, Hebrew University, Jerusalem, Israel;
2Biomedical Engineering, Technion- Israel Institute of Technology, Haifa,
Israel; 3Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):O12
Objectives
Following previous in vivo stimulation of the retina, we aimed to
achieve a first direct measurement of the response of mammalian
retinal neurons to ultrasonic (US) stimuli, and to study and
characterize this response.
Methods
We coupled a high-density phased array (986 elements on a 25x35
mm2 area) to a system for multi-electrode-array (MEA) recording with
256 contacts. Mouse retinas were dissected and placed on the MEA,
and sonicated at 2.3 MHz, applying varying durations and intensities,
as well as stimulated by light. The acquired data were processed to
detect action potentials (spikes) elicited by retinal ganglion cells, and
analysed to reveal the relations between the stimuli and the
responses.
Results
We found prominent spike responses for stimuli in the range of 4.3-
7.3 W/cm2 and 0.5-1 s, which disappeared when the focus was
steered 1.5 mm away. Furthermore, we found that the relation be-
tween the response strength and the stimulation intensity, orduration, followed a logistic sigmoid curve, while the response la-
tency was described by a decreasing exponent. Lastly, we found indi-
cations that the observed responses to US stimuli are related to the
"2nd OFF" component in the responses to light stimuli.
Conclusions
These findings are the first direct demonstration of the response of
the mammalian retina to US stimulation. The properties of the US
transducer and the stimulation frequency indicate that non-invasive
US stimulation of human retina is feasible, and may potentially
evolve as an important tool for diagnosis and treatment of retinal
diseases.
O13
Motor response elicitation and pupil dilation using megahertz-
range focused ultrasound neuromodulation
Christian Aurup1, Hermes Kamimura2,1, Shutao Wang1, Hong Chen1,
Camilo Acosta1, Antonio A. Carneiro2, Elisa E. Konofagou1
1Columbia University, New York, New York, USA; 2Universidade de São
Paulo, São Paulo, Brasil
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):O13
Objectives
Using transcranial focused ultrasound for the modulation of brain ac-
tivity has been identified as a possible non-invasive means of treat-
ing neurological disorders. Most studies involving sedate rodents use
frequencies in the kilohertz range, which allow for optimal transmis-
sion of acoustic power through the skull. The trade-off of using lower
frequencies involves a lack of target specificity. Higher frequencies
must be used in order to modulate activity in a more highly-
specified manner. This study demonstrates that focused ultrasound
in the megahertz range can be used to evoke motor- and cognitive-
related responses in mice under deep anaesthesia by targeting spe-
cific brain structures. Contralateral-paired hind limb movements were
observed when stimulating cortical regions, demonstrating the ability
of MHz-range FUS to stimulate activity in highly-localized brain re-
gions. Additionally, pupil dilation was observed when deep-seated
anxiety-related structures were targeted, demonstrating the ability of
FUS to modulate cognitive activity in a highly-specified manner.
Methods
For this study, wild-type adult male mice were anesthetized with
intraperitoneal injections of sodium pentobarbital (65 mg/kg) and
fixed in a stereotaxic frame. A single-element FUS transducer with
fundamental frequency of 1.94 MHz was fixed to a 3D positioning
system for accurate navigation through the brain. A 6x6 mm grid
centred +2 mm rostral of the lambda skull suture was sonicated
in a random order using a centre frequency of 1.9 MHz, pulse
repetition frequency of 1 kHz, 50% duty cycle, 1 second pulse
duration, 1 second inter-pulse interval for a total of 10 pulse rep-
etitions. The acoustic pressure applied was varied in order to
evaluate thresholds for eliciting physiological responses like
motor movement, eye movement, or pupil dilation. Motor move-
ments were validated using video recordings and electromyog-
raphy via needle electrodes implanted into the biceps femoris of
both hind limbs. Videos were recorded using a high-resolution
camera focused at the right eye and processed to measure eye
movements or changes in pupil size.
Results
The minimum acoustic pressure required to elicit motor move-
ments was 1.45 MPa when targeting the somatosensory cortex,
calibrated using an excised mouse skull. Higher pressures in-
creased the success rate from 20% (at the 1.45 MPa threshold) to
70% (1.79 MPa). Targeting eye-motor and anxiety related regions
of the brain elicited eye movements and pupil dilations up to
20%. Sonicating the superior colliculus resulted in both eye move-
ment and pupil dilation at a lower threshold pressure (1.20 MPa) than
the hippocampus and locus coeruleus which required pressures greater
than 1.80 MPa.
Conclusions
This study successfully demonstrated that MHz-range transcranial fo-
cused ultrasound can be used to elicit motor- and cognitive-related
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):15 Page 5 of 114physiological responses with high specificity in mice in vivo. It
was also shown that the success rate of stimulation increased
with acoustic pressure for motor movements associated with
cortical activity modulation but highly depends on the region of
the brain targeted. These findings emphasize the complex and
yet to be determined mechanism of action involved in ultrasonic
neuromodulation.Fig. 4 (abstract O13). Evaluation of the pressure threshold and
success rate associated with applying FUS to location within the
somatosensory cortex. This location resulted in contralateral hind-
limb movement relative to the sonication site. Moving the transducer
symmetrically about the midline resulted again in contralateral
movement relative to the new sonication site
Fig. 5 (abstract O13). Superior colliculus (top) threshold determined
to be approximately 1.2 MPa while the locus coeruleus (bottom) was
evaluated to be greater than 1.8 MPaO14
Thermal dose effects by MR-guided focused ultrasound on the pig
brain tissue - preliminary results
Dong-Guk Paeng1,3, Zhiyuan Xu2, John Snell1, Anders H. Quigg1,
Matthew Eames1, Changzhu Jin3, Ashli C. Everstine4, Jason P. Sheehan2,
Beatriz S. Lopes5, Neal Kassell1
1Focused Ultrasound Foundation, Charlottesville, Virginia, USA;
2Neurosurgery, University of Virginia, Charlottesville, Virginia, USA;
3Ocean System Engineering, Jeju National University, Jeju, Korea (the
Republic of); 4Biology, University of Virginia, Charlottesville, Virginia, USA;
5Pathology, University of Virginia, Charlottesville, Virginia, USA
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):O14
Objectives
The objective of this research is to investigate the effects of ther-
mal dose (TD) delivered by magnetic resonance-guided focused
ultrasound (MRgFUS) on in vivo pig brain tissue. In current clin-
ical applications of transcranial MRgFUS systems, continuous
acoustic wave emission is used to heat brain tissue to peak tem-
peratures over 58°C. However, there are some situations where it
has proven difficult to reach the desired peak temperature due
to high absorption of acoustic energy by skull bone. There are
reports that thermal effects on tissue are well correlated with
thermal dose, which suggest that treatment delivery could be
prescribed in terms of thermal dose rather than peak temperature or
electric/acoustic power. It is also been demonstrated that the
thermal dose threshold for permanent tissue damage is about
240 cumulative equivalent minutes (CEM) at 43°C for most of tis-
sue. Currently available transcranial MRgFUS systems only allow
the prescription of acoustic power and duration. In order to in-
vestigate the effects of thermal dose on in vivo brain tissue, we
have developed a closed-loop control system to allow prescriptionthermal dose. This system monitors tissue heating via MR thermometry
and provides pulse width modulation of output acoustic power in order
to hold target tissue at a fixed temperature, and hence receives a
nearly constant dose rate.
Methods
A FUS system (ExAblate 4000 Neuro 650 kHz system, InSightec) was
used for sonication and an MRI system (Discovery MR75-3.0T, GE
Medical systems) was used for thermometry and pre- and post-
imaging. A closed-loop control system was implemented on a per-
sonal computer to control pulse width modulation of the FUS system
acoustic power in order to maintain a specified temperature based
on the MR thermometry. Accumulated thermal dose was calculated
in real time and used to stop the sonication so that a prescribed
thermal dose was delivered to the targeted tissue. Phantom studies
were performed to test the control system to prepare for animal ex-
periments. One acute and six chronic experiments (with three day
survival) were conducted to observe the effects of TD on pig brain
by behaviour observation and post MR imaging of the brain (1 hour
and 70 hours post procedure). Craniotomy was performed to create
an acoustic access window, and sonication was applied on 4 spots in
the thalamus of each pig. Histology was also performed to compare
it with MR imagery. Temperature in the pig brain tissue was esti-
mated by rectal temperature for the MR thermometry baseline. TD
was varied from 7 to 200 CEM while the target temperature was
changed from 46 to 52 °C with appropriate acoustic power depend-
ing on target position and individual pig. This study was approved
by the University of Virginia Institutional Animal Care and Use
Committee.
Results
From the acute experiment, we could observe the lesions on MR im-
ages after 1 hour of sonication and histology subsequently confirmed
the lesions. For the chronic experiments, no obvious problem was
observed in the behavior of any of the six animals. Eighteen sonic-
ation spots in 5 pigs were analyzed through MR images. One pig ex-
periment failed to control temperature due to introduction of air
bubbles between the brain and scalp during surgery procedure, and
2 sonication spots were excluded due to technical problems. Large
tissue changes were observed in MR images in all 6 spots over 100
CEM.
The diameter of those tissue changes in MR T2-weighted axial im-
ages were measured and averaged to 2.9 ± 0. 4 mm. There is incon-
sistency in generating lesions for TD below 100 CEM. No lesion was
shown in some lower TD from 7 CEM and 61 CEM, while some
smaller lesions (<2 mm in lesion diameter) were shown in TD from
18 CEM to 85 CEM except one large tissue change of 3.5 mm in
diameter at 31 CEM. Some tissue changes were shown in both post
MR images after 1 hour and 70 hours of sonication, while some were
visible only at the 70 hour time point. Histology of 3 pig experiments
is now available and the histology reports support the tissue changes
and lesions in MR images. Lesion diameters in MR T2-weighted axial
images versus TD in CEM are shown in Fig. 6 for all the results from
the chronic pig study.
Conclusions
These preliminary results from pig brain tissue generally con-
firmed the previous results from rabbit brain tissue in generating
tissue changes over a certain TD, even though there are some
differences in the FUS systems and the experimental procedures
and analysis. For lower thermal dose below 61 CEM, there is sig-
nificant variability in generating of tissue changes, while large tis-
sue changes whose average diameter is 2.9 mm were observed
in MR T2-weighted axial images for higher TD over 100 CEM,
which were reported with similar tendency but a little difference
in TD from the rabbit brain study. These results may contribute
to open the way to prescribe the thermal dose rather than peak
temperature or acoustic power for brain treatments, and expand
the treatment envelope beyond the current limitations in select-
ing targets and patients. This project is ongoing and will be fur-
ther pursued with additional experiments for consolidation of the
results and analysis.
Fig. 6 (abstract O14). Pig chronic study results showing the
relations of lesion diameter (mm) based on enhancing region
appearing in T2-weighted axial MR images with applied thermal
dose in CEM.
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In vivo feasibility study of boiling histotripsy with clinical
Sonalleve system in a neurological porcine model
Thomas Looi1,4, Vera Khokhlova2, Charles Mougenot5, Kullervo Hynynen3,
James Drake1
1Hospital for Sick Children, Toronto, Ontario, Canada; 2University of
Washington, Seattle, Washington, USA; 3Sunnybrook Research Institute,
Toronto, Ontario, Canada; 4University of Toronto, Toronto, Ontario,
Canada; 5Philips Healthcare, Markham, Ontario, Canada
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Objectives
To determine if a clinical focused ultrasound system (Philips Sonalleve)
can be used to perform mechanical liquefaction of brain tissue for
neurological lesioning through a simulated fontanelle in a porcine
model (simulating neo-natal patients). This work will determine the
power of the system required to induce lesions using a boiling histo-
tripsy (BH) pulsing protocol. Post-treatment, the lesion volume and
border will be measured with MRI imaging and histological
examination.
Methods
A porcine model was used as the in vivo model with a max-
imum weight < 6.8 kg (4.9 - 6.8kg). A horse-shoe incision and
blunt dissection was used to expose the skull. A craniotomy was
performed to create a 4–5 cm2 opening in the skull simulating
the fontanelle in a neonatal patient. A degassed mixture of
ultrasound gel and water (ratio 10:1) was poured on top of the
dura to ensure good acoustic coupling. The scalp was sutured
closed with 2–0 Vicryl cutting needle. The animal was placed su-
pine feet first with the craniotomy centred about the Sonalleve
V2 system with Flex-M surface coils. Pre-treatment T1-weighted
(T1-w), T2-weighted (T2-w) and T2*-weighted (T2*-w) MRI im-
aging was conducted as a baseline. Each animal was treated at
four cluster locations where each cluster consisted of seven son-
ication points; one point in the centre and six points uniformly
distributed over a 4-mm diameter circle. The clusters were lo-
cated approximately 15 mm deep in the brain, 7 mm off the
midline, and separated by 14 mm in a rectangular geometry. In
initial treatment on the first animal, the power was increased
from 100 to 500 W for each cluster. After initial analysis, the
treatment was repeated on second animal with refined power
levels of 325, 350, 375, and 425 W. The treatment sequence con-
sisted of 12000 pulses of 1.2 MHz frequency, 1 and 10 ms pulseduration, and 1% duty cycle for both 1 and 10 ms pulse dur-
ation. These protocols have been shown to generate BH lesions
in ex vivo bovine liver in another Sonalleve system. During treat-
ment, MR thermometry was used to monitor for surface, focal,
and far field heating. A dedicated MATLAB-based interface was
connected to the Sonalleve cavitation sensor to detect the sig-
nal generated during treatment points. After treatment, post T1-
w, T2-w and T2*-w MRI scans were completed for comparison.
The animals were euthanized, perfusion fixated and their brains
were removed for histology. The brain specimens were cut at
the centre for the treatment clusters to get a cross-sectional cor-
onal view where each slice was 5 microns. The slides were
stained with haematoxylin and eosin (H&E) and examined for le-
sion presence, blood and border definition.
Results
A total of 4 piglets were sonicated with the following configur-
ation: 1 piglet with 5 clusters (100 – 500 W), 2 piglets with 4
clusters (325-425 W) using 10-ms long pulses and 1 piglet with 4
clusters and 1-ms long pulses. For all power levels, the MR-
measured temperature in the near or far field of the treatment
was below the noise level. For 10-ms long pulses, 100 and 200
W acoustic powers, no noticeable imaging change was observed
during sonication and post-treatment MR evaluation. As power
was increased from 300 to 400 W, a temperature increase of up
to 5C was measured at the focus. With more discrete power
levels, it appeared at 375W that the lesion was more contained
whereas higher power levels created wider areas of tissue
change. It was observed the timing of MR magnitude of the tar-
get cluster changed as the power level increased where the tis-
sue change occurred at 15 s at 300 W, 12 s at 350 W, 10 s at
375 W and 5 s at 425 W. After sonication was completed, the de-
tected temperature rise decreased immediately versus dissipating
over time. This would indicate the detected thermometry was
due to a phase change of the tissue rather than temperature in-
crease. During treatment, a high amount of lower broad band
emissions at frequency < 1.2MHz were detected by a cavitation
sensor. Post-treatment MR imaging showed that at power levels
between 300 and 400 W, there were areas of hypointensity indi-
cating the lesion. H&E staining confirmed the presence of the
mechanical lesion where various anatomical targets were fraction-
ated. Power levels were sufficient to rupture vessels and cause a
focused area of haemorrhage at the treatment cluster. It showed
that BH treatment dissolved the anterior ventricle wall with pres-
ence of elements of blood. H&E staining also showed that max-
imum lesion diameter was approximate 7 mm in coronal plane
therefore the treatment borders matched the treatment plan. For
the piglet treated with 1-ms long pulses, the post-treatment im-
aging change was not noticeable. However, at 375 and 400 W
power, H&E slides showed two areas where there was a perfor-
ation of the anterior ventricle wall with a lesion size of up to 2 mm. It
appeared that the shorter pulse duration generated smaller but more
focused lesions.
Conclusions
This pilot study shows that the clinical Sonalleve system is capable of
generating mechanical ablation of a brain tissue in an in vivo porcine
model using boiling histotripsy pulsing scheme. The power threshold
to initiate lesions in brain using 10 ms pulses (375 W) was found to
be similar the power levels used in BH studies in ex vivo bovine liver
and porcine kidney tissue at a similar depth in tissue (250 – 300 W)
in a Sonalleve V2 system at the University of Washington. The treat-
ments can be accelerated by using higher power outputs and shorter
pulses. H&E histological evaluation showed that BH treatment caused
rupture of vessels focally while also creating wider well defined areas
of mechanical ablation with no damage to surrounding tissue. Add-
itional work is underway to characterize the pressure levels gener-
ated by the Sonalleve to correlate the power and pressure for
treatment.
Fig. 7 (abstract O15). Top Row: Left to Right: Treatment area, Pre
T2-w (100–500 W), Post T2-w (100–500 W), Pre- T2-w (325–425) and
Post T2-w (325–425); Bottom Row: Histology Left to Right: 10 ms
treatment (375W), 10 ms treatment - zoomed (375W), 1ms treatment
(375W and 425W), 1 ms treatment – zoomed.
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Objectives
Chronic Plantar fasciitis (CPF) is a common cause of plantar heel pain
that is a result of a degenerative process of the plantar fascia and its
surrounding perifascial structures [1]. It is the most common cause of
heel pain, affecting 10% of the U.S. population, and one of the most
common foot and ankle problems.
More than twenty different treatments have been used for plantar
fasciitis. Conservative treatments (rest, ice, stretching and NSAIDs)
have been shown to effectively treat symptoms but 10% of patients
fail conservative management and continue to have symptoms
within 12 months and beyond. Surgery consisting of partial PF re-
lease is often considered with 50% of patients having residual symp-
toms, in addition to surgical risk exposure.
High frequency ITU, a novel potential approach to treating Plantar
Fasciosis, was studied for the creation of small thermal injuries nonin-
vasively inside symptomatic Plantar Fascia (PF). It has been shown to
initiate a tissue repair cascade and promote collagen generation in
musculoskeletal tissue [2, 3]. A double blinded, randomized, sham
controlled clinical study for ITU treatment of chronic Plantar Fasciitis
has been conducted by IRB approved clinical protocol to access clin-
ical efficacy of the procedure.
Methods
Custom 3.2 MHz high intensity (10 kW/cm2) ultrasound therapy sys-
tem was designed and fabricated (GTS, Mesa, AZ, USA). Field simula-
tions, testing and Schlieren images verified intensity, high focal
pressure (17.3 MPa) and focal distance of 13–15 mm.
Each treatment consisted of 250–320 100 ms pulses creating
matrices of small ablative thermal lesions of 4–5 joules at pre-
programmed pitch of 1.6 mm. Each patient underwent two treat-
ment sessions in 2 weeks, each treatment time did not exceed 12 mi-
nutes. ITU placebo group consisted of the same treatment with
energy set to 0.
Treatment effects were assessed with diagnostic imaging ultrasound
at 12 MHz (Spark, Ardent Sound, Mesa, AZ, USA) by a certifiedsonographer. Ultrasound images were analysed to determine symp-
tomatic hypoechoic lesion size with PF.
Patient reported outcomes consisted of PROMIS physical function
computer adaptive test (PF-CAT), PROMIS global health, Foot Function
Index pain subscale (FFIPS) [4, 5] and a non-validated heel pain specific
questionnaire.
Clinical protocol included (35) patients diagnosed with chronic heel
pain due to Plantar Fasciitis (more than 3 months) and failed conven-
tional therapy treatments.
Patients were randomized to standard therapy (anti-inflammatory
pills, stretching and gel heel cups) plus ITU (“Treatment” group,
n=26) of standard therapy plus sham ITU (“Control” group, n=9).
Primary investigator, sonographer and study coordinator administer-
ing the study were blinded to group assignments. P-values were cal-
culated via 2-tailed paired T-tests for both treatment and control
groups.
Results
Patient-Reported Outcome Measures: Compared to the baseline as-
sessment of Pain, the Treatment Group showed significantly im-
proved pain scores compared to the Control (sham treatment) Group
in follow-up visits including 12 weeks after the initial treatment.
Foot Function Index Pain Score: Compared to the baseline assess-
ment, the treatment group pain scores also showed significant im-
provement compared to the sham group.
Diagnostic Ultrasound Imaging: During the 12 week follow-up period
changes to the overall thickness of the PF were not statistically sig-
nificant, while calculated volume size of hypoechoic lesions within
the PF, just distal to the Calcaneus, showed significant change. For
the experimental group (n=28) the average hypoechoic lesion vol-
ume reduction was followed and compared to the baseline measure-
ments just before the first Treatment; 2 week follow-up and 2nd
treatment date (−28%), 4 weeks (−50%), 6 weeks (−66%) and 12
weeks (−80%).
For the control group (n=10), the average hypoechoic lesion volume
was followed and compared to the baseline just before the first
Treatment; 2 weeks and 2nd sham treatment (+9%), at 4 weeks
(+16%), 6 week (+29%) and 12 weeks (+31%). Unlike the experimen-
tal group, these lesions grew in size during the follow-up period.
P-values calculated for all outcome results discussed above for both
treatment and control groups were below .01, showing the statistical
significance of the results.
Conclusions
(1) Results of the double blinded randomized, sham controlled
study for the treatment of Plantar Fasciitis with ITU appeared
to have statistically significant positive results within 12 weeks
post-treatment in 80% of treated subjects.
(2) Both quantitative measurements from diagnostic ultrasound
imaging and applied standardized assessment protocols
consisting of PROMIS PF-CAT, FFIPS along with Patient
Reported Outcome Measures showed statistically significant
coincidental improvements in treated subjects vs. control group.
(3) Intense Therapeutic Ultrasound has shown potential for
effective treatment of Chronic Plantar Fasciitis. Better designed
studies with increased # of subjects will be considered to
support ITU as an effective tool for the proposed clinical
treatment.
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Objectives
Acute and Chronic pain of the Common Extensor Tendon (CET) re-
gion, lateral epicondylitis or tennis elbow is a common pathology of
both athletes and non-athletes affecting up to 3% of the population
at large [1], while the prevalence of chronic problems caused by
overuse in tennis players can be as high as 40%. Elbow tendinopathy
represents an important set of pathologies that account for lost re-
creation time, decreased quality of life, and work-related disability
claims. Conservative treatment of the Epicondylitis or -osis is recom-
mended as the initial strategy by most authors. This strategy includes
identification and correction of possible etiological factors, and a
symptom related approach. Generally, the initial treatment consists
of a multifactorial approach that may include a combination of rest
(complete or modified activity), medication (NSAIDs for Epicondylitis),
stretching and strength training. More aggressive treatments for CET
include: Cortisone injection, Plasma Rich Platelets (PRP), Tenotomy,
ESWT.
High frequency ITU, a novel potential treatment for CET, was studied
for the creation of small thermal injuries noninvasively inside symp-
tomatic Common Extensor Tendon (CET). It has been shown to initi-
ate a tissue repair cascade and promote collagen generation in
musculoskeletal tissue [2–5]. A blinded, randomized, clinical study for
ITU treatment of chronic Lateral Epicondylitis has been conducted by
IRB approved clinical protocol to assess clinical efficacy of the
procedure.
Methods
Custom 4.5 MHz high intensity (47.9 KW/cm2) ultrasound therapy sys-
tem was designed and fabricated (GTS, Mesa, AZ, USA). Field simula-
tions, testing and Schlieren images verified intensity, high focal
pressure (37.9 MPa) and focal distance of 6 mm.
Each treatment consisted of 80 14 ms pulses creating matrices of
small ablative thermal lesions of 1 joule at manually targeted area
set by diagnostic ultrasound imaging. Each subject underwent two
treatment sessions 4 weeks apart. Each treatment time did not ex-
ceed 10 minutes. Treatment effects were assessed with diagnostic
imaging ultrasound at 20 MHz (Spark, Ardent Sound, Mesa, AZ, USA)
by a certified sonographer. Ultrasound images were analysed to de-
termine changes in the peri-tendon region, including hypoechoic
areas, calcifications and dependent free fluid.
Subject reported outcomes consisted of PRTEE survey [6], physical
examination, Universal Analog Visual Pain Score17 and a Patient
Reported Satisfaction Survey [7].
Fig. 12 (abstract O17). See text for description
Fig. 13 (abstract O17). See text for description
Fig. 14 (abstract O17). See text for description
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):15 Page 9 of 114Clinical protocol includes 25 subjects diagnosed with chronic Tennis
Elbow, or Lateral Epicondylosis (more than 3 months) and failed con-
ventional therapy treatments.
Subjects were subjected to standard therapy (stretching and strength
exercises, hot and cold compresses and compression support) plus
ITU.
Primary investigator, sonographer and study coordinator administer-
ing the study were blinded to group assignments. P-values were cal-
culated via 2-tailed paired T-tests at each visit of the clinical study.
Results
The results presented below are initial findings for the first 12 sub-
jects currently being followed through the study.
PRTEE: Patient Reported Tennis Elbow Evaluation Final Score is a
weighted Pain Score based on 15 questions grouped into 3 categor-
ies: Overall Pain, Functional Disability and Usual Activities. Subjects
respond to each question with a Pain Score of 0–10. Each category is
then summed and weighted with a maximum score of 100 (Overall
Pain 100%, Functional Disability 50% and Usual Activities (50%),
n=12, Fig. 12.
Self-Reported Outcome Measures Surveys show a significant im-
provement and treatment satisfaction with Subjects reporting im-
provements in elbow pain 100%, improvement in Daily function 83%
(vs. 17% no improvement) and treatment satisfaction 83% (vs. 17%
not satisfied), n=6, Fig. 13.
Universal Analog Pain Scores also show progressive reduction (−3 on
a 10 point scale) throughout the same period, n=12, Fig. 14.
Diagnostic Ultrasound Images: Diagnostic Ultrasound Images show a
consistent increase of free fluid 2 weeks after the first treatment, with
a progressive reduction in free fluid at 8 weeks in subjects with no to
mild peri-tendon calcifications. These subjects correlated well with
improving PRTEE survey scores. Subjects with little or no improve-
ment in PRTEE scores consistently presented with moderate to se-
vere peri-tendon calcifications.
P-values calculated for the above reported outcomes were not statis-
tically significant for Visits 2 and 3 (P>0.05) while results for Visits 4
and 5 demonstrated P< 0.05.
Conclusions
1. Feasibility of Intense Therapeutic Ultrasound treatments of
chronic pain in CET region has been established with the initial
results (n=12) of the ongoing clinical study.
2. Significant reduction of pain scores per activities (PRTEE) and
Self-Reported Outcome Measures (83% improvement) with
average Universal Pain Scores reduction from 5.0 to 2.0 were
statistically significant (p<0.05) at 8 and 12 weeks post
treatment.
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Objectives
Managing colorectal liver metastases (CLM) is a major clinical chal-
lenge, and surgery remains the only potentially curative treatment.
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):15 Page 10 of 114Five-year survival rates of up to 51% have recently been reported.
However, only 10–20% of patients are eligible for surgery, which is
often precluded by the number, size and/or location of metastases,
or because the necessary resection will leave insufficient volume of
functional liver. Radiofrequency ablation (RFA) is the main technol-
ogy that has been used in association with surgery as a tool to ex-
pand the number of patients who may be candidates for liver
directed therapy. However, RFA has several limitations. There is a risk
of inadequate treatment due to the heat sink effect of blood flow,
RFA does not allow reliable real-time monitoring, and it require intra-
parenchymal introduction of a probe. Moreover, only small hepatic
volumes can be targeted. These limitations could explain the high
rates of local recurrence seen after RFA.
High intensity focused ultrasound (HIFU) has been proven effective in a
wide range of clinical applications, especially prostate cancer. The
ablation achieved by conventional HIFU is small and ellipsoidal. The di-
mensions vary according to transducer characteristics but are typically
1–3 mm (transverse) and 8–15 mm (along beam axis). In clinical prac-
tice, hundreds of superimposed ablations are required; and the proced-
ure may take up to two hours. Even so, HIFU has several potential
advantages in the treatment of liver tumours: there is no need to punc-
ture the parenchyma, the extent of the thermal lesions achieved is not
reduced by hepatic perfusion, and it is possible to monitor the effects
of therapy in real time. However, extra-corporeal treatment of the liver
is difficult because presence of the ribcage may stop propagation of
ultrasound waves and respiratory motion may cause targeting prob-
lems. HIFU treatment of CLM needs to be improved, and reducing the
duration of surgical intervention by increasing the size of ablated fields
is particularly important. A HIFU device enabling destruction of larger
liver volumes has been developed based on toroidal transducers.
Preliminary in vitro and preclinical work demonstrated the potential,
feasibility and safety of such HIFU ablations. During laparotomy in a
porcine model we demonstrated that this HIFU device achieves re-
producible ablations with an average volume of 7 cm3 (with 20 mm
diameter and 25 mm long axis) in 40 seconds. Such preclinical work
has to be translated into clinical practice through controlled trials,
and the aim of this study was to assess the feasibility and safety of
HIFU ablation in patients undergoing hepatectomy for CLM, as well
to collect efficacy and accuracy data. This study is registered with
Clinical-Trials.gov (NCT01489787).
Methods
This study was a prospective, single-centre phase I/II study evaluating
the feasibility, safety and accuracy of HIFU during surgery in patients
with CLM. The protocol was reviewed and validated by a national ethics
committee (CPP Sud-Est IV) according to French and European direc-
tives. Since this study was the first use in man of intra-operative hepatic
HIFU, ablations were made only in areas of liver scheduled for resec-
tion. This allowed real-time evaluation of HIFU ablation while protecting
participating patients from any adverse effects related to this new tech-
nique. The transducer has a toroidal shape 70 mm in diameter and is
divided into 32 ultrasound emitters of 0.13 cm2 operating at 3 MHz.
The radius of curvature is 70 mm. A 7.5 MHz ultrasound imaging probe
was placed in the centre of the device and was used to guide the treat-
ment. The imaging plane was aligned with the HIFU focal zone.
Six patients were included in the Phase I. Two single thermal abla-
tions were created in each patient. Thirteen patients were included
in Phase IIa and two HIFU ablations were to be placed precisely in a
target previously identified in ultrasound images (step 1) and then at
distance (step 2) from a target. Five patients were included in
Phase IIb until now. HIFU ablations were created to ablate metas-
tases (20 mm maximal diameter) with safety margins in all direc-
tions. The exposure time varied from 40 s to 370 s according to
the diameter of the metastases to be treated.
Results
In agreement with preclinical studies, the demarcation between ab-
lated and non-ablated tissue was clearly apparent in ultrasound im-
ages and histology. The dimensions measured on ultrasound
imaging were correlated (r=0.88, p<0.0001) with dimensions mea-
sured during histological analysis. All HIFU ablations were obtained
in 40 seconds. The average dimensions obtained from each HIFU ab-
lation were a diameter of 21.0 ± 3.9 mm and a depth of 27.5 ± 6.0 mm.The phase IIa study showed both that the area of ablation could be
precisely targeted on a previously implanted metallic mark and that ab-
lations could be created deliberately to avoid such a mark. Ablations
were achieved with a precision of 1–2 mm. In Phase IIb, one metastasis
of 10 mm in diameter was ablated in 40 seconds with safety margins.
Using electronic focusing metastases of 2 cm in diameter were ablated
with safety margins (>3 mm in all directions) in 370 seconds. The di-
mensions of HIFU ablations created in 370 s were a diameter of 48 mm
and a long axis of 51 mm.
Conclusions
This new HIFU device safely achieved large volume liver ablations in
40 s, with a precision of one to two millimetres under real-time mon-
itoring. HIFU ablations of small metastases (<20 mm) and peri-
lesional healthy liver were successfully created with planned safety
margins of at least 3 mm in all directions.
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Objectives
To evaluate the efficacy and the main side-effects during the clinical
trial of this new ultrasound hyperthermia system combined with
chemotherapy in oral cancer, meanwhile, to observe the preliminary
clinical response of this combined therapeutic modality.
Methods
Thirty four cases of oral squamous cell carcinoma entered this clinical
trial, from which 23 had advanced oral carcinoma and were treated
with new ultrasound hyperthermia system combined plus docetaxel–
cisplatin–fluorouracil regimen (test group). Eleven patients only re-
ceived chemotherapy with docetaxel–cisplatin–fluorouracil regimen
(control group). The thermo-index were detected during the course of
hyperthermia, the chief-complain of the patients were also recorded.
The systemic physiological, biochemical and immunological index were
tested before and after the treatment respectively. The therapeutic re-
sponse was estimated 1 month after 2 cycles of the treatment.
Results
Twenty three cases of oral squamous cell carcinoma enrolled the clinical
trial of local ultrasound hyperthermia combined with chemotherapy.
230 times of ultrasound hyperthermia in total were performed. The ultra-
sound hyperthermia system operated smoothly, no malfunction was
found. The main thermo-index were: the maximum heating temperature
was108 F, the average heating temperature was 106 F, the minimum
heating temperature was 104 F, the fraction of heating time more than
108 F was 0.46, the average treatment time was 37.74±8.88min. PR+CR
was 71% (test group). The main local side-effects were low-grade pain
(6/23). The incidence of adverse effects was similar between both study
groups, no bone marrow suppression (over III).
Conclusions
The system combined with docetaxel–cisplatin–fluorouracil regimen
is effective and safe in the treatment of advanced oral cancer. The
main side-effects of local ultrasound hyperthermia combined with
chemotherapy are low-grade pain or tolerable pain. There is no im-
mune function and obtains satisfying short-term response.
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This talk examines the challenges associated with the design of clin-
ically viable ultrasound applicators operating at the relatively low fre-
quency (20 kHz) and intensity (<100 mW/cm2, spatial peak, temporal
peak) levels, and tailored to treatment of chronic wounds, such as
venous or diabetic ulcers. These challenges were associated with the
architecture and weight, and principle and efficiency of operation, in-
cluding electrical power consumption. The ultimate goal of this work
was to test the efficacy of the applicators in human subjects.
Methods
A fully wearable Band-Aid™-like, dial-in delivery, battery-operated
ultrasound applicator was designed. The applicator included light
weight (<25g) piezoelectric flexural transducer and was powered by
10-12V fully rechargeable lithium-ion batteries (total weight <200g);
it was able to operate for up to 4 hours between re-charging. To
emphasize the uniqueness of the design, it might be useful to note
that typically, the thickness of the capacitive piezoelectric element is
inversely proportional to the frequency, therefore a 20 kHz element
would need to be 10 cm thick. Such element would be bulky and re-
quire hundreds of volts (demanding a large power amplifier), in exci-
tation signal thus eliminating any chance of being a portable design.
To overcome this, a mechanical displacement amplifier, which trans-
lates 2 MHz ultrasound waves into 20 kHz output at the desired pres-
sure amplitude (55 kPa; i.e. 100 mW/cm2) with only 12 volts
excitation was chosen as a preferred solution.
The applicators were extensively tested to ensure that the ultrasound
field energy was below the level needed to generate inertial cavita-
tion and any temperature elevation that would exceed 1°C. Also, the
uniformity of the acoustic field distribution was verified. The pilot
study included 32 individuals between ages of 18 and 80 having
venous (n=23) or diabetic (n= 9) wounds that remained open for a
minimum of 8 weeks. In compliance with the IRB study protocol the
subjects were randomly assigned to either treatment or control
group, with an equal chance of being assigned to receive active
ultrasound treatment or sham (current standard care). Treatment ses-
sions lasted 15 minutes and were administered once a week for a
period of 12 treatments, or until the wound’s closure. Clinical efficacy
was evaluated by measuring the reduction in wound area over time.
For both etiologies, i.e. both venous and diabetic wounds the rate of
closure was statistically faster (p<.05) in the treated group compared
to the control group.
Results
The study findings show that the ultrasound treated venous ulcer
group had statistically improved (p<0.04) rate of wound size change
(reduction of 14.3%/week) compared to the rate of wound size
change for the control group (increase of 3.6%/week on average).
Diabetic wound closure was achieved typically after 4 sessions for
treated wounds, as opposed to 7 sessions for the control group. Time
to heal was also statistically faster (p< .05) for treated wounds
(~5 weeks) when compared to non-treated wounds (~12 weeks).
Conclusions
Overall, the results from this study support the notion that low fre-
quency ultrasound treatment can successfully improve healing out-
comes in chronic wounds with different morphology and etiology.
The evaluated device used safe levels (<100mW/cm2 ISPTP) of ultra-
sound energy and featured unique portability, which opens possibil-
ity for personalized home treatment of chronic wounds in the future.
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Thermal ablation with transcranial MRI-guided focused ultrasound
(TcMRgFUS) is being tested clinically for as an alternative to surgery
for functional neurosurgery and brain tumour resection. The current
TcMRgFUS system, which operates at 650–670 kHz, is limited by skull
heating to a small central region in the brain. Use of a lower acoustic
frequency will reduce skull heating, but at the same time the focal
heating will decrease and the risks of uncontrolled cavitation (the
formation of microbubbles) increase. The purpose of this study was
to evaluate the feasibility of thermal ablation in nonhuman primates
using a system that operates at a lower acoustic frequency and to
determine whether it can increase the “treatment envelope” for
TcMRgFUS.
Methods
The experiments were approved by our institutional animal commit-
tee. Thermal ablation with the 230 kHz ExAblate Neuro system
(InSighTec) was tested over five sessions in three rhesus macaques.
In each session a target in the thalamus was sonicated transcranially
at 40–50 s at acoustic power levels ranging from 90–560 W. The
TcMRgFUS system software modulated the acoustic power in real
time with a closed-loop controller that maintained a low-level of
acoustic emissions, which are correlated with cavitation activity. MR
temperature imaging (MRTI) was acquired at 3T (LX, GE) in a single
plane using a 14 cm surface coil (TR/TE: 29/13 ms; flip angle: 30°).
Measurements of the peak temperature rise at the focus and on the
outer brain surface were compared for the different animals as a
function of the applied acoustic energy. For the brain surface we
measured the average temperature at the hottest 5% of the voxels
and over a two voxel wide strip and we also normalized the meas-
urement by the outer skull area. Temperature measurements were
used to calculate the accumulated thermal dose, which was then
compared to post-sonication T2-weighted, T2*-weighted, and
contrast-enhanced T1-weighted MRI. The focal and skull-induced
heating on the brain surface were compared to an earlier study per-
formed in macaques with a 650 kHz version of this system.
Results
Focal heating sufficient to create an MRI-evident thermal lesion was
achieved in 4/6 targets; the peak thermal dose exceeded 240
CEM43°C at these targets (Fig. 15). Heating at the focus was slightly
higher than that measured on the brain surface. The focal heating
increased linearly as a function of the applied energy at a rate of
3.2 ± 0.4°C per kJ (R2: 0.81). The surface area of the outer skull
ranged from 47–55 cm2. For the hottest 5% of the voxels on the
brain surface included in the MRTI imaging plane, the tem-
perature rise increased linearly as a function of temperature at a
rate of 126.6 ± 7.3°C per kJ/cm2. For a two voxel wide strip over
the entire brain surface, this increase was 62.7 ± 7.5°C per kJ/cm2. The
extent of MRI-evident changes (apparent oedema in T2-weighted MRI,
BBB disruption post-contrast, no petechiae in T2*-weighted MRI) were
consistent with 240 CEM43°C contours. One lesion imaged one week
after FUS increased in size.
Conclusions
Analyses of the MRTI and post-sonication MRI suggest that the le-
sions were consistent with thermal mechanisms. The temperature
rise increased linearly with the applied energy, and no evidence of
cavitation-related petechiae were evident after sonication. The MRI-
evident lesions were consistent with isodose contours drawn at 240
CEM43°C, a conservative threshold often used to guide thermal abla-
tion. However, since it is known that thermal damage can take sev-
eral hours to manifest in MRI and the lesion we imaged at one week
increased in size, it is likely that the size of the lesion was underesti-
mated by this dose value.
Similar tests in macaques with a version of this system operating at
670 kHz (Hynynen et al., Eur J Radiol 2006; 59: 149–56) measured
skull-induced heating of 130°C per kJ/cm2 of outer skull surface,
more than twice of that measured here (63°C per kJ/cm2). While no
or minimal focal heating was observed at 670 kHz, with this 230 kHz
system we were able to reach ablation-level thermal dose values.
Thus, these preliminary results thus suggest that this low frequency
system can expand the area of the brain that can be targeted for
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back system successfully maintained a low level of acoustic emission
(and presumably microbubble activity) and immediately stopped the
sonication when excessive levels were detected. However, additional
work is needed to understand whether low-level cavitation activity
played a role in the focal heating, to characterize the lesions in hist-
ology, and to examine whether safe cavitation levels can be main-
tained in tumours where the cavitation threshold may vary.Fig. 15 (abstract O21). MRTI (top) and post-FUS imaging (bottom)
obtained in two sessions in Monkey 1. Thermal dose contours at 30
(orange) and 240 (red) CEM43C were calculated from the MRTI.
Immediately after each session, a small lesion was observed in
contrast-enhanced T1-weighted MRI (CE-T1WI). The dimensions of
this area were consistent with the 240 CEM43 contours. The lesion
produced in session 1 was largely non-enhancing in in CE-T1WI at
week 2. It was visible in T2-weighted imaging (T2WI) and increased
in sizeO22
Growth slowdown in a brain metastasis model by antibody
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Objectives
HER2-targeting antibodies prolong survival in patients with HER2-
positive breast cancer metastases outside the brain. However, the re-
sponse of brain metastases to these drugs is poor and it is hypothe-
sized that the blood–brain barrier (BBB) limits drug delivery to the
brain. We aim to improve delivery by temporary disruption of the
BBB using focused ultrasound (FUS). Here we evaluate the treatment
benefit of combining two antibody therapies that target the HER2-
receptor with FUS-mediated BBB disruption in a breast cancer brain
metastasis model.
Methods
MDA-MB-361 HER2-positive human cancer cells were injected in the
right brain hemisphere of nude rats. The animals were divided in
three treatment groups of 10 animals each: the control-group re-
ceived no treatment; the antibody-only group received trastuzumab
and pertuzumab (antibodies that target the HER2-receptor); and FUS
+antibody-group received trastuzumab and pertuzumab in combin-
ation with FUS-mediated BBB disruption. The six weekly treatments
started five weeks after tumour implantation, when the tumour
diameter was around 2 mm. The FUS treatments took place in a 7TMR-scanner using a single-element, spherically-focused 690 kHz-
transducer. Trastuzumab and pertuzumab were injected before the first
sonication. At the start of each sonication (duration 60s, 10-ms bursts,
burst repetition frequency 1 Hz), the ultrasound contrast agent Optison
(100 μl/kg) was injected. The complete tumour was treated in 4 to 14
sonications that were separated 1 to 1.5 mm. Peak negative pressure
amplitudes in water between 0.46 and 0.62 MPa were used.
Before and after the sonications, MR imaging was performed consist-
ing of T2-weighted (T2w), T1w and T2*w imaging to locate the
tumour, confirm BBB disruption and study the presence of hemor-
rhages. In two animals tumour leakiness was studied by comparing
T1w imaging before and after gadolinium injection before the tu-
mours were sonicated. The difference in signal intensity change in
pre- and post-contrast T1w images was determined between the
tumour and contralateral brain region (= SI%). In all FUS-treated ani-
mals BBB disruption was confirmed with contrast-enhanced T1w im-
aging and quantified using the same method as for the tumour
leakiness. Pre- and post-sonication T2*w images were inspected for
hypo-intense regions, which can indicate extravasated erythrocytes.
Every other week, high-resolution T2w imaging was performed to de-
termine tumour volume. The growth rate (r) was determined by fitting
the tumour volumes to the following formula: volume(t)=a*exp(r*t), in
which t is the time in days. The growth rate of each tumour was deter-
mined for the treatment period (week 5 to 11) and the follow-up
period (week 11 till sacrifice). An animal was classified as ‘responder’ if
the growth rate was lower than the mean growth rate of the control
animals minus two standard deviations.
The animals were euthanized if the tumour size exceeded 13 mm in
diameter or if the condition of the animal was poor. From nine ani-
mals, histology was obtained (hematoxylin and eosin (H&E)) and the
brains of five animals were stained for HER2.
Results
BBB disruption was successful in all sessions with an average SI% of
21.2% (range 4.5 – 77.6%). The mean SI% of two tumours before BBB
disruption during the six treatment weeks were 0.4% and 0.6%, indi-
cating that the tumours were not leaky before disruption (Fig. 16). In
33% (20/60) of the FUS-sessions, regions were present that were
clearly more hypo-intense on post- than on pre-sonication T2*w im-
ages, suggesting hemorrhages. In the remaining 67% of the sessions,
no or a small difference in hypo-intensity was observed.
In the FUS+antibody-group, 4/10 animals were classified as re-
sponders during the treatment period (week 5 to week 11) with an
average growth rate of 0.010±0.007, compared to 0.043±0.013 for
the non-responders. There was no difference in the average SI% of
the responding rats (21.8%±16.7) and the non-responding rats
(20.7%±9.7). None of the control or antibody-only animals were clas-
sified as responder. When the FUS+antibody-animals are grouped,
no significant differences in mean growth rates were observed be-
tween the control, antibody-only and FUS+antibody animals for the
treatment period, nor for the follow-up period.
High-resolution T2w imaging showed that the tumour was
homogenous in almost all animals till week 13–15, when cystic and
necrotic areas started to develop. The tumours showed also a hetero-
geneous appearance on H&E stained sections and the complete
tumour was expressing the HER2-receptor in the examined animals.
Conclusions
In this study, we demonstrate that FUS-mediated BBB disruption in
combination with antibody therapy can slow down the growth of
brain metastasis from breast cancer. As the tumours were not leaky
before BBB disruption and no difference in growth rates was ob-
served in the antibody-only group, the disruption of the BBB is ne-
cessary for drug delivery to these brain metastasis. Interestingly, only
part of the rats responded to the treatment, the other animals had
the same growth rate as the control-group. This is in line with a pre-
vious study (Park et al. 2012, J. Control. Release), where antibody
therapy was combined with FUS in a different brain metastasis
model and in part of the animals a strong response was observed,
while the other animals did not respond. We did not observe a differ-
ence in tumour volume at the start of the treatment, in HER2 expres-
sion on histopathology, or in contrast-enhancement on MR images
between the responders and non-responders to explain this. Better
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help in translating this technique to the clinic.Fig. 16 (abstract O22). a T1weighted image before contrast
administration. The red arrow indicates the tumour. b No difference
in enhancement of the tumour is observed after contrast
administration (SI=0.4%). c After focused ultrasound-mediated
blood–brain barrier disruption, the tumour enhances after contrast
administration (SI=30.1%)
Fig. 17 (abstract O24). See text for descriptionO23
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Objectives
To determine the factors influencing outcome after MR-guided fo-
cused ultrasound (MRgFUS) thalamotomy for essential tremor.
Methods
Between May 2012 and February 2013, 6 patients were treated with
MRgFUS thalamotomy. The first 4 patients have been reported
(Lipsman et al., Lancet Neurol. 2013 May; 12(5): 462–8). Prospective
recording of data from preoperative screening to 3 month follow up
according to an experimental protocol using the clinical rating scale
for tremor (CRST), and then a 2 year follow up examination and as-
sessment were done. Maximum temperature at the focus of sonic-
ation was determined and post-treatment day 1 MRI scans were
reviewed for lesion size and location. A point derived by our current
method of determining the probable location of the ventral inter-
mediate nucleus (VIM) of the thalamus was taken as the starting
point for each treated case and a deviation vector from that point to
the centre of each lesion produced was plotted.
Results
For the 6 patients, the mean CRST A scale (rest, posture and action)
for the treated hand and arm prior to treatment was 7.2. At 1 week
post-treatment, the mean CRST A was 0.67. At 3 months, the mean
CRST A was 0.83 and at 2 years approximately 3.33. (At 2 years, the
CRST A for 2 patients was estimated from a narrative account). Mean
lesion size, excluding one very large lesion with a volume 2.7 times
the mean volume of the other 5 patients, was 90.2 mm3. Only 2 pa-
tients had no decline in thalamotomy effect. Of these, one had a
relatively large lesion of 107.5 mm3, which was located at the pre-
dicted location of the VIM nucleus. The other patient’s lesion was lo-
cated 2.4 mm lateral to the predicted VIM location. He had
prominent ataxia following his treatment. This subsided by 3 months.
The patient with the large lesion, treated for left hand tremor, had
persistent tingling of the left side of his mouth, and his left thumb
and 3 fingers but excellent early relief of tremor. Although there was
some persisting reduction of tremor at 2 years, he could no longer
write, nor drink without spilling. The centre of his lesion was 1.3 mm
lateral and 0.3 mm posterior to the expected VIM location. In its
superior-inferior dimension his lesion measured 9.4 mm. Themaximum temperature achieved at treatment was 63°C, higher than
the mean of 58°C. This decline may, in part, be due to the progress
of his condition, with increasing tremor on his untreated side and
the onset of tremor in both legs. Two of the patients with a decline
in function had relatively small lesions.
Conclusions
Not all patients have lasting benefit from MRgFUS thalamotomy. The
effect of relatively large lesions may be more durable, but lesioning
temperatures of greater than 60°C should likely be avoided.
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ultrasound for cerebral functional procedures
Michael Schwartz1,2, Robert Yeung1, Yuexi Huang1, Nir Lipsman2,
Jennifer Jain1, Martin Chapman1, Andres Lozano2, Kullervo Hynynen1
1Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; 2Surgery
(Neurosurgery), University of Toronto, Toronto, Ontario, Canada
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):O24
Objectives
To determine the factors that lead to bone marrow injury in the
skulls of patients undergoing MRgFUS cerebral ablations for the
treatment of movement disorders such as ventral intermediate (VIM)
nucleus thalamotomy for tremor and pallidotomy for L-dopa induced
dyskinesia (LID), and to follow the course of healing.
Methods
All patients undergoing functional cerebral ablations produced for the
mitigation of movement disorders are followed with serial MRI scans
according to study protocol to assess the evolution of the cerebral le-
sions. In one patient subjected to very high power sonication in the at-
tempt to produce a pallidotomy for LID, skull lesions were noticed on a
follow up MRI scan, produced 4 months after his MRgFUS procedure. A
review of other treated patients is currently underway.
Results
Multiple ovoid lesions throughout the calvarium, new since the im-
mediate post-treatment MRI scan done January 30, 2015, were seen
on the MRI scan done May 12, 2015 (Fig. 17). Their appearance re-
sembles that of bone infarcts. The MRI scan was repeated on October
2, 2015. Many of the ovoid lesions were still visible. This patient
underwent sonication increasing to a maximum power of 1100 W for
31 seconds. During the procedure, the scalp and skull were con-
stantly cooled with flowing degassed water at 13 °C. Despite this
sonication, the target locus in the globus pallidus reached only 48 °C.
Conclusions
High power and duration sonication for functional cerebral lesions
may cause injury to skull bone marrow. A review of all patients
treated with MRgFUS for movement disorders is currently underway
to determine whether there have been other cases, and to determine
the threshold for bone marrow injury.O25
In vitro study using MR-guided focused pulsed ultrasound for
destroying clots using thrombolytic drugs
Christakis Damianou1, Nikolaos Papadopoulos2
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Fig. 18 (abstract O26). Maximal average temperature as a
function of effective energy. The graph is based on the data of
502 sonications
Fig. 19 (abstract O26). Maximal cavitation activity as a function
of effective power. The graph is based on the data from
253 sonications
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In this paper an extensive study of using MR-guided focused pulsed
ultrasound system is presented for the treatment of stroke using
thrombolytic drugs in a model in vitro.
Methods
A single element spherically focused transducer of 4 cm diameter; fo-
cusing at 10 cm and operating at 1 MHz was used. The transducer
was mounted in an MR compatible robotic system of 3 axes. The ar-
tery was modelled using a silicone tube. Tissue was modelled using
agar-evaporation-silica gel. Coagulated blood was used to model
thrombus. A thermocouple was placed in the thrombus in order to
measure the thrombus temperature.
Results
The effect of power, presence of bubbles, temperature, presence of
agar-evaporation milk-siligal gel, time of sonication, pulse repetition
frequency, presence of standing waves, flow velocity were investi-
gated. The goal was to maintain a temperature increase of less than
1°C during the application of pulsed ultrasound (called safe
temperature). With the application of ultrasound alone or thrombo-
lytic drug alone there was no notable destruction of the thrombus.
Conclusions
With the combination of ultrasound and thrombolytic drugs suffi-
cient destruction occurred after 30 min, but the rate of destruction
of thrombus (mL/min) is considered low. Thus, the clinical use of fo-
cused ultrasound for sonothrombolysis despite the full parametric
study that we performed is considered pessimistic.
O26
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Objectives
Current trans-cranial Magnetic Resonance guided Focused Ultrasound
Surgery (tcMRgFUS) treatments are limited to the targets that are lo-
cated at the centre of the skull. Superficial and peripheral targets are
prone to lower acoustic intensity reaching the focal point due to the
geometry of the skull and the ultrasound transversal through it. A pos-
sible solution for this problem is reduction of the transmitting fre-
quency. Reducing the frequency is a trade-off between higher skull
penetration and lower tissue absorbing. In addition, lower frequency
has a lower threshold to induce cavitation. Previously it was reported
([1]) that the transient cavitation threshold for the muscle tissue acts
linearly with frequency as where Pth is the cavitation pressure threshold
and f is the transmitting frequency. However this threshold was not re-
ported to cause any unintentional pathological damage. In the pre-
sented work, different levels of acoustic intensities resulting in various
occurrences of cavitation were applied to an in-vivo pig brain model,
reaching various temperature levels and causing various pathological
effects.
Methods
36 subjects underwent craniotomy and were sonicated using various
ultrasonic parameters (ExAblate Neuro low frequency system, 220 Khz,
by INSIGHTEC, Ltd). The temperature rise was measured using MR
thermometry (1.5T GE HDx MRI by GE Healthcare, with an integrated
Head Coil, by InSighTec) and cavitation signal was measured and re-
corded using integrated hydrophones. 20 subjects underwent 2 weeks
follow up with post procedural MR imaging one, five, seven and four-
teen days after the procedure. The brains were harvested, fixed in for-
malin and sliced to 3 mm slices. Macro-pathological slices for randomly
selected subjects were also performed.Results
Figure 18 represents the graph of temperature rise as a function of
applied energy. Figure 19 represents the graph of cavitation activity
as a function of maximal acoustic power. Figure 20 shows a follow
up imaging for 2 lesions performed on a single subject, Fig. 21 is a
macro pathology slide for the subject presented in Fig. 20. In general
the temperature rise grew linearly with the applied acoustic energy;
the cavitation activity was linearly dependent to the maximum ap-
plied acoustic power. For sonications that were in the central cavita-
tion activity area as presented on Fig. 19 the lesions were well
defined and increased in size till the 5th day follow up and then re-
duced in size becoming scarf tissue as presented on Figs. 20 and 21.
Macro pathology revealed that tissue rapture is seen on the micro
level; however it is well defined and limited within the lesion area.
Conclusions
Cavitation threshold levels that were observed in brain agree
with the levels reported in literature. Additional levels of cavita-
tion were observed and associated with effects on tissue as seen
in MRI and histology. The data collected suggests cavitation
levels that can be applied while keeping lesioning effect to the
confined area and avoiding haemorrhages in tissue. Integrating a
real time control over the level of cavitation and keeping the
level below the safety threshold results in safe and effective tis-
sue ablation in brain.
Fig. 20 (abstract O26). An example for two weeks follow up
imaging for T2, T1 and T2 flair images presented. Two lesions are
visible on the 1 and 5 days follow up images, single lesion is seen
for the 7 days follow up and no lesion is visible at the 14 days
follow up imaging. The lesions locations are marked by red circles at
the 14 days follow up images in order not to hide the lesion and
edemic tissue for the earlier follow up images. The lesion on the left
was produced by the sonication reaching 58°C, whereas the lesion
on the right reached temperature of 56°C
Fig. 21 (abstract O26). Macro pathology of the slides presented on
Fig. 20. Only one lesion was detected
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Objectives
Real-time cavitation monitoring during the focused ultrasound
(FUS) induced blood–brain barrier (BBB) opening is crucial in
assessing and controlling the BBB opening outcomes and safety.
Currently, passive cavitation detection using a single-element de-
tector for quantification of the stable and inertial cavitation doses
has shown good correlation with the opening volume and the
molecular delivery efficiency in nonhuman primates (NHPs). How-
ever, an off-line magnetic resonance imaging (MRI) is required for
confirming the targeting or opening area in the brain after the
FUS procedure. It is therefore essential to develop transcranial
cavitation mapping in providing the spatial distribution of cavita-
tion intensity in real time in order to precisely assess and control
the BBB opening outcomes with accurate targeting during the
procedure. The aim of this study is to develop real-time cavita-
tion mapping using time-exposure acoustics and passive sparse
matrix beamforming with the performance evaluated in both the
in vitro primate skull (NHP and human) experiments and the
in vivo NHP experiments during BBB opening.
Methods
Similar to array-based passive cavitation detectors, a linear probe
(L7-4, Philips) with a programmable data acquisition system
(Vantage, Verasonics) was used to acquire cavitation signal pas-
sively during the sonication (frequency: 0.5 MHz, pulse length: 10
ms, PRF: 5 Hz, pressure: 150–600 kPa) with in-house made micro-
bubbles (lipid-shelled and monodisperse with a diameter of 4–5
μm) and a single-element FUS transducer with a coaxially aligned
flat-band hydrophone as a single-element passive cavitation de-
tector. Time-exposure acoustics for an integration of a series of
passive cavitation images over the exposure time reconstructed
by dynamic receive beamforming using sparse matrix calculation
in graphic processing unit (GPU; Tesla K40, NVIDIA) were devel-
oped for the reconstruction of passive cavitation maps in real
time. For the in vitro experimental setup, a phantom with a
channel of 4 mm in diameter and an infusion pump was used to
mimic the vessel with microbubble circulation (a concentration of
2×105 bubbles/mL with a flow rate of 1 mL/min), and the FUS
transducer and the linear array were both focused at the channel
orthogonally. B-mode imaging with the linear array was per-
formed before acquiring the passive cavitation signal in order to
confirm the alignment of both the linear array and the FUS trans-
ducer to the channel. Three sets of passive cavitation maps were
acquired using this in vitro setup: 1) without the skull, 2) with
the NHP skull and 3) with the human skull placed between the
phantom and the linear probe. The effects of acoustic pressure,
exposure time and aperture size to the intensity and focal size of
the cavitation maps were all evaluated, as well as the computa-
tional cost in GPU and the sensitivity through the skull. Further-
more, the in vivo cavitation maps were acquired during the
sonication for BBB opening in NHPs (duration: 2 min) and com-
pared with the BBB opening outcomes in the MRI.
Results
The results of the in vitro experiments showed that the cavitation lo-
cation corresponded to the microbubble disruption in B-mode
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tion maps increased with pressure. Increasing the exposure time
eliminated the interference outside of the focus and enhanced
the focalization by minimizing the focal area, while both the in-
tensity and the focal area reached a plateau at the exposure time
of 62.5 μs. The focal size especially in the axial direction in-
creased with decreasing aperture size, suggesting an improved
focalization by using a larger aperture size of the array-based
PCD. The computational time for the exposure time of 62.5 μs
was 9.5 s, which can be decreased to 0.27 s in achieving real-
time monitoring by decreasing the exposure time to 1.44 μs. By
placing the skull, it was found that the cavitation signals were
still detectable through the NHP and human skulls at 300 kPa
and 600 kPa with the mapping system, respectively. For the
in vivo experiments, the BBB opening in NHP were successfully
monitored with passive cavitation mapping targeting at the caud-
ate and the hippocampus, the deep subcortical structure in the
brain.
Conclusions
A real-time cavitation mapping technique using time-exposure
acoustics and passive sparse matrix beamforming has been devel-
oped with the performance and the sensitivity through the pri-
mate skull evaluated, and was used for monitoring of the BBB
opening in NHPs. This novel transcranial monitoring technique
providing both the spatial and intensity information of cavitation
in real time during the FUS procedure is promising in assessing
and controlling the targeting, treatment efficacy, and safety
precisely.O28
Blood brain barrier opening using focused ultrasound for the
reduction of amyloid beta plaques in synergy with antibodies in a
rabbit model fed with high cholesterol diet
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Objectives
An animal model that creates Amyloid beta (Ab) plaques in the brain
was implemented by delivering high cholesterol diet in rabbits for 3
months. The goal was to reduce the plaques using focused ultra-
sound (FUS) in combination with external antibodies.
Methods
A single spherically focused transducer was used which operates at 1
MHz, has focal length of 10 cm and diameter of 3 cm. The rabbit was
placed in a custom made MRI compatible positioning device. Theo-
flavin staining was used in order to measure the plaque load at the
end of each experiment.
Results
Using pulse FUS the blood brain barrier (BBB) was opened re-
peatedly up to 5 times at three day intervals. The opening of the
BBB disruption was imaged using contrast-enhanced T1-weighted
fast spin echo. By increasing the number of sessions, the number
of plaques decreases (both for internal and external antibodies).
With the use of FUS only (internal antibodies) the drop of aver-
age number of plaques/mm2 was reduced by 20% (in 5 sessions).
The effect of external antibodies was more drastic. With 5 BBB
sessions the average number of plaques/mm2 was reduced by
60%.
Conclusions
This study demonstrated that by opening the BBB, it will be pos-
sible to deliver internal and external antibodies to the brain,which eliminates Alzheimer disease (AD) plaques. More important
by opening the BBB frequently (up to 5 times in this study) the
reduction in the number of plaques is enhanced. Therefore FUS
has the potentials to be used non-invasively for the treatment of
AD.O29
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Objectives
Blood–brain barrier (BBB) is composed of both physical barrier
with tight junctions and functional barrier with active efflux
transporters. Mechanism of the functional barrier is mediated by
P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP)
in brain endothelial cells. Past studies have shown that focused
ultrasound (FUS) combined with microbubbles can disrupt the
physical barrier of the BBB by exerting mechanical stress on the
tight junctions; however, no study was performed to investigate
the impact of FUS and microbubbles on the functional barrier of
the BBB. Therefore, this study investigated the impact of BBB
disruption induced by FUS and microbubbles on the expression
of P-gp. We also investigated correlation between magnitude of
the BBB opening and the down-regulation of P-gp.
Methods
A single target region was sonicated (0.5~0.7 MPa) transracially in
one hemisphere in 3 rats using a 1 MHz FUS transducer; the other
hemisphere served as a control. For the BBB disruption, 10 ms bursts
were applied at 1Hz pulse repetition frequency (PRF) for 120 s and
combined with IV injection of a microbubble ultrasound contrast
agent (Definity 0.1 ml/kg). An MR contrast agent (Magnevist 0.4
mM/kg) and Evans Blue (0.15 ml/kg) were injected immediately after
the sonication to indicate area of the BBB disruption in MR image
and fluorescence spectroscopy, respectively. In order to measure
the P-gp expression using a confocal fluorescence microscopy, the
brains were fixed after perfusion and then stained immunohisto-
chemically with a monoclonal antibody (C219) which reacts with a
P-gp epitope.
Results
A T1 contrast enhanced MR image and Evans Blue fluorescent in-
tensity at the sonicated regions indicated localized BBB disruption
(Fig. 22). Both the MR contrast intensity and the Evans Blue fluor-
escent intensity were significantly increased in the targeted re-
gions compared to the control regions (p<0.001). The fluorescence
intensity of the P-gp expression at the confirmed locations of the
BBB disruption was reduced by an average of 63.2±18.4% com-
pared to the control area in all three rats. From the three soni-
cated regions, a total of 31 locations were selected and the P-gp
fluorescence intensities were measured to observe the correlation
between the degree of the BBB opening and the P-gp expres-
sion. Both the Evans Blue intensity and the MR contrast intensity
were significantly correlated with the P-gp expression intensity
(r=−0.72, p<0.001; r=−0.62, p<0.001, respectively). Histologic ana-
lysis on the sonicated region of the brain tissue revealed no ap-
parent damage in the endothelial cells, and no significant
amount of extravasated red blood cells was observed.
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This study demonstrates that the BBB disruption induced by FUS
and microbubbles reduces the expression of P-gp, and the level
of the down-regulation of P-gp is significantly correlated with the
magnitude of the BBB opening. These results suggest FUS +
microbubble as a promising mean for the brain drug delivery
through the BBB by overcoming both the physical and the func-
tional barrier of the BBB.Fig. 22 (abstract O29). a A T1 contrast MR Image of a rat brain at
sonification region (the opposite hemisphere of the brain served as
control). b The fluorescence intensity of the P-gp expression at the
soicated locations were reduced by an average of 63.2±18.4%
compared to the control locationsO30
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Objectives
MR-guided focused ultrasound (MRgFUS) can be used for a large
range of non-invasive therapies using mechanical and thermal mech-
anisms. For instance, it has been demonstrated that a combination
of low intensity focused ultrasound and synthetic microbubble scan
be used to safely, locally, and transiently disrupt the blood–brain bar-
rier (BBB)[1].
Typically, transcranial MRgFUS thermal ablation requires large
aperture phased arrays with many elements operating at lower
frequencies and higher powers than body systems due to high
transmission losses through the skull. However, in low pressure
applications at low duty cycles, such as BBB disruption or neuro-
modulation, it may be feasible to use 'body' systems that have
smaller aperture transducers with fewer elements [2]. The
objectives of this study were to use a clinical body MRgFUS
system to:1) Quantify the ultrasound transmission and focal distortion
through a human cranium at different orientations and in
different focus locations inside the skull to assess the possible
treatment envelope with such a device.
2) Demonstrate the ability to disrupt the blood–brain barrier (BBB)
in rat neurovasculature through a human cranium.
Methods
A clean, degassed human cranium (gift of Dr. Quiñones-Hinojosa,
JHU Neurosurgery) was mounted in degassed water above a 256-
element phased-array transducer (14 cm focal length) of a clinical
body MRgFUS system (Sonalleve V2, Philips, Vantaa, Finland). Hydro-
phone measurements were made with a lipstick hydrophone (Onda
Corp., Sunnyvale, USA) mounted to a 3D stage, both in water and
through the human skull in 11 locations (three orientations, 3–4
depths at each, ranging between the centre of the cranium and 2
cm from the skull surface). 40-cycle sonications at 1 MHz were ap-
plied at different acoustic powers ranging from 5 to 20 W (water)
and 20 to 500 W (trans-skull). In each location, the full-width at half-
maximum (FWHM) of the ultrasound focal point (in three dimen-
sions) and its peak negative pressure were measured. This setup and
the locations sampled are shown in Fig. 23.
Results
Hydrophone measurements demonstrated a great deal of vari-
ation in ultrasound transmission with changing transducer/skull
incidence angle and skull thickness. The pressure attenuation
ranged from −5.8 dB to −9.3 dB (mean +/−standard deviation, −8 dB
+/− 1 dB), and the FWHM varied between 1.83 mm and 3.79 mm
(2.2 mm +/− 0.3 mm in the anterior/posterior direction, 2.7 +/−
0.7 mm in the left/right direction). The insertion losses as a func-
tion of depth at different orientations are shown in Fig. 24. The
dorsal midline skull (with the ultrasound beam passing through
the sagittal and coronal sutures) was thicker than either of the
angled approaches (passing through the parietal and temporal
bones) and experienced a greater insertion loss for most sonic-
ation target depths. For both angled approaches, the insertion
loss decreased as the focus was moved away from the skull sur-
face. For the centered approach, the insertion loss increased
slightly as the focus moved closer to the skull surface. It appears
that the intervening skull thickness dominates the attenuation,
though the angle of incidence seen by transducer elements also
affects transmission.
Gadolinium enhancement in the brain on post-sonication T1-
weighted MRI indicated successful BBB disruption. Disruption accur-
acy is shown in Figs. 25 and 26. For sonications of sufficient pressure
to produce BBB disruption, the region of gadolinium enhancement
did not appear to be shifted at all from the desired target. For higher
estimated in situ pressures (>0.55 MPa), the disruption region was
larger and less uniform, as evident in the 0.58 MPa point in Fig. 25.
Even without element-by-element refocusing, the focusing quality
and targeting precision appeared to be adequate. Post-experiment,
there were no signs of gross damage to the animals to suggest sig-
nificant off-target sonication.
Conclusions
Transcranial FUS focal point distortion was minimal despite the lack
of element-by-element transducer refocusing. The clinical MRgFUS
body transducer and driving electronics had sufficient power and
aperture to generate the in situ pressures for BBB disruption through
a human skull, using a variety of clinically practical approaches and
patient orientations.
Though transcranial thermal ablation typically requires high acoustic
powers, a lower operating frequency, and large aperture arrays with
high number of elements, this study demonstrates that a clinical
body MRgFUS system with a smaller transducer may be a safe and
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):15 Page 18 of 114feasible alternative for non-invasive BBB disruption and other low-
pressure therapeutic ultrasound transcranial applications, potentially
offering a wide treatment envelope.
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[2] Airan, R. D., et al. (2015). 23rd ISMRM.Fig. 24 (abstract O30). Insertion losses for different sonication
orientations and depths
Fig. 25 (abstract O30). Baseline T1-weighted coronal image, left,
and post-contrast post-BBB disruption image, right, showing two lo-
cations of BBB disruption with the estimated in situ
pressures labelled
Fig. 26 (abstract O30). Sagittal images showing columns of BBB
disruption produced by the labelled estimated in situ pressures.
Ultrasound propagation is from the right to the left of these images.
Fig. 23 (abstract O30). a and b: Coronal and sagittal
representations of the locations examined. c: Picture of the
hydrophone and skull arrangement for one of the 'Left 45°'
orientations. The transducer is below the tableO31
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Objectives
Pulsed ultrasound, coupled with peripheral injection of microbubbles,
has been shown in pre-clinical studies to be an effective method for
enhancing the delivery of chemotherapy to the brain. In this work,
an intra-skull implantable ultrasound device, SonoCloud®, was devel-
oped for temporarily disrupting the BBB. The device was implanted
in patients with recurrent glioblastoma (GBM) undergoing systemic
carboplatin chemotherapy in a Phase 1 clinical trial and the safety of
repeated BBB disruption was assessed.
Table 1 (abstract O32). Scan parameters












160×160×160 1.0×1.0×1.0 11 0.05 8, 36 1008 167 15000
UTE
T2*
160×160×160 1.0×1.0×1.0 6 0.05, 0.09,
0.13, 0.17,
0.25
15 1008 122 20000
FOV Field on view, Res Resolution, TR Repetition time, TE Echo time, FA Flip angle,
BW Bandwidth (read out), # views – number of radial views/rays acquired
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A Phase 1 clinical trial began in July 2014 at a single centre at the
Hospital Pitie Salpetriere in Paris, France. Patients with recurrent GBM
with an enhancing volume of less than 35 mm in diameter were in-
cluded in the trial. Participants were implanted with a 11.5-mm diam-
eter biocompatible 1 MHz ultrasound transducer, which was fixed
into the skull bone thickness. The device was either implanted during
a regular surgical resection of the enhancing region or during a
unique ambulatory procedure under local anaesthesia. Once a
month, the device was connected to an external radiofrequency gen-
erator using a transdermal needle, and patients received a two mi-
nute pulsed ultrasound exposure in combination with systemic
administration of an ultrasound contrast agent (7 min mean total
duration procedure). BBB disruption was assessed immediately after
sonications using dynamic T1-weighted imaging with a gadolinium
based MR contrast agent. Systemic intravenous injection of carbopla-
tin chemotherapy was delivered immediately following MR imaging.
Patients followed a progression of ultrasound dose in which the pres-
sure was increased from 0.5 to 0.8 MPa throughout the course of the
study.
Results
As of July 2015, eleven patients had been included in the study
with a total of 25 BBB disruption procedures performed. No ad-
verse effects were observed in patients treated. BBB opening was
clearly observed in 12/25 treatments on contrast-enhanced T1w
imaging. The procedure was safely tolerated in all patients. No
evidence of acute haemorrhage, petechia, ischemia or oedema
was observed in post-sonication SWAN T2*, Diffusion or FLAIR
MRI sequences.
Conclusions
The BBB was safely opened by pulsed ultrasound using an implant-
able ultrasound device in patients with recurrent glioblastoma. Add-
itional follow up and recruitment will be used to further evaluate the
safety and potential efficacy of such an approach.
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Objectives
For MR guided focused ultrasound treatments in or close to bone,
such as for transcranial applications focusing through the intact skull
bone and treatments of bone metastases, significant heating can
occur in the bone due to its high ultrasound absorption. MR imaging
of bone is in general challenging due to the short T2 relaxation time
of bone. For MR temperature imaging the short T2 also severely de-
creases the accuracy that can be achieved with the standard proton
resonance frequency shift method. Instead researchers have investi-
gated the temperature dependence of the MR signal intensity (SI)
and T1 relaxation time for temperature monitoring (1–4). Miller (1)
and Fielden (3) et al. showed that the SI from cortical bone decreases
with increasing temperature using ultrashort echo time (UTE) pulse
sequences, and Ramsay et al. (2) found that, contrary to what Miller
and Fielden observed, the SI increases with increasing temperature
using a short TE gradient recalled echo (GRE) pulse sequence. Han
et al. (4) further showed that T1 increases with temperature, also
using UTE.
In this work we investigate the temperature dependence of the SI
(dSI/dT) and the T1 and T2* relaxation times (dT1/dT and dT2*/dT,respectively) using a 3D UTE pulse sequence to investigate which
parameter has the highest sensitivity to temperature change.
Methods
All imaging was performed on a 3T MRI scanner (MAGNETOM
PrismaFit, Siemens Healthcare, Erlangen, Germany) using a 3D UTE
pulse sequence. The sequence utilizes radial, ramped sampling of k-
space in 3D starting at the k-space centre after a 80 μs non-selective
hard RF pulse, allowing TEs down to 50 μs. T2* was measured by per-
forming an exponential fit to data acquired at TE = 50, 90, 130, 170,
and 250 μs (other scan parameters are listed in Table 1). The 50 μs
TE was also used for dSI/dT calculations. T1 was measured using the
variable flip angle (VFA) method (5) with TR = 11 ms and FA = 8 and
36° (other scan parameters are listed in Table 1).
An approximately 4-cm long bovine femur (marrow and connective
tissue removed) was placed in a phantom holder that allowed
heated water to circulate around the bone, Fig. 27. One fiber optic
probe measured the water temperature, and three probes were
inserted in 1-mm diameter, 2-cm deep, holes drilled in the bone to
measure the temperature of the bone. The water was warmed to
~22, 35, 50, and 65°C and data was collected when all 4 probes mea-
sured within 1°C. The whole setup was places in a 20-channel RF
head coil for signal detection.
Results
Figure 28 shows 2D maps of SI and T1 and T2* relaxation times for
the 4 different temperatures. Mean and standard error values from a
9x9 ROI close to each probe is shown in Fig. 29, together with calcu-
lated changes in %/°C. A decrease in SI of 0.3-0.5%/°C, and increases
in T1 and T2* of 0.5-0.9%/°C and 0.6-0.9%/°C, respectively, was ob-
served. Using the temperature dependent spoiled GRE signal equa-
tion (6) and the observed values for dT1/dT and dT2*/dT, dSI/dT can
be closely predicted.
Conclusions
The decrease in SI is in accordance with previously published results
by Miller and Fielden. The measured change in T1 using UTE agrees
well with the 0.6%/°C reported by Han, although we measured
higher absolute T1 values (~160-175 ms at 25°C, compared to ~115-
125 ms as reported by Han).
The effect of T1 and T2* on SI are counter-acting each other
(both increasing), which reduces the sensitivity of dSI/dT. This
may suggest that dT1/dT and dT2*/dT are more suitable candi-
dates for bone MR thermometry, and Fig. 29 also shows higher
sensitivity for relaxation times that for SI. However, it should be
noted that SI can be detected from a single image, whereas T1
and T2* measurements utilize two or more images, therefor
resulting in longer scan times.
Future studies will acquire data with longer TEs (out to ~10 ms) to in-
vestigate the difference in temperature sensitivity for shorter and
longer T2 components in the bone. These results will be compared
to the increase in SI with temperature observed by Ramsay using a
TE ≈ 1 ms. The temperature dependence of the long and short T2*
components can be found by a multi-exponential fit. Flip angle map-
ping will also be implemented to improve the accuracy of the T1
measurements (7).
Fig. 29 (abstract O32). Changes versus temperature for a SI, b T1,
and c T2*. Mean and standard error value from a 9x9 voxel ROI close
to each probe is shown
Fig. 28 (abstract O32). 2D maps of SI and relaxation times for the 4
different temperatures (~22, 35, 50, and 65 °C), a SI, b T1, and c T2*
Fig. 27 (abstract O32). Scan setup. A ~4 cm long bone sample was
placed in a phantom holder that allowed water circulation to
homogenously heat the bone. 4 fiber optic probes were used; 1 in
the water and 3 in the bone sample.
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Objectives
MR-guided focused ultrasound (MRgFUS) brain systems deliver tar-
geted thermal energy into the brain using a hemispheric array oftransducers that surround the head with an intervening water bath
(Fig. 30a). During treatment the localized heating (hot spot) is
measured from a change in image phase between baseline (pre-
treatment) and dynamic (during treatment) images. Accelerating
temperature mapping by undersampling k-space is desirable to in-
crease spatiotemporal resolution and coverage, but is difficult to do
with parallel imaging since coils must be placed outside the trans-
ducer, far away from the head. Multiple groups have instead devel-
oped accelerated temperature mapping methods that exploit
temporal correlations between baseline and dynamic images [1, 2].
However, circulation of the water bath to cool the skull causes dy-
namic signal changes that are not captured by baseline images
(Fig. 30b), which breaks those correlations and results in artefacts
throughout the temperature maps. We propose a spatially-
segmented approach for reconstructing temperature maps in brain
MRgFUS, in which we separately estimate a water bath image with-
out a baseline, and a temperature map in the brain with a baseline.
The method can estimate artefact-free temperature maps from
undersampled data during brain MRgFUS treatments using a single
receive coil.
Methods
Our iterative approach alternates between updating the parameters
of a k-space hybrid signal model which is fit in the brain region of
the image [1], and a baseline-free estimate of the water bath image.
The fitting of k-space hybrid brain model results in a phase drift-
corrected brain image without the temperature phase shift and a
sparse temperature phase shift map. An algorithm to fit the model is
described in [1]. The water bath is reconstructed using a POCS algo-
rithm that alternately enforces data consistency, consistency with a
water bath support mask (brain and water bath masks are obtained
from a baseline image), and sparsity in the Coiflet domain using soft
thresholding [3]. Figure 30c illustrates the overall undersampled dy-
namic image model.
To test the method, a gel-filled human skull phantom was soni-
cated by an InSighTec ExAblate Neuro 4000 transcranial MRgFUS
system (InSighTec Ltd, Haifa, Israel) while imaging with a GE 3T
MR750 scanner (GE Healthcare, Waukeshaw, WI). 27 single-slice
2DFT gradient echo images were collected with the body coil
and 28 x 28 x 0.3 cm3 field of view, 256 x 128 acquisition matrix,
30° flip angle, 13 ms TE, and 28 ms TR. Images and maps were
reconstructed to a 128 x 128 matrix and retrospectively randomly
undersampled by 2x, with full sampling over 22 central k-space
lines. Temperature maps were reconstructed by fitting the k-
space hybrid model to the entire image, or to the brain only
with keyhole or POCS methods used to reconstruct the water
bath image.
Results
Figure 30d shows the temperature reconstruction results. When
the k-space hybrid model is fit to the entire image without dis-
tinguishing between the brain and water bath, phase artefacts
obscure the hot spot in the reconstructed temperature map and
(in this case) lead to an overestimation of the temperature rise in
the sonicated region across image dynamics (RMSE across dy-
namics: 0.0121°C). Restricting the temperature reconstruction to
within the brain, in combination with keyhole reconstruction of
the water bath image (using the baseline image’s k-space to fill
in missing k-space lines), produces temperature maps with lower
errors in the hot spot but still large errors outside (RMSE across
dynamics: 0.0039°C). The proposed k-space brain/POCS bath ap-
proach yields a more accurate estimate of the water bath image
(not shown), resulting in much lower in-brain temperature arte-
facts (RMSE across dynamics: 0.0029°C).
Conclusions
Unpredictable water bath motion confounds model-based ap-
proaches to accelerated MR temperature mapping, resulting in large
temperature artefacts due to aliased water bath signal. We demon-
strated that a spatially-segmented reconstruction that applies a
model-based reconstruction in the brain and a POCS reconstruction
in the water bath can reconstruct temperature maps without under-
sampling artefacts at a moderate acceleration factor using a single
receive coil. Future work will focus on integrating the approach with
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):15 Page 21 of 114other accelerated temperature mapping methods [2] and extending
it to non-Cartesian trajectories [4]. The method is compatible with
multiple receive coils.
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Objectives
MR-guided focused ultrasound (MRgFUS) brain treatments are cur-
rently guided by one thermometry sequence: single-slice 2DFT MR
thermometry. In this work, we divided treatment monitoring into
two tasks, with different thermometry design goals for each, and
developed sequences optimized for these goals: “Focal Spot
Localization” and “Monitoring”. These sequences achieve greater im-
aging performance by utilizing multi-echo spiral thermometry,
region-specific update rates, and MASTER slice interleaving.
Currently, focal spot targeting confirmation requires several low-power
sonications to obtain high-resolution measurements in three dimen-
sions. We developed a Focal Spot Localization sequence that obtains
high-resolution measurements in-plane, at improved temperature pre-
cision compared to 2DFT, while also providing multiple-slices for
through-plane characterization. This would reduce the number of soni-
cations required, improving treatment time. Additionally, even lower-
power sonications could be detected, improving patient safety.
During ablative treatment sonications, single-slice monitoring cannot
detect through-plane shifts of the ultrasound focus, or unexpected
out-of-plane heating. We developed a multi-rate thermometry Moni-
toring sequence that interleaves different sequences at different
update rates to simultaneously achieve fast and precise focal moni-
toring, 3-dimensional focal spot measurement, and full brain moni-
toring. Fast and precise multi-slice monitoring of the focus ensures
accurate thermal dose estimates for treatment feedback, while
(slower) full-brain monitoring ensures patient safety.
Methods
All sequences were implemented using RTHawk (HeartVista, Menlo Park,
CA) on a GE 3T 750 Signa scanner (GE Healthcare, Milwaukee, WI)
equipped with the InSighTec Exablate Neuro (InSighTec, Haifa, Israel). All
imaging was performed with the body coil, as is normally used with the
Exablate system. Conventional 2DFT was implemented as a gold standard
for comparison. The new sequences all use a 36 cm FOV to ensure that
the transducer and water bath do not alias. Volunteer imaging was done
with informed consent under IRB approval. Multi-frequency reconstruction
was performed on all spiral data. Temperature uncertainty was measured
as the per-voxel temporal standard deviation of temperature measure-
ments, and averaged within manually segmented ROIs. Performance was
also tested inside the transducer, using a gel phantom. Sequence parame-
ters are compiled in Table 2.
The Focal Spot Localization sequence is a 5-slice 3-echo thermometry
sequence, with doubled in-plane resolution as compared to conven-
tional 2DFT (1.1x1.1 mm vs 1.09x2.18 mm), and acquisition time of 7 s.
The Monitoring sequence interleaves 3 distinct sequences at different
rates to monitor 29 total slices. The “Focus” is monitored using 3-slice
3-echo spiral imaging, for high-speed high-precision measurement of
focal heating. Two adjacent slices, the “Boundary”, are monitored at half
the temporal rate (also using 3-echo spiral) to fully characterize the
focal spot. The remaining 24 slices, “Background”, were acquired using
8 blocks of 3-slice MASTER, with spiral readouts. Use of MASTER im-
proves temperature uncertainty, compared to traditional slice interleav-
ing, by increasing echo time. Limiting each MASTER block to 3 slices
reduces inherent diffusion and motion-encoding artefacts. The three
component sequences were interleaved such that Focus utilized 45%
(15% per-slice) of the timeline, Boundary used 15% (7.5% per-slice),
and Background the remaining 40% (1.7% per-slice).
Results
Figure 31a compares temperature uncertainty in vivo between 2DFT
and Focal Spot Localization while Fig. 31b compares 2DFT with
Monitoring for the same volunteer. Large images compare the centre
slice, while stacks of images at the right show additional slices moni-
tored by the new sequences. Figure 31c compares 2DFT and Moni-
toring uncertainty within the transducer. The new sequences obtained
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Relative “Efficiency” is also listed in Table 2, which accounts for differ-
ences in speed and voxel volume. Each multi-echo spiral sequence is
more than 150% as efficient as 2DFT. Background is 69% as efficient
(but collects 3 slices per TR, for an effective 120% efficiency).
Conclusions
In this work, we have shown that multi-slice multi-echo spiral thermom-
etry is an effective imaging approach for volumetric treatment monitor-
ing. Improved imaging performance was successfully used to achieve
imaging objectives for different aspects of ablative treatments. Focal
spots may be localized faster and with reduced heating using the
higher-resolution higher-precision Focal Spot Localization sequence.
The mixed update rate Monitoring sequence successfully delivers high-
speed high-precision monitoring of the targeted focus, while improving
safety by simultaneously monitoring the full brain at a lower update
rate. These sequences have also been validated within the transducer,
to help ensure they will work in the clinical setting.Fig. 31 (abstract O34). Temperature uncertainty comparisons
between 2DFT and a Focal Spot Localization, in vivo; b Monitoring,
in vivo; c Monitoring, phantom within transducer. Large images
compare centre slices, while stack of images at right show additional
slices. Dotted outline in 1C delineates the phantom
Table 2 (abstract O34). Implemented Sequence Performance
Parameters. tSNR efficiency is proportional to (δxyz*√(Tseq)*σT)−1 . For














2DFT 3.82 28 1 1.09×2.19 3 MM 0.48°C 0.66°C 100%
Focal Spot
Localization
7.00 36 5 1.10×1.10 3 mm 0.16°C 0.38°C 253%
Monitoring -
Focus
2.39 36 3 2.00×2.00 2 mm 0.15°C 0.41°C 182%
Monitoring -
Boundary
4.78 36 2 2.00×2.00 2 mm 1.03°C 0.33°C 160%
Monitoring -
Background
9.56 36 24 2.00×2.00 2 mm 0.15°C 0.54°C 69%O35
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Objectives
To demonstrate how MRI can be used in FUS treatments near metal-
lic hardware for treatment planning, sonication monitoring and treat-
ment assessment.
Methods
Using standard MRgFUS product sequences, we treated a 73-year-old
patient with a metastasis in the right femur that was painful despite
prior radiation and surgical stabilization with a metallic rod, demon-
strating the inability of both echo-planar imaging (EPI) and gradient-
recalled echo (GRE) imaging to be used for conventional proton res-
onance frequency (PRF) shift thermometry.
Based on the experience from this patient treatment, we have pro-
posed an imaging strategy for MRgFUS near metallic hardware using
multi-spectral imaging (MSI) techniques (Fig. 32a). Both MAVRIC-SL
[Koch et al.; MRM 2011; pp. 65:71] and 2DMSI [Hargreaves et al.; ISMRM
2014, #615] are spin-echo-train-based imaging approaches that enable
artefact-reduced imaging near metal. MAVRIC-SL compensates for dis-
tortions induced by field inhomogeneities by additional encoding
along the slice dimension. Its ability to adjust the image contrast makes
it a promising candidate both for treatment planning and assessment.
2DMSI limits the excitation to finite spectral and spatial regions
(“frequency bins”) that can be imaged with minimal artefact quickly
enough to be used for sonication monitoring.
We preliminarily tested the feasibility of MAVRIC-SL for treatment plan-
ning and assessment in a 65-year-old patient without metal hardware
and with a metastasis in the right pelvis undergoing MRgFUS treatment
for pain palliation. We used a GE 3T MRI system equipped with an
InSightec ExAblate2000 FUS system. Proton density (PD) weighted
MAVRIC-SL images were acquired prior to the treatment in addition to
standard 2D fast-spin-echo (FSE) images. After treatment, T1-weighted
MAVRIC-SL images were acquired before and after gadolinium injection
in addition to standard 3D fast RF-spoiled GRE images with 2-point-
Dixon fat suppression (LAVA-Flex, see Fig. 32c for details).
We tested the feasibility of 2DMSI to monitor a 25 s sonication in an acryl-
amide egg-white phantom containing the CoCr stem of a knee replace-
ment and a pork loin sample containing a CoCr augment plate from the
same hardware, each placed in a container filled with water. We acquired
a time series of 10 single-slice 2DMSI images with a temporal resolution of
8 s/frame and the sonication starting after the third image. Each 2DMSI
image was composed of 12 frequency bins ranging from −4.5 kHz to +5.4
kHz, and was acquired with TE = 30 ms, (bin) TR = 500 ms, 280 x 280 mm
FOV, 5 mm slice thickness and 128 x 128 matrix size (effective number of
phase encodings after half Fourier). To monitor the temperature-induced
signal change, we subtracted the mean signal of the 3 baseline images
from all 10 images voxel-by-voxel.
Results
Figure 32b shows the GRE and EPI image acquired in the patient
with metallic hardware. With both techniques, the stabilized femur
and its surrounding area are not visible due to distortions and signal
dephasing. For comparison, the MAVRIC-SL image depicts the anat-
omy including the bone marrow surrounding the metallic rod.
Figure 32c presents the acquired images for treatment planning and as-
sessment in the patient without metal. PD-weighted MAVRIC-SL achieves
a contrast comparable that of the conventional FSE image and allows for
localization of the metastasis in the lower part of the right pelvis. The T1-
weighted MAVRIC-SL pre/post contrast difference image reveals the treat-
ment area similar to the LAVA-Flex water difference image.
Figure 33 shows the thermometry results in the phantom and the tis-
sue sample. In both cases, metal-induced field inhomogeneities of
up to ± 4 kHz cause strong distortions and signal loss in the GRE
image, whereas 2DMSI clearly depicts the area around the metal. In
the phantom, the 2DMSI difference images yield a clear signal
change at the focal spot next to the metallic stem and a noticeable
Fig. 33 (abstract O35). GRE and 2DMSI image and 2DMSI signal
change during sonication in the phantom (a) and the ex vivo tissue sample
(b). The 2DMSI difference images are cropped and masked to the dashed
area. For the tissue sample, the 2DMSI difference image in the lower right
shows the average over the three time frames during sonication
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sue sample, despite a 70% reduction in SNR due to the lower water
content. Averaging over the frames during sonication improves the
localization of the focal spot.
Conclusions
We have presented initial results for our proposed imaging strategy
for MRgFUS in the presence of metallic hardware.
MAVRIC-SL is an established technique for artefact-reduced imaging
near metal. Here, we have shown that the image contrast can be ad-
justed to yield the relevant information for both planning and assess-
ment of MRgFUS treatments. The reduced image resolution
compared to the standard FSE protocol (to keep the scan duration at
an acceptable length) did not noticeably reduce diagnostic image
quality for the treating radiologist.
We have also demonstrated that 2DMSI enables the measurement of
temperature-induced signal changes in close proximity to metallic hard-
ware and thus in regions where conventional PRF shift thermometry fails.
The bin-selective approach allows for a temporal resolution of 8 s/frame,
which is sufficiently high to resolve the temperature evolution in sonica-
tions as short as 20 s, which is the typical duration in MRgFUS treatments.
In case of less severe metal-induced artefacts, the number of frequency
bins could be reduced to increase the temporal resolution. Averaging over
time frames could facilitate the detection of the focal spot in lower SNR
cases. For the given temporal resolution and the low temperature sensitiv-
ity of the T2 relaxation time of aqueous tissues, the measured signal
change is expected to be highly dominated by the temperature sensitivity
of the PD, whereas a higher temporal resolution is expected to increase
the T1 weighting. While the latter provides higher temperature sensitivity
and thus lowers the SNR requirements, PD weighting offers the benefit of
a tissue-independent temperature mechanism that could facilitate quanti-
tative thermometry.
In conclusion, the proposed imaging strategy has the potential to enable
MRgFUS treatments near metallic hardware. The patient population at
greater risk for cancers, and hence osseous metastases, overlaps with the
elderly demographic more likely to have metallic hardware such as joint
replacements. Further, orthopaedic bone stabilization is often used as a
treatment for osseous metastases at risk for fracture. Overcoming these
technical limitations is therefore important to allow the use of MRgFUS in
a larger patient population.Fig. 32 (abstract O35). a Components of the proposed imaging
strategy for MRgFUS near metallic hardware. b GRE and EPI images
underlying conventional PRF thermometry and a MAVRIC-SL image,
all acquired in a patient with a femur stabilized with a metallic rod.
The dashed line in the x-ray image depicts the location of the MRI
slices. c Comparison of both planning images and difference images
(pre and post contrast injection) for treatment assessment, acquired
in a patient without metallic hardwareO36
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Objectives
Phase change nano droplets (PCND), whose diameters are 200–400
nm, are droplets of perfluorocarbon (PFC) covered with phospholipid
layers. Since they can be vaporized by ultrasound and transformed
to microbubbles, they will be utilized as ultrasound contrast agents
and ultrasound therapy sensitizers. There are several types of PCND
which are often used in research, whose internal compositions are
different, such as perfluoropentane (PFP) and perfluorohexane
(PFH).Its boiling point can be adjusted by changing the mixture ratio
of PFP and PFH.
The lifetimes of generated microbubbles changed from PCND are dif-
ferent from type to type. In this study, the lifetime dependence to
ambient temperature at the moment of its vaporization was investi-
gated. If remaining efficiency depends on the ambient temperature,
this drug has a potential to be used as indicator of thermal memory
effects and temperature monitoring agents.
Methods
Experimental setup for ultrasound exposure and high-speed imaging
are shown in Fig. 34.In this study, we used the two types of PCND,
whose internal compositions were PFP and the mixture (MIX; PFP:
PFH = 1:1), respectively. Their main differences are boiling points
(PFP: 29°C, MIX: 40°C), and the boiling point of MIX is estimated by
thermodynamic calculation.
For the observation of the vaporization of PCND, we used two-
layer structure of polyacrylamide gel phantom (layer with PCND
and layer without PCND), and set the layer with PCND at the focal point
of the transducer. PCND were vaporized by ultrasound (5 MHz centre
frequency, 5 cycle bursts, Peak Negative Pressure = 3.5 MPa),
which were irradiated with an arbitrary ultrasound beam control-
ler (Verasonics) and a linear array transducer (EUP-L73S, Hitachi
Aloka Medical). Time-lapse behaviours of PCND through phase changes
were recorded with the high-speed camera (HPV-1A, SHIMADZU),
coupled with inverted microscope (NIKON Eclipse Ti-U). The ambient
temperature (gel phantom temperature) conditions were controlled
with a hot water bath and thermo plate (TOKAI HIT) on the stage of the
microscope.
Fig. 36 (abstract O36). High speed images of vaporization at 26, 48 °C
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First, we observed the vaporization of the two types of PCND at 37 °C.
The high-speed images of vaporization at 37 °C are shown in Fig. 35.
As to MIX (B.P. = 40 °C), generated microbubbles disappeared soon
(within 10 μs) after the ultrasound exposure. On the other hand, as
to PFP (B.P.=29 °C ), generated microbubbles remained for a while
(more than thirty seconds). Because the main difference of these two
types of PCND is the boiling point, we assumed that temperature is
the key factor, and tried to control the difference between the boil-
ing point and the ambient temperature. Then, we did some
vaporization experiment at various temperatures. Some of the high-
speed images of vaporization at 26 °C, 48 °C are shown in Fig. 36.
As to PFP (B.P. = 29 °C), generated microbubbles disappeared
soon after the sonication at 26 °C, although they remained for
some time at 37 °C. As to MIX (B.P.=40 °C), generated microbub-
bles had long lifetimes at 48 °C, although they had very short
lifetimes at 37 °C. It can be considered that the lifetimes of gen-
erated microbubbles are greatly affected by not only the internal
composition, but also the ambient temperature. Besides, behav-
iours after vaporization at 26~48 °C are shown in Fig. 37.
Whether generated microbubbles will remain or disappear was
switched around the boiling point.
Conclusions
We found that the lifetime of microbubble highly depended on the
ambient temperature at the moment of vaporization. This effect has
a potential to be used as indicator of thermal memory effects and
temperature monitoring agents.
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Objectives
Blood Brain Barrier (BBB) protects the brain from most of the pathogen
circulating within the bloodstream. Thus, the BBB renders a difficult
brain penetration for most of the drugs used for brain therapy. Focused
ultrasound has the ability to bypass the BBB in small regions consid-
ered as targets for various drugs such as chemotherapies. Being able to
open the BBB in a restricted focal zone is a necessary step before using
this method for therapies such as drug delivery. Here we developed an
in-house primate-dedicated stereotactic frame mounted on a multiele-
ment focused ultrasound array to perform BBB opening, using combin-
ation of FUS and ultrasound contrast agent (UCA). Stereotactic images
were loaded in a planning software that allows controlling the
localization of the BBB opening. Sonications were real-time monitored
using a passive cavitation detector (PCD) to detect signatures of stable
or transient inertial cavitation originating from the UCA.
Methods
Experiments were conducted on an anesthetized macaque (Macaca fas-
cicularis) each month during one year. Animal was anesthetized with a
mixture of Ketamine (3mg/kg) and dexmedetomidine (15μg/kg) and
Fig. 39 (abstract O37). a. Planning software and target ROI
definition. b. T1 map before BBB opening. c. T1 map after BBB
opening. d. T1 difference between both images, arrow indicates the
BBB opening on the targeted ROI
Fig. 38 (abstract O37). Picture showing the animal within the setup
and inside the MRI
Fig. 40 (abstract O37). Representative spectra obtained with the
PCD. Black color represents the spectrum before injection of UCA,
grey colour represents the spectrum with UCA. More and higher
harmonics are identified when UCA is present. Broadband noise
level is not different with or without UCA
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0.2mg/kg/min). The temperature of the animals was maintained at
~37°C using a heated water blanket. Animal physiology was monitored
during the whole experiment. A homemade stereotactic frame holding
the monkey head was affixed to a 512-element transducer resonating
at 1 MHz (SuperSonic Imagine, France). Images were imported in a
planning software in which all the positions of the head of the monkey
in regard to the transducer were stored, along 6 axis of freedom (2 ro-
tations and one translation for the transducer and one rotation and
two translations for the head). Once the coordinate of the target was
chosen in the stereotactic frame coordinates, the planning software
allowed determining the position of the frame and the transducer. MRI
was performed using a 3T Siemens Verio system (Siemens, Germany).
Body coil was used for excitation and an 8-channel phased-array coil
(Life Services LLC, USA) dedicated to primates was used for reception.
T1 longitudinal relaxation time was obtained at baseline using an
MP2RAGE sequence prior to BBB opening1. Ultrasound excitation
consisted of a 0.6 MPa Peak Negative pressure (as estimated at
focus in the brain) sinusoidal tone burst of 10 ms, with a pulse
repetition frequency of 1 Hz during 120s. Excitation followed a
bolus injection of 1.5 mL of the UCA (Sonovue, Bracco,
Switzerland) and lasted for 2 minutes.
The backscattered signal from microbubbles during insonification
was recorded using a wideband (−6dB bandwidth: 4.5 - 14.4
MHz) transducer (Imasonic, France) acting as a PCD. The PCD was
fixed at the right temporal bone window of the monkey perpen-
dicularly to the FUS beam. This minimizes signal contamination
from the main excitation field.
A bolus of 1.5 mL of an MRI contrast agent (Dotarem, Guerbet,
France) was injected 5 minutes after the end of ultrasound excitation.
A second MP2RAGE dataset was obtained 10 minutes after contrast
agent injection to monitor the localization of the BBB opening result-
ing in a T1 decrease in the region of interest (ROI) induced by the
contrast agent.
A conventional clinical scan consisting on a T1-, T2- and T2*-
weighted MRI and DTI was performed at the end of the experiments
to assess clinical status of the animal.
Results
This study was conducted in a living macaque during one year.
Figure 38 shows the apparatus in position with the monkey and
inside MRI. After BBB opening, T1 decrease was obtained in the
ROI defined by the planning software (example on Fig. 39),
indicating that BBB was opened in the targeted ROI. T1 values
were 1000 +/− 70 ms before and 662 +/ -31 ms after the HIFU
procedure resulting in a ~33% decrease in T1. The size of the
area of BBB opening was 3.2 mm in diameter, and 5.6 mm along
the axis of the beam.
Figure 40 shows the typical spectra obtained before and during infu-
sion of gas microbubbles. Level of harmonics increased significantly
for third (+13.6 dB) and fourth harmonics (+21.6 dB), but no signifi-
cant increase in broadband noise was detected, suggesting that no
transient inertial cavitation occurred during the insonification. After
the experiment, the animal recovered and no side effects were
observed during the 3 weeks following each BBB opening procedure.
At the end of all the BBB opening procedures, T1-, T2- and T2*-
weighted scans and DTI did not show any evidence of tissue damage
(oedema, haemorrhages or bleeding) induced by the ultrasound pro-
cedures (Fig. 41).
Conclusions
The procedure allowed successful repeated transient opening of
the BBB in a small ROI in a living primate with no side effects.
No signatures of transient inertial cavitation were detected during
experiments. This suggests that this method is safe for the
animal. This study will be replicated in other animals with the
long-term objective of developing a system suitable for human
applications.Acknowledgements
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Fig. 42 (abstract O38). a Contralateral side (control) of TH+ stained
neuronal cells. b Ipsilateral side (treated) of TH+ stained neuronal
cells. c Statistical analysis of the averaged TH+ stained neuronal cells
of the two groups
Fig. 41 (abstract O37). a. Colour Coded fractional anisotropy. b. T1-
weighted image. c. T2-weighted image d. T2*-weighted image. No
signs of oedema, haemorrhages or bleeding could be seen 3 weeks
after BBB opening
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Objectives
Currently, the existing Central Nervous System (CNS) drug deliv-
ery techniques are confined to either targeted but invasive or to
non-targeted and non-invasive methods. Focused Ultrasound
(FUS) coupled with the systemic administration of microbubbles
has been proven to open the Blood Brain Barrier (BBB) locally,
transiently and non-invasively, thus facilitating the diffusion of
neurotrophic factors. Neurturin, a member of the glial derived
neurotrophic factors (GDNF) family has been demonstrated to
have restorative effects on the depleted by Parkinson’s disease
dopaminergic neurons (DA). Moreover, our group has shown the
bioavailability and downstream signalling of Neurturin in wild
type mice and the restorative effect in Parkinsonian mice. Despite
the promising results, the potential of multiple treatments with
Neurturin in reversing the disease phenotype is still to be deter-
mined. The aim of the current study was to investigate the neu-
rorestorative effect of triple delivery sessions of the neurotrophic
factor Neurturin in a Parkinsonian mouse model.
Methods
For this study, twelve wild type mice (12 months old) were in-
fused with sub-acute dosages of MPTP causing apoptotic degen-
eration in the nigrostriatal pathway. After the stabilization of the
lesions and the decontamination period, the entire cohort was
sonicated on the left hemisphere (ipsilateral side) targeting twice
the Caudate Putamen region (CPu), to cover the entire area, and
once the Sabstantia Nigra region (SN). Half of the mice received
an IV injection of 0.5mg Neurturin accounting for the treated
group, FUS+/NTN+, while the rest constituted the control group,
FUS+/NTN-. Magnetic resonance imaging (MRI) was performed
after each sonication to verify the accuracy of the BBB opening
in terms of targeting. The procedure was repeated once biweekly
to a total of three treatments. Following the third treatment, the
survival period lasted for 28 days letting the neurotrophic factor
to develop its restorative effects. On the 29th day, the mice were
sacrificed and coronally sectioned for tissue processing. The brain
slices of both the SN and the CPu were stained for tyrosine hy-
droxylase positive cells (TH+) with a custom protocol. The stained
slices were imaged to count the TH+ nerve cell nuclei on the SN
while the axons and dendrites were quantified by a custom
MATLAB algorithm. For each mouse the contralateral side was
compared to the ipsilateral side to eliminate inter-animal
variation in the number of nuclei and projections. A quantifica-
tion algorithm was used to compute the percentage of the rela-
tive difference (RD) between the two hemispheres, i.e., RD =
(Ipsilateral – Contralateral)*100%. The process was repeated forall slices that cover the entire SN region and averaged across the
mice. The error of the technique was measured as the standard
deviation from the mean.
Results
There was no significant difference in the number of neurons be-
tween the ipsi- and contralateral sides. This result was in accordance
with our knowledge of Neurturin restoring impaired neurons and not
regenerating them. The RD was found to be significantly higher for
the FUS+/NTN+ compared to the FUS+/NTN- group. This significance
strengthens with the negative percentage of the FUS+/NTN- group
implying a possible sensitivity of the Parkinsonian brain in multiple
sonications.
Conclusions
These findings indicate a potential of multiple treatments on the re-
versal of the Parkinsonian phenotype as is the first time significance
is reported. To strengthen this argument a second cohort of 20 mice
is currently undergoing the same treatment aiming to apply various
other imaging and quantification techniques to investigate the res-
toration of the functionality of the previously depleted neurons.
Nonetheless, the current findings are essential considering the thera-
peutic effect of multiple treatments with FUS enhanced drug delivery
in patients.O39
Long term effects of single vs repeated low intensity pulsed
focused ultrasound treatment with microbubbles
Zsofia I. Kovacs1, Tsang-Wei Tu1, Georgios Z. Papadakis1,2, William C. Reid2,
Dima A. Hammoud2, Joseph A. Frank1,3
1Frank Laboratory, Radiology and Imaging Sciences, National Institute of
Health, Bethesda, Maryland, United States; 2Center for Infectious Disease
Imaging (CIDI), Radiology and Imaging Sciences, National Institute of
Health, Bethesda, Maryland, United States; 3National Institute of
Biomedical Imaging and Bioengineering, National Institute of Health,
Bethesda, Maryland, United States
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):O39
Objectives
One potential issue for using MR-guided pulsed Focused Ultra-
sound (pFUS) to open the blood brain barrier (BBB) is the lack of
data on the long term effects. Safety determination in the brain
have been limited to the MR characterization after repeated BBB
opening that can be achieved without haemorrhage, oedema and
behavioural changes in non-human primates [1,2]. We use
multimodal imaging technics to characterize long term effects of
pFUS + MB in the rat brain to evaluate the effects of repeated
BBB opening by pFUS and microbubbles (MB) on morphology to
the rat striatum and hippocampus as monitored by magnetic res-
onance imaging (MRI), positron emission tomography (PET) and
histology over 12 weeks.
Methods
Female rats were divided into two groups and received either pFUS +
MB (OptisonTM, GE Healthcare, Little Chalfont, UK) once or six times
targeting the striatum and the contralateral hippocampus. 200 μl of MB
were administered intravenously over 1 minute starting 30 sec before
pFUS. Rats received 3 daily doses of 300 mg/kg 5-Bromo-2′-deoxy-
uridine (BrdU, Sigma Aldrich, St. Louis, MO) intraperitoneally before
sonication to label proliferating cells in vivo.
Fig. 44 (abstract O39). DTI and glucoCEST (9.4T MRI) of the rat
brain (baseline, 1 day, 2 weeks and 3 weeks post pFUS) show
changes in the grey and white matter tract at both sonicated
locations. 2 weeks after pFUS + MB increased fractional anisotropy
on DTI suggests astrogliosis in the striatum (a) and axonal injury in
the external capsule (b). Decreased signal intensity in glucoCEST
indicates lower glucose metabolism at the site of the sonication (a)
Fig. 43 (abstract O39). 3.0T MR images of a rat brain show Gd-
extravasation immediately after pFUS + MB and delayed haemorrhage
at the sonicated tissue (left striatum and right hippocampus) associated
with BBB opening
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1% duty cycle (9 focal points, 120 sec/9 focal points - striatum,
120 sec/4 focal points - hippocampus) using a single-element
spherical FUS transducer (centre frequency 589.636 kHz; focal
number 0.8; aperture 7.5 cm; FUS Instruments, Toronto, Ontario,
Canada). T2, T2* and Gd-enhanced T1-weighted images were ob-
tained by 3.0 T MRI (Philips, Amsterdam, Netherlands), T2, T2*,
diffusion tensor imaging (DTI) and chemical exchange saturation
transfer (CEST) imaging was performed by 9.4 T MRI (Bruker,
Billerica, MA). Parameters for DTI: 3D spin echo EPI; TR/TE 700
ms/37 ms; b-value 800 s/mm2 with 17 encoding directions; voxel
size 200 μm, isotropic. Diffusion weighted images were corrected
for B0 susceptibility induced EPI distortion, eddy current distor-
tions, and motion distortion with b-matrix reorientation using
Tortoise. Parameter for glucoCEST: 2D fast spin echo with (MT)
and without (M0) magnetization transfer (MT) pulses (TR/TE 3.5 s/
11.5 ms; in plane resolution: 200 μm, thickness: 0.8 mm; MT
pulse: 3 μT, 1 s). The MT offset frequencies (Δω) were set from
−2 kHz to +2 kHz with 100 Hz stepping to detect the proton me-
tabolites of glucose (1.2 ppm, 2.1 ppm, 2.9 ppm). Fractional an-
isotropy (DTI-FA) and the asymmetry of magnetization transfer
ratio (MTRasym) were derived for mapping structural injury and
glucose metabolism.
Quantitative of glucose uptake was performed with FDG-PET
(Siemens, Munich, Germany). Each rat received under anaesthesia
(O2 3–4 L/min & Isoflurane at 3–3.5 4%) 0.7 – 1.1 mCi of 18F-
FDG via tail vein injection and was allowed to regain conscious-
ness for an uptake period of 30 minutes in total. They were
anesthetized again and a PET/CT study was acquired using
Siemens Inveon Multimodality scanner (Siemens Medical Solutions
USA, Inc.). CT scan was performed for localization and attenuation
correction purposes. PET images were reconstructed using
OSEM3D/MAP algorithm, with Ramp projection filter, scattered
corrected, 2 OSEM3D iterations, 18 MAP iterations, 128 × 128
image size, and approximately 0.5mm resolution at the centre of
the field of view (FOV).
Animals were euthanized 6 or 12 weeks after the first pFUS treat-
ment. Histological evaluation of brain and tracking of BrdU tagged
cells was performed at different time points. Values were compared
to baseline.
Results
Preliminary results showed contrast enhancement on T1-
weighted MRI in rats receiving a single sonication, indicating
BBB disruption in the striatum and the hippocampus. Gd-
extravasation or T2 and T2* abnormalities were not seen in the
brain 1 day post pFUS + MB at 9.4 T MRI. Hypointense regions
appeared on T2* MRI 2 weeks after pFUS + MB (Figs. 43 and
44) consistently with microhemorrhage within the parenchyma
that decreased in volumes by week 3. White matter fiber struc-
ture- and gray matter-abnormalities on DTI MRI were detected
in regions with T2* abnormalities (Fig. 44) suggestive of in-
creased astrogliosis (Fig. 44a) and transient axonal damage
(Fig. 44b). GlucoCEST showed loss of contrast as early as 1 day
post pFUS and these changes persisted up to week 3 (Fig. 44a).
Qualitative analysis of MRI and GlucoCEST as well as 18F-FDG up-
take with PET showed no difference between the sonicated re-
gion and the contralateral hemisphere 6 weeks post sonication.
Conclusions
We have observed a complex graded molecular and cellular sterile
inflammatory response in the brain up to 24 hrs after pFUS + MB.
However, little is known about the long term effects in rats using ad-
vanced imaging techniques. The DTI data showed that pFUS caused
a low degree of structural injury at the location of sonication. How-
ever, the decrease in glucose concentration revealed by glucoCEST
indicated that the pFUS could cause hypo-metabolism in the brain
even after 3 weeks post sonication. These preliminary results suggest
the importance of long term monitor of the brain following low in-
tensity pFUS + MB.
Further research investigations are in process to evaluate changes
following multiple targeted treatments in the brain.References
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Objectives
Very little is known about the graded cellular and molecular re-
sponses in the brain following pulsed Focused Ultrasound (pFUS)
coupled with microbubbles (MB) exposures being advocated to
increase drug or gene delivery through the disruption of the
blood brain barrier (BBBD). We investigated the proteomic
changes in the brain in response to Pulsed Focused Ultrasound
(pFUS) + intravenous (IV) ultrasound contrast agent MB associated
with BBBD.
Methods
MRI-guided pFUS was performed at 0.3 MPa acoustic pressure, 10 ms
burst length and 1% duty cycle (9 focal points, 120 sec/9 focal
Fig. 46 (abstract O40). Stackplot of significantly increased
expression of both pro- & anti-inflammatory factors over time
following pFUS + MB to the brain. Proteomic profile is observed
with sterile inflammatory response in the brain (Left). Stackplot of
significant mRNA >2 fold mRNA expression at various time
points (0.5, 6 and 12 hrs) post pFUS + MB in the brain. Peak
mRNA expression was observed at 6 hrs post sonication that
persisted to 12 hrs (Right)
Fig. 45 (abstract O40). T2*wMRI at 3.0T performed on day 6 post
pFUS + MB. Recruited Fluorescent (Fl) SPIO labelled splenic
macrophages homing to sonicated brain. FlSPIO (orange), CD68
macrophages (green) and microglia Iba1 (red) are consistent with
injury to brain
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quency: 589.636 kHz; focal number: 0.8; active diameter: 7.5 cm; FUS
Instruments, Toronto, Ontario, Canada). 200 μl of OptisonTM MB (GE
Healthcare, Little Chalfont, UK) were administered IV over 1 minute
starting 30 sec before pFUS. Gd-enhanced T1-weighted images were
obtained with a 3.0 T MRI (Philips, Amsterdam, Netherlands). Quanti-
tative protein and mRNA expression in the brain following pFUS +
MB were analysed with Bio-Plex ProTM Assay (Bio-Rad Laboratories,
Inc., CA), enzyme-linked immunosorbent assay (ELISA), Western blot,
Real-Time PCR (RT-PCR) or immunofluorescent staining. Proteomics
were normalized to sham and statistical analysis was performed by
one-way ANOVA corrected for multiple comparisons. 2 fold increase
in mRNA expression was determined as significant. Rats were
injected with 8 mg/kg Rhodamine encapsulated magnetic polymers
(Biopal Inc., Worcester, MA) 3 days prior to pFUS to tag splenic mac-
rophages. No evidence of damage or microhaemorrhage was ob-
served on histology.
Results
The results of harvested brains at various times post sonication were
as follows:
1. pFUS + MB resulted in BBBD by T1wMRI and by histology
(albumin staining) without evidence of microhaemorrhages;
2. pFUS + MB induced a rapid (within 5 minutes) increased
expression of pro-inflammatory and anti-inflammatory
cytokines, chemokines and trophic factors originating from
components of the neurovascular unit lasting up to 24 hours
post sonication;
3. Proteomic analysis revealed increased heat shock protein 70
(HSP70), tumour necrosis alpha (TNFa), interferon gamma
(IFNg) and interleukin (IL) 1a, 1b, 2, 5, 6, 17 and 18 consistent
with damage associated molecular patterns (DMAP) (Chen and
Nunez 2010) and activation of nuclear factor kappa-light-chain-
enhancer of activated B cells (NFkB) inflammatory pathways
observed with sterile inflammatory response to injury or insult
(Fig. 45);
4. RT-PCR demonstrated activation of inflammatory genes
associated with NFkB pathway along with anti-apoptotic genes,
immune cell chemoattractants, selectins and cell adhesion
molecule (CAM);
5. Evidence of influx of fluorescent bead labelled splenic
macrophages in the brain by day 6 post pFUS along with
activated astrocytes and microglia consistent with mild injury
to the parenchyma.
Conclusions
The temporal molecular response to pFUS + MB is indicative of
sterile inflammatory response (Gadani, et al. 2015) in the
parenchyma originating from neurovascular unit. The pattern of
pro-inflammatory cytokines immediately after pFUS + MB expos-
ure is consistent with sterile inflammation initiated by DAMP that
are released in response to ischemia or trauma associated with
sterile inflammation observed with mild trauma or ischemia [1,2].
Increases in monocyte chemoattractant protein (MCP-1), vascular
endothelial growth factors (VEGF), stromal derived factor 1 (SDF-
1), erythropoietin (EPO) and brain derived neurotropic factor
(BDNF) are associated with BBBD as well as stimulating angiogen-
esis, neurogenesis and stem cells migration consistent with mild
injury following pFUS + MB exposure to the brain. These results
indicate that pFUS + MB rapidly effects to the cerebral vascula-
ture as evident by BBBD in addition to the shockwave from MB
collapse induces mild stress within various cellular elements in
the neurovascular unit.
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Objectives
Burst-mode low-pressure focused ultrasound (FUS) has been shown
to induce transient blood–brain barrier (BBB) opening, and has high
potential for use in non-invasive and targeted delivery of therapeutic
molecules into the brain. FUS-BBB opening requires imaging guid-
ance mean during the intervention, yet current imaging technology
only enables postoperative outcome confirmation. In this study, we
propose an approach to visualize short-burst low-pressure focal
beam distribution that allows to be applied in FUS-BBB opening
intervention guidance.
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An backscattered acoustic-wave reconstruction method based on
synchronization between emission from focused ultrasound and re-
ceiving diagnostic ultrasound elements and passively beam formed
processing were developed. FUS transducers with the frequency ran-
ging from 0.5-2 MHz were employed, and a commercialized diagnos-
tic ultrasound was synchronously integrated with short-burst FUS
excitation (burst length ranging from 0.01 to 10 ms). In-vitro phan-
tom experiments were conducted to evaluate the constructed map-
ping, to quantitatively analyse its performance, and to evaluate the
focal beam reconstruction limit. In vivo experiments with prior MRI
anatomical scans were conducted to verify the feasibility of guiding
the transcranial FUS-BBB opening procedure as well as its BBB-
opened accuracy and reliability on small animals.
Results
A focal beam can be successfully visualized at all FUS frequency ex-
posures (0.5 – 2 MHz) without involvement of microbubbles or
acoustic cavitation triggering. The detectable level of FUS exposure
with 0.467 MPa 0.05 ms single-burst exposure was identified. The sig-
nal intensity (SI) of the reconstructions was linearly correlated with
the FUS exposure both in-vitro and in-vivo (r2 both higher than 0.9).
Conclusions
We confirmed that focal beam pattern can be visualized and allow suc-
cessful guidance of FUS-BBB opening in small animals, with the SI level of
the reconstructed focal beam correlated with the success and level of
BBB-opening. The proposed approach provides a feasible way to perform
real-time and closed-loop control of FUS-based brain drug delivery.Fig. 47 (abstract O41). In vivo treatment example showing the use
of selected FUS exposure level to perform FUS-BBB opening
Table 3 (abstract O42). Imaging Parameters
Pulse Sequence Readout Flip (°) TE (ms) TR (ms) Miscellaneous
FSE 3D 90 76 2500 ETL=100
DESS 3D 15 4.5/37 20.8 Spoiler=10cyc/voxel
FSE Fast Spin Echo, DESS Double Echo Steady State, TE Echo Time, TR
Reception Time, ETL Echo Train LengthO42
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Objectives
Diffusion-weighted imaging has been used to evaluate tissues ab-
lated tissues using MR-guided focused ultrasound (MRgFUS), includ-
ing uterine fibroids, prostate, and brain tissue [1–4]. Quantitative
studies in canine prostate found a 36% reduction in the apparent dif-
fusion coefficient (ADC) after either high intensity ultrasound ablation
or cryoablation of the prostate, despite differences in histology [4].
More recently we studied the evolution of the ADC decrease and
found that the time-course for the onset of ADC decrease afterablation of the canine prostate was inversely correlated to the ther-
mal dose achieved [5]. As a result, areas that saw high levels of ther-
mal dose saw a more rapid irreversible decrease in ADC, making ADC
an early marker for loss of tissue viability in the prostate. Diffusion-
weighted EPI inside of the InSighTec ExAblate 4000 Neuro System
following thalamotomy demonstrates poor image quality. As a result,
T2-weighted imaging is the method of choice for lesion detection in-
side the transducer although it may not be the earliest marker for
ablation. More recently, a double echo in steady state (DESS) pulse
sequence has been proposed to monitor lesion development. DESS
generates two images, the first echo is mostly a gradient echo (GRE),
the second echo is mostly a spin echo with some diffusion weighting
[7]. The purpose of this work was to investigate the time course of le-
sion contrast in a pig model of thalamotomy on a diffusion-weighted
steady state sequence in comparison to T2-weighted FSE. In addition,
we probe the thermal dose dependence of the contrast by evaluat-
ing thermal lesions of two different peak temperatures.
Methods
MRgFUS thalamotomy was performed in a porcine model (n=2) under MR
thermometry guidance. In one lesion in one animal, image collection
began approximately 40 minutes after a low peak temperature sonication
Tpeak = 52°C in the thalamus. In a second animal, two high peak
temperature lesions Tpeak = 60°C were created in the thalamus, and image
collection began immediately. In all cases, double-echo in steady-state
(DESS) and fast spin echo (FSE) T2-weighted imaging acquisitions were in-
terleaved. The parameters for both sequences are summarized in Table 3.
Contrast to surrounding tissue was computed for all time points using re-
gions of interest determined after lesion detection.
Results
Example images demonstrating the lesion on DESS and on FSE after
the lower peak temperature sonication are shown in Fig. 48. The le-
sion demonstrates higher conspicuity in DESS than FSE.
In the quantitative analysis, in all three lesions, DESS provided super-
ior contrast to T2-weighted FSE images at the early time points
(Fig. 49), which equilibrated at the later time points. This is presum-
ably due to the mixed diffusion and T2 contrast for the steady state
sequence. As edema increases, the steady state sequence loses its
advantage over T2-weighted FSE.
Higher peak temperature lesions demonstrate a faster time-course
than the lower peak temperature lesion, seen in Fig. 49. In fact, both
high temperature sonication lesions were conspicuous within
minutes on the DESS sequence.
Conclusions
DESS provides a higher contrast between the lesion and the sur-
rounding healthy tissue early after treatment is completed. This will
allow for an earlier treatment evaluation while the patient is still in
the brain transducer. Future work will include an in-depth simulation
analysis on how both the diffusion weighting and T2-weighting con-
tribute to the lesion detection time-course in FSE and DESS.
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Fig. 49 (abstract O42). Contrast between lesion and surrounding
healthy tissue as a function of time for fast spin echo (FSE) and
Double Echo Steady State (DESS) images. Contrast for DESS is
initially higher for both treatments indicating DESS can serve as an
early indicator of lesion formation in brain treatments
Fig. 48 (abstract O42). Lesion Detection Using Fast spin echo (FSE)
and Double Echo Steady State (DESS) images. Lesion is not visible
with FSE until 60 min while the lesion is detected using DESS
at 46min
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):15 Page 30 of 114O43
Monitoring thermal lesion formation with a steady state mri
sequence in an in-vivo porcine muscle model
Juan C. Plata1, Vasant A. Salgaonkar2, Matthew Adams2, Chris Diederich2
1Radiology, Stanford University, Stanford, California, USA; 2Radiation
Oncology, University of California San Francisco, San Francisco, California,
USA
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):O43
Objectives
The apparent diffusion coefficient computed from diffusion
weighted imaging has been shown to have a 36% signal drop
following tissue destruction with high intensity ultrasound and
cryoablation [1]. Since this MR contrast mechanism is endogen-
ous, previous studies have looked at monitoring the apparent
diffusion coefficient (ADC) [1], or temperature and ADC [2], dur-
ing treatment in order to study the progression of the ADC sig-
nal to assess when tissue viability is lost. More recently, a
double echo steady state (DESS) sequence (Fig. 50) has been
proposed to achieve a similar goal faster and with improved
registration between the temperature images and the lesionmonitoring images [3]. Due to its sensitivity to ADC changes
and its short TR, DESS could serve as a monitoring platform for
both temperature and lesion formation. Since DESS is a steady-
state sequence, there are multiple echo pathways that also
contribute to the measured signal. The first echo, Echo1, is ef-
fectively a gradient echo dominated by free-induction decay from
to the preceding RF pulse. Although there are multiple echo
pathway contributions for the second echo, Echo2, it is mainly a
spin echo of Echo1 of the previous repetition with an effective
echo time of TE2=2TR-TE1. The purpose of this work was to as-
sess whether DESS imaging can provide lesion formation informa-
tion during thermal ablation of in vivo porcine muscle.
Methods
In order to assess the DESS sequence in vivo, interstitial abla-
tions were performed within 40–45 kg farm pigs under MRI
guidance. All animal experiments were reviewed and approved
by our institution’s Administrative Panel on Laboratory Animal
Care (APLAC). MRI compatible interstitial ultrasound applicators,
consisting of a two element array of 1.5 mm x 10 mm tubular
ultrasound transducers, each with independent power control,
were used to generate thermal ablative lesions within in vivo
porcine muscle. The ultrasound applicators, with integrated
water-cooling, were inserted within 13g (2.4 mm OD) Celcon
plastic implant catheters which were placed free-hand 10–12
cm deep into the inner thigh muscles. For each experiment,
two distinct thermal lesions were planned. For the first trial,
thermal ablation was performed using the distal transducer
only; after imaging and allowing time for the cool-down, the
ultrasound applicator was translated back 2 cm within the sta-
tionary catheter for repositioning prior to the second trial. A
second thermal lesion was then produced using the proximal
element. This translation and sequencing from distal to prox-
imal element were used to isolate the thermal lesions. All abla-
tive sonications (n=4) were 10 min in length, with
approximately 5–6 W acoustic power at 7.45 MHz delivered. Ap-
plicator and sonication parameters were chosen to generate cir-
cumferential lesions with an extent of approximately 1cm away
from the active transducer segment. A Double Echo Steady
State (DESS) sequence was developed using HeartVista’s Spin-
Bench and RTHawk platforms in order to monitor thermal le-
sion development. The phase of the first echo of the image
was used to obtain temperature information using PRF therm-
ometry while the magnitude of the second echo was used to
detect lesion induced changes in signal intensity DESS magni-
tude images. At the end of the treatment DESS magnitude im-
ages were compared to contrast enhanced (CE-MRI) and gross
histology.
Results
Temperature information was successfully obtained from the
first echo, and the lesion was monitored using the second echo
(Fig. 51). Lesion extent obtained from the magnitude of the
second echo correlated well with CE-MRI and gross histology
(Fig. 52).
Conclusions
Lesion formation was visible using the proposed DESS sequence,
allowing for more direct lesion monitoring during treatment.
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Fig. 52 (abstract O43). Lesion Extent Comparison. Magnitude images
before and after contrast are compared to the magnitude image of
the final Echo 2 image prior to contrast injection and gross histology
Fig. 51 (abstract O43). DESS Lesion Development. Magnitude
images with a temperature change overlay are shown on the (row
a) and magnitude images in the second echo (row b) are presented.
Lesion development is clearly noticeable in Echo 2 and is present
early during heating with contrast becoming stronger over time
Fig. 50 (abstract O43). DESS Pulse Sequence Schematic. The
Sequence consisted of two echoes a gradient echo (TE = 4 ms) and
a spin echo (TE = 46 ms). A spoiler gradients of 60 cycles/cm or 6
cycles/voxel was used
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Objectives
MR-guided focused ultrasound (MRgFUS) is a non-invasive
technique for the treatment of painful bone metastases. Proton
resonant frequency shift (PRF) thermometry is the standardmethod for monitoring temperature during MRgFUS interven-
tions. It can precisely measure the changes in temperature in
water-based tissues, but fails to detect temperature changes in
bone and in tissues with high lipid content, such as bone
marrow.
Current clinical protocols for bone treatments rely on measure-
ment of the temperature change of adjacent muscle to esti-
mate the temperature of the bone. This approach carries a
significant risk of overtreatment in that more energy might be
used than is needed to ablate the target. In fact, we observe in
HIFU treatments of bone metastases that the highest
temperature in soft tissue is only reached 10–15 seconds after
the end of the sonication. Collateral treatment of the near-field
soft tissues during MRgFUS increases the risk for muscle and
vascular injury, which can result in significant perioperative or
chronic pain.
Deeper penetration of the ablation through the cortical bone
into the bone marrow or tumor is often desired for local con-
trol of osseous lesions. In the treatment of osteoid osteomas,
complete ablation of the nidus is required for pain relief and
to avoid recurrence, but the thickened cortical bone makes
ultrasound penetration difficult. Therefore, temperature meas-
urement within the bone is desirable.
Previous studies have shown a change in T2 of subcutaneous
fat, red and yellow bone marrow in controlled calibration ex-
periments and during treatments with focused ultrasound
(Ozhinsky, et al. J Ther Ultrasound 2015; Baron et al. Magn
Reson Med 2014). The goal of this study was to determine if T2
based thermometry could be used to monitor the temperature
change in ex-vivo and in-vivo bone marrow during focused
ultrasound ablation of intact bone.
Methods
All experiments were performed using an ExAblate 2100 system
(InSighTec, Haifa, Israel) integrated with a 3.0 Tesla MR scanner
(GE Healthcare, Waukesha, WI, USA). Bone marrow T2 was
quantified with a double-echo fast spin-echo sequence with
water suppression (TE = 35/186 ms, TR = 1500 ms, echo train
length = 40, FOV = 32 cm, 128 x 128 matrix size, 10mm slice
thickness, 15 sec/slice).
For ex-vivo validation, we performed MRgFUS ablation in an ex-vivo
porcine femur (sonication: 20 sec, acoustic power: 30 W). The focus
of the sonication was placed in the middle of the marrow, but due
to the high ultrasound absorption of cortical bone most of the en-
ergy is absorbed in the cortical bone.
Focused ultrasound ablation was also performed in a swine
model. All experimental procedures were done in accordance
with NIH guidelines for humane handling of animals and re-
ceived prior approval from the local Institutional Animal Care
and Use Committee. Each of the three animals received 12–14
sonications on femur and ilium bones (acoustic power: 10-35W,
duration: 20–40 sec). As in the ex vivo validation, the focus was
placed in the middle of the marrow. At the end of the focused
ultrasound, pre- and post-contrast 3D Fast SPGR images were
acquired.
Results
Figure 53 shows the results of the ex-vivo experiment, where
we measured a T2 elevation of 269 ms. Assuming the T2/temp
coefficient of 7 ms/°C (Ozhinsky, et al. ISMRM 2014), this corre-
sponds to a temperature rise of 38°. The ex-vivo experiment
shows that it takes on the order of 15 minutes for the marrow
to return to the baseline temperature.
Figure 54 shows the results of the in vivo experiment in a
swine model. We measured a T2 rise of 231 ms within the
bone marrow, which corresponds to temperature change of 33°
C from baseline. The in-vivo experiment showed excellent cor-
respondence between the area of T2 elevation in marrow dur-
ing the ablation and the resulting non-enhancing area in the
post-contrast images.
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In this study we have demonstrated for the first time that T2-based
thermometry can be used in vivo to measure the heating in the mar-
row during bone ablation. The ability to monitor the temperature
within the bone marrow allowed visualization of the heat penetration
into the bone, which is important for local lesion control and treat-
ment of osteoid osteomas. Therefore, T2 based temperature map-
ping, in addition to PRF-based thermometry could be used to
monitor heating during the bone focused ultrasound treatments and
improve safety and efficacy of MRgFUS bone applications.Fig. 54 (abstract O44). T2 Measurement in in-vivo bone marrow:
a T2 map during ablation of a single sonication, showing the
ROI; b post-contrast 3D Fast SPGR image after ablation (total of
six sonications per location) c plot of T2 values within the ROI
over time
Fig. 53 (abstract O44). T2 Measurement in ex-vivo bone marrow
during and after the heating: a Localizer image showing the ultrasound
transducer in the table; b T2 map during heating, showing the ROI;
c Plot of T2 values within the ROI over timeO45
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Objectives
Tissue mimicking phantoms (TMPs) are routinely used for calibration
and quality assurance of medical devices including thermal therapy
applicators prior to their use in clinic. TMPs are also used in thermal
therapy research as alternatives to ex vivo soft tissues and organs as
they possess several advantages including greater availability and
shelf life, high uniformity, and customizability. The efficacy of thermal
ablation therapies depends on several factors including targeting ac-
curacy and temperature elevation in the treated tissue. Thus, an ideal
TMP for thermal therapy applications should have the capacity to re-
port ablated volumes and geometries as well as absolute tempera-
tures. Magnetic Resonance Imaging -guided High Intensity Focused
Ultrasound (MR-HIFU) is a therapeutic technique that can be used to
precisely target and heat tissue non-invasively to induce thermal ab-
lation or mild hyperthermia, among other applications. The objective
of this study was to develop a novel, MR compatible tissue-
mimicking thermochromic (TMTC) phantom for studying and charac-
terizing HIFU devices, heating methods, and sonication parameters.
Specifically, the intent of this work was to develop a phantom that
reports on targeting accuracy, thermal energy deposition, and spatial
heat distribution following HIFU. Additionally, the objective was to
employ the TMTC phantom in characterization of two different HIFU
devices, and to assess the temperatures and distribution of heating
post-HIFU in relation to the treatment plan.
Methods
Polyacrylamide gel phantoms containing silica particles (1.0% w/v),
bovine serum albumin (BSA, 3% w/v), and thermochromic ink (5.1%
v/v, colour change temperature threshold of 60 °C) were produced.
Both a preclinical Therapy Imaging Probe System (TIPS, Philips
Research, Briarcliff Manor, NY) and a clinical MR-HIFU system
(Sonalleve V2, Philips, Vantaa, Finland) were used for HIFU exposures
targeted within the TMTC phantoms. The TIPS system contains an 8
element annular array with an 80 mm focal length, as well as a 2-axis
motion control system to move between targets. The Sonalleve sys-
tem contains a 256-element phased array transducer (focal length =
140 mm), as well as a motion control system with 5 degrees of free-
dom. HIFU exposure parameters for the TIPS were: frequency 1.0
MHz, acoustic power 30 W, with sonication durations of 60, 120, and
180 s. HIFU exposure parameters for the Sonalleve were: frequency
1.2 MHz, acoustic power 100 W, and duration 20–70 s, targeted to re-
gions of 4–16 mm in diameter using electronic steering of the focal
point. Together with the Sonalleve system, a clinical 1.5T MR scanner
(Achieva, Philips Healthcare, Best, the Netherlands) was used for ex-
posure planning and real-time thermometry utilizing the proton res-
onance frequency shift (PRFS) method. In addition, T2-weighted MR
imaging and quantitative T2 mapping were performed to visualize
and characterize thermal lesions within the TMTC phantoms after
both Sonalleve and TIPS sonications. Post-MRI, HIFU-induced colour
changes within the phantoms were identified, photographed, and
compared to the sonication plan as well as to MRI T2 and
temperature maps.
Results
Tissue-mimicking thermochromic phantoms were developed,
produced, and validated for use in characterizing HIFU devices and
sonication methods. HIFU thermal ablations (maximum temperature
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within the phantoms. These colour changes corresponded to max-
imum temperatures recorded using real-time MRI thermometry. A
gradual colour change from yellow to magenta was visible between
40 °C and 64 °C. At temperatures above 64 °C, no further colour
change was observed. In addition, heated volumes were visible on
T2-weighted MRI and T2 maps as regions of permanent hypointen-
sity and of lower T2 values, respectively, due to BSA coagulation. In-
creased HIFU energies and target diameters lead to greater colour
change and a larger volume of colour change, respectively, as well
as, correspondingly, to greater absolute change in T2 and a larger re-
gion of T2 change.
Conclusions
A tissue-mimicking thermochromic phantom was developed to as-
sess the spatial targeting accuracy, maximum temperatures, and
temperature uniformity of HIFU exposures. This TMTC phantom
changes colour (over a range of temperatures that is relevant to ab-
lative HIFU procedures) upon heating, allowing for quantitative mea-
surements of absolute temperature and delineation of heated
regions, and thus may be useful in HIFU device characterization, par-
ameter optimization, quality assurance, and user training. TMTC
phantoms can also provide volumetric temperature information in
experiments where MRI-based real-time thermometry is not feasible,
as the stepwise nature of the colour change associated with changes
in temperature allow for assessment of temperature gradients within
and at the periphery of the heated region.Fig. 55 (abstract O45). a HIFU target planning within a TMTC
phantom performed on T1-weighted MR images using the Sonalleve
therapy planning software. Each of the nine target locations is 12 mm
in diameter. b HIFU thermal ablations produced temperatures above
60 °C as seen on real-time MRI thermometry. A coronal temperature
map for a single sonication location is shown. c Intensity changes (due
to BSA coagulation) on T2-weighted MRI with high spatial accuracy
relative to the treatment plan. d HIFU thermal ablations resulted in
permanent colour changes at the targeted locations within the TMTC
phantom, correlating with the T2 changes and MR thermometry, and
with high spatial accuracy relative to the treatment planO46
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Objectives
During HIFU ablation of abdominal and pelvic lesions, a bal-
ance needs to be established between ablation speed and heat
accumulation in the pre-focal subcutaneous layers, resulting in
a safe but time-efficient intervention. As the de facto standard
form of magnetic resonance thermometry, which is based on
the proton resonance frequency shift, is ill-suited for
temperature monitoring in the adipose tissues, several alterna-
tives have been proposed. Baron et al. (Baron, MRM, 2014) have
demonstrated the feasibility of monitoring heating in adipose
tissue layers using apparent T2 mapping based on dual echo
fast spin echo imaging. A linear (5.2 ms/○C) and reversible T2 -
temperature dependency was shown reproducible over a rele-
vant temperature range.
In this study, the strategy developed by Baron et al. was combined
with reduced field-of-view (FOV) imaging using perpendicular selec-
tion gradients, in the literature referred to as zonally-magnified or
local-look imaging (Mansfield, J. of Phys.,1988). Reducing the FOV in
phase-encoding (PE) direction while preventing fold-over allows to
improve the spatio-temporal resolution of apparent T2-based therm-
ometry. This opens new possibilities such as near-field monitoring
during sonication at relevant temporal resolutions using sequence
interleaving but also high resolution inter-sonication monitoring of
accumulative heating.
Methods
All imaging experiments were performed on a 1.5-T MR Scanner
(Achieva, Philips Healthcare, Best, The Netherlands) using a research
version of the Sonalleve HIFU Platform (Philips Healthcare, Vantaa,
Finland) that is supplied with an integrated four-channel loop coil
and a 16-channel back coil.
Two imaging experiments were performed in this study. Under nor-
mothermic conditions, a volunteer was imaged using a dual echo
fast spin echo sequence, with a single slice placed at the location of
the subcutaneous fat layer (coronal orientation, TE1/TE2: 11/140 ms,
train length: 24 lines/excitation, FOV: 400 x 105 mm2, matrix size:
168 x 48). The purpose of these experiments was to demonstrate
the feasibility of apparent T2-mapping using a reduced FOV in PE
direction.
A next experiment aimed at demonstrating the feasibility of re-
solving a temperature gradient along the subcutaneous fat
layer of a volunteer, comparing a cooled and slightly heated
state. Heating (37○C skin temperature) and cooling (14○C skin
temperature) were achieved using a water-filled cushion to-
gether with a circulation unit, which was placed outside of the
MR room. Skin temperatures were monitored using a fibre optic
probe (Luxtron, LumaSense, Santa Clara, CA), placed between
skin and cushion. Imaging parameters were the following: sin-
gle slice, sagittal orientation, TE1/TE2: 11.8/130 ms, train length:
20 lines/excitation, FOV: 200 x 52 mm2, matrix size: 200 x 40.
In both imaging experiments, the radio-frequency pulse gener-
ating the initial transverse magnetization was implemented as
a fat-selective binomial pulse (1-2-1) and the corresponding se-
lection gradient was oriented parallel and perpendicular to the
imaging slice, respectively. As a consequence, the volume ex-
periencing the spectrally non-selective refocussing pulses was
limited to the subcutaneous tissue layers. This aims at prevent-
ing disturbance of the magnetization in the water compartment
at the location of the focus.
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An overview of the results of the imaging experiment under normo-
thermic conditions is shown in Fig. 56(a-c). Reduction of the FOV in
phase-encoding direction (left-right in the image) was achieved with-
out apparent fold-over artefacts.
Figure 56(d-f) shows the signal intensity at the first echo time
(panel d), the signal intensity at the second echo time (panel e)
and the difference in apparent T2 between the heated and
cooled state as an overlay (panel f, background: intensity at the
first echo time). A gradual change along the anterior-posterior
direction (left-to-right in the image) is observed in the difference
of the apparent T2.
Conclusions
Dual echo fast spin echo imaging in combination with reduced
FOV imaging using perpendicular selection gradients was
successfully shown to allow for apparent T2-mapping with no/
minimal fold-over artefacts under normothermic conditions.
Furthermore, comparing a cooled and slight heated state, a gradi-
ent in the apparent T2 difference could be resolved at high reso-
lution (~1mm). Both examples show the potential of reduced
FOV apparent T2-mapping, enabling near-field monitoring at
improved spatio-temporal resolution. The potential interference in
interleaved T2/PRFS imaging scenarios is currently under
investigation.Fig. 56 (abstract O46). Overview of the result obtained in the two
imaging experiments. The results obtained under normothermic
conditions are shown in panels a-c, where panel a shows the signal
magnitude at the first echo time, panel b the signal magnitude at
the second echo time, and panel c the apparent T2. Panels d-f give
an overview of the results obtained in a sagittal slice under cooled
and slightly heated conditions. Panel d and e show again the signal
magnitude at the first and second echo time, respectively, while
panel f shows the difference in apparent T2 between the heated
and cooled stateO47
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Objectives
Focused Ultrasound (FUS) therapy is a promising approach for treat-
ing cancerous lesions in the body. In addition to cell destruction, FUS
hyperthermia has been shown to have immunomodulatory effects,
increasing dendritic cell infiltration and activating the body's immune
response to reduce metastases and future recurrence [1–2]. However,
the development and understanding of FUS immunomodulation has
been limited by an inability to characterize the immune response
in vivo. This ability would enable optimal timing of ex vivo immuno-
phenotyping, resulting in more efficient and more statistically power-
ful studies with fewer animals. Here we describe and validate a novel
double-transgenic murine model of breast cancer that we have de-
veloped to meet this need.
Methods
A double transgenic PyNGL murine model was bred to express a
nuclear factor-kappaB (NF-kB) reporter transgene (NGL) into the
polyoma virus middle T oncogene model. This mouse exhibits
spontaneous mammary tumour formation comparable to that of
human breast cancer as well as a spatially-resolved, detectable
change in bioluminescence with NF-kB activation, a key factor in
immunomodulatory inflammation. By monitoring bioluminescence
with In Vivo Imaging Systems (IVIS) imaging, tissue collection for
immunophenotyping can be optimally timed. Experiments were
performed to validate the mouse model when treated with FUS.
Baseline luminescence maps were first obtained with IVIS prior to
treatment. Subsequently, FUS thermal treatment was applied with
either hyperthermia (CEM43 < 20) or ablative (CEM43 > 200)
doses with a custom-designed MRgFUS system built in-house [3].
IVIS was used to monitor the change in luminescent inflamma-
tory response every 12 hours after undergoing thermal therapy
until the collection of tissues. This enabled the time of maximum
immune response post-FUS treatment to be localized. Subsequent
mice were sacrificed 48 hours post-treatment (the optimum time
point based on the IVIS data) and analyzed with flow cytometry
for infiltration of immune markers such as T cells (CD3,CD4,CD8), cyto-
kines, and macrophages. Histology sections were taken of the skin, tu-
mours, and spleen to assess cellular damage and composition (results
not shown).
Results
For both treatment groups, a change NF-kB activation was ob-
served with IVIS as soon as 24 hours post-treatment and
reached a peak between 48 and 96 hours, consistent with the
anticipated timeline for recruitment of inflammatory immune
cells. Activation was spatially consistent with the area of
MRgFUS treatment (Fig. 57a) and remained above baseline acti-
vation levels for the duration of luminescent imaging. The var-
ied thermal doses were shown to have different effects on NF-
kB activation - hyperthermia resulted in a consistent decrease in
activation in the treated tumour (n=3) while ablation resulted in
an increase in activation (n = 1) (Fig. 57b). Additional mouse
studies are currently underway to confirm these results. Immu-
nophenotyping revealed a large influx of T-cells 48 hours post-
treatment in response to hyperthermia in comparison to the un-
treated control. Analysis of the ablated tumour tissue revealed
Fig. 58 (abstract O47). A preliminary cellular analysis of treated
tumours excised 48 hours post MRgFUS treatment and analyzed
with flow cytometry. CD3+, CD4+, and CD8+ are cellular markers for
T-cells that are involved in the in vivo immune response. A substantial
difference in immune cell infiltration can be observed between the
treatment groups
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to the control. (Figure 58). No superficial skin burns were ob-
served on the treated mice in the area of applied MRgFUS
treatment.
Conclusions
The use of a novel transgenic reporter mouse with spontaneous
tumor generation enables spatiotemporally-resolved quantification of
the immune response to FUS treatment in vivo. Cell analysis from ex-
cised tissue was supplemented by spatially-localized monitoring of
the in vivo inflammatory immune response. Preliminary results
showed that immune modulation measured by NF-kB activation de-
pends on thermal dose. The increase in infiltrating T cells with hyper-
thermia, and lack thereof in the ablation case, suggests that the
immune response may be more effectively activated by FUS treat-
ment at a lower thermal dose. More experiments are ongoing to fur-
ther explore the difference between thermal doses varying from
hyperthermia to ablation as well as long term studies to investigate
the effect of FUS-induced immune activation on metastases outside
of the primary tumour.
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Objectives
Hypoxia is a common feature of radioresistant tumours, result-
ing in a decreased efficiency of radiotherapy (Harada, 2011).
Several approaches have been proposed to overcome this limi-
tation, including the adjuvant use of hyperthermia and chemo-
therapy. We propose the use of High Intensity Focused
Ultrasound (HIFU) to target these hypoxic regions, which lack
perfusion and so provide good targets for thermal ablation.
One of the challenges when targeting hypoxia is the accurate detec-
tion of poorly oxygenated regions, ideally non-invasively, for treat-
ment planning. Several imaging techniques may be used in clinical
practice for this purpose. Recently Photoacoustic (PA) imaging has
been proposed for distinguishing between oxy- and deoxy-
haemoglobin inside tumours. The technique is based on the gener-
ation of acoustic waves by the tissue after being exposed to short
pulses of light. These waves can be detected using a transducer and
the distribution of optical absorption in tissue is then reconstructed
with US spatial resolution.
For this study, we used PA imaging to detect hypoxia in a radioresis-
tant head and neck tumour model, implanted subcutaneously in
mice. Selected hypoxic regions were targeted with HIFU, under US-
guidance, using a dedicated small animal system, and the outcome
of the treatment was evaluated histologically.
Methods
Twelve female NCr nude mice (6 weeks old) were subcutaneously
injected with 5x105 CALR cells (head and neck tumour model) in the
right flank. Tumours were measured up to 3 times a week, until they
reached a volume of 200–300 mm3.
Animals were imaged using a MultiSpectral Optical Tomography
(MSOT, iThera Medical) device with an excitation wavelength
range of 660–1350 nm (details in Morscher, 2014). Coupling gel
Fig. 60 (abstract O48). Pimonidazole staining section, corresponding
to the tumour in Fig. 59. Hypoxic areas are characterised by bright
green regions, surrounding a (darker) necrotic core, as exemplified by
the blue arrows
Fig. 59 (abstract O48). PA image of control tumour (green ellipse,
300mm3). Red: oxy-haemoglobin; blue: deoxy-haemoglobin
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is placed in a horizontal position in a holder under isoflurane
anaesthesia. Furthermore, they are enveloped in a thin poly-
ethylene membrane as it provides acoustic coupling, before be-
ing submerged in a water tank. Multiple transverse 2D slices of
the tumour were acquired at 680, 700, 715, 730, 760, 770, 800,
850 and 900nm, in 0.5mm steps (from head to tail), and were
reconstructed using interpolated model-matrix inversion
(Rosenthal, 2010). The reconstructed data were multispectrally
unmixed using a linear regression technique to identify the dis-
tribution of oxy and deoxygenated haemoglobin.
Animals were US imaged 24h after PA imaging (injectable anaesthe-
sia: mix of hypnovel, fentanyl and medetomidine), using an E-cube
scanner with a phased array transducer (f=12MHz). Animals were im-
aged in the same direction as in the PA experiment, with a 0.5mm
step between each image acquisition. For the HIFU exposures, a pre-
clinical VIFU2000 (Alpinion) system was used (single element
spherical-focused transducer, 1.5MHz). Although hypoxic regions are
not visible in B-mode images, they are generally distributed around
areas of necrosis that can be identified by their hypoechogenicity.
We compared these regions with those in PA images to define the
target regions, which were exposed using the VIFU system at differ-
ent acoustic power levels in order to define the thermal lesioning
threshold for these tumours. Six animals were HIFU-exposed, at 31.1
+/− 3.1 W (N=2), 26.3 +/− 2.6 W (N=3) and 23.0 +/− 2.3 W (N=1), for
8 seconds, one exposure per tumour. In addition, a Passive Cavitation
Detection (PCD) system consisting of a Precision Acoustics broad-
band sensor, 20 mm outer diameter, weakly focused co-aligned
to the HIFU focal peak and connected to a data acquisition sys-
tem (Spectrum MI.2031, 8-bit) via a 1.5MHz notch filter. A 20dB
pre amplifier was used to record data at a rate of 12x1.5MHz in
5 of the treatments. Broadband activity between 3-9MHz was
analysed to detect inertial cavitation. Animals were allowed to re-
cover for 24h after HIFU, at which point an i.p. injection of pimo-
nidazole (a marker for hypoxia) was given and they were
sacrificed 45min later. Tumour samples were collected, snapped
frozen in cardice and stored at −80°C for histological analysis,
which included pimonidazole and H&E staining.
Results
PA imaging suggested that this tumour model develops a necrotic
core surrounded by hypoxic areas, despite the well vascularised rim
around the tumour, when the volumes reaches ~200 mm3, after ~14-
26 days, (Fig. 59). This was confirmed by H&E and pimonidazole
staining (Fig. 60), although the latter did not show as extensive hyp-
oxic regions as did the PA imaging.
US imaging was able to reliably identify the largest necrotic regions, which
we used to compare with PA images to identify target areas for treatment.
Of the HIFU treatments performed, the lowest acoustic power was inter-
rupted. The remaining exposures resulted in tissue lesioning, observed
after H&E histological analysis, and were identified as further extensive
areas of necrosis and haemorrhage. None of the exposures resulted in skin
burns. One interesting effect was that treated tumours did not take up the
pimonidazole dye, which suggests a significantly reduced tumour perfu-
sion at 24h. Inertial cavitation was detected in both higher power expo-
sures, but not at lower power exposures.
Conclusions
The hypoxia distribution observed with photoacoustic imaging
correlated well with that expected from the literature on this
tumour model (Box et al., 2013). For future studies, we intend
to co-register the PA and US images for a more precise treat-
ment plan and use a larger cohort of animals to validate the
results obtained with both modalities, using the standard histo-
logical techniques - pimonidazole and H&E.
The pimonidazole results, intended to indicate the oxygen distribu-
tion, showed lack of penetration of pimonidazole, probably due to
vascular occlusion, within 24 hours after HIFU treatment, whereas up-
take in control animals processed at the same time was normal. Fu-
ture studies will investigate this effect at different time points aftertreatment, with both post-exposure PA imaging and histological ana-
lysis, and investigating both hypoxia and perfusion staining. The ef-
fects of HIFU on vasculature have been studied before, but it is
important to understand the time course of these effects in pre-
clinical models as this may have a significant impact on the outcome
of combined therapies, such as HIFU-chemotherapy and HIFU-
radiotherapy.
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Objectives
Stem cell therapies are promising regenerative medicine approaches.
Pulsed focused ultrasound (pFUS) induces microenvironmental
changes in normal and diseased tissues that can enhance local hom-
ing and efficacy of intravenously-infused mesenchymal stromal cells
(MSC) and further improve disease outcomes. How pFUS interacts
with tissues to produce the necessary molecular changes is unclear.
Mouse muscle tissue was sonicated at increasing powers while
passive cavitation was measured. Sonicated tissue was harvested for
cyclooxygenase-2 (COX2) expression to correlate with physical ultra-
sound effects, as COX2 expression is critical for molecular signalling
cascades that induce MSC homing. Lastly, mice were given inhibitors
of mechanosensitive channels prior to pFUS to investigate their role
in propagating physiological effects of pFUS.
Methods
C3H mice were treated with pFUS to the hamstring using a VIFU 2000
system. Under ultrasound imaging guidance, pFUS was delivered at 1
MHz, 5 Hz pulse repetition frequency, 5% duty cycle, and varying trans-
ducer output powers (ranging from 10–80 W). Passive cavitation detec-
tion was performed with a hydrophone. Mice were euthanized 16 hr
post-pFUS and harvested muscle was homogenized and analyzed for
COX2 expression by ELISA. For drug studies, mice were given GdCl3
(0.04 mmoles/kg) or ruthenium red (0.01 mmoles/kg) by intravenous in-
jection at the beginning of sonications. Statistical comparisons were
performed by one-way analysis of variance (ANOVA) using Bonferroni
post-hoc tests with p values <0.05 considered significant.
Results
Statistically significant increases in COX2 expression were measured
at 20, 40, 60, and 80 W compared to untreated muscle. COX2 expres-
sion measured after sonications at 60 and 80 W were significantly
greater than COX2 expression after sonications at 20 or 40 W. Statisti-
cally significant increases in cavitation were not observed at 20 or 40
W, but were observed at 60 and 80 W. Increases in COX2 expression
in were blocked at 20 or 40 W when either Gd or ruthenium red
were administered during sonication. Forty watts was previously the
maximum power that produced the necessary molecular changes
without inducing tissue damage and therefore, was the maximum
power investigated in this study.
Conclusions
Mechanical influences from pFUS drive molecular changes in tissue
that are critical to stem cell homing processes. We have previously
determined that COX2 expression is an acceptable proxy for molecu-
lar outcomes. At lower powers (20 and 40 W), cavitation from the
sonications is not detectable, suggesting that cavitation-independent
mechanical forces (i.e., acoustic radiation forces) drive COX2 expres-
sion. At higher powers (60 and 80 W), cavitation is detectable and
COX2 expression is elevated compared to sonications at 20 and 40
W. It is unclear whether the cavitation detected at these powers
drives the additional COX2 expression, or if it is the result of in-
creased acoustic radiation forces at those powers. Regardless, 40 W
was maximum power we previously determined not to cause detect-
able tissue damage and from the point of view of regenerative medi-
cine, would be the maximum power used for those applications. At
these powers, COX2 increases were blocked by Gd, a non-specific
mechanostretch receptor blocker, and ruthenium red, a more specific
blocker of transient receptor potential (TRP) channels. At the powers
used for regenerative medicine, the acoustic radiation forces from
pFUS activate TRP-class calcium channels to initiate the molecular
cascade that necessary to induce stem cell homing.O50
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Objectives
Pulsed focused ultrasound (pFUS) enhances homing of IV-infused
mesenchymal stem cells (MSC) to murine kidneys during cisplatin
(CIS)-induced acute kidney injury (AKI). pFUS acts as a neo-adjuvant
to MSC therapy and the combination leads to better AKI outcomes
(renal function and survival) than MSC alone. In wild-type mice,
nearly twice as many MSC home to diseased kidneys following pFUS,
but >10 times as much interleukin (IL)-10 is produced by MSC that
home to pFUS-treated kidneys. This suggests that pFUS sonications
modify the renal microenvironment to increase potency of MSC that
home to sonicated kidneys. Interferon-g (IFNg) has long been known
to increase MSC potency and has been shown to be upregulated in
kidneys after pFUS. This study investigates the role of IFNg released
by kidneys in response to pFUS improving the therapeutic efficacy of
IV-infused MSC.
Methods
IFNg knockout (KO) mice received CIS (15 mg/kg ip), kidney pFUS (4
MPa; 5% duty cycle) and/or MSC (106 human MSC). Intravenous MSC
injections were performed 3–4 hr post-pFUS. Groups included mice
that had AKI only, AKI+pFUS, AKI+MSC, AKI+pFUS+MSC, and normal
mice. Mice received CIS on Day (D) 0 and pFUS/MSC on D1. Some
mice were euthanized on D2 and kidneys were harvested for mo-
lecular analyses. Other mice were euthanized on D4 to measure renal
function (blood urea nitrogen [BUN]; serum creatinine [SCr]). Statis-
tical comparisons were performed by one-way analysis of variance
(ANOVA) using Bonferroni post-hoc tests with p values <0.05 consid-
ered significant.
Results
Following pFUS to the kidneys of IFNg KO mice, MSC homing to son-
icated kidneys was enhanced ~2 fold compared to untreated contra-
lateral controls. However, increased MSC homing did not lead to
improved AKI outcomes compared to mice that received MSC injec-
tions alone. Levels of BUN and SCr, as well as expression of kidney in-
jury molecule 1 (KIM1), were all significantly reduced by MSC
treatment alone, but not further reduced by combination pFUS/MSC
treatment like was previously observed in wild-type mice. Further-
more, significantly greater human IL-10 (IL-10 produced by MSC) was
not observed in the pFUS+MSC group compared to mice that re-
ceived MSCs alone.
Conclusions
pFUS creates a molecular zip code in AKI kidneys that enhance
homing permeability and retention (EHPR) of infused MSC. While
MSC infusions alone improve AKI to some extent in IFNg KO
mice, the combination of pFUS+MSCs does not yield further im-
provements in disease outcomes like it did in wild-type mice.
This demonstrates the pFUS-independent mechanism of AKI re-
pair by MSCs does not require renal IFNg, but that the pFUS-
dependent mechanism of improved repair/recovery does. It is
likely that the IFNg released by pFUS is not solely responsible for
potentiation of MSCs, but rather works in concert with a number
of other immunological signaling molecules to achieve increased
potency. However, IFNg appears to be the critical link for pFUS
to function as a neo-adjuvant to MSC therapy in AKI as it is re-
leased and/or produced following pFUS. While functional out-
comes correlate with lack of IL-10 production by MSCs in the
IFNg KO mice, further studies will be necessary to elucidate its
role in AKI recovery. These data provide molecular insight to jus-
tify using pFUS as a modality to improve MSC therapy during
AKI, which often has limited therapeutic options clinically.
Fig. 61 (abstract O51). Displacement of HIFU-induced shear-wave
at different time frame (after the first acoustic output pulse), with
constant acoustic power output of 3.72 W, using a) 100 cycles
per pulse, b) 20 cycles per pulse
Fig. 62 (abstract O51). Wavenumber comparison between HIFU-
induced shear-wave using 20 cycles per pulse versus 100 cycles per
pulse, at constant time frame (85.4 μs after acoustic output pulse)
and constant acoustic power of 3.72 W
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Objectives
Focused ultrasound can induce shear-wave when certain require-
ments of acoustic power are met, e.g. pulse length, amplitude,
frequency. Our group recently found that the characteristics of
HIFU-induced shear-wave (HiSW) can be manipulated by changing
different acoustic pulse-length and amplitude. By manipulating
the HIFU pulse, we could control the wavelength and displace-
ment of the HiSW. Our objective is to demonstrate that HiSW
can be manipulated into either i) small and sharp propagating
wave, or ii) long wavelength and large displacement propagating
wave.
Methods
Optical Coherence Tomography with Phase-sensitive technique was uti-
lized for shear-wave imaging. Phase-sensitive Optical Coherence Tom-
ography performs a 256 (time axis) x A-scanlines (depth axis) over the
period of 2 milliseconds at the same location for each HIFU pulse. This
PhS-OCT-scan repeats in 256 different locations (width axis), forming a
complete B-scan dataset over time (3D-dataset). The camera runs at
46200 kHz A-scan rate, exposure 17.4 μs, sensitivity 450 e/count.
Ex-vivo porcine skin is embedded inside 2%-agar phantom to
ensure good contact with HIFU transducer. The HIFU transducer
(2.09 MHz, 20 mm diameter, 13 mm focal length) is placed at
the bottom of the sample. The scanning plane captures the top
surface of the ex-vivo sample, defined by the centre point of
the HIFU focus, and the axial- and lateral-direction of the HIFU
beam.
HIFU-induced shear-wave (HiSW) is captured in reducing num-
ber of cycles per pulse, from 100 cycles/pulse to 20 cycles/
pulse. The captured image is then processed offline for quanti-
tative analysis of the HiSW, regarding the wavenumber of the
HiSW signal.
Results
The displacement of HiSW correlates well with the reduction of HIFU
cycles per pulse. Lowering HIFU cycles-per-pulse number would re-
duce HiSW displacement. A reduction of 80% HIFU cycles-per-pulse
number (100 vs. 20 cycles/pulse) results in a reduction of less than
50% HiSW displacement (approximately 140 nm vs. 90 nm). Reducing
the HIFU cycles-per-pulse parameter also leads to a sharper HiSW,
regarding the peak wavenumber of HiSW (refer to Fig. 62, peak
wavenumber of 4.2 mm- 1 in 100 cycles per pulse, as opposed to
3.7 mm−1 in 20 cycles per pulse). However, the sharper HiSW is
greatly burdened by the relatively short propagation, as the high-
frequency components quickly attenuate over travelling distance.
Conclusions
Understanding the response of HIFU-induced shear-wave (HiSW)
under different acoustic settings, we can adapt HIFU into both diag-
nostic and treatment regime. In particular, our experimental setup
would benefit the diagnostic and treatment of skin cancer at the
same time. PhS-OCT can recover elasticity information from HiSW
speed map. The acoustic power output is relatively low, with Isata
measuring 23.6 mW.cm−2 maximum (100 cycles per pulse, total
acoustic power output of 3.72 W), which is suitable for diagnostic
purposes. By manipulating the acoustic settings, we could either a)
induce a sharp HiSW for tracking purposes, or b) induce a strong
HiSW with long propagating distance for diagnostic purposes, i.e.
elasticity measurement.O52
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Objectives
Traditional transducer designs require a half-wavelength resonator,
posing a lower bound for the size of the transducer. The Langevin
type transducers are common for frequencies of about 30–60 kHz,
comprising a stack of piezoelectric rings pressed to a metal reson-
ator. Their size is about 50–100 mm, depending on frequency and
speed of sound in the resonator material. This type of transducers is
employed in ultrasonic cleaning baths, ultrasonic dental scalers, ultra-
sonic scalpel and in many other applications. The low frequency and
the relatively large displacement-amplitude provided by the trans-
ducer make it ideal to generate cavitation, which may be useful, in
turn, for the fragmentation of solid structures, plaque removal,
tearing and cutting biological material etc.
Fig. 63 (abstract O52). Schematics of the Twin Piezo Motor: 2
piezoelectric bars at opposite polarity are pressed by a central bolt
between the back mass and the tip. The tip is designed to be in
resonance in bending mode at the required frequency
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a miniature low frequency, large displacement-amplitude transducer
of a new design, in which the resonating element is a metallic, beam
shaped tip, vibrating in a transverse (bending) mode. Geometry of
the tip may be adjusted for a resonance in the required frequency
range, while preserving small footprint.
The Twin Piezo Motor is assumed to be capable of generating cavita-
tion in applications where space is heavily restricted. One possible ap-
plication is Ultrasonic Lithotripsy (USL) - breaking kidney stones by
cavitation. The required solution should pass through the urinary tract
over a ureteroscope or a catheter, achieving full contact or getting very
close (<2 mm) to the target stone. Upon activation, the transducer tip
is assumed to generate a cavitation cloud on the adjacent stone sur-
face, causing its fragmentation into small enough pieces.
Methods
We developed a series of transducer models, based on theory and fi-
nite element simulations (COMSOL Inc.). Some of the models had ac-
tually been built and tested. We used electric impedance analysis
(LCR 3532–50, HIOKI Inc.) to locate resonances of the transducer; by
comparison with simulation results we could identify the mode of vi-
bration. Fast camera (Phantom V7.3 Turbo, Vision Research Inc.)
equipped with a 200 mm lens (AF Micro-Nikkor 200mm f/4D IF-ED,
Nikon Inc.) was used to record tip movement and cavitation dynam-
ics in water. The setup enabled recording at frame rate of about
300,000 frame per second. Back illumination was used to enhance
contrast. For driving the transducers we used a function generator
(AFG 1022, Tektronix Inc.) and power amplifier (2100L, E&I ltd.), with
custom transformers for impedance matching.
Results
We started by investigating the dental scaler (Selector U2 Plus, Apoza
ltd.); we showed that it generates intense cavitation in water. Also, it
can fragment a piece of chalk in water. A movie of 300,000 frames
per second was produced, showing the dynamics of a cavitation
cloud on a water-solid interface at a distance of 1 mm from the vi-
brating tip. Another interesting movie demonstrated the generation
of mist by ultrasonic energy.
The transducer of the dental scaler is of the Langevin type; it is quite
large, located inside the hand-piece, and the acoustic vibrations
propagate along a shaft from the transducer to the active tip. We
looked for a method to generate similar tip vibrations, producing the
same results of cavitation, but with much smaller device.
The concept of the Twin Piezo Motor was developed, where the reson-
ance is determined by transverse vibrations of the tip. Two piezoelectric
bars of opposite polarity serve as piezoelectric engine such that when
the left bar elongates, the right one contracts and vise versa. This
combined motion is assumed to excite the transverse mode in the tip.
Finite element simulations supported the design of the transducer, and
first few samples were built, having overall length of 19 mm and width
of 7 mm. The existence of the tip resonance was verified by impedance
analysis: a minimum appeared in the anticipated frequency, and it was
invariant under structural variations of the transducer.
The large amplitude vibration of the Twin Piezo Motor occurs at select-
ive frequency and was demonstrated visually by the generation of mist.
A nice movie at frame rate of 6688 frames per second was recorded.
Conclusions
The design of the Twin Piezo Motor is based on the resonance of the
tip in transverse (bending) mode, with 2 piezoelectric bars at oppos-
ite polarities serving to generate the vibration. We demonstrated the
resonative vibration of the tip and the generation of mist by tip vi-
brations. When the vibratory tip is in full contact with a wet stone,
the device exhibits some grinding capabilities, reducing the size of
the stone. Direct evidence for cavitation in water is still missing. The
simple assembly of the transducer is done by one central bolt hold-
ing the components together. The first samples that we have built
are too big; they have to be further diminished in a factor of 2 or 3
in order to pass through urinary tract.
Fig. 64 (abstract O52). COMSOL simulation of the Twin Piezo Motor:
The resonance frequency is determined by tip transversal vibrations
Fig. 65 (abstract O52). First prototype of the Twin Piezo Motor. The
vibratory tip is located close to the surface of an artificial stone
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Objectives
The application of Focussed Ultrasound (FUS) in upper abdominal
organs is particularly challenging due to complexity of breathing mo-
tion, a multitude of risk structures and possible occlusions through
the rib cage. TRANS-FUSIMO Treatment System (TTS) is a newly de-
veloped software (MEVIS, Fraunhofer, Bremen) enabling Magnetic
Resonance (MR) guided FUS (MRgFUS) in upper abdominal organs.
MR organ motion tracking data is used for a model-based motion
compensation while monitoring the temperature [1]. Due to the
complexity of the system, TTS demands thorough validation before
its use in animal trials. One important system parameter in this evalu-
ation of FUS is the duration of sonication. The delay when starting a
sonication, the deviation from the planned sonication time, and the
delay in the system after a sonication is stopped, needs to be mea-
sured accurately to quantify system performance.
Methods
The evaluated version of the TTS uses the software interface of
Signa 1.5 T MR Scanner (GE Healthcare, UK ) and the transducer
of Conformal Bone System 2100 (CBS) (INSIGHTEC, Israel) . On the
CBS transducer system, steerable sonications are realized by so
called subsonications that have an individual focus position, and
duration. Subsonications are organized in sonication banks and
the active subsonication can be switched during sonication
rapidly (2ms). Starting a sonication on the CBS, however has a
considerable delay of approximately 2–3 seconds. To enable pre-
cise control of the sonication time, TTS employs a sonication
strategy that exploits the short switching times between subsoni-
cations. For example, to start a static sonication, it builds a sonic-
ation bank with two subsonications. The first is a subsonication
with very low power (0.001 W) and a long duration. It is the de-
fault subsonication and used to start the sonication. In the TTS,
this step is called arming the transducer. The second subsonica-
tion has the actually prescribed sonication focus position and
power information. It is activated immediately after the user
choses to start the sonication via the TTS execute command. For
safety reasons, the second sonication’s duration is limited to 250
ms and it is actively looped by the software until the prescribed
duration of the sonication has passed, or until the user stops the
sonication via a stop command (Fig. 66).
The sonication is monitored via single shot EPI MR Sequence of 512
phases, with TE: 26.4, TR: 100, flip angle: 40, freq phase: 128 x 96 pa-
rameters on the MR machine. To synchronise the MR to the TTS, the
MR is configured to start monitoring after a TTL-Trigger pulse sent
from the TTS.
Testing To collect data during sonication, fiber optic hydrophone (Pa
Ltd, UK) was used. The fiber optic hydrophone works on the principle
of interferometric detection of changes in the optical thickness of a
thin polymer film at the tip of the optical fiber sensor downlead.
Changes in the thickness may be induced acoustically (through the
acoustic pressure) or thermally.
The system is capable of differentiating between the two and mak-
ing simultaneous measurements of both (Morris et al. 2009). How-
ever, in this study, the main purpose was to record the signal during
sonication.
Experiment set-up consisted of a water tank filled with degassed
water. Gridded surface sensor holder was placed on the top of
the water tank (Fig. 67). Fibre-optic hydrophone sensor was
mounted on the grid surface. MR Scan was used to find the
exact location of the tip of the sensor. This data was used to
sonicate to the tip of the fibre-optic sensor by using TTS. Fibre-
Fig. 67 (abstract O53). Schematic view of experimental set-up
Fig. 68 (abstract O53). Time diagram for the execution of the
sonication with Trans-fusimo Treatment System
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control unit. Hydrophone system has its own software to control
its hardware. To obtain reading from hydrophone, a computerised
scope such as PicoScope (Picotech, UK) was connected via the
“AC out” connector on the front panel. The system was designed
to have an output impedance of 50 Ohm. PicoScope has two in-
puts, first is the output of the hydrophone, and second is the
monitoring trigger pulse coming from TTS. In order to initiate re-
cording of data, detected by hydrophone, a TTL pulse generated
by TTS, was utilised. The time information for the TTL pulse, the ‘exe-
cute’ command and ‘stop’ commands were recorded as a tag line in
the software (Fig. 68). Deviation during sonication was calculated
as t2- t1 (1). Delay after sonication stop button pressed was cal-
culated as shown below (2) length of the signal on PicoScope
(t3) minus delay in the start time ( t1) during sonication
duration.
Deviation ¼ t2−t1 ð1Þ
Delay ¼ t3− −t1þ t2ð Þ ð2Þ
Picoscope was programmed using LabView (National Instruments, UK)
with 100 ms of time resolution to record the signal simultaneously with
the TTL pulse.
Results
With sonication power of 30W for 30 seconds, the deviation of the
actual sonication duration from the planned duration was found
smaller than 1 second. The time until the transducer stops sonicat-
ing, after the stop button was pressed, was calculated as less than
200 ms.
Conclusions
In this study, feasibility of measuring the deviation of the actual son-
ication and delay after stop button release was tested. The method-
ology described in this study proves that it is possible to quantify
these parameters. With the established methodology, the next step
is to quantify the repeatability and reliability of the system with dif-
ferent sonication timings and power values using the Transfusimo
Treatment Software (TTS) and the conformal bone system transducer.
Transfusimo Treatment System (TTS) is planned to be tested on ani-
mals based on these results.
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Objectives
Acoustic cavitation can be used for in vitro and in vivo gene delivery as
an alternative to viral-based transfection methods.
Gene delivery into expression hosts is one of the first critical
steps in recombinant DNA applications. Commonly used
methods for DNA delivery into useful biotechnology organisms
include, chemically mediated transformation, electroporation
and viral transduction. These methods are often cumbersome,
long and limited to a single or few specific hosts. This work
aims at presenting our development on a confocal ultrasound
device for transfecting eukaryote cells with increased efficiency
and acceptable viability in a reproducible manner or for deliver-
ing functional DNA into Kluyveromyces lactis and Escherichia coli,
respectively a yeast and a bacterium.
Methods
This device is based on two piezo ceramic spherical shells placed in
a confocal manner (1.1 MHz; Diameter and curvature radius 50 mm,
angular gap 90°). This particular configuration is favorable for the ini-
tiation and control of cavitation activity. The crossing of the two
beams forms an interference patterns that traps the bubbles in the
focal zone. The device also integrates a regulation process to control
Fig. 71 (abstract O54). Comparison of sonoporation and
electroporation transfection on 2 cell Lines
Fig. 72 (abstract O54). Yeast and E. coli transformation efficiency
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ultrasound signal as a function of the recorded acoustic response of
the cavitation bubbles. With this control loop, the measured activity
is within 5% of the desired value. The sonicated volume is placed in
2 ml Eppendorf tubes for cells and yeast (650μl) or in 0.2ml tubes for
E-Coli (200μl).
Results
For transfection, the device was evaluated on 11 adherent cell
lines and 10 non-adherent cell lines. The presented results are
limited on Jurkat and K562 cell lines considered difficult to
transfect. The peGFP-C1 transfection efficiency and cell viability
were evaluated 24h post sonication. Results show a proportional
relation between transfection efficiency and cavitation activities
for both cell lines. Optimal transfection rates were 77% and
49% for Jurkat and K562 respectively. The corresponding viabil-
ities were 42% and 84%. These results are comparable to
nucleofection method. On a third adherent cell line, A549, this
exposure condition gave 80% transfection efficiency for 75% of
cell viability.
For transformation, the efficiency was evaluated versus the cavitation
index characterizing the cavitation activity level.
Conclusions
A user-friendly and cost-effective ultrasound device was
developed. It is well adapted for routine in vitro high-yield
transfection and transformation experiments as it does not re-
quire the use of any transfection reagent or gas micro-bubbles.
It provides a well-adapted method for low cost routine pDNA
in vitro delivery for both adherent and non-adherent cell lines
yeast and bacteria. This method allows reducing cost for trans-
formation by sonicating bacteria straight in their culture
medium. Our results confirm ultrasound as an alternative of
non-viral technology for the efficient transient transfection of a
wide range of different cells including non-adherent cells or
fresh human cells, and the preparation of stably transfected
cells.Fig. 69 (abstract O54). Stable GFP expression for K562 Cells and
e-coli bacteria colonies upon sonication
Fig. 70 (abstract O54). Experimental set-up
evaluation versus sonication parametersO55
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Objectives
Currently, no non-invasive cardiac pacing device acceptable for
prolonged use in conscious patients exists. The main approach
is invasive, employing intravascular catheters, which has associ-
ated risks. HIFU can be used to perform remote pacing using
reversibility of electromechanical coupling of cardiomyocytes.
This technique might be useful in the short term in the clinical
settings in various conditions: temporary pacing for bradycardia
or any clinical condition with risks of asystole; terminating or
examining the inducibility of tachyarrhythmia; screening and
optimization of cardiac resynchronization therapy. Here we de-
scribed an extracorporeal cardiac stimulation device and study
its efficiency and safety. We conducted experiments ex vivo
and in vivo in a large animal model (pig) to evaluate clinical
potential of such a technique.
Fig. 73 (abstract O55). a Electrophysiological readings of continuous
ultrasonic pacing of the heart at 120 min-1 (sinus rhythm: 100 min-1).
b Electrophysiological readings of ultrasound-induced non-sustained
ventricular tachycardia (165 min-1, sinus rhythm 85 min-1) performed by
synchronizing the acoustic emission with the relative refractory period.
c-d Example of atrioventricular stimulation with a single ultrasonic
probe. Phased array transducer enables consecutive stimulations of the
RA (yellow pulse) and the RV (red pulse) with a chosen delay. e HIFU
pressure thresholds at the target (peak positive - blue curve- and peak
negative -red curve)) vs ultrasound pulse duration to induce ventricle
stimulation. f Transverse MR images of the anesthetized pig used during
the in vivo proof of concept. g Example of basic electrophysiological
and arterial pressure readings. Arterial pressure is reported to prove
induction of premature ventricular contraction and non-sustained
ventricular tachycardia
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Experiments were performed with an MR-guided HIFU platform
combining a 1.5T MRI (Siemens Avanto, Germany) and a focused
ultrasound device (Image Guided Therapy, France, 256 elements,
13/13 cm aperture/focal, operating at 1 MHz). MR images were
recorded using a balanced steady-state free precession sequence
(TE/TR/FA/BW = 1.36ms/493ms/80°/1149 Hz.pixel−1, spatial reso-
lution 1x1 mm2, slice thickness 3 mm, 256x256, 40 slices, 3 stacks
acquired in transverse, sagittal and coronal orientations) to select
the location of the stimulation site and to adjust beam focusing
characteristics (mechanical positioning and electronic beam steer-
ing). Ex vivo acoustic stimulation threshold was determined per-
forming 756 sonications in the right atrium (83 sonications), the
left (431 sonications) and the right ventricles (242 sonications) in
10 ex vivo beating hearts from pigs. In vivo non-invasive stimula-
tion proof of concept was shown performing 314 sonications in 4
anesthetized pigs including 42 sonications without ultrasound
contrast agent in the first two animals. The last two animals were
injected with ultrasound contrast agents using SonoVue (Bracco,
Italy, mean terminal half-life: 12 min, range from 2 min to 33
min). Two consecutive 0.1 mL.kg−1 boli intravenous injection were
performed in each animal. Local cardiac electrograms (bipolar
measurements) were continuously recorded by three MR-
compatible pacemaker leads (CapSureFix MRI Model 5086,
Medtronic, MN, USA) inserted into the right ventricle, the left
ventricle and the right atrium and connected to a clinical electro-
physiology recording system (Bard Inc., NJ, USA). At the end of
each in vivo experiment, a navigated delayed inversion-recovery
3D Flash sequence was performed (TE/TR/TI/FA/BW = 3.93ms/
714ms/320ms/13°/130Hz.pixel−1, spatial resolution 0.5x0.5 mm2,
slice thickness 2.5 mm, 576x576, 52 slices). The animals were
injected with 0.2 mmol.kg-1 gadoterate meglumine (Gd-DOTA,
Dotarem®, Guerbet, Roissy, France) and scanned 15 minutes post
injection. Gross examination of each heart was performed after
the heart excision. Histological analysis was performed to assess
acute damages screening from acoustic stimulation. Tissue sam-
ples of stimulated heart (N=40) as well as control regions (N=24)
were collected in 4 ex vivo and 4 in vivo hearts.
Results
Using HIFU it was possible to perform ventricular continuous
pacing (A) or to induce ventricular tachycardia (B). Consecutive
stimulations of different heart chambers with a single ultrasonic
probe was shown, allowing to modify the resulting atrio-
ventricular delay (C-D). The results of the 756 stimulation sites
performed in the right atrium (RA, 83 sonications), and the left
and right ventricles (431 and 242 sonications respectively) in 10
ex vivo beating hearts from pigs were processed to determine
stimulation threshold. For each HIFU pulse duration tested ran-
ging from 30 μs to 10 ms, the success of stimulation increases
with the acoustic pressure at focus. Two different pressure
thresholds were highlighted: one around 4MPa peak negative for
HIFU pulse durations above 1 ms and one around 6 MPa peak
negative for HIFU pulses ranging from 50 μs to 1 ms (E). The
same setup was used in vivo in 4 pigs to show clinical potential
(F). Electrophysiological changes were confirmed by arterial pres-
sure modifications (G). The minimal stimulation threshold of 4
MPa negative pressure at the focus (as determined from ex vivo
experiments) could not be reached with our current in vivo
setup. The maximal peak negative pressure was estimated to be
around 2 MPa in situ, due to the limited acoustic window. At this
pressure level, stimulation of the LV was observed but with an in-
sufficient success rate. To overcome this limitation and demon-
strate in vivo feasibility, ultrasound contrast agents were injected
intravenously to enhance HIFU mechanical effects on tissue,
hence decreasing the stimulation threshold. Using this protocol,
consistent cardiac stimulation was achievable for up to 1 hoursessions in 4 different animals. No damage was observed in
inversion-recovery MR sequences performed in vivo in the 4 ani-
mals. No signal increase could be seen in the myocardium in the
delayed-enhancement MR images that would indicate irreversible
injury. Gross pathology and Masson’s staining revealed no differ-
ences between stimulated and control regions, for all the ex vivo
and in vivo cases.
Conclusions
To the best of our knowledge, this study is the first ex vivo and
in vivo proof of feasibility of controlled noninvasive ultrasound-
based cardiac stimulation in large animals. The ex vivo
characterization demonstrated the potential of this technique in
an environment where acoustic parameters were well-controlled
and quantitatively determined the stimulation threshold as a
function of ultrasound pulse duration and amplitude. The
in vivo proof of feasibility performed in large animals showed
that this novel technology offers good prospects for clinical de-
velopments. Encouraging safety results show that acute stimula-
tion during hour-long sessions did not cause any detectable
thermal and mechanical damage under the experimental pa-
rameters used.O56
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Objectives
Extracorporeal acute cardiac pacing by high intensity focused ultra-
sound (HIFU) could be a disruptive technology in the field of cardi-
ology. Two clinical applications in which acute cardiac pacing by
HIFU may be valuable are: (1) preoperative patient screening in car-
diac resynchronization therapy surgery where currently 20-40% of
operations fail; (2) Emergency life support, which may prevent an
event of cardiac arrest from causing sudden death. Both applications
Fig. 74 (abstract O56). Results Highlights. a a Short axis ultrasound
(US) imaging of noninvasive HIFU pacing in a rat. The HIFU focus is
marked by the curser which is placed on the most dorsal part of the
rat’s left ventricle. A sequence of premature ventricular contractions
(PVCs), were successively paced by US guided multi harmony HIFU
insonation. The PVC sequence is marked on the ECG trace. b A rat
heart following HIFU pacing showing no sign of gross damage and
an example of Eosin (H&E) staining showing no sign of inflammation 24
hours post pacing. c-e Numerical simulation results of multi harmony
HIFU pacing in a small animal model cardiomyocyte demonstrating
Premature Action Potentials (PAPs) induction throughout the entire
diastole and showing PAP peak voltage was assumed within the same
temporal delay from insonation onset as was demonstrated by
extracorporeal HIFU pacing in rats. Contractions (PVCs), were successively
paced by US guided multi harmony HIFU insonation. The PVC sequence
is marked on the ECG trace. b A rat heart following HIFU pacing showing
no sign of gross damage and an example of Eosin (H&E) staining showing
no sign of inflammation 24 hours post pacing. c-e Numerical simulation
results of multi harmony HIFU pacing in a small animal model
cardiomyocyte demonstrating Premature Action Potentials (PAPs)
induction throughout the entire diastole and showing PAP peak voltage
was assumed within the same temporal delay from insonation onset as
was demonstrated by extracorporeal HIFU pacing in rats
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While ultrasonic cardiac stimulation was first applied 87 years ago,
the mechanisms of ultrasonic cardiac pacing are yet unknown. Our
work aims to unveil the dominant mechanisms of HIFU cardiac
pacing, using a combined experimental and modeling approach.
Recently, we published results demonstrating HIFU extra systole in-
duction in whole anesthetized rats. Sequences of multi harmony
HIFU paced extrasystoles were obtained owing to adequate spatio-
temporal control, which employed online ultrasound guidance and
real-time vital signs signal processing. An illustration of a sequence
of HIFU paced premature ventricular contractions (PVCs) is presented
in panel A of the figure below. Visual inspection post pacing showed
no indication of gross damage or petechia, histological evaluation
didn’t show staining or signs of inflammation 24 hours post pacing.
Panel B of the figure below shows a heart post HIFU pacing and
histological staining results 24 hours post pacing. Extrasystole induc-
tion was demonstrated temporally throughout the entire cardiac
cycle beyond the absolute refectory period and spatially across the
entire left ventricle. Passive Cavitation Detection (PCD) was applied
in conjunction with US imaging on a gel phantom, and on rats. The
gel phantom was sonicated with a HIFU pacing sequence, PCD posi-
tive cavitation indication was correlated with observed hyperechoic
imaging. Similar PCD indications were recorded during in-vivo HIFU
pacing, while hyperechoic imaging was not observed. Analysis of
these experimental results suggests membrane currents as the dom-
inant cellular level mechanism and cavitation as the dominant ultra-
sound tissue interaction mechanism. The hypothesis we test here
through modeling and simulation is that HIFU induced intramem-
brane cavitation could induce Premature Action Potentials (PAPs) in
a model of a cardiomyocyte by altering the membrane capacitance.
Methods
The Livshitz & Rudy guinea pig LV cardiomyocyte model and O’Hara
et al. human LV cardiomyocyte model were adapted to include vari-
able capacitance induced ionic currents and membrane voltage alter-
ations. Numerical simulation in Matlab was applied to calculate the
temporal membrane capacitance changes due to simulated HIFU
insonation, and the resulting ion and membrane voltage dynamics.
The simulated HIFU insonation reconstructed the minimal peak nega-
tive pressure that was observed to be required for HIFU pacing in
rats.
Results
Numerical simulation results demonstrated HIFU PAP induction
throughout the entire diastole (evaluated by the temporal offset
from the preceding AP peak of the membrane voltage trace). An
illustration is shown in panels C-E of the figure below. The mem-
brane potential is shown in blue. A baseline sinus rhythm was
produced by electrical stimulation at 2Hz, the electrical stimula-
tion is noted by the down facing black bars at 0 and 500ms.
Ultrasonic pacing was applied at different times during the dia-
stole, the ultrasonic pacing is noted by the upward facing red
bars.
Membrane depolarization was gradual, and the ion dynamics com-
position was similar to that of normal sinus rhythm. The temporal
offset between insonation onset and the resulting PAP replicated the
in-vivo observations. Moreover, PAP induction was demonstrated to
occur also during insonation.
Conclusions
The simulation results of a small animal model reproduced our in-
vivo observations. This supports our hypothesis of the suggested
dominant mechanisms. The simulation results of a human cardio-
myocyte model share similar characteristics and attributes to those
of the small animal model, offering the prediction that HIFU pacing
could be performed in humans with the same pacing patterns that
were applied on whole anesthetized rats.
The presented results offer new insights to the study of HIFU pacing
and predict that HIFU pacing may be performed in human subjects
without membrane disruption.
Fig. 75 (abstract O57). Focal spot observation in 3 orthogonal
planes: local maximum pressure is given in arbitrary unit. Focal spot
dimensions: 3x3x10 mm. Cross-sections of the time-reversal cavity
and MSM are shown on the right in light green
Fig. 76 (abstract O57). Bubble clouds formed by simultaneous
targetting of 2 different focal spots on various positions
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Objectives
Ultrasound pulse therapy such as histotripsy or lithotripsy re-
quires focusing very high pressures to mechanically fragment and
liquefy tissues. Large spherical transducers are commonly used to
achieve these pressures at the focal spot and mechanical steering
is then required to treat large regions. Using 2 dimensional arrays
of high power transducers is another possibility, but electronic
steering is still highly limited by the number of elements that
cannot exceed several hundreds for reasons of cost and complex-
ity. In this study, using both numerical simulations and experi-
ments, we have developed a 3-dimentional time reversal cavity
(3D-TRC) to focus high intensity pulses over a large volume only
using electronic steering, and keeping the number of elements to
a minimum.
Methods
We designed a 3D-TRC by enclosing a 3D-multiple scattering
medium (MSM) in a reverberating cavity. We used simulations with
the k-wave software (pseudo-spectral calculation method, B. E.
Treeby and B. T. Cox) and an experimental realisation of our device
to optimise its focussing and steering capacity. In both simulations
and reality, the cavity was 15x13x20 cm, with steel walls, and filled
with water. MSM was either made of steel rods (diameter 0.8mm), or
successive metal grids (wire diameter 0.8mm, size of cell 5 mm).
Transducers were placed in the back of the cavity, opposite the
aperture.
In the simulations, we defined a 119x204x506 matrix, with 0.5
mm grid steps, representing a water volume, in which we placed
the steel cavity. A source was placed in front of the cavity in the
centre or on the side of the aperture, and emitted a 2-cycle
pulse at frequency 1 MHz. Signal was picked up by transducers
in the back of the cavity, and stored. Time reversal focusing (TRF)
then allowed us to refocus these signals on the initial source
point. We explored different kinds of MSM and different sizes
and shapes of transducer elements in the cavity. Particularly, we
compared the performances of our cavity with either a 128-
element linear transducer of high elevational width or an array of
128 square elements of different sizes.
For cavitation experiments, we chose to use 2 high power linear
transducers (128-elements, 1 MHz, Imasonics, Besançon, France),
placed orthogonally at the back of the cavity, sonicating the MSM
with an angle of 60 degrees. The probes were driven by custom
multi-channel electronics (Correlec, France). 40 μs US pulses emitted
through the cavity were temporally spread to up to 1 ms, picked up
by a HGL 200 hydrophone (Onda, Sunnyvale, CA) and stored. Time
reversal focusing (TRF) by compressing these signals in space and
time then allowed us to reach the needed high negative pressures.
Steering the focal spot over a large volume was achieved by moving
the hydrophone. We reemitted the reversed signal at a pulse repeti-
tion frequency (PRF) of 260 Hz to form a bubble cloud, which was
observed using an ultrasound scanner (Supersonic Imagine, Aix-en-
Provence, France).
Results
Simulations showed that an array transducer of square elements
3 λ x 3 λ large, with an MSM made of 2 orthogonal very thin
rod forests gave the best overall performances in terms of focus
quality and steering. Figure 75 shows the focus quality in the
centre of the cavity aperture. We thus tried to reproduce thisconfiguration as well as possible in our experiments, but for prac-
tical reasons had to work with linear transducers instead.
With our real device in a water tank, hydrophone measurements con-
firmed the spatio-temporal focalisation of the signal. Observations in a
plane 10 cm away from the cavity showed a 1.2 x 1.2 mm focal spot,
with a temporal peak less than 2 cycles long. At full power, the peak
pressure obtained at the focus was about 40 MPa (linearly extrapolated
value). These observations were consistent over a large area (−3 dB
area 10x6 cm). The negative pressure obtained was sufficient to
achieve cavitation. It was even possible to generate bubble clouds in
various spots at the same time by emitting the stored signals corre-
sponding to several locations successively at a PRF of 313 Hz between
the different signals and between 16 and 260 Hz overall. Figure 76
shows the bubble clouds formed by the targeting of 2 simultaneous
focal spots. We also succeeded in creating lesions in a slice of ham.
Conclusions
Through simulations and experiments, we designed and optimised a
3D-TRC that allowed us to very locally reach the high negative pres-
sures needed to induce cavitation and create lesions in a simple
target.
We are confident that we could further improve our experimental re-
sults if we fully exploit our simulation results, and move on to a
transducer array.
Fig. 77 (abstract O58). 12-element 1.5 MHz HIFU sector array
transducer integrated with an ultrasound imaging probe (ATL P7-4)
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Objectives
Boiling histotripsy (BH) uses millisecond-long pulses of HIFU shock
waves emitted at low duty cycle to induce localized boiling in tissue
within each pulse. Further interaction of ultrasound with the vapor
cavity for the rest of the pulse results in mechanical fractionation of
tissue into subcellular debris. Our group is developing BH as a non-
invasive treatment of renal and hepatic masses. The feasibility of pro-
ducing single BH lesions in vivo in an exposed porcine liver has been
demonstrated previously. The goal of the present work was to evalu-
ate the feasibility and safety of transcutaneous, volumetric BH abla-
tion of porcine liver and kidney in acute pig studies.
Methods
Pigs (37–40 kg, n=4) were anesthetized and placed on the surgical
table in either lateral (for kidney treatment) or supine (for liver treat-
ment) position. A 1.5 MHz HIFU transducer (12-element sector array
of 7.5 cm aperture, F#=1.07) with a central opening (2 cm) to allow
for ultrasound treatment guidance was attached to a 3D positioning
system and submerged in a degassed water bath coupled to the ab-
domen (Fig. 77). The HIFU focus position, pre-recorded with the ultra-
sound imaging system, was aligned with the targeted region at the
depth of 2.5-4.5 cm from the skin surface. The pulse-average power
output threshold for initiating BH at each location was measured by
sonicating the focal point with BH pulses at gradually increasing
amplitude until a hyperechoic region was observed at the focus, indi-
cating boiling. Prior to the in vivo experiments, similar measurements
of threshold output power were performed in freshly harvested
ex vivo porcine liver and kidney for comparison to the transcutane-
ous in vivo setting. The subsequent in vivo sonications were per-
formed slightly above the threshold (10-15% increase in driving
voltage). The following treatment parameters were used: pulse duration 5
or 10 ms, pulse repetition frequency (PRF) 1 or 2 Hz (with the duty factor
fixed at 1%). A total of 10–30 pulses were delivered per focal point (this
number will be further referred to as BH dose), with the focal points
spaced 1–1.5 mm apart in a rectangular grid with 0.5-1.5 cm linear dimen-
sions. The BH treatment was not gated by or synchronized with the re-
spiratory motion. Following BH exposure, higher resolution ultrasound
assessment of the treated regions was conducted. Necropsy was then per-
formed and the treated portions of the liver and the kidneys were col-
lected for gross and histologic assessment.
Results
Kidney treatments. Lower poles of 7 kidneys were targeted and n=11
volumetric lesions containing cortex, medulla, and renal sinus were cre-
ated. The transducer driving voltage required to initiate the subcostal
transcutaneous treatment in the kidneys was 30 – 50% higher than that
observed in the exposed ex vivo tissue; the partially transcostal expo-
sures (30-40% of the beam obstructed by the ribs) required 120-150%
larger driving voltage. The respiration-induced motion of the target did
not appreciably interfere with the treatment Post-BH, higher resolution
ultrasound images revealed well-defined hypoechoic cavities. At nec-
ropsy no gross evidence of collateral damage was appreciated within
the beam path and no subjects had gross hematuria. On gross inspec-
tion of the kidney, small clots were seen within the collecting system in
all treated kidneys with regions of petechial hemorrhage surrounding a
centrally located fractionated volume of parenchyma. Histologically, all
BH exposures produced completely fractionated cortex sharply demar-
cated from histologically normal untreated tissue (Fig. 78). In themedulla, blood was noted within the collecting ducts with areas of fo-
cally fractionated tissue at higher dose exposures (20–30 pulses per
focal spot). Within the wall of the collecting system, focal petechial
hemorrhage was visualized only at the higher dose exposures without
disruption of the wall.
A treatment acceleration strategy was attempted, in which a smaller
number (10 vs 30) of shorter (5 ms vs 10 ms) pulses were delivered
per focal spot at higher PRF (2 Hz vs 1 Hz) at a larger driving voltage
(15% increase). This strategy reduced the overall treatment time 6-
fold (resulting in the lysis rate of 3.8 cc/hour), yet achieved the same
degree of tissue fractionation as found with the slower treatment.
Liver treatments. Subcostal BH lesions were successfully produced in
two out of three livers where treatment was attempted. The thresh-
old for treatment initiation in terms of driving voltage was larger
than in the ex vivo porcine liver by 70-200% and was also larger than
in the transcutaneous kidney exposures despite very similar treat-
ment depth and body wall thickness.
Most probably, the higher thresholds arose from the aberrative effects of
fat within the HIFU beam, as the central section of the body wall con-
tained a much thicker fat layer compared to that overlying the kidney (1.5
cm vs 0.5 cm). The respiration-induced motion of the target was much
more pronounced compared to the case of kidney treatments, and led to
a noticeable spread of the lesion relative to the planned shape. The hepa-
tocytes in the central region of the lesion were completely fractionated,
while at the lesion periphery the treatment effect was less demarcated.
Connective tissue structure of the liver lobules, as well as the liver capsule
remained intact, consistent with our ex vivo findings (Fig. 78). In the cases
where higher power outputs were used (150-200% increase compared to
the exposed ex vivo liver), bruising and thermal damage confined to the
fatty layer of the body wall were observed.
Conclusions
These data indicate that transcutaneous and partially transcostal
volumetric BH treatment of the kidney and liver is feasible in the por-
cine model. In the kidney, delivering shorter pulses at higher PRF
and higher amplitude with constant duty cycle allowed for more
rapid, yet equally efficacious tissue fractionation. In the liver, the le-
sions were successfully generated through a thicker fat layer, without
control for respiratory motion. The treatment precision and efficacy
can be further enhanced by implementing strategies for phase cor-
rection and gating based on respiratory motion. This work was sup-
ported by NIH R01 EB7643, K01 EB 015745, NSBRI through NASA NCC
9–58, and Urology Care Foundation.
Fig. 78 (abstract O58). Representative photos (left) and tissue
sections stained with hematoxylin and eosin (middle) and
Masson’s trichrome (right) of porcine liver (top) and kidney
(bottom) tissue treated transcutaneously in vivo. Photos show
bisected BH lesions (white arrows) with the contents washed
out. Histological evaluation reveals regions of completely
homogenized tissue (H). Within the lesion, intact collagenous
structures (yellow arrow) were present in both organs treated.
In the kidney, distinct borders with normal tissue (N) were
observed. Small haemorrhagic regions (b) were present in both
tissues within and around the border of the lesions.
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):15 Page 47 of 114O59
Non-invasive, rapid ablation of large tissue volume using
histotripsy
Jonathan E. Lundt, Steven P. Allen, Jonathan R. Sukovich, Timothy Hall,
Zhen Xu
Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, USA
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):O59
Objectives
Current tumour ablation techniques are typically thermal-based, includ-
ing radiofrequency (RF), microwave, and high intensity focused ultra-
sound (HIFU). RF and microwave ablation methods are limited to
treating tumours no greater than 3 cm in diameter and at a rate of ap-
proximately 2 cm3/minute. While HIFU is capable of treating larger vol-
umes, the treatment duration is excessive. Perfusion-mediated
convection (commonly referred to as the “heat sink effect”) presents a
major challenge for thermal ablation in highly vascularized tissues. The
heat sink effect has been shown to prolong treatment times and result
in heterogeneous tissue necrosis. Histotripsy is a noninvasive, non-
thermal, ultrasound ablation method that uses high-amplitude, very
low-duty cycle focused ultrasound pulses to generate controlled cavita-
tion and thereby mechanically homogenize target tissues into liquid-
appearing acellular debris. Our previous in vivo studies have shown that
histotripsy is not affected by the heat sink effect and can produce
homogenous tissue disruption in the highly vascular liver and kidneys
noninvasively through the ribcage and other overlying tissues. Because
histotripsy uses microsecond-duration pulses separated by up to sec-
onds of off-time for a given focus, it is possible to electronically steer
the focus of a phased array transducer to excite cavitation events
throughout a large volume consisting of many overlapping foci during
the off-time period. We hypothesize that histotripsy combined with
electronic focal steering can achieve rapid ablation of a large target vol-
ume. As such, histotripsy can be used to treat tumours that cannot be
treated by RF and microwave ablation at a rate exceeding that of these
methods. This study presents the first investigation of this hypothesis.
Methods
Histotripsy was applied using a 250 kHz, 256-element phased
array transducer with a 30 cm diameter aperture and 15 cmfocal distance, generating 1.5-cycle, 6-microsecond acoustic
pulses. First, to establish treatment parameters including pulse
repetition frequency (PRF) and the number of pulses to deliver, a
single-focus lesion was generated in tissue-mimicking phantoms.
Tissue-mimicking agarose hydrogel phantoms containing a layer
of red blood cells (RBC) allow direct visualization of cavitation
and cavitation-induced damage. Cavitation activity and lesion pro-
gression during histotripsy treatment were monitored by high-
speed optical imaging (Phantom V210, Vision Research) as a func-
tion of PRF and the number of pulses applied. Based on the RBC
phantom results, ex vivo bovine hepatic tissue was treated by
electronically scanning the therapy focus at 200 Hz over 1000
sites (or .2 Hz per focal site). 120 pulses were delivered per site
to cover approximately 43 cm3 and 58 cm3 volumes of target tis-
sue (equivalent to spheres 4.3 cm and 4.8 cm in diameter, re-
spectively) over the course of a total treatment time of 10
minutes. The in situ peak rarefactional pressure amplitude was es-
timated to be 71 MPa at the geometric focus and 49 MPa at the
most distal electronic steering foci. Lesion size and morphology
were assessed by gross sectioning and magnetic resonance im-
aging (MRI). Tissue damage was examined by histology using
haematoxylin and eosin (H&E) staining of 5-micron sections.
Results
RBC phantom results established that fractionation efficacy de-
graded at PRFs above 0.2 Hz and that 120 pulses were sufficient
to homogenize material within the perimeter of a single lesion.
Therefore, 0.2 Hz PRF and 120 pulses per single focus were se-
lected for subsequent ex vivo tissue experiments using histotripsy
with electronic focal steering. Morphology of the single lesion
was approximated as an ellipsoid with an 8 mm major diameter
and a 4 mm minor diameter. Based on the single lesion size, the
center-to-center spacing between adjacent steering foci for elec-
tronic focal steering treatment was selected to be 2.5/3.2 mm in
the lateral plane and 4.1 mm in the axial direction. A total of
nine ex vivo bovine liver tissue samples were treated by histo-
tripsy with electrical focal steering. Results from ex vivo experi-
ments show that a completely homogenized and well-defined
lesion was generated by histotripsy with electrical focal steering
within 10 minutes for all nine treatments. Gross morphology sec-
tioning (Fig. 79a) of ex vivo tissue shows a well-defined region of
damage where the treated tissue was liquefied to homogenate.
After rinsing away liquid-appearing material, only pale, fibrous
structures and vessels larger than about 2 mm in diameter re-
main. MRI (gradient recalled echo sequence) (Fig. 79b) shows a
distinct region of damage with sharp margins of individual foci
clearly visible. Histology (Fig. 79c) shows a sharp transition zone
(~50 microns) between cells with intact cell walls and a region of
scattered cellular material and cell nuclei. For the smaller lateral
spacing (2.5 mm), no intact cells remained in the treatment re-
gion, while a small fraction of scattered cells were observed in
some treatments using larger spacing. MRI 3D volume measure-
ments show the treatment volume to be 43 +/− 6 cm3 for the
smaller spacing and 58 +/− 6 cm3 for the larger spacing (mean
+/− standard deviation), yielding an average ablation rate of 4.3
and 5.8 cm3/minute, respectively.
Conclusions
Treatment of large and multiple tumour nodules remains a
challenge for current tumour interventions, which are mostly
thermal-based. This work demonstrates that histotripsy com-
bined with electronic focal steering achieved homogenous and
complete ablation of a large target volume at a rate two-fold
faster than microwave and RF ablation. Since histotripsy is non-
thermal, the treatment should not be affected by the heat sink
effect and is expected to remain effective and efficient even in
highly vascular organs. With the capability of achieving rapid,
homogenous cell disruption, histotripsy has the potential to
substantially improve upon current tumour ablation methods.
Fig. 80 (abstract O60). BH lesion produced in ex vivo human clear
cell renal carcinoma (left) and benign human kidney cortex (right)
with two different BH doses (10 and 30 pulses, respectively) are
similar in size, demonstrating increased tumour tissue susceptibility
to BH-induced damage compared to benign tissue
Fig. 79 (abstract O59). a Gross morphology of ex vivo bovine liver
sample following treatment and irrigation of lesion with tap water. The
acoustic axis of the transducer was oriented from left to right with
respect to the image. Scale bar: 10 mm (b) MRI of ex vivo sample
following treatment. The scan plane is orthogonal to the acoustic axis
of the transducer and positioned at the geometric focus. Scale bar: 10
mm (c) H&E histology at 400X total magnification. Intact cells can been
seen at the left of the image, fractionated cellular debris and nuclei at
the right. Scale bar: 10 microns
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Objectives
Histotripsy is a pulsed high intensity focused ultrasound (HIFU) tech-
nology that mechanically disrupts targeted tissue without a thermal
effect. Our group has developed boiling histotripsy approach (BH), a
technique that utilizes millisecond-long HIFU bursts to create bubbles
at the focus via rapid shock-induced boiling. Interaction of subse-
quent shocks in the pulse with the ensuing vapor cavity mechanic-
ally homogenizes tissue into sub-cellular micron-sized debris in a
process involving acoustic fountaining. As a noninvasive, non-
thermal approach, BH may have several advantages over existing
clinically available thermal ablative technologies for renal masses.
Preliminary data suggests differential sensitivities to the effects of
histotripsy of specific locations within the kidney, while the sensitivity
of human renal tumours to the effects of BH is unknown. The aim of
this study was to evaluate and compare the effect of BH on samples
of freshly excised human renal tissues and associated tumours
ex vivo.
Methods
Freshly excised human kidneys, benign renal tissue, and renal
tumour tissue were obtained via IRB approved institutional
rapid autopsy and tissue procurement programs. Tissue was ob-
tained from n=11 patients: n=6 whole benign kidneys, n=5
fragments of benign parenchyma, and n=4 tumours (clear cell
renal carcinoma (ccRCC): n=2, papillary RCC: n=1, oncocytoma:
n=1). All specimens were acquired within 4 hours from death/
nephrectomy. Tissue samples were degassed for over 30 mi-
nutes in phosphate buffered saline (PBS) and then embeddedin low melting point agarose gel. Agarose embedded tissue
was then placed in a holder in a bath of degassed PBS. BH ex-
posures were performed under B-mode ultrasound guidance
using a 1-MHz 7-element HIFU transducer (aperture 14.7 cm,
F#=0.95) with the following pulsing protocol: pulse duration of
10 ms, pulse repetition frequency of 1 Hz, peak focal pressures
of p+=88 MPa, p-=17 MPa, shock amplitude of 98 MPa. Single
focal volumes within the tumour sample or the renal cortex,
medulla, or collecting system were treated at various doses de-
fined here as the number of pulses irradiated into a single
focal spot (3–300 pulses/focus). Treated kidneys and tumour
samples were evaluated grossly and/or formalin-fixed for histo-
logic assessment with hematoxylin and eosin staining.
Results
Bh pulses produced hyperechoic bubbles at the focus in all tissue
types consistent with rapid boiling induced by each pulse. Treatment
within the renal cortex and tumour tissue resulted in the develop-
ment of progressively hypoechoic cavities apparent between pulses,
consistent with historipsy treatment effect of homogenizing tissue,
while the feedback was less pronounced in the medulla and collect-
ing system. On inspection, tumour tissue appeared more susceptible
to the effects of BH than benign tissue; lesions created in tumour tis-
sue with 10 pulses were similar in size to those created with 30
pulses in the cortex (Fig. 80). Histologically, evidence of BH induced
tissue homogenization was observed in tumours at much lower dose
threshold of f 5 pulses/focus compared to those in benign tissues:
15–30 pulses/focus in the cortex, 45–60 pulses/focus in the medulla,
and 90–120 pulses/focus in the collecting system.
Conclusions
BH mechanical ablation of human ex vivo renal tumours is feas-
ible, yielding anticipated tissue homogenization. The observed
increased resistance of benign renal tissue to the effects of BH
compared to renal tumours, if confirmed in vivo, may help pre-
serve renal function while providing a margin of safety when
developing BH for clinical ablation of renal tumours. This work
was supported by NIH R01 EB7643, K01 EB 015745, Urology
Care Foundation and National Space Biomedical Research Insti-
tute (NSBRI) through NASA NCC 9–58.O61
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Table 4 (abstract O61). See text for description
200 kHz 320 kHz 850 kHz 1380 kHz
Maximum pressure in water (MPa) 1.0 1.1 2.7 3.6
Estimated maximum pressure in
rat brain (MPa)
2.2 1.4 2.8 3.9
Fig. 81 (abstract O61). Peak pressure spatial distribution (MPa) in
the coronal (top), sagittal (middle) and axial (bottom) planes, in water
(left) and in rat brain (right) at 200kHz
Fig. 82 (abstract O61). Peak pressure spatial distribution (MPa) in
the coronal (top), sagittal (middle) and axial (bottom) planes, in water
(left) and in rat brain (right) at 850kHz
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In order to study the influence of the frequency on transcranial ultra-
sonic stimulation (TUS), we propose to take advantage of the har-
monics of the transducer to investigate a large frequency span with
one single element. We calibrated the transducer in the 200kHz-
1380kHz range and performed numerical simulations to predict the
pressure field that can be generated by this transducer in a rat brain
for the same range of frequencies. The transducer was successfully
used for neuromodulation experiments on rodents at 320kHz.
Methods
We calibrated a single element transducer with resonance peaks at
200kHz, 320kHz, 850kHz and 1380kHz (H115, Sonic Concepts, Bothel,
USA) with a heterodyne interferometer. The pressure in the focal
plane after transmission through pure degassed water was measured
for each frequency with a power ranging from 18 to 75 electrical
watts. Electrical power was generated by a function generator (Han-
dyscope HS5, Tiepie Engineering Sneek, The Netherlands) connected
to a 75 W amplifier (75A250A, Amplifier Research) and input voltage
and current applied to the transducer were monitored with the chan-
nels of the Handyscope (Handyscope HS5, Tiepie Engineering Sneek,
The Netherlands).
The acoustic propagation of focused ultrasound was then simulated
in an entire rat head in order to investigate the pressure amplitude
and spatial distribution as a function of frequency. The simulations
were performed with k-Wave [1], a k-space pseudospectral method-
based solver. 3D maps of the skull, brain and tissues were extracted
from a rat microcomputed tomography scan. Brain and tissues were
assumed to have the same sound-speed and density as water, and
the transducer was modelled as a spherical section (63mm radius of
curvature and 64mm active diameter) with the properties of ceramic.
Rather than keeping the resolution constant when investigating the
influence of frequency, we fixed the ratio of wavelength to the
spatial step to approximately 12 for all simulations. Absorption was
taken into account in the skull (2.7dB/cm/MHz) and in the brain
(0.37dB/cm/MHz) with a 1.01 power law of frequency. A 230μs-
long pulse was simulated, as was used in vivo with the same
transducer [2]. Ultrasound propagate in a cone filled with water
before entering the rat head, the geometrical focal point being
located about 7mm deep from the surface, inside the brain. The
simulations are first performed in pure water and compared to
the amplitude measured experimentally: the scaling factor is used
as a correction factor in order to estimate the absolute pressure
in the rat head.
Results
The values of maximum pressure measured in degassed water and
simulations in rat brain are summarized in Table 4. One can observe
that the same setup is capable of producing more than 1MPa (re-
spectively 1.4MPa) in pure water (respectively in the rat brain) for all
frequencies ranging from 200 kHz to 1380kHz.
The maximum pressure in the coronal (top), sagittal (middle) and
axial (bottom) planes at the geometrical focal spot is displayed in
Fig. 81 for 200 kHz (left) and 850 kHz (right) in a linear scale. As the
propagation axis is along the y direction, top figures show the focal
plane (view from above the animal) and middle and bottom ones in-
clude the propagation path. Stripes originating from standing waves
can be seen for both frequencies (Fig. 81, middle and bottom) but
are more confined in the 850 kHz simulations. In the axial plane the
-6dB area is confined in a 27.5mmx49mm box at 200kHz and 9mm x
25mm at 850kHz.
Conclusions
Simulations show that the same transducer can be used to produce
more than 1.4MPa in a rat brain at 200kHz, 320kHz, 850kHz and
1380kHz, which is higher than the threshold for in vivo TUS in ro-
dents [2]. This work paves the way to exploratory work over a large
bandwidth with one single experimental setup.
This work was supported by the Bettencourt Schueller Foundation
and the "Agence Nationale de la Recherche" under the program
“Future Investments” with the reference ANR-10-EQPX-15.References
[1] B. Cox et al., k-space propagation models for acoustically heterogeneous
media: Application to biomedical photoacoustics, J. Acoust. Soc. Am., 2007
[2] Y. Younan et al., Influence of the pressure field distribution in transcranial
ultrasonic neurostimulation, Med. Phys., 2013
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Objectives
As the effects of focused ultrasound (FUS) in anti-cancer drug
delivery are widely studied, there is growing interest in the
mechanism of how FUS enhances therapeutic effects of drug. In
this study, in vivo experiment for pancreatic cancer in animal
model was designed to investigate whether non-thermal effect
of FUS more effectively enhances the chemo-treatment.
Methods
A pancreatic xenograft model was established by inoculating human pan-
creatic cancer cells (CFPAC-1) in BALB/c nude mouse. Animals were ran-
domly assigned to the following six groups: control, gemcitabine (GEM)
only, FUS1 only, FUS2 only, GEM with FUS1, and GEM with FUS2. Weekly
treatments were performed for three weeks and post-treatment tumour
size monitoring was followed for five weeks. For FUS treatment groups,
animals were sonicated for 20 sec at 1MHz under the guidance of ultra-
sound images. In combined treatment of GEM and FUS, GEM was adminis-
tered in IV immediately after the sonication. At the same total acoustic
energy, acoustic power and the duty cycles were set in two FUS condi-
tions. Acoustic power was 7.5 W for FUS1 and 80.5W for FUS2. Duty cycle
for FUS1 and FUS2 was 50% and 5%, respectively.
Results
Tumour growth rate of animals treated with FUS only (FUS1 & FUS2)
was lower than the rate of control group while it was higher than
the GEM only group. Animals treated with combination of FUS and
GEM showed reduction of tumour growth after two treatments. In
FUS2+GEM groups, tumour size reduced until five weeks after the
treatment procedure was completed (Fig. 83).
Conclusions
In comparison to longer burst with relatively low acoustic pressure that
might have thermal effects on tissue, short burst at high acoustic pres-
sure more effectively control tumour growth in combination with
chemo-agent. This result indicates that mechanical reaction induced by
FUS can more effectively enhance chemotherapy for pancreatic cancer.Fig. 83 (abstract O62). See text for descriptionO63
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Interventional Oncology has been proposed as a group of thera-
peutic procedures that are useful at obtaining local disease
control with minimal invasive techniques. We describe our experi-
ence with Focused Ultrasound in different tumor settings as well
as with different HIFU devices. The 8 years experience of the
HIFU Surgical Oncology Unit of Hospital University Mutua Terrassa
(Barcelona, Spain) and the 3 years experience of the Interventional
Oncology Unit of Institute Khuab Barcelona treating malignant tumors
have recently added a new setting for benign & malignant tumors in
Santa Elena Clinic in Madrid (Spain). We compare our experience with
the reported data in the literature with conventional treatments. We
underline some considerations about the role of tumor ablation in the
Western World stage.
Methods
From February 2008 to December 2015 we have treated more than
150 tumor cases. Of those, more than 50 cases of non-resectable
pancreatic tumors were treated, and we include the first 45 patients
from March 2010 to April 2015 to the analysis. All of them also
underwent systemic chemotherapy with a standard combination. De-
vices employed were the JC system as well as the JC200 of USgHIFU
from HAIFU Chongqing, China. We have recently added a Echopulse
system from Theraclion, France.
Results
The distribution of the 150 cases treated reflects a majority of pan-
creatic and liver tumors. We specifically analyze the pancreatic tu-
mors. Clinical responses (ablation obtained) were 82% in all cases.
We obtained 11 complete responses (25%) at the end of the com-
bined treatment. Major complications included severe pancreatitis
(2), skin burning grade III that required plastic surgery (2), duodenal
perforation (1). Median Survival is 18 month (6 mo – 3.4 year) and
Overall Percent Survival is 33.5% at 5 year follow up.
Conclusions
Focused Ultrasound is an effective and safe Interventional Oncology
ablation of benign & malignant tumors. Compared with reported
data, it shows survival advantage in non- resectable stage III and IV
pancreatic cancer. Interventional Oncology (tumor ablation) needs to
be considered as a novel group of therapies along Medical, Radiation
and Surgical Oncology and re-defined at the light of this experience.
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Objectives
All modern cancer nanotherapeutics, from antibodies and antibody-
drug conjugates to oncolytic viruses, suffer from poor passive accu-
mulation, limited penetration and non-uniform distribution in tu-
mours. The present work seeks to exploit microstreaming mediated
by sustained inertial cavitation to enable the active transport of bio-
logics from the bloodstream deep into the tumour mass.
Methods
A new generation of nanoscale cavitation nuclei, known as polymeric
cups, have been developed both for intra-tumoural and intravenous
administration [1]. The cups have a mean diameter of 480 nm, and
partially encapsulate and stabilize a single air nanobubble of typical
diameter 200–300 nm. Upon exposure to 0.5 MHz ultrasound at in
situ peak rarefactional pressures on the order of 1–2 MPa, the cups
exclusively produce sustained broadband acoustic emissions associ-
ated with inertial cavitation, and generate sustained microstreaming
capable of enhancing the transport of co-administered nanothera-
peutics unbound to the cups. The cavitating cups can be mapped in
real time using a conventional diagnostic ultrasound array and novel
Passive Acoustic Mapping (PAM) algorithms capable of identifying
Fig. 84 (abstract O65). Improved magnitude and distribution of
cavitation using rapid short pulse (RaSP) sequences. SonoVue
microbubbles flowing through an 800-μm-in-diameter tunnel was
exposed to a beam of ultrasound (laterial FWHM: 5 mm). Each image
represents the lateral distribution of acoustic cavitation activity over
time for different exposure conditions (peak-rarefactional pressures:
146–903 kPa, pulse lengths 5, 25, 50, and 16,666 cycles, pulse repetition
frequencies: 1,250 Hz)
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sound exposure [2]. The present work investigates the usefulness of
sustained cavitation mediated by sub-micron cavitation nuclei in en-
hancing the delivery of different types of oncolytic viruses and anti-
bodies in vitro and to solid tumours in vivo.
Results
In vitro experiments consisted of a flow-through channel in an agar gel
as previously described [3]. Little extravasation from the channel was
observed in the absence of cavitation or in the presence of non-inertial
cavitation mediated by ultrasound contrast agents. By contrast, the
generation of sustained inertial cavitation activity mediated by the
polymeric cups enables significant penetration of either small mole-
cules, antibodies or viruses to >200 microns away from the vessel wall.
In vivo experiments were carried out using several cell lines and a
variety of animal models, including CT-26 in BalbC mice, and HEPG-2
and SKOV in CD1-nude mice, first to quantify any enhancement in
delivery and subsequent impact on survival for viruses and antibodies.
Cavitation-enhanced delivery was found to enhance oncolytic virus ac-
tivity in all cases, as quantified by both fluorescene/luminescence and
qPCR, by 1–4 orders of magnitude depending on the type of virus be-
ing delivered. In separate experiments, the distribution of antibodies to
tumours was found to be similarly enhanced, even though the intratu-
moural antibody dose could not be quantified accurately. Cavitation-
mediated delivery significantly inhibited tumour growth both for vi-
ruses and for antibodies, and resulted in much more reproducible
therapeutic responses across different subjects.
Conclusions
Cavitation-enhanced delivery using sub-micron cavitation nuclei, or
polymeric cups, was found to significantly enhance the extravasation,
delivery, intratumoural distribution and therapeutic efficacy of both
antibodies and viruses for a given systemic dose. The ability to map
cavitation activity in real time also offers significant opportunities for
real-time monitoring and optimization of successful delivery. Future
work will focus on optimizing combined drug and polymeric cup
dosing regimes to maximize therapeutic benefit.
References
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Objectives
Acoustic cavitation – the volumetric oscillation of a bubble due
to an acoustic field – is a mechanical force harnessed in thera-
peutic ultrasound to treat diseases. It can dissolve clots, deliver
drugs into cells, deliver drugs across capillaries (e.g., blood–brain
barrier opening), and release drugs from liposomes, but it can
also cause haemorrhage, kill cells, elicit an immune response, and
damage tissue. Current ultrasound parameters have limited con-
trol over acoustic cavitation due to our lack of understanding of
how microbubbles behave in therapeutically relevant acoustic
fields. We introduce a rapid short pulse (RaSP) sequence that has
better control of cavitation (e.g., its distribution) than conven-
tional ultrasound parameters. A subset of this design has been
previously shown to produce greater therapeutic benefits (e.g.,
improved drug distribution) in the context of blood–brain barrier
opening (Choi et al., PNAS 2011). In order to demonstrateimproved dynamics of our RaSP sequence over conventional pa-
rameters, we have performed a multi-dimensional analysis of
cavitation (e.g., type, magnitude, duration, distribution) using pas-
sive acoustic mapping and a high-speed microscopy.
Methods
Traditional therapeutic parameters are composed of long pulses (10–100
ms), which result in microbubble displacement in the axial direction due
to a primary acoustic radiation force, clustering due to secondary acous-
tic radiation forces, coalescence, rectified diffusion, fragmentation, and a
variety of other effects due to acoustic cavitation. Many of these effects
are undesired sources of mechanical stress that can cause damage. To
avoid these effects, we have significantly reduced the length of our
pulses (0.01 ms) while increasing the pulse repetition frequency (10,000
Hz). Our pulse shape and sequence exploits the presence of flow by fa-
cilitating microbubble movement between pulses. A 0.5MHz focused
ultrasound transducer was used to sonicate (PRP: 146-900kPa, PRF: 0.62-
10kHz, PL: 5, 25, 50, and 50,000 cycles) microbubbles (SonoVue) flowing
within a 800-μm diameter tube, while a ATL L7-4 linear array was used
to capture acoustic emissions generated by the cavitation activity. The
type, magnitude, distribution, and duration of cavitation activity was
analysed using passive acoustic mapping and spectral analysis while a
smaller subset of parameters was analysed using a high-speed micro-
scope (5,000 frames per second).
Results
Cavitation persistence during short-pulse excitation increased by 5-fold
at low pressures (<150kPa) when compared to a 100-ms long pulse.
High pressures and long pulse lengths produced high magnitude iner-
tial cavitation during the first millisecond, which rapidly decreased in
energy due to destruction of cavitation nuclei. Cavitation activity was
then biased upstream from the focal point due to new microbubbles
entering the focal volume. High-speed microscopy observations re-
vealed rapid displacement, clustering, and coalescence at these param-
eters. Low pressures and short pulse lengths resulted in a more
consistent magnitude and distribution of cavitation activity throughout
the sequence (figure). High-speed microscopy observations revealed re-
duced clustering rates and reduced axial displacements.
Conclusions
In conclusion, low-pressure rapid short pulse sequences improved
the uniformity of cavitation within the focal volume when compared
to long pulses. This improvement was due to the increased lifetime
and mobility of the microbubbles within the focal volume. Our dem-
onstration of improved spatio-temporal control of cavitation may im-
prove the efficacy of a wide range of therapeutic applications such
as blood–brain barrier opening, sonoporation, and sonothrombolysis,
by enhancing therapeutically relevant cavitation dynamics and elim-
inating unwanted mechanical stress.
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Objectives
The TARDOX study (Oxford, UK, NCT02181075) is a Phase I first-in-
man proof-of-concept study which aims to demonstrate safety and
feasibility of targeted drug delivery using lyso-thermosensitive liposo-
mal systems in combination with mild hyperthermia mediated by
focused-ultrasound (FUS) applied non-invasively. The primary end-
point of the study is demonstration of enhanced intratumoural deliv-
ery of doxorubicin to liver tumours for the same systemic dose of
the drug, when given in liposomal form (ThermoDox®) and released
locally by ultrasound-induced mild hyperthermia.
Methods
In March 2015, a patient with hepatocellular carcinoma and several
liver lesions was recruited to the study and received a single treat-
ment cycle of 50mg/m2 ThermoDox® and FUS. Following an
ultrasound-screening session, a single tumour was selected for FUS-
targeting, estimated to be of volume 13.7cm3 using a volumetric ap-
proximation based on MRI taken the day prior to treatment.
On the day of treatment, the patient was positioned supine over the
water bath of the clinical ultrasound-guided extracorporeal FUS de-
vice (Model JC200 Focused Ultrasound Tumor Therapeutic System,
Haifu Medical). General anaesthesia was induced using high-
frequency jet ventilation to minimise respiratory movements of the
liver. The water temperature was 14.5°C and patient normothermia
was maintained using a controllable heated blanket (Bair Hugger™).
Under portable ultrasound guidance, an 18-gauge co-axial needle
was placed percutaneously (above the water level) into the core of
the target tumour through a sterile field. The central co-axial needle
was instrumented with a clinically approved thermistor, interchanged
with a core biopsy device according to a treatment protocol. A
second, peripheral co-axial needle was placed near to the tumour
margin and was used only for thermometry.
Immediately following the 30-minute intravenous ThermoDox® infu-
sion, the JC200 was used to induce hyperthermia in the target tumour
using a transcostal approach under conditions of real time thermom-
etry. Thermometry data was acquired via a data acquisition unit (Agi-
lent HP34970A) connected to a PC running a custom LabView client.
The FUS hyperthermia strategy and parameters were selected based
on thermometry obtained from previous ex vivo liver tissue using the
same system (presented at 3rd European Symposium on FUS Therapy,
London 2015). Alignment of the JC200 to the central thermistor was
confirmed by low-power test shots. Once the target tumour was con-
toured through the intercostal space, FUS coverage was planned auto-
matically using single shot mode with a 2mm dot interval, over 11
slices each of 2mm thickness, giving a prescribed volume of 10.5cm3 .
The tumour was treated at 50 Watts, 100% duty cycle, row-by-row and
slice-by-slice. Rather than heating slices contiguously, a slice separation
of four was used in an attempt to dissipate heat more rapidly across
the volume and achieve a more uniform bulk temperature rise.
Core tumour biopsies were taken a) prior to drug infusion, b) follow-
ing completion of drug infusion, and, c) following FUS, for analysis of
intratumoural doxorubicin concentration. Biopsy samples were taken
in pre-weighed and watertight eppendorfs, which were reweighed
before analysis. Samples were frozen at −80°C until the day of ana-
lysis, when they were thawed and homogenized. Daunorubicin was
added into each sample pot before extraction as an internal stand-
ard. Solvent extraction was used to obtain both anthracyclines and
their metabolites. A validated high performance liquid chromatog-
raphy (HPLC) assay with fluorescence detection was used to establishthe intra-tumoural concentration of doxorubicin. The ratio of the area
under the curve for doxorubicin : daunorubicin was used to calculate
the doxorubicin concentrations per gram of tissue. Chromatograms
were obtained using Gemini C6-Phenyl guard and analytical columns
with Waters 2695 separations Module and 474 fluorescence detector
(Watford, UK) with excitation 480nm and emission 560nm.
Dynamic contrast enhanced (DCE) MRI, perfusion CT and 18F-FDG PET-
CT imaging was performed the day prior to treatment and at day 17
and 29 post-treatment. An additional DCE MRI was performed the day
following treatment. Response evaluation was performed using princi-
ples of RECIST & CHOI and the SUVmax metric for the target lesion.
Results
The patient recovered smoothly from anaesthesia and was dis-
charged the following day following clinical review, MRI and blood
tests. During the 30-day follow-up period, blood tests were taken at
two and four weeks and no adverse events over grade two were re-
ported (NCI CTCAE V4 toxicity criteria).
On the treatment day, following the drug infusion, one complete
treatment cycle (354 units) was delivered, followed by a partial cycle
(68 units) to maintain hyperthermia over 30 minutes. Post-drug, the
JC200 reported an output of 21.1KJ (50W x 422s), taking 32 minutes
in real time. Thermometry analysis showed the bulk intratumoural
temperature was maintained >40°C for 14m 13s, and >41°C for 50s.
During the FUS treatment period, mean and maximal temperatures
were 39.8°C and 41.8°C respectively. The peripheral temperature was
maintained >38°C for 2m 42s with mean and maximal temperatures
of 37.7°C and 38.8°C respectively.
HPLC analysis for the biopsy taken prior to drug administration dem-
onstrated absence of a doxorubicin peak. Following FUS, HPLC re-
vealed a greater than two-fold increase in intra-tumoural doxorubicin
concentration, from 2.56 to 5.32μg/g.
Both intra-procedural ultrasound and day 1 MRI demonstrated absence
of any changes suggestive of thermal ablation. Subsequent radiological
analysis of the target tumour over the four-week period revealed a de-
crease in attenuation from 75 to 28 Hounsfield units on CT and a reduc-
tion in longest axial dimension from 35mm to 25mm on CT and 34mm
to 26mm on MRI. PET analysis demonstrated a drop in SUVmax from
4.5 to 3.4-3.8. No such response was seen in control tumours.
Conclusions
The use of LTLD with extra-corporeal FUS hyperthermia for targeted drug
delivery in human liver tumours is feasible and may enhance delivery of
doxorubicin and its therapeutic efficacy over LTLD alone. Further cases
treating tumours of a variety of histological types, size and anatomical lo-
cations are needed to support this hypothesis and collate safety data.
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Objectives
Nucleic acid-based therapies provide a powerful approach to the
treatment of genetic diseases but are challenged by limited delivery.
Thus efficient gene delivery strategies are continually being sought.
Here mRNA delivery is investigated as, in contrast to the commonly
delivered plasmid DNA, mRNA does not require opening of the nu-
clear envelope, thereby reducing the level of cell injury necessary for
transfection. We present for the first time an investigation on the effi-
cacy of lithotripter shock waves (SW) assisted mRNA delivery, based
on optimised post-exposure RNA stability and shock wave parame-
ters, in a tissue mimicking system. In addition, we compare SW in-
duced gene augmentation to gene inhibition through the delivery of
siRNA.
Furthermore we aimed to determine the transfectability of dissimilar
cell types as a function of acoustic pressure and number of SW, to
provide insights into the breadth of applicability of SW in the medi-
ation of various gene therapies.
Fig. 86 (abstract O67). Enhancement of lithotripter SW induced
RNA nucleotide delivery. a GFP mRNA delivery using optimal
shock wave parameters resulted in a 6- and 52- fold increase in GFP
fluorescence intensity relative to sham at 24 and 48 hours respectively. A
statistically significant difference (*) was found at the p< 0.05 level. The
flourescence were taken at 48 hours. b representative GFP intensities of
GFP siRNA shock wave treated cells (+ siRNA/ +SW) scramble siRNA
shock wave treated cells (+ scR/ + SW), sham cells (+ siRNA/ - SW) and
controls ( - siRNA/- SW). Below are the flourescence intensities across the
tissue phantom ROI; the dashed lines demarcate the RNA- incorporated
channel. The black arrow represents the direction of SW propagation.
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To optimise SW treatment for optimal transfection, a baseline set of
24 SW conditions was established (n=9 per condition). Three cell
lines varying by disease, organ and organism origin were cultured,
suspended in continually degassed water and spatially subsumed by
the focal zone of a clinical Storz Modulith SLX-F2 electromagnetic
shock wave source. The focal volume was measured to be 7.85 mm x
7.85 mm x 42.40 mm. The acoustic exposure parameters comprised
peak positive (8.6 – 37.0 MPa) and negative (4.1 – 7.0 MPa) pressures,
125 –1000 shock waves and 1–2 Hz PRF (up to 4 Hz at lower ener-
gies due to the capacitance of the shock wave source). Transfectabil-
ity was assessed as the proportion of permeabilised cells (as assayed
by propidium iodide (PI) inclusion) above the proportion of non-
viable cells (as assessed using the MTS assay). The structural and bio-
logical stability of eGFP RNA was determined by gel electrophoresis
and a cell-free in vitro translation method, respectively. Transfections
were measured by fluorometry and conducted using a 2 mL tissue
mimicking system in which cells embedded in 1% purified agar gels
were compartmentalised from a 2.5 mm radius RNA-incorporated
channel.
Results
Transfectability was determined at the tested shock wave conditions
and 2-D interpolation used to determine the optimal SW dose for max-
imal cellular uptake per cell type (murine colorectal carcinoma cells
shown in Fig. 85). Permeabilisation of normal human kidney cells
showed little correlation to SW parameters while poor cell viability re-
covery at 24 hours for human breast cancer cells resulted in marked
cell damage. No statistically significant difference (p<0.05) was found
between stabilities of sham RNA and optimal SW exposed RNA. Deliv-
ery of eGFP mRNA as measured by expression was enhanced 52-fold
by SWs relative to sham treatment (Fig. 86a). A 2-fold decrease in GFP
expression was achieved following SW–mediated eGFP siRNA delivery
to human breast cancer cells stably expressing GFP (Fig. 86b).
Conclusions
While SWs did not discriminate between normal cells and the charac-
teristically permeability-enhanced cancer cells, optimal SW treatment
was cell type specific. Transfection results suggested that SWs may
be a mechanism for achieving gene augmentation, by allowing RNA
stability and significantly enhanced target protein expression in the
absence of external cavitation.Fig. 85 (abstract O67). Transfectability of murine colorectal carcinoma
cells as a function of the number of shock waves (0 – 1000) and
lithotripter energy level 3 (P+ = 8.6 MPa) to 9 (P+ = 37.0 MPa) at 2 HzO68
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Objectives
Pancreas cancer remains one of the deadliest of all types of cancer
and the most difficult to treat. It is currently the fourth leading cause
of cancer death in the United States, and is anticipated to become
the second by 2020. Unlike many other cancers, the survival rate for
pancreas cancer has not improved substantially, with the five-year
survival rate over the past few decades only increasing from 2 to 6%.
Current treatment with conventional chemotherapeutics is ineffective
due to the presence of extensive stromal desmoplasia and reduced
vascular network impeding delivery of chemotherapeutic agents. Our
group has evaluated two effects of focused ultrasound (cavitation
and mild hyperthermia) to enhance the penetration of chemothera-
peutic drug doxorubicin in a genetically engineered mouse model
(KPC mouse) of pancreatic ductal adenocarcinoma. This abstract
presents the culmination of this work to date.
Methods
All experimental procedures were approved by the Institutional
Animal Care and Use Committee of the University of Washington. A
KPC transgenic mouse model was used in all these studies. This
model closely recapitulates the genetic mutations, clinical symptoms
and histopathology found in human pancreas cancer. The tumours
have a differentiated ductal morphology with extensive dense stro-
mal matrix and poorly developed vasculature. Doxorubicin was used
as the chemotherapeutic agent as a proxy to gemcitabine (current
Fig. 87 (abstract O68). Scatter plot of normalized Dox concentration
(the outcome) versus cavitation noise level (a) and cavitation
persistence (b). The outcomes tend to increase with both the
persistence and the noise level. The data from control group
(squares), outcomes from the simultaneous treatment group
(circles) as well as from sequential treatment group (triangles)
are shown. The result lines from generalized estimating equation
(GEE) model of cavitation noise level (a) and cavitation
persistence (b) are also plotted for the simultaneous pHIFU
treatment and Dox administration (dash line) and the Dox
administration after pHIFU treatment (solid line)
Fig. 88 (abstract O68). Box-and-whisker plot of doxorubicin (Dox)
concentration in tumours of KPC mice treated with low temperature
sensitive liposomal doxorubicin (LTSL-Dox) and non-liposomal
doxorubicin (Dox), with and without the application of MR-HIFU.
* denotes significance at the p < 0.05 level
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ically approved available forms.
Cavitation. A preclinical focused ultrasound system (VIFU 2000,
Alpinion Medical Systems), was used for treatment planning, to
apply pHIFU exposures, and monitor cavitation during treat-
ment. The system used either a 1.1 or 1.5-MHz transducer, both
of which had a circular central opening of 38-mm diameter
fitted with a focused ring-shaped transducer for PCD and an
ultrasound imaging probe (C4-12 phased array, center fre-
quency: 7-MHz, Alpinion Medical Systems) for in-line targeting
of the tumour. HIFU focal pressures were applied between 1.6–
12.4 MPa and 2.2–17 MPa for the 1.1- and 1.5-MHz transducers,
respectively. Passive cavitation detectors (PCD), aligned confo-
cally with the HIFU transducers, were used to record broadband
emissions from bubble activity during treatment. The following
cavitation metrics were calculated from the acquired PCD sig-
nals: cavitation probability, cavitation persistence and broad-
band noise level. Doxorubicin (Dox) was administered during or
post pHIFU treatment. The enhancement of drug uptake in the
treated area of the tumour was evaluated by multispectral im-
aging, fluorescence microscopy and high-pressure liquid chro-
matography (HPLC). The untreated area of the same tumour
was used as an internal control. Control animals were not
treated with pHIFU.
Mild Hyperthermia. A clinical Magnetic Resonance-guided High
Intensity Focused Ultrasound (MR-HIFU) system (Sonalleve V1, Philips,
Vantaa, Finland) with a 256-element phased array transducer (focal
length 12 cm, frequency 1.2 MHz) was used to apply the focused
ultrasound exposures. Therapy planning and real time temperature
monitoring was performed using a clinical magnetic resonance
imaging (MRI) system (Achieva 3T, Philips, Best, the Netherlands) and
a dedicated small animal MR receive coil. The MR sequence was
a 2D echo planar fast field echo (FFE-EPI) pulse sequence (TR = 50 ms,
TE = 20 ms, flip angle = 20°, voxel = 0.9 x 0.9 x 4.0 mm3, FOV = 100 x
100 mm2, EPI-factor = 7, parallel imaging (SENSE) factor = 2 (RL),
saturation bands = 3, dynamic scan time = 1.8 s). Mild hyperthermia
treatments were applied (continuous wave ultrasound, acoustic power
7 W) for 10 – 15 minutes, with a binary feedback control algorithm
keeping the temperature between pre-defined threshold temperatures
(Tmin = 41°C, Tmax = 42.5 °C).
Non-liposomal doxorubicin (Dox) or doxorubicin in the form of a
low temperature sensitive liposome (LTSL-Dox) was administered
before treatment. The enhancement of drug uptake in the
treated area of the tumour was evaluated by fluorescence micros-
copy and HPLC. Mice not treated with mild hyperthermia were
used as controls.
Results
Cavitation. Above the cavitation threshold, the doxorubicin concen-
tration in the treated regions of the tumour was significantly greater
compared to the controls. The normalized doxorubicin concentra-
tions were found to be associated with the cavitation metrics
(Fig. 87). The pHIFU exposures associated with high cavitation activity
resulted in disruption of the stromal matrix and enhanced the con-
centration by up to 4.5-fold compared to control animals. The in-
crease in drug concentration was supported by both multi-spectral
imaging and fluorescence microscopy.
Mild Hyperthermia. The MR-HIFU system enabled localized upkeep of
mild hyperthermia within a tight temperature range (41.2 ± 1.3°C) to
a target tissue area 6 mm in diameter. Hyperthermia induced by
ultrasound increased the median doxorubicin concentration within
tumour tissue (Fig. 88) when applied in combination with the sys-
temic administration of low temperature sensitive liposomal doxo-
rubicin (up to 15-fold) or non-liposomal doxorubicin (up to 2-fold)
with no significant differences in cardiac levels of doxorubicin. The
increase in drug concentration in LTSL-Dox + hyperthermia and Dox +
hyperthermia treated animals was supported by fluorescence micros-
copy. None of the tumours showed damage caused by the application
of hyperthermia.Conclusions
Focused ultrasound can be used to induce cavitation or mild
hyperthermia to significantly increase the concentration of
doxorubicin into pancreas tumours in the KPC mouse model.
The promising results in these studies demonstrate two separ-
ate ultrasound-induced techniques that can be used to over-
come the barriers to drug penetration in pancreas tumours.
This work was supported by the Focused Ultrasound foundation
(grant AM01) and US National Institutes of Health (NIH
R01CA154451) from the National Cancer Institute (NCI).
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Objectives
Bisphosphonates (BP) like zoledronic acid (ZOL) have demonstrated
clinical utility in the treatment of patients with bone metastases.
However, ZOL exhibits antitumour effects only at high doses incom-
patible with a clinical use due to renal toxicity. Bisphosphonates ex-
hibit a high affinity for bone mineral, which reduces their
bioavailability for tumour cells. We examined if low intensity ultra-
sound could enhance the effects of a clinically relevant dose of ZOL
in experimental breast cancer and bone metastasis murine models.
Methods
A plane transducer working at a frequency of 2.9 MHz was used. The
free field acoustic power was adjusted between 8 and 13 watts ap-
plied for 30 minutes in order to produce and maintain mild hyper-
thermia (43°C). These parameters enhance locally the temperature in
mice and produce mechanical stimulation without creating cavita-
tion. In vivo experiments were performed in a bone metastases
model and on a subcutaneous tumour xenograft model. Animals
were randomly assigned to different groups (vehicle, ZOL, US, ZOL
+US). Clinically relevant dose of ZOL was used (100 μg/kg). Osteolytic
lesions were detected by radiography. Tumour angiogenesis and
tumour cells proliferation were assessed by immunohistochemistry.
Unprenylated Rap1A, a surrogate marker of the penetration of ZOL
into tumour cells, was observed by Western Blotting. A quantification
of remaining bisphosphonate in bone after ultrasonic treatment was
performed using a fluorescent bisphosphonate (FAM-RIS).
Results
With the acoustic parameters used, no signs of cavitation were found.
Temperature in tumours was 42.0 ± 2.8°C during US treatment. No le-
sion was observed in surrounding tissues. US alone did not have any ef-
fect on bone metastasis and tumour outgrowth. In the bone metastasis
model, mice treated with ZOL+US had osteolytic lesions that were 58%
smaller than those of ZOL-treated animals (p<0.01). ZOL+US also sig-
nificantly decreased skeletal tumour burden. In the animal model of pri-
mary tumours, ZOL+US treatment reduced by 42% the tumour volume,
compared with ZOL-treated animals (p<0.01). In all cases tumour angio-
genesis and tumour cell proliferation were reduced. Using a fluorescent
bisphosphonate, it was demonstrated that US forced the release of bis-
phosphonate from the bone surface, enabling a continuous impregna-
tion of the bone marrow. Additionally, US forced the penetration of
ZOL within tumours, as demonstrated by the intratumoural accumula-
tion of unprenylated Rap1A.
Conclusions
In conclusion, our results demonstrate the potential of low intensity
ultrasound as an effective strategy to force bisphosphonate desorp-
tion from bone and its penetration through tumour tissue, enabling
bisphosphonate antitumour activity (both in bone and outside bone).
Our findings made US a promising modality in oncology to trigger
anticancer therapy with bisphosphonates.
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The in vivo characterization of Gadolinium (Gd) based MRI Contrast
Agents (MR-CA) diffusion within brain extracellular space is of great
interest for the understanding of drug transport in brain parenchyma
in the framework of new pharmaceutical developments for Central
Nervous System diseases. We present here a new method to study
the diffusion process of different MR-CAs after a transient and local
Blood–brain Barrier (BBB) permeabilization induced by ultrasound. By
estimating the Free Diffusion Coefficients from in vitro studies, and
the Apparent Diffusion Coefficients from in vivo experiments, an
evaluation of the tortuosity (λ) in the right striatum of 11 Sprague–
Dawley rats has been performed.
Methods
Four Gd-chelates with different hydrodynamic diameters (dH)
were tested: three commercially available MR-CA (MultiHance,
Gadovist and Dotarem) and a new class of Gd-based nanoparti-
cles (AGuIX, Nano-H). These latest compounds are composed of a
core of polysiloxane, grafted with two or three Gadolinium che-
lates. They are sufficiently small (dH < 5 nm) to escape hepatic
clearance. Diffusion Light Scattering (DLS) measurements were
performed to estimate the hydrodynamic diameter of all com-
pounds (Table 5). The MRI acquisitions were performed with a
7T/90 mm Pharmascan scanner (Bruker). The contrasting power
of each CA is characterized by its longitudinal relaxivity, r1. To
evaluate the CAs’ longitudinal relaxivities at 7T and 37°C, bundles
of tubes containing different CA-concentrations in 0.3% w/w agar
gel were prepared. The T1 values of these tubes were measured
using an IR-FGE sequence, by fitting the signals as a function of
TI (S(TI) = | A-Bexp(−TI/T1*) |, where T1= T1*x[B/A–1]). Figure 89(a)
shows an IR-FGE MR image for one particular TI, and Fig. 89b
shows the signal fits in each tube. From the T1-maps (Fig. 89c)
the longitudinal relaxivity was extracted by the linear fit: R1 = 1 /
T1 = 1 / T10 + r1 x [CA], where T10 is the T1 of the media without
Gd. Relaxivity values r1 are summarized in Table 5 for all com-
pounds. The Free Diffusion Coefficients (DFree) of these com-
pounds were then estimated by injecting 10 μL of a 5 mM
solution in a tube filled with 0.3% w/w agar gel. The diffusion
was followed for 1 hour by acquiring five T1-maps. The tubes
were kept at 37°C during the acquisition. A T10-map acquired be-
fore the injection was used as a reference.
MR-CA concentration maps were then calculated from T1 maps using
the previous equation. On each CA map, the following 2D Gaussian
function (3) was fitted:
CA x; yð Þ ¼ A  exp −a x−x0ð Þ2−b x−x0ð Þ y−y0
 
−c y−y0
 2  ð3Þ
where A is the Gaussian amplitude and (x0,y0) are the coordinates of
its center along the absolute axes (x,y). a, b and c are functions of
the Gaussian spreads (σx and σy) along its main axes (X and Y) and
of the angle θ between these axes and (x,y).
By taking σ2x and σ
2
y as the molecules mean square displacements
along X and Y, the diffusion coefficients along these axes, Dx,vitro and
Dy,vitro, are given by Dx,y,vitro = σ
2
x,y/2t, where t is the time after injec-
tion, i.e. the diffusion time. The Free Diffusion Coefficient was then
calculated as the mean value of Dx,vitro and Dy,vitro. Hydrodynamic
diameter of the CA was deduced from Dfree using the Stokes-Einstein
formula (4):
DFree ¼ kT= 3πηdH
  ð4Þ
where k is the Boltzmann constant, T is the temperature in Kelvinand
η is the viscosity of the agar gel (6.92 x 10−4 Pa.s). Focused ultra-
sound induced BBB permeabilization was then performed in the
right striatum of 11 Sprague–Dawley rats (120 g, Janvier, France).
To do so, we used our previously developed motorized MR
guided transcranial FUS system (Image Guided Therapy, France)
[1]. It enables to position the ultrasound beam in the rat brain at
high precision. A 1.5MHz, 8 channel MR compatible concave
transducer was calibrated and mounted on the system for this
study (Imasonic, France). It was coupled to the shaved rat head
with echographic gel. After reference anatomy, T1 weighted and
Fig. 89 (abstract O70). For each compound the r1 value was
estimated by fitting the IR-FGE signals as a function of TI(S(TI) = |A ‐
B × exp(‐ TI/T1*)|, where T1 = T1* × [B/A ‐ 1]). Fig. a shows an IR-FGE
MR image for one particular TI, and Fig. b shows the signals fits in
each tube. From the T1, and Fig. b shows the signal fits in each tube.
From the T1-maps (Fig. c) the longitudinal relaxivity was extracted by
the linear fit: R1 = 1/T1 = 1/T10 + r1 × [CA]
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follows: sonovue microbubble intravenous injection (Bracco, Italy),
pulsed ultrasound were shot at 0.5MPa (3ms/100ms for 60s).
Then, 200μL of 5mM MR-CA were injected intravenously. The Gd
chelates diffusion starting from the BBB disruption site was
followed by repeatedly acquiring T1-maps for about 1 hour, as
for the in vitro measurements. Animals were kept under general
anesthesia during the whole procedure (1.5% isoflurane).
The same Gaussian fitting procedure was applied and the Apparent
Diffusion Coefficients (ADC) of all compounds in the striatum were
estimated as the average ADC = (Dx,vivo + Dy,vivo)/2.
Results
Figure 89 presents the steps to measure CA longitudinal relaxiv-
ities. Figure 90a shows examples of in vitro CA-maps obtained for
MultiHance. The fitted 2D-Gaussian functions are presented in
Fig. 90b, whereas in Fig. 90c the linear fit on their spreads is
plotted. Figure 91 shows an example of in vivo dataset acquired
by injecting Dotarem in one rat after focal BBB disruption. In
Fig. 91a the original CA maps acquired within 66 minutes after
the CA injection are pictured, and their respective Gaussian fits
are shown in Fig. 91b. The linear fit over these Gaussian spreads
is given in Fig. 91c. As can be noticed in Table 5, both DFree and
ADC are decreasing with increasing hydrodynamic diameters
(Dotarem > Gadovist > MultiHance > AGuIX). Furthermore, quan-
titative values of hydrodynamic diameters deduced from Dfree
measurements are really consistent with DLS measurements. The
ADC values have been used to estimate tissue tortuosity λ=(DFree/
ADC)0.5 (Table 5), showing a very good agreement with the tortu-
osities evaluated with more standard techniques [2].
Conclusions
The agreement between the values of λ found after the blood–
brain barrier permeabilization and the known values typical of
healty brain tissue confirms the validity of this method to esti-
mate the ADC values in the tortuous regime, but also that the
diffusion properties of the tissue are not altered by the ultra-
sound induced BBB permeabilization protocol unlike by direct in-
tracerebral injection [3]. This should be taken into account for
CNS drug development since pharmacodynamics might be modi-
fied by direct injection.
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[3] Marty et al., CMMI 2013, 8: 12–9Table 5 (abstract 70). Extracted parameters for each compound (Dotarem,
Gadovist, MultiHance and AGuIX). Notably, the apparent dH estimated from
the Stokes-Einstein equation is in agreement with DLS measurements, and
both DFree and ADC values decrease when molecular size increases. The


















Dotarem 3 4.7 45 16 1.5 1.4 1.7
Gadovist 3 5.5 39 15 1.7 1.8 1.6
MultiHance 3 7.3 28 11 2.3 2.3 1.6
AGuIX 2 8.0 11 6 5.8 3.5 1.5
Fig. 90 (abstract O70). In vitro diffussion of MultiHance:
a concentration maps and their repective 2D Gaussian fits (b)
acquired during 1 hour CA injection in 0.3% w/w agar gel.
Fig. c shows the squared Gaussian spreads as a function of time
and their fits (σ2x,y = 2t × Dx,y vitro)
Fig. 91 (abstract O70). In vitro diffusion of Dotarem in the frontal
hemisphere of a rat brain after ultrasound-induced BBB permeabilization
(a) and the corresponding 2D Gaussian fits of CA-sports (b). Fig. C shows
the linear fits of the squared Gaussian spreads as a function of time after
CA injection
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Objectives
Microbubble-mediated focused ultrasound (FUS) can induce lo-
calized and reversible blood–brain barrier disruption (BBBD),
aiding in targeted drug delivery to the brain. Acoustic cavita-
tion is well-accepted as the primary mechanism in opening the
BBB. In addition to its therapeutic potential, inducement of in-
ertial cavitation by FUS can result in permanent damage to the
brain tissue. Previous studies have shown the utility of cavita-
tion detection for monitoring all bubble activities during treat-
ment; however translation of FUS induced BBBD requires the
development of a closed-loop, real-time control system that can
tailor the opening while simultaneously keeping the brain damage-free.
Here, we propose an acoustic emissions-based controlling paradigm that
can not only modulate the BBBD outcomes based on the feedback from
stable cavitation responses (harmonic emission, HE), but also suppress the
likelihood of brain damage by monitoring the inertial cavitation compo-
nents (broadband emission, BE).
Methods
This controlling system has been designed and tested in a preclinical
dual-transducer setup. Two FUS single-element transducers were
driven at different frequencies (F = 274.3 KHz, F = 30 Hz), and ori-
ented at 120° to create a sub-centimeter focal depth-of-field. Cavita-
tion activities were monitored using a passive detector (central
frequency: 650 kHz).
Injections of OptisonTM into the tail vein in rats (n = 43) were
performed with a computer-controlled injector that constantly ro-
tated the syringe to keep the microbubbles mixed. HE and BE
were monitored in real time and used as the basis for control of
the next FUS pulse. The impact of multiple pulse parameters, in-
cluding acoustic pressure, pulse repetition frequency (PRF), and
total duration, was studied. To minimize the potential damage
caused by inertial cavitation, the exposure level was reduced if
BE was detected and terminated in the event it crossed a set
threshold. The performance of the control system was assessedby BBBD in rats in vivo. Trypan Blue dye was injected as our
model drug for visualizing and quantifying BBBD by fluorescent
imaging 1-h post FUS treatment.
Results
A pilot study investigated the microbubble-dose effects on the
linearity of the HE-pressure dependence and on the inertial cavi-
tation threshold (ICT). The linearity of the HE was confirmed, and
the ICT was found to decrease as microbubble dose (100, 200,
and 400 μl/kg) was augmented. Assessment of the controller per-
formance demonstrated that: 1) Control of HE is possible while
keeping BE-free; 2) The use of microbubble infusion after an ini-
tial bolus allows the proportional controller to rapidly converge
and prevents the decline of emissions, thus reducing the likeli-
hood of BE due to the limited number of cavitation nuclei at the
later stage of sonication; 3) A higher PRF (1 vs. 4 Hz) significantly
enhanced the percentage of received emissions within the preset
goal (Good Burst Rate, GBR), both in bolus injection mode (2-fold,
P<0.05) and in infusion injection mode (7-fold, P<0.001); 4) Using
an infusion and a PRF=4 Hz, the GBR for HE of 85.6% ±4.0% dur-
ing 120-pulse sonications was achieved. Statistical comparison of
GBR between the 60-, 90- and 120-pulse sonication showed no
significant difference (P>0.05), suggesting the robustness of the
controller. Total HE was exponentially correlated with the radiant
efficiency of epi-fluorescence emitted from the Trypan Blue dye
(R2 = 0.78).
Conclusions
We have designed a real-time, closed-loop FUS controller based
on passive cavitation detection for microbubble-mediated ultra-
sound therapy. The controller performance has been optimized
through microbubble infusion and changing PRF. Controlled BBBD
in rat in vivo was achieved based on the guidance of the present
controller.
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Objectives
Two-dimensional (2D) receiving arrays with ~104 total number
of elements would serve as a powerful tool for ultrasound im-
aging, especially in the situations when the region of interest is
imaged through inhomogeneous layers like skull or ribs. While
2D arrays with such a large number of elements are not yet
practically available, their imaging capabilities can be studied
by replacing them with synthetic 2D receiving arrays that are
made using a single hydrophone that is raster scanned by a
computer-controlled positioner. The goal of this study is to il-
lustrate such an approach experimentally by using a synthetic
2D array in two applications: acoustic holography of therapeutic
ultrasound sources and ultrasound imaging through a skull
phantom.
Methods
To create a synthetic array, a miniature ultrasound probe was
moved point-to-point using a computer-controlled positioning
system. Measurements were made in degassed water using sev-
eral experimental arrangements, in which the ultrasound probes
were either capsule or needle hydrophones with sensitive di-
ameters of 0.15, 0.2, or 0.5 mm. The scans were executed using
positioning systems with stepper motors and linear slides that
provided a resolution of several microns per step. In each scan,
the hydrophone was sequentially located at the nodes of a
square grid with a pitch less than half the wavelength. Typical
Fig. 92 (abstract O72). Piezoelectric transducer (left) and
distribution of the particle velocity magnitude on the transducer
surface while operating in the transient regime (right)
Fig. 93 (abstract O72). Skull phantom thickness pulse-echo
measurements. Left: typical B-mode image in a transversal plane.
Right: phantom back-side profile reconstructed from the
pulse-echo measurements
Fig. 94 (abstract O72). B-mode image of a 2-mm diameter
spherical scatterer placed behind the skull phantom. Left: image
constructed without account for the inhomogeneous layer. Right:
image reconstructed with account for the layer
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corresponded to the number of elements of the corresponding
virtual synthetic array. At each hydrophone position, an ultra-
sound source emitted a tone burst which was received by the
hydrophone. Then, a hydrophone was moved to a new location
and the operation of emission-reception was repeated. The
pressure waveform at each location was recorded using a
digital oscilloscope and transferred to a computer.
Results
Synthetic arrays were used for two applications: The first was acous-
tic holography, which was shown in our previous work to be a
powerful technique for characterizing ultrasound sources and the
fields they radiate [see 1,2]. Beyond the CW version of holography
that is appropriate for most regimes of ultrasound therapy, transient
holography is directly relevant to imaging applications and therapies
like histotripsy [3]. Here, a transient hologram was detected by a syn-
thetic array (150×150 size, 0.7 mm pitch) in order to characterize a
piezoelectric HIFU source (10 cm diameter, 10 cm focal length) ex-
cited by a 7-cycle tone burst at a frequency of 1 MHz. The recon-
structed vibration velocity magnitude is shown in Fig. 92.
The second application of synthetic arrays was ultrasound
pulse-echo imaging through an inhomogeneous layer mimick-
ing a human skull. Transcranial ultrasound imaging remains
problematic due to severe aberrations caused by the skull.
Wide-aperture 2D arrays can help to achieve usable imaging
resolution by compensating for aberration effects. In the experi-
ments, a skull phantom was made from epoxy resin mixed with
aluminum oxide powder. The phantom had the following pa-
rameters: density 1.4 g/cm3, longitudinal velocity 2.6 mm/μs,
shear velocity 1.3 mm/μs, and absorption coefficient 4 dB/cm at
1 MHz, 7 dB/cm at 2 MHz. The phantom thickness was made
nonuniform with one side being flat and the other side having
profile variations similar to human skull. To simulate the “flash-
mode” imaging regime, the skull phantom was insonified from
the flat side by a short 2-MHz tone burst emitted by a broad-
band wide-aperture (several cm diameter) flat source. A needle
hydrophone was raster scanned in a plane region proximal to
the skull phantom. The corresponding synthetic array was of
100×100-element size and 0.5 mm pitch. Several mm-sized scat-
terers were placed in water at 3–4 cm distance from the other
side of the phantom. The imaging consisted of two steps. In
the first step, the skull phantom thickness was mapped using
echo arrival time differences between the front and back sur-
faces (Fig. 93). Then the 3D image was built based on a delay-
and-sum algorithm. The image was built both without and with
account for the presence of the inhomogeneous skull phantom.
Typical image improvement can be seen in Fig. 94: the lateral
resolution was significantly improved when the aberrations were
accounted for in the procedure.
Conclusions
Synthesizing a 2D array with a large number of elements can be
effectively done even with a single hydrophone. To mimic the
array, a hydrophone placed in the desired array elements’ loca-
tions by a computer-controlled positioner can be used. Array
synthesis is possible and effective if the acoustic field under
study can be generated repeatably with high accuracy. Capturing
acoustic field measurements in 2D provides detailed information
about 3D fields in both CW and transient regimes. This informa-
tion has practical utility in both therapeutic and imaging applica-
tions. The work was supported by the Russian Science
Foundation grant no. 14-15-00665 and NIH R21EB016118.
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Objectives
Visualise and model cell deformation under the action of shock
waves in order to optimise therapeutic efficacy while minimising
side-effects during treatment.
Methods
Shock waves from a clinical shock wave source (Minilith,
STORZ) were applied to a tissue-mimicking phantom with
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):15 Page 59 of 114embedded cells. The pressure profile of the shock wave was
measured inside the phantom using a PVDF needle hydrophone
and the induced strain rate was estimated to be 105-106 s−1.
The deformation of individual cells were tracked using an ultra-
high speed camera with frame rate up to 20 Mfps. The cell re-
sponse was analysed by its area and perimeter change over
time. A Finite Element (FE) model was developed to compare
to the experimental findings with the same setup using a com-
bined non-linear fluid and hyper-viscoelastic framework.
Results
Under the compression phase of shock waves, cells showed 3-5% of
area decrease and 1-2% of perimeter reduction, whereas under the
tension phase, cells showed 15-20% of area increase and 6-8% of
perimeter rise. Simulation results matched with the experimental
findings by proposing a new constitutive model differentiating the
compressive behaviour from its tensile counterpart.
Conclusions
The results of this study suggest that at high strain rate the cell ap-
pears as much stiffer in compression than in tension because of the
intrinsic deformation mechanisms. The accurately characterised cell
properties can thus help to predict cell response in order to optimise
the therapeutic efficacy of shock wave applications such as litho-
tripsy, orthotripsy and cancer treatment.Fig. 96 (abstract O73). Comparison of cell contours during shock
wave interactions
Fig. 95 (abstract O73). Imaging processing for the ultra-high
speed imagesO74
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There are therapeutic and diagnostic uses of imaging probes,
which benefit from exceeding the Mechanical Index limits of
diagnostic ultrasound and support that these benefits occur
without negative bioeffects. Without imbedded software restric-
tions, the in situ pressure levels of these devices can exceed
the typical diagnostic limits on Mechanical Index and spatial
peak pulse average intensity (ISPPA). When calibrating imaging
probes at these levels in water, nonlinear propagation effects
are present, which complicates the derating process for esti-
mating in situ fields. Different derating approaches have been
proposed to predict pressures in tissue from measurements in
water. One conventional derating method is to scale the focal
pressures and another method is to scale the source amplitude
to compensate for linear losses on the way to focus. This sec-
ond method is described as nonlinear derating and has been
shown to provide accurate results for strongly focused thera-
peutic transducers. However, applicability of these derating
methods to diagnostic probes operating at therapeutic inten-
sities is still in question. Here, the derating methods were
tested for a diagnostic probe used in kidney stone propulsion
technology.
Methods
A standard diagnostic ultrasound curved array probe operating
at 2.3 MHz (C5-2, Philips Ultrasound, Andover, MA, USA) was
considered. The array comprises 128 elements; however, the re-
sults presented hereafter were obtained by considering 64 cen-
tral elements of the array to be active (Fig. 97). In the
azimuthal plane the focus can be steered electronically, while a
cylindrical acoustic lens focuses the field at a fixed depth in
the elevation plane.
A combined measurement and modelling approach was used
to establish an equivalent source boundary condition for non-
linear simulations of the array field in water based on the 3D
Westervelt equation [1]. Simulations were performed for propa-
gation entirely in water and in the presence of a tissue mimick-
ing phantom placed at a distance of 1 cm in front of the
probe surface. The acoustic properties of the phantom were set
the same as in water, except for the frequency dependent ab-
sorption of α0 = 0.5 dB/cm/MHz with power exponent n = 1.2
and corresponding dispersion that were set according to the
properties of the phantom.
Two derating methods were tested to estimate the in situ (z = 50
mm) pressure field in tissue from the waveforms simulated in water.
Derated waveforms were then compared with direct simulation re-
sults in tissue. In the conventional derating method, the pressure
field calculated in water at the focus was multiplied by the absorp-
tion exponent accounting for the propagation distance of 40 mm in
tissue to the focus. In the nonlinear derating method, the pressure
amplitude at the focus in tissue was assumed to be the same as in
water for the lower source voltage scaled with the same absorption
exponent value.
Results
Axial distributions of the peak positive and peak negative pressures
are shown in Fig. 98 for several output voltages in the free field in
water (a) and in the presence of the tissue phantom (b). The focal
lobe of the probe (20 mm long) is relatively large in comparison with
the focal length of 50 mm because the transducer has a relatively
low linear focusing gain (9.3). Therefore, at high power outputs non-
linear propagation effects accumulate over the long propagation dis-
tance and are not localized near the focus as is the case for strongly
focused therapeutic sources.
Peak positive and peak negative pressures at the focus, z = 50
mm, as functions of source voltage are shown in Fig. 99. The
nonlinear saturation of the peak positive pressure is clearly
Fig. 98 (abstract O74). Axial distributions of the peak positive and
peak negative pressures for a free field propagation in water and
b propagation in the presence of a tissue phantom (shown in blue)
for outputs of 10, 30, 50, 70 and 90 V. The water/phantom interface
is positioned 1 cm from the array centre
Fig. 99 (abstract O74). Peak positive and negative pressures at the
focus (z = 50 mm) versus transducer output voltage. Propagation is
simulated in water (black curve) and in a tissue phantom (blue curve).
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curve), though at higher voltage levels. The conventional derat-
ing process of scaling focal pressures is illustrated by the green
curve in Fig. 99. As denoted by the vertical dashed arrows, this
method overestimates peak positive pressure at moderate volt-
ages (up to 50 V) and underestimates it at higher voltages.
Nonlinear derating is illustrated by the red curve. As shown by
the horizontal arrows, peak positive pressures are significantly
overestimated (by up to 50%) for source voltages higher than
20 V. For lower voltages, the nonlinear derating matches results
in tissue within 10% of accuracy. Peak negative pressure magni-
tudes estimated by derating methods are smaller than those
obtained in direct numerical simulations. Peak negative pres-
sures predicted by the conventional derating method can be
50% smaller than in simulations, while the discrepancy remains
less than 20% for the nonlinear derating method.
Focal waveforms obtained in simulations in tissue (blue curve)
and using the derating methods (red and green curves) are
compared in Fig. 100 for 55 V (a) and 90 V (b) outputs. At 55 V
the nonlinear derating method predicts 40% higher peak posi-
tive pressure than simulations, while peak negative pressures
are in closer agreement. The waveform resulting from conven-
tional derating is fortuitously close to the simulated waveform.
At 90 V all waveforms are significantly different; the peak posi-
tive pressure obtained in simulations is approximately in the
middle between the results of the two derating processes.
Conclusions
Nonlinear acoustic fields generated by a diagnostic ultrasound
probe are simulated in water and in a tissue phantom using
the 3D Westervelt equation. Two derating approaches were ap-
plied to estimate the pressure field in tissue using the results
obtained in water. It was shown that the conventional derating
method can either overestimate (up to 50%) or underestimate
(up to 25%) peak positive pressure depending on the source
voltage, while it underestimates peak negative pressures by up
to 50%. The nonlinear derating method provides accurate
results at low intensities (here up to 20 V); however, it overesti-
mates peak positive pressures by up to 50% at higher intensity
levels. These simple derating procedures therefore cannot
substitute direct numerical modelling to provide reasonable ac-
curacy for nonlinear in situ pressures for diagnostic probes. The
study was supported by the grants RSF 14-12-00974, NIH
EB007643 and DK043881.
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Fig. 97 (abstract O74). Geometry of focused ultrasound beam
produced by C5-2 array probe with 64 active elements
Fig. 100 (abstract O74). Focal waveforms (z = 50 mm) obtained
by direct modelling of propagation in the tissue phantom (blue
curve) as well as by derating from free field water simulations
(red curve for nonlinear derating, green curve for conventional
derating). Results are shown for output levels corresponding to
a 55 V and b 90 V
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Objectives
It is commonly admitted that the use of multifrequency acous-
tic excitations, and particularly a dual-frequency signal, can
stimulate the cavitation activity resulting in a decrease of the
inertial cavitation threshold for instance. However, past works
were usually dedicated to the experimental characterization of
the influence of bifrequency excitations on the cavitation cloud
activity, and only few researches focused on the nonlinear dy-
namics of a single bubble in a dual-frequency acoustic field. In
this study we describe analytically the aperiodic oscillations of
a single dual-frequency driven bubble by assuming weakly non-
linear oscillations. These results are compared to experimental
studies on a single laser-nucleated bubble driven by bifre-
quency excitations with varying difference frequency.
Methods
The analytical study relies on the asymptotic expansion of the
Rayleigh-Plesset equation in weakly nonlinear oscillations using
the Bogolyubov-Krylov method. Approximate analytical solu-
tions are obtained for bubbles excited by a dual-frequency sig-
nal for which both high-frequency components are close to the
primary resonance frequency of the bubble. For studying ex-
perimentally the bubble radial oscillations, a laser-nucleated
bubble is generated and trapped in a bifrequency acoustic
pressure field centred at 33kHz, within a cubic water cavity. For
typical bubble radii ranging between 50 and 85μm, radial oscil-
lations are visualized with a high-speed camera (frame rate 180
kpps), allowing to probe the temporal evolution of the bubble
radius as well as the maximal reached bubble radius.
Results
Theoretical results reveal that the maximal reached bubble radius
can be higher for bifrequency excitation than for monofrequency ex-
citation. The possible enhancement of the bubble radial dynamics is
due to the multiple energy transfer and pumping from each fre-
quency component of the dual-frequency signal to other spectral
components that are favourably energetic. Results also highlight the
existency of a specific difference frequency value above which the
bifrequency excitation is no longer efficient. Linear and weakly non-
linear bubble radius evolutions are thus studied experimentally in
the aim of demonstrating such enhancement. While linear radial
oscillations of a bubble in a dual-frequency excitation well reveal the
beating phenomenon, increasing the excitation amplitude leads to
the regime of nonlinear oscillations where non-spherical radial
oscillations are rapidly observed. The breathing of such non-spherical
oscillations triggered on the difference frequency component is
discussed.
Conclusions
The oscillations of a spherical bubble driven by a dual-frequency ex-
citation have been analysed both analytically and experimentally. An
asymptotic expansion of the bubble radial dynamics revealed that
the dual-frequency excitation may lead to larger amplitudes of the
bubble oscillations for sufficiently high driving amplitudes and for
specific values of the frequency difference. This enhancement is re-
lated to the generation of high-order frequency harmonics by nonlin-
ear mixing. These results allow describing the mechanisms
underlying frequency energy transfer in multi-frequency excitations.O76
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Objectives
High intensity focused ultrasound is a rapidly developing technology
for the ablation of tumours. Liver cancer is one of the most common
malignancies worldwide. Since liver has a large number of blood ves-
sels, blood flow cooling can reduce the necrosed volume and may
cause regeneration of the tumour to occur. All cancer cells should be
ablated without damaging of the critical tissues. Feasibility of ablat-
ing the tumour close to blood vessel wall is studied. Importance of
nonlinear propagation effects, blood flow cooling and acoustic
streaming effects is investigated during focused ultrasound therapy.
This work is a step towards the development of surgical planning
platform for a non-invasive HIFU tumour ablative therapy in a real
liver geometry.
Methods
The developed computational model is based on the nonlinear
Westervelt equation with relaxation effects taken into account,
bioheat equations for the perfused tissue and blood flow do-
mains. The nonlinear Navier–Stokes equations are employed to
describe the flow in the large blood vessels. The effect of acous-
tic streaming is also taken into account. Three dimensional
meshes for the hepatic artery, hepatic vein, vena cava and liver
were reconstructed on the basis of the MRI image. The present
numerical experiments are carried out in a patient specific liver
model. The model has been validated by comparison with ex-
vivo MRI temperature measurements.
Results
In this three-dimensional field-coupling study we illustrate how a
computational model can be used to improve the treatment effi-
ciency. It was also shown that relaxation effects can affect the
temperature distribution. In large blood vessel both convective cool-
ing and acoustic streaming can change the temperature considerably
near blood vessel. Temperature elevation by HIFU in ex-vivo porcine
muscle was also studied experimentally by MRI and numerically. We
demonstrated that for peak temperatures below 85-90°C numerical
simulation results are in excellent agreement with the experimental
data in three dimensions.
If destruction of all tumour cells near the blood vessel boundary is
necessary, a shorter sonication time with higher power deposition is
suggested. The total simulated treatment time is only 30 seconds.
Comparing with the treatment time of several hours we can see that
computational fluid dynamics can sufficiently reduce the treatment
time and improve the quality of treatment.
Conclusions
The proposed three dimensional physical model for HIFU study was
conducted in an image-based liver geometry. It was shown that tu-
mours near the blood vessel wall can be ablated without damaging
blood vessel wall. These results can be further used to construct a
surgical planning platform for a non-invasive HIFU tumour ablating
therapy in real liver geometry from CT or MRI image and can lead in
the future to a substantial improvement of the focused ultrasound
ablation of liver tumour. The whole tumour ablation took only 30
seconds in the considered simulation case, which is very small com-
paring with the current treatment time of several hours. Through this
study we are convinced that high ultrasound power and nonlinear
propagation effects with appropriate treatment planning can suffi-
ciently reduce the treatment time. The presented model can be used
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):15 Page 62 of 114in planning tools for the thermal ablation of tumour in other organs
and is also applicable to acoustic hemostasis treatment.
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Objectives
Characterization of high-intensity focused ultrasound (HIFU) output is
important for both efficacy and safety of clinical treatment. Acoustic
intensity is one of the key parameters, and can be calculated from
the measured pressure waveform. However, hydrophone scanning in
the focal region is time consuming. Recently, an infrared camera has
been used to measure the temperature elevation at the surface of an
absorber, from which the relative distribution as well as the absolute
intensity of the focused acoustic field can be determined. Its advan-
tage is the rapid assessment of ultrasound beams, but only linear
acoustics is considered by this approach. Derivation of nonlinear
acoustic intensity with the significant generation of harmonics by in-
frared thermometry is investigated theoretically in this study.
Methods
Numerical simulation was carried out for wave propagation in the
free field and thermal generation in an absorber. The pressure wave-
forms at the focus were simulated using KZK equation, and the cor-
responding spectra were calculated after fast Fourier transformation
(FFT). A new model was established to describe the acoustic field in
the absorber and the thermal conduction towards the interface, and
then compared to the current two models (superposition and stand-
ing wave model), especially at high frequency and absorption. The
temperature elevations on the surface of absorbers (either different
materials or thickness) are calculated by the Heat Transfer equation
using finite difference method, from which the acoustic intensity can
be derived by changing the ultrasound exposure time.
Results
The amplitudes of harmonics are found to decay exponentially, which can
be fitted by a simple equation with only three parameters, at different out-
put power levels (up to 200 W). The difference of deposited acoustic en-
ergy in the absorber and heat conduction between the standing wave
model and our model becomes significant at high frequency and attenu-
ation. The acoustic intensities derived from the simulated temperature ele-
vation at the interface at different conditions are found to be within 5%
less than those calculated by KZK equation. There is a monotonic decrease
of temperature elevation with the thickness of absorber, which results in
similar derivation accuracy using our approach.
Conclusions
The proposed approach may provide an easy and rather accurate way
of characterizing the HIFU field with significant nonlinear effects. Ex-
perimental work will be performed to further validate this approach.
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Objectives
Computational modelling of therapeutic ultrasound procedures sup-
ports device design, safety and efficacy analyses, mechanistic investi-
gations, and (personalized) treatment planning. However, reliable
modelling depends on the availability of good data about theacoustic and possibly thermal behaviours of relevant tissues and
their variability, and comparison between different modelling efforts
requires publicly available, standardized properties. The IT’IS data-
base of tissue properties has been created to fulfil these specific
requirements.
Methods
The IT’IS Foundation (www.itis.ethz.ch) has created a comprehensive,
publicly available, and evolving database (http://www.itis.ethz.ch/
virtual-population/tissue-properties/overview/) of tissue properties
that includes dielectric properties and values of density, heat capacity,
thermal conductivity, heat generation rate, transfer (perfusion) rate, low
frequency electrical conductivity (including information about anisot-
ropy in fibrous tissues), and viscosity for more than 100 biological tis-
sues. The underlying values are based on an extensive review of the
literature and have been carefully selected based on various criteria, in-
cluding the origin of the data (e.g., species) and the quality of the
measurement methodology (freshness of tissue, accuracy of method).
In some cases, dispersion relationships (frequency dependence),
temperature dependence, or anisotropy is also reported.
Since September 2015, the IT’IS database also includes acoustic proper-
ties, i.e., speed-of-sound, attenuation, and the non-linearity parameter
(B/A). The non-linearity of the attenuation frequency-dependence was
determined by fitting a power law to tissue-specific data, whenever
these data were sufficient. Additionally, previously determined relation-
ships for frequency-dependent attenuation have been geometrically
sampled to provide input for the fitting of pooled data.
Quality assurance procedures have been implemented that automatic-
ally detect unexpectedly large changes between successive database
versions and all modifications performed since the release of the first
online database version are documented in a log file available online
and tracked by a versioning system. Additionally, Digital Object Identi-
fies (DOI) are issued for each database version to guarantee traceability.
Results
An online resource has been created, which provides information
about recommended tissue properties and their variability (standard
deviation, extreme values) for a large number of tissues. All values
are available for online viewing and can be downloaded in various
formats. Additional documents available for download are a) a sum-
mary of all general considerations, remarks, and known issues re-
garding the database; b) the rational for each tissue substitution; c)
previous versions of each database; d) a log file documenting the
changes between versions; e) the list of all publications used to gen-
erate the database; and f) tables including the specific references as-
sociated with each tissue and each property for which provide a
value is provided. The suggested values are also available as part of
the tissue properties database of the Sim4Life simulation platform
(ZMT Zurich MedTech AG), which facilitates computational modeling
of focused ultrasound and induced heating. Within Sim4Life, the
database is automatically synchronized with the Virtual Population
V1.x and V3.x anatomical models to maximize model usability and
minimize human error when setting up simulations.
Conclusions
A publicly available online database encompassing acoustic and ther-
mal tissue properties and their variability has been compiled and qual-
ity assurance measures implemented to support computational
modelling of therapeutic ultrasound. This specific database has already
served for a range of modelling projects in the context of therapeutic
focused ultrasound. The previously assembled dielectric and thermal
properties have been extensively used for dosimetric and thermal ther-
apy modelling purposes, resulting in over 100 citations and enabling
the replication and comparison of simulation results.
The IT’IS material parameter database is an evolving web re-
source. Accordingly, it relies on input from database users and
on contributions via our online forum. This forum is designed for
users to suggest additional references, to question the assump-
tions behind the current values, and to discuss possible
improvements.
Additional data points are added as they become available in the lit-
erature or experimentally. Yet besides adding data to fill existing
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that permits filtering according to specific criteria (e.g., considering
only data measured in human tissue), adding properties (e.g.,
thermoregulatory), introducing distinctions between absorption and
attenuation, and providing calculators (e.g., to relate CT bone density
data to acoustic property maps.Fig. 101 (abstract O78). Automatic synchronization of the IT'IS
database of tissue properties with the IT'IS Virtual Population Models
in Sim4Life
Fig. 102 (abstract O79). Diagram of the flow chart of the perfusion
setupO79
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Objectives
The principle of focused ultrasound therapy (FUS) is to elevate
the pathological tissue temperature rapidly therefore to ablate
the target tissue. While absorbing the thermal energy from ultra-
sound beam, the target tissue also have thermal exchange with
surround tissues by conduction and convection. The blood ves-
sels can generate more effective convection on the proximity. If
the target pathological tissue locate the proximity of blood ves-
sel, the thermal convective effect from blood flow must be
considered.
Thiel fluid is an advanced technology to store tissues, and it does
not cause significant difference on thermodynamics properties.
Therefore the Thiel kidney is the idea specimen for the perfusion and
FUS therapy experiment.
Thiel swine kidneys are used to study the effect of blood flow on fo-
cused ultrasound (FUS) therapy. This article will demonstrate the
preparation of a pair of perfused Thiel porcine kidney which is used
to simulate the blood circulation. And the MRgFUS on perfused por-
cine and human kidneys is conducted to evaluate the effect of blood
flow on FUS nearby tissues.
Methods
The simulator consists of a pair of Thiel porcine kidneys or hu-
man kidneys, a waterproof plastic bag, and a heart lung machine(Maquet HL30, Germany). The Thiel kidneys are placed into the
sealed waterproof plastic bag, and the renal artery is used as the
inflow, while the renal vein as the outflow. A tube is connected
to the plastic bag to extract the saline water back to the heart
lung machine to complete the circulation. Cable ties are required
to close the distal of the artery to guarantee the whole saline
water is perfused into the kidney's blood circulation network
(Fig. 102).
The simulator is placed under the image-guided FUS surgical envir-
onment. Multiple image technologies is used for the FUS therapy ex-
periment. X-Ray (OEC9900, GE, USA), MR scan (1.5T, GE, USA) are
used to image the perfusing model.
The ExAblate 2000 (Insighte, Haifa, Isreal) focused ultrasound is used to
ablate the kidney perfusion model. The result will state the effect of
blood flow on FUS therapy. The parameters for MRgFUS in this
experiment are as follows: TE=100ms, TR=150ms, Flip Angle=60°, Slice
Thickness=5mm. Acoustic Power=20W, Duration Time=20s. The target
position were selected nearby main vessels, approximately 5mm
away from the vessels. Each selected position were sonicated
twice, one under the condition with blood flow, while the other
without. The overall flow speed is controlled at 500 mL/min for
porcine kidneys and 200 mL/min for human kidneys. The
temperature rises are recorded.
Results
The MR scanning protocol could provide clear image of the
blood vessels inside the kidneys. Especially with blood flow, the
vessels appear much brighter than surrounding tissues (Fig. 103).
Under the X-ray scans, the perfusion process is monitored and re-
corded, clear blood flowing in to the kidneys and flowing away
from the kidneys is clear (Fig. 104).
Three pairs of selected sonication showed reasonable results. A
significant temperature drop was observed when a perfusion
blood flow was available within the porcine or human kidneys.
And there was a 2~4°C higher temperature rising in the no-flow
condition.
Conclusions
From this early-stage experiment, it indicated that the blood flow
have influence on FUS ultrasound therapy. The target tissue
under FUS therapy has conductive thermal transfer to the sur-
rounding, and the blood flow supplies extra thermal transfer,
which has considerable contribution on the tissue cooling down.
The experimental results indicate a clear temperature drops is ob-
served when a perfusion blood flow is available within the kid-
neys, compared with the no-flow condition has a 2 ~ 4°C higher
temperature rising. Therefore it is reasonable to consider the in-
fluence from blood flow when choose the thermal dose if the
target tissue is nearby the vessels, especially the main vessels.
Fig. 104 (abstract O79). See text for description
Fig. 103 (abstract O79). MR scan of perfused kidneys
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Objectives
Thermal models for magnetic resonance-guided focused ultrasound
(MRgFUS) therapies may be used to predict outcomes, improvemonitoring, and inform real-time controllers that guide treatments.
When accurate, these models have potential to identify which pa-
tients will or will not benefit from MRgFUS and to improve treatment
safety, time-efficiency, and efficacy. However, accurate thermal
models require accurate knowledge of properties including the tissue
thermal diffusivity (α) and the Pennes perfusion parameter (w). This
study presents the in vivo use of a new analytical method for esti-
mating α and w from MRgFUS pre-clinical experiments in rabbit
muscle and from clinical MRgFUS treatments of uterine fibroids.
Methods
The method utilizes an integral temperature solution for a Gaussian heat-
ing pattern with no axial conduction assuming constant, uniform tissue
properties [1]. By replacing the perfusion term with its 3rd order Taylor
series approximation, instead of assuming it is zero [1–3], the in-
tegral can be evaluated to provide a closed-form analytical solu-
tion [4]. Using MR temperature data in the focal plane, a least-
squares optimization of the analytical solution yields estimates of
α and w. Experiments were performed on 3 New Zealand white
rabbits with IACUC approval. Rabbits were positioned supine on
the MRgFUS system and sonications were performed in the back
muscle (5 heating locations, 28 sonications). Transducer power (P)
was 8 W and heating time (HT) ranged from 21.7-23.6 s. MR tem-
peratures (Siemens 3T Trio, 3D seg-EPI, TR/TE=35-44/11 ms,
FA=15-30°, BW=738-744 Hz/pixel, voxel=1×1×3mm, FOV=128-
192×80-132mm2, 8 slices, ETL=9, and tacq=3.6–5.4 s) were calcu-
lated by a 2D referenceless technique [5] using the proton reson-
ance frequency (PRF) method.
To establish whether the estimation method works with clinical pro-
tocols, 7 sonications (InSightec Exablate 2000, P=14-24 W, HT=20 s)
were performed in a quality assurance (QA) phantom using uterine
fibroid MRgFUS protocols (GE Discovery, coronal single slice fast
spoiled GRE, TR=25-26 ms, TE=12-13 ms, FA=30°, BW=44 Hz/pixel,
matrix=256×128, FOV=280×280mm2, slice thickness=3-5 mm, and
tacq =3.2-3.3 s). Temperatures were calculated via a baseline refer-
ence reconstruction using the PRF method. In addition, retrospective
analysis was performed on clinical fibroid MRgFUS data from 9 pa-
tients (n=12 sonications, P=32-138 W, HT=20 s) with imaging and re-
construction parameters described above.
Estimates of α and w were made using MRgFUS data from voxels
within 6 mm of the beam axis and included all temperatures ac-
quired during heating and the first temperature image acquired from
cooling (tfit~ 24 s), i.e. the default acquisition scheme used by the
clinical MRgFUS system. To assess the effect of additional cooling
temperature data, 10–20 additional images were acquired when pos-
sible so that the fitting time could be extended to tfit~ 80 s.
Results
Figure 105 shows the results for all sonications in rabbit muscle. Blue ×
markers indicate tfit~ 24 s and red + markers utilize tfit~ 80 s. The shaded
region identifies the range of α values obtained from invasive probe mea-
surements (KD2 Pro, Decagon Devices, USA) applied after euthanasia.
While there are no independent measures of w in this study, perfusion
values for human resting muscle are 0.6 kg/m3/s [6]; higher values could
be possible if FUS induces vasodilation, though not as high as the largest
estimates. By including cooling data (red), results cluster more closely
around the measured α range (shaded) and the anticipated low w levels.
Estimates of α and w in a QA phantom are shown in Fig. 106. The phan-
tom’s α is unknown, but, based upon similar phantoms, should be be-
tween 0.130-0.160 mm2/s. w should be 0 kg/m3/s due to no perfusion.
Again, including the additional cooling data causes estimates to more
closely converge anticipated property values. Thus, obtaining properties
with clinical MRgFUS imaging is feasible, but it requires the acquisition of
cooling images that are no longer allowed in some clinical systems.
Property estimates from clinical fibroid treatments are shown in Fig. 107.
The magnitude and range of α estimates is higher than anticipated;
one published study found uterine fibroid α from 0.066-0.176 mm2/s
[7]. Only 2 of 12 estimates are within 10% of that range. When available
(3 of 12 datasets), additional cooling data brought α estimates closer to
expected values. Published data quantifying fibroid perfusion is limited,
so it is difficult to comment on the accuracy of w estimates.
While the method can accurately estimate properties in vivo (rabbit
data) and using clinical imaging with cooling data (phantom data),
Fig. 106 (abstract O80). Estimates of thermal diffusivity and
perfusion in a quality assurance phantom using clinical imaging
protocols. The true value of perfusion is zero and that of thermal
diffusivity is unknown
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explanations for this disconnect include increased noise and poten-
tial for chemical shift and motion artefacts when compared to the
rabbit and phantom data.
Additionally, it is known that tissue attenuation, w, and α are
temperature/dose dependent properties [8–10]. Assuming uniform,
constant properties in clinical data where the temperature rise was
as large as 54 °C is likely to introduce errors. In fact, the 2 clinical
datasets providing the most realistic α estimates were those with the
lowest temperature rise (9 and 11 °C). By utilizing the low
temperature rise data from pretreatment sonications instead of
therapeutic ablations, clinical estimates of α and w may improve. Fu-
ture work will focus on investigating this possibility.
A summary of all data is found in Fig. 108. Results are pre-
sented as the mean with standard deviation in parentheses.
Conclusions
This study shows that a and w can be estimated from in vivo data. Esti-
mates improve when including cooling data beyond that which is clin-
ically acquired and when the observed temperature change is less than
10 °C. Obtaining consistent property estimates from clinical data re-
quires further investigation.
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Objectives
In high intensity focused ultrasound (HIFU) applications, nonlinear
acoustic effects can result in the formation of high-amplitude shock
fronts in focal waveforms, with amplitudes that can exceed 100 MPa.
The presence of such shocks leads to increased tissue heating and
initiation of boiling in milliseconds. Even though this shock-wave
heating is very strong, shock fronts are highly focused and produce
extreme heating effects in a very small focal volume. For single le-
sions, nonlinear heating thus can be utilized for rapid tissue ablation
only within very small volumes before boiling starts to change the
process. However, if the focus is steered, this enhanced heating com-
bined with thermal diffusion can be used to accelerate thermal treat-
ments over large volumes. The goal of this work was to evaluate the
efficacy of using shock-wave heating to accelerate the thermal ablation
of tissue volumes while keeping the same exposure conditions for inter-
vening tissues.
Methods
Simulation studies were performed for a multi-element 1.2 MHz HIFU
phased array of a clinical system (Fig. 109a, Sonalleve V1, Philips,
Vantaa, Finland). Several acoustic power levels were considered
within the possible range of array outputs from 104 W to 1300 W,
corresponding to intensities at the array elements from 1.2 W/cm2 to
15 W/cm2. A pulsing scheme was combined with discrete electronicsteering of the array focus over a series of targets arranged in circles
with radii of 2 and 4 mm (Fig. 109b) to generate volumetric lesions
in ex vivo bovine tissue. Point numbers in the sonication sequence
are indicated in the Fig. 109b. The circles were positioned in a plane
at 25 mm depth in a bovine liver tissue sample of 50 mm thickness
(Fig. 109c), and the period between consecutive pulses was 40 ms.
Acoustic field in tissue was modelled using the Westervelt equa-
tion and a previously developed finite-difference algorithm.
Temperature modelling in tissue was conducted using the bio-
heat equation with heat sources calculated from the acoustic
modelling. Temperature simulations were optimized in the follow-
ing way. First, the effect of a sonication at a single focus was
computed in the time domain on a fine grid, which covered only
the focal volume until the diffused temperature distribution was
broad enough to be transferred to a sparser grid that covered
the entire tissue sample. Second, volumetric modeling of the bio-
heat equation was conducted on the sparser grid in a spatial-
frequency domain where an analytic solution is available. Based
on the linearity of the bioheat equation, the temperature distribu-
tion calculated at the first step was added to the current
temperature distribution in tissue at each consecutive steering
position of the focus with the time delay equal to the heating
and diffusion time of the sonication in a single focus.
Temperature simulations were conducted for a constant time-
average intensity at the array elements, considering either a peak in-
tensity of 1.2 W/cm2 over a HIFU pulse duration of 20 ms, 8 W/cm2
over a duration of 3 ms, or 15 W/cm2 over a duration of 1.6 ms. For
comparison, the initial intensity of 1.2 W/cm2 corresponds to a total
acoustic output power of 104 W. Sonication of targets was per-
formed starting from the centre of the circles spiraling outward and
continued until the minimum temperature rise inside the circle of 4
mm radius in the focal plane reached 45°C. Assuming ex vivo expo-
sures with initial temperature of 20°C, this temperature rise is repre-
sentative for tissue denaturation within the irradiated volume. Here
we term the focal plane as the plane of the maximum heat depos-
ition for each intensity output. To equalize the temperature over
each circle, the distribution of sonication points was rotated with
each consecutive cycle to irradiate locations in between the sonic-
ation points of the previous cycle (Fig. 109b).
Results
Shown in Fig. 110 are waveforms simulated at the position of max-
imum heat deposition in tissue for different peak intensities at the
array elements from 1.2 to 15 W/cm2. These output levels corre-
sponded to quasilinear sonication (1.2 W/cm2, red curve), sonication
with a fully developed shock of 95 MPa at the focus (8 W/cm2, pink
curve), and sonication with a higher focal shock amplitude of 118
MPa (15 W/cm2, blue curve).
Shown in Fig. 111 are spatial distributions of heat deposition
rates in tissue in the axial plane of the array simulated for differ-
ent peak intensities at the array elements. Heat depositions are
normalized relative to the heat deposition calculated for the
same intensities assuming linear wave propagation. It is seen that
at 8 W/cm2 with a shock front of about 100 MPa, the tissue heat-
ing at the focus is about 35 times higher than predicted linearly
and is highly localized in space. With further increase of the in-
tensity to 15 W/cm2, the shock front at the focus is about 120
MPa resulting in 40 times more effective heating. In addition, the
region of the presence of high-amplitude shock and therefore en-
hanced heating is enlarged.
Corresponding temperature distributions in the focal plane are
shown in Fig. 112 at times when the temperature rise inside the cir-
cle of 4 mm radius reaches 45°C. For the lowest peak intensity (1.2
W/cm2) this temperature level was reached in 84 seconds. For higher
outputs it required 34 and 13 seconds, correspondingly, showing
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the volumetric temperature rise occurred more quickly while the
boundary between treated and untreated tissue became more clearly
defined.
Conclusions
HIFU irradiations of tissue volume in three different nonlinear re-
gimes were considered. It was shown that with the same time-
average power, the use of pulsing schemes with higher peak power
leads to faster heating of the desired volume and less heat diffusion
to the surrounding tissues. Such regimes therefore show clinical ad-
vantages to accelerate thermal HIFU therapy while keeping the same
safe exposure conditions for surrounding tissues and sharper margins
of treatment. The study was supported by the RSF 14-12-00974, NIH
NIBIB EB007643, and student Global Internship Program from the
Focused Ultrasound Foundation.Fig. 112 (abstract O81). Spatial 2D distributions of temperature
rise in tissue in the plane of maximum heat deposition for
different peak intensities at the array elements balanced by the
pulse length within 40 ms time window between the pulses:
a 1.2 W/cm2 and 20 ms, b 8 W/cm2 and 3 ms, and c 15 W/cm2
and 1.6 ms. As indicated in each frame, temperature maps are
shown at the time point when temperature rise everywhere
inside the circle of 4 mm radius reaches 45°C. This temperature
rise would ensure tissue denaturation for ex vivo exposures with
initial tissue temperature of 20°C
Fig. 111 (abstract O81). Spatial 2D distributions of heat
deposition rates in tissue in the axial plane of the array for
different intensities at the array elements: a 1.2 W/cm2, b 8 W/cm2, and
c 15 W/cm2. Heat deposition rates are normalized to the heating rates
calculated at the same intensities assuming linear wave propagation
conditions. The distributions therefore illustrate nonlinear
enhancement and better spatial localization of heating using
shock-wave exposures
Fig. 110 (abstract O81). Acoustic pressure waveforms simulated
at the maximum of heat deposition in tissue for different
intensities at the array elements: 1.2 W/cm2 (red curve), 4, 5, 6,
7, 8 W/cm2 (pink curve), 10, 12, and 15 W/cm2 (blue curve).
Dashed curve is the focal waveform for 1.2 W/cm2 simulated
linearly. While quasilinear regime of focusing with slightly
distorted focal waveform is realized for initial intensity of 1.2 W/
cm2, high amplitude shocks are formed at intensities of 8 W/cm2
(95 MPa) and 15 W/cm2 (118 MPa)
Fig. 109 (abstract O81). a Distribution of radiating elements on
the surface of the therapeutic array; b Discrete trajectory of the
beam's focus in the focal plane. c Geometry of the numerical
experiment: ultrasound beam is focused within tissue layer (liver)
of 5 cm thickness centred at the geometric focus of the
spherical shell. Acoustical modelling was performed both in
water and in liver sample, while temperature modelling was
performed only in liverO82
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Objectives
Ultrasonic hemostasis may provide an effective method in surgery
and prehospital settings for treating trauma and elective surgery
patients. Application of HIFU therapy to hemostasis was primarily
Fig. 113 (abstract O82). Angiography image of blood vessels
Fig. 114 (abstract O82). Photograph of vessel thrombus in
dissected femoral artery
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High-intensity focused ultrasound (HIFU) has been shown capable
of coagulation of internal bleeding. The main drawback of the
thermal hemostasis strategy is low ultrasound absorption ability
of blood and, as a result, low heating and coagulation rate at
real blood flow.
The purpose of this study was to evaluate the feasibility of HIFU
thermal and combinational (cavitation, boiling, non-linear behav-
iors, and coagulation agents) effects for ultrasonic hemostasis of
deep arterial bleeding.
Methods
In this paper, HIFU therapy and imaging transducer designs, non-
linear acoustic fields modeling and calculations, as well as in vivo
hemostasis experiments on lamb’s femoral artery confirming en-
hanced ultrasonic hemostasis at deep arterial bleeding are de-
scribed. For ex vivo and in vivo hemostasis experiments an
ultrasonic applicator was designed and tested. The ultrasonic ap-
plicator design had HIFU therapy transducer and imaging probes
and was configured to be compatible with 3D mechanical scan-
ning system. HIFU transducers are comprised 1–2 MHz spherical
elements made from porous piezoceramics with 80 mm aperture
having radius of curvature 40–60 mm. Centre opening with 40
mm diameter was reserved for ultrasonic imaging and Doppler
probes such as linear, convex or 3D arrays.
Acoustic measurements of ultrasonic transducers have been per-
formed in 3D Scanning System (UMS3) using the fiber optic
hydrophone (FOPH 2000) and using AFB from Precision Acoustics
Ltd. Waveforms from the hydrophones and the driving voltage
were recorded using a digital oscilloscope Lecroy. The transducer
was driven by a function generator Agilent 33521B, a linear RF
amplifier E&I model 2400L RF, and operates in a CW or burst
modes. The acoustic intensity in the focal plane measured in
water tank at 1000–5000 W/cm2 (ISAL) was kept for the objects
treatment. The experiments were made on acoustic vascular
phantoms, as well as on lamb’s femoral artery in vivo at different
protocols. During ultrasound exposure of lamb’s femoral artery,
arterial blood flow was temporarily stopped using intravascular
balloon. In some protocols intravenous coagulation agents (lipo-
somes) activated by HIFU at the point of bleeding were used.
Targeting accuracy was assessed by necropsy and histologic
exams and efficacy (vessel thrombosis) by angiography and
histology.
Results
New effective HIFU therapy and imaging transducer designs and
treatment protocols for ultrasonic hemostasis of deep arterial bleed-
ing were developed and evaluated. The results of theoretical calcula-
tions and modelling along with the acoustic measurements of non-
linear ultrasonic fields were presented. The results of ex vivo experi-
ments on tissues and vascular phantoms allowed to choose the opti-
mal HIFU treatment protocols. In vivo hemostasis experiments on
lamb’s femoral artery confirmed enhanced thermal effect of HIFU in
non-linear regimes. Using of HIFU transducers with resonant fre-
quency of 1,6 MHz at intensity of 5000 W/cm2 (ISAL) allowed to stop
bleeding from major blood vessels that were punctured with an 18-
or a 14-gauge needles during 3–15 sec.
Thrombogenic evidence (blood clotting) and collagen denatur-
ation (vessel shrinkage) were found in necropsy and histologically
in all targeted arterial vessels with minimal damage to adjacent
tissue structures. Coagulation cascade behaviors (postponed
thrombosis) was also observed during next few hours after treat-
ment. Thrombogenic efficiency of intravenous coagulation agents
(liposomes) activated by HIFU at the point of bleeding was also
demonstrated.Conclusions
We have demonstrated that HIFU can be used to stop active bleed-
ing from vascular injuries including punctures and lacerations. The
coagulation strategy that employ thermal and combinational effects
(cavitation, boiling, non-linear behaviours, and coagulation agents)
for fast ultrasonic hemostasis of deep arterial bleeding has been pro-
posed. The results of theoretical modelling, ex vivo experiments on
tissues and vascular phantoms, as well as in vivo experiments in
lamb’s femoral artery proved the efficacy, safety and selectivity of de-
veloped HIFU transducers and combinational treatment methods
that can be used for various therapeutic, surgical and cosmetic
applications.
Fig. 115 (abstract O82). Lamb's femoral artery
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Objectives
Twin-Twin Transfusion Syndrome (TTTS), resulting from vascular
anastomoses within monochorionic placentae, is a major cause of
prematurity, death and handicap in human twin pregnancy. Feto-
scopic laser ablation of these anastomoses is an established ther-
apy but carries significant fetal and maternal risks due to
invasion of the intrauterine space and confers no survival advan-
tage. High intensity focused ultrasound (HIFU) is a non-invasive
treatment which can be used to ablate tissue and occlude blood
vessels. In TTTS a non-invasive method of vascular ablation could
reduce associated risks and increase the scope of treatment. We
aimed to use existing HIFU technology to target and ablate
placental vasculature in the pregnant sheep model, which has
vessels similar to human monochorionic placental vascular anas-
tomoses, to assess the clinical potential of HIFU. Previously, re-
sults of a preliminary study in which placental vessels were
exposed through the uterine wall which had been surgically exte-
riorized to allow invasive instrumentation for monitoring of fetal
and maternal physiology have been presented. In this study, non-
invasive, trans-cutaneous, placental vessel occlusion was
attempted using a standardised treatment protocol which was
designed to study efficacy & safety
Methods
HIFU (1.66 MHz, 5 s) exposures in 5 anaesthetised ovine pregnan-
cies were placed 5 s, and 2 mm, apart using a treatment depth
dependent range of free-field exposure levels (Ispta from 2000 to
5000 Wcm-2) applied non-invasively through cleaned and depi-
lated abdominal skin (coupled through a bag filled with degassed
water. Up to 6 placental vasculature targets were identified usinga colour Doppler ultrasound probe (P10-4, Z.One Zonare)
mounted behind a 19 mm diameter central aperture in the HIFU
transducer (Sonic Concepts H148MR: 64 mm diameter, 63 mm
focal length). Exposures were delivered using a purpose written
Matlab GUI which controlled the exposure parameters (frequency
and power level by controlling the signal generator settings), ex-
posure timing and position of an automated gantry holding the
treatment head precisely using a signal generator. Between 4
and 7 exposures were placed in each placentome during a single
mechanical ventilation pause of up to 90 seconds. Ventilation
pauses were at least 3 minutes apart to allow normalisation of
maternal oxygen saturation and end tidal CO2. Cavitation was de-
tected passively during most exposures using a sensor mounted
on the side of the therapy device and with its focal zone coa-
ligned with the HIFU focal peak. Tissue harmonic B-mode im-
aging data were used to identify whether hyperecho occurred
during exposure. Treatment success was determined as an ab-
sence of detectable flow on colour Doppler (on the minimum
velocity setting) immediately post treatment. After exposure, ani-
mals were allowed to recover, and monitored for obstetric com-
plications. They were sacrificed 21 days post-exposure and a post
mortem was conducted to identify exposed placental vessels and
any iatrogenic harm to mother or fetus. Exposed and control (un-
exposed) samples were fixed in 4% formalin for 5 days, embed-
ded in paraffin wax, and histological examination was performed
on unstained, and on Haematoxylin and Eosin stained 10 μm
thick sections.
Results
Target vessels were identified in 28 sites, in 5 sheep, using colour
Doppler measurements made using the imaging capability of the
combined imaging and treatment head. HIFU occlusion was suc-
cessful in 27 of 28 targeted vessels as indicated by an absence
of flow previously detected using colour Doppler imaging per-
formed at the pre-treatment target identification position. Two
exposures were initially unsuccessful, one of which was retreated
effectively, and in the other, retreatment was not attempted due
to side effects in the overlying skin. The majority of exposures
demonstrated significant levels of either broadband emissions in-
dicative of inertial cavitation, or solely of half harmonic emissions,
suggestive of stable cavitation activity. US imaging obtained dur-
ing HIFU exposure often, but not always, demonstrated the cre-
ation of hyperechoic regions, usually towards the end of the
exposure duration, and during more than one exposure. The ex-
posure level chosen for the given treatment depth in the first an-
imals resulted in skin burns. This was eradicated or reduced to
mild erythema by (i) more thorough cleaning and depilation, with
reduced depilation time to reduce inflammatory response, (ii) re-
duction of the exposure levels by approximately 1 dBm and (iii)
the use of ice to cool the degassed water in the coupling bag.
Post mortem examination demonstrated no evidence of iatro-
genic harm to mother and fetus, with normal fetal growth and
development and no evidence of obstetric complications. The ex-
posed samples demonstrated macroscopic evidence of tissue
damage surrounding placental vessels. Histological examination is
currently on going, but initial results show evidence of clotting
within exposed vessels
Conclusions
We report the first successful use of non-invasive, ultrasound guided,
HIFU to target, ablate and monitor placental vasculature ablation in a
pregnant sheep model. The exposure conditions used appear to be ef-
fective and safe. This proof of concept study demonstrates potential for
the clinical translation of this technique.
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Fig. 116 (abstract O84). (left) Single-shot GRE-EPI MR-ARFI/
thermometry sequence integrating MEG before echo train with
alternating polarities (blue) to encode both temperature and ARFI. The
10ms delay (yellow box) represents tissue relaxation before the next
ARFI encoding. Synchronization of HIFU sonication with MR sequence
is depicted here by the external trigger TTL. (SARFI) and (STHERMO)
HIFU shot schematically represented. (right) 2D multi slice balanced-
SSFP images used for targeting and localization of HIFU transducer.
Transverse orientation is in blue border, sagittal in red and coronal in
green. Yellow box represents tree slices positioned around focus
acquired with the modified EPI sequence
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MR-guided High Intensity Focused Ultrasound (MRgHIFU) allows
non-invasive ablation of pathological tissue. Temperature meas-
urement via the Proton Resonance Frequency Shift (−PRFS)
along with online thermal dose calculation is commonly used as
the principal monitoring parameters. Alternatively, the local dis-
placement of soft tissues induced at the HIFU focal point by
Acoustic Radiation Force Impulse (ARFI) can be encoded in the
phase of the MR image with a motion-sensitive encoding gradi-
ent (MEG) synchronized with short ultrasound pulses. Although
temperature monitoring provides essential information on ther-
mal ablation advancement, no information are provided on tis-
sue physical properties modifications that can alter the focusing
quality of the HIFU beam during the treatment. In the present
work, we propose a fast implementation of a simultaneous MR-
ARFI/thermometry allowing subsecond multi-slice imaging of
temperature and displacement during HIFU ablation. A rapid MR
method providing simultaneous ARFI and temperature monitor-
ing with sufficient spatial coverage would be beneficial to pro-
vide better control of the therapeutic process and improve
patient safety.
Methods
All experiments were performed at 1.5T (Siemens Avanto, Erlangen,
Germany) with a MR compatible High Intensity Focused Ultrasound
platform (Image guided Therapy SA, Pessac, France). It consisted
of a 256 elements phase array transducer (focal length 13 cm,
aperture 13 cm, 1 MHz operating frequency). A single shot echo
planar imaging sequence was modified to insert a bipolar motion
encoding gradient (MEG) before the echo train (Fig. 116). The
MEG direction was chosen parallel to the acoustic propagation
axis to encode longitudinal displacements induced by HIFU
pulses, with adjustable duration (D) and amplitude (A). The polar-
ities of the MEG were alternated for each dynamic to encode dis-
placement into the phase image with either a positive or
negative contribution. An analogic synchronization pulse (TTL)
was generated from the sequence and sent to the trigger input
of the HIFU generator. Its timing (δ) could be adjusted relative to
the beginning of the second lobe of the MEG. The HIFU sonic-
ation was split in two independent shots with amplitudes noted
SARFI and STHERMO.
Sequence parameters were:
Ex-vivo: 3 coronal slices with fat saturation, FOV= 92x147mm2, TR/TE/
FA = 200ms/29ms/45°, voxel size=2.3x2.3x5mm3, with a bandwidth of
1500Hz per pixel, Grappa acceleration (factor = 2), A=25mT/m, =5.3ms
and δ= 3ms for the MEG -In-vivo: 3 slices in the coronal plan with fat
saturation and saturation slabs surrounding the FOV in the phase
direction,
FOV=156x170mm2, TR/TE/FA = 500ms/28ms/50°, 2.3x2.3x5mm3 voxel
size, with a bandwidth of 2003Hz per pixel, A=25mT/m, =5.3ms and
δ= 3ms for the MEG.
Proof of feasibility was performed on one healthy volunteer using 6
elements brain array coil, 10 slices were acquired during 3min with
FOV=156x170mm2, TR/TE/FA = 1000ms/28ms/60°, 1.6x1.6x3.mm3
voxel size, with a bandwidth of 1447Hz per pixel, A=25mT/m, =5ms
for the MEG. 3 orthogonal orientations were successively acquired.
Results were analysed by the calculation of the standard deviation of
temperature and displacement along acquisition time on whole brain
and on region in centre of the brain where HIFU ablation are cur-
rently performed.
Results
This sequence and the associated post-treatment allow real-time
visualization of temperature and ARFI displacement with a temporal
resolution up to 75ms with the minimum repetition time and a
spatial resolution of 2.3x2.3x5 mm3.
For ex-vivo ablations (N=15) SARFI = 340W, STHERMO = 255W and sonic-
ation duration was 60s at the natural focus position. At the end of
sonication, a temperature increase of 15±0.9 °C was observed. Initial
ARFI displacement measured was 30±1.1μm and progressively de-
creased to reach 21μm at the end of sonication.For in-vivo ablations (N=10) SARFI = 425W, STHERMO = 425W and sonic-
ation duration was 30s at the natural focus position. Apnea was
maintained for 45s and no respiratory motion was observed. At the
end of sonication, a temperature increase of 25±1.2 °C was mea-
sured. ARFI displacement measured exhibited an increase then de-
crease pattern with a maximum found for an absolute temperature
of 49°C (see Fig. 117).
In both in-vivo and ex-vivo ablations the decrease of ARFI displacement
(Fig. 117) described a linear curve fitted as y (T [°C]) =−0.90T+2.19 for
ex-vivo and y (T [°C]) =−1.82T+9.46 in-vivo.
On Fig. 118 standard deviation of temperature and ARFI displace-
ment, in all orientations, are shown in a region in centre of the brain.
The refresh rate was 1Hz for 10 slices.
Conclusions
In this study, a HIFU ablation monitoring method has been
validated in-vivo in pig liver and ex-vivo in pig muscle. This fast
sequence enabled multi-slice acquisitions while remaining at a
sub second temporal resolution. In addition, improvement of the
sonication duty cycle allowed fast ablation with the possibility to
independently control the power for ARFI encoding and the
amount of power to induce a heating. During HIFU ablation mon-
itoring, this method allowed visualization of temperature and
ARFI displacement time evolution. For in-vivo and ex-vivo abla-
tions, a significant decrease in ARFI displacement was observed
along the ablation attesting a stiffening of the tissue at the focus.
This qualitative index of tissue stiffness could give additional in-
formation on ablation process.


















Equation 1: T and D represent temperature and displacement images
at the ith dynamic in the time series. δ denotes phase images and (+, −)
stands for polarity of the MEG gradient, whereas “ref” stands for refer-
ence phase data acquired prior to sonication. Other parameters are the
gyromagnetic ratio , the PRFS constant , the echo time TE and the static
magnetic induction B0 = 1.5T, A and the duration and amplitude of the
MEG gradient, respectively.
Fig. 118 (abstract O84). Results on healthy volunteer of standard
deviation for temperature and ARFI displacement on 10 slices during
3min acquisition. In boxplot 1:TSTD in centre of the brain 2:DSTD in
centre of the brain 3:TSTD on whole brain 4:DSTD on whole brain
Fig. 117 (abstract O84). Results for in vivo and ex vivo. a Temperature
(top) coronal images obtained at the beginning (right) and at the end
of heating period (left). b Time course of ARFI displacement (blue) and
Temperature (red) of a single pixel at the focus. c Represents a box plot
of the displacement variation on populations of temperature increase
of 4 degrees. A mask of 20x20 pixels around the focus was applied on
data with a 3x3 Spatial Gaussian filter
Fig. 119 (abstract O85). Left: user interface of the MR-guided
hyperthermia platform. It includes multi-plane MR thermometry
and phased array controller module. Right: diagram of the MR
thermometry-based HT system
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Objectives
Hyperthermia (HT, 40-45°C, 30–60 min) has been combined
successfully with several cancer treatment modalities, such as radiation,
chemotherapy and drug delivery [1,2] to enhance treatment efficacy.We have implemented an MR-guided hyperthermia (MRgHT) platform
by performing operational modifications to a commercially available
MR-Guided Focused Ultrasound (MRgFUS) ablation system within its
hardware and software constraints. This platform enables automated
modulation of acoustic power and changes in sonication beam patterns
based on real time MR thermometry feedback to produce long-duration
hyperthermia in large contiguous volumes. It is currently demonstrated
for an endorectal focused ultrasound array already in clinical trials for
prostate ablation. With strong clinical rationale for HT augmented radi-
ation and chemotherapy for several cancers, this MRgHT platform has
potential for rapid clinical translation.
Methods
The real-time thermometry application (Fig. 119) was developed for
the RTHawk real-time MRI system (HeartVista, Inc., Menlo Park, CA),
connected to a 3T MR scanner (GE Healthcare, Waukesha, WI) and
the 2.3-MHz ExAblate 2100 prostate array (InSightec, Haifa, Israel). The
application included an SPGR pulse sequence (TE = 13.4 ms, FOV = 28–
32 cm, 3 s/slice), a real-time PRFS thermometry reconstruction pipeline
and a custom interface for data visualization and prescription. The sys-
tem provided for interleaved simultaneous acquisition of multiple slices
at different orientations, with customizable ROIs for temperature meas-
urement and feedback control.
The beam controller module was developed for the RTHawk MR
Thermometry application (Fig. 119). Its features included multi-point
temperature sampling, feedback power control and real-time switch-
ing of custom beam patterns. To interface with vendor ultrasound
control software, a Control Proxy Server application was developed.
It accepted connections from the beam controller module over the
local area network and translated the commands received over this
connection into calls of the vendor-provided software interface.
The delivery of hyperthermia was performed in a tissue mimicking phan-
tom with heating for 16 min at 1.3 W/cm2 array surface intensity. We im-
plemented temperature monitoring in four regions of interest (ROI) in a
diamond pattern (20 mm separation) and switching the ultrasound beam
focus to the ROI with minimum temperature. Transducer output power
was controlled not to exceed the target temperature of 7°C.
Results
Figure 120a shows MR thermometry images, acquired during the heating
stage and after approaching steady state. Uniform temperature increases
within a 1°C envelope were observed in all ROIs (Fig. 120b). HT uniformity
could be further improved by using a larger number of focus points with
independent control and custom multi-focus beam patterns.
Conclusions
We have implemented a real-time MR thermometry-guided ultra-
sound beam control system integrated with the ExAblate platform
for long duration prostate hyperthermia therapy and validated it in
phantom experiments. Future work will focus on implementing
phased patterns for different treatment scenarios (Salgaonkar, et al.
Med Phys 2014) and in-vivo validation.
This work was supported by Focused Ultrasound Foundation, NIH
R01CA12276, R01CA111981, R00HL097030, UCSF-RAP.
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Fig. 120 (abstract O85). a Thermal images, captured during MR
thermometry guided switching between single focus patterns and
at steady state; b Plot of mean temperature within the four ROIs
during the heating experiment. Colour bar below shows active
single focus heating pattern matched to the corresponding ROI
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Objectives
The Sacroiliac Joint (SIJ) is a common pain generator in both
arthritic and metastatic disease [1]. Successful denervation of SIJ
pain requires complete interruption of the lateral branch nerves
innervating the POLYMERIC CUPS AS NANOSCALE CAVITATION
NUCLEI FOR ACTIVE TRANSPORT with the inability to directly
visualize the targeted nerves, introduces substantial uncertainty in
successful outcomes for current denervation approaches. Percu-
taneous radiofrequency neurotomy (RFN) requires insertion of
multiple RF probes along the SIJ in order to achieve the desired
lesion. However, clinically, the finite number of the RF probes
makes creation of the continuous lesion challenging and elevates
the risk of thermal lesions incompletely disrupting the targeted
innervation. Magnetic Resonance guided High Intensity Focused
Ultrasound (MRgHIFU) can potentially serve as a more reliable
and non-invasive treatment of SIJ pain. The goal of this study
was to study the feasibility of MRgHIFU denervation of the SIJ in
a sub-acute swine model.
Methods
Three swine (weight range 30–35 kg) underwent bilateral MRgHIFU
ablation (ExAblate 2000; InSightec Ltd., 3 Tesla MRI) of the SIJ in the
supine position. All procedures were carried out according to an ap-
proved Institutional Animal Care and Use Committee protocol. To
create a thermal lesion cutting across the lateral branches, traveling
from intervertebral and sacral foramen to the SIJ, individual sonica-
tions were stacked along the SIJ slightly medial to the joint from su-
perior to inferior points as shown in Fig. 121. The beam angle was
adjusted to achieve near-perpendicular incidence on the sacral bone
or SIJ, and was angled away from the spine to avoid ablation of the
sacral nerve roots. To efficiently interrupt the lateral branches, thediameter of which ranges from 0.2 to 1.5 mm [3], both near-field
heating (right side, Fig. 121b) and direct heating (left side, Fig. 121c)
approaches were applied. The resonant frequency was set to 1.35
MHz, sonication duration was 20 s. In the first experiment, 42 sonica-
tions with acoustic energy of 840–1300 J were applied using 90 s
cooling time. These parameters were adjusted after the first explora-
tory experiment. In the subsequent two animals, the energy was low-
ered to 574–800 J, the number of sonications was reduced to 15,
and the cooling time was increased from to 120–150 s. Thermometry
imaging was performed in the axial plane in animal 1, and in sagittal
plane in animals 2 and 3. Contrast enhanced (CE) imaging was per-
formed immediately following treatment with MRI and 48 hours after
treatment with CT. During those 48 hours, animals were maintained
on preventative medications for potential pain. Veterinary staff per-
formed assessment of pain and animal behavior twice a day to moni-
tor for any unwanted side effects such as deep pain or impaired
ambulation. The animals were euthanized with an IV injection of
pentobarbital (100mg/kg) while under anaesthesia at the end of the
CT scan. At necropsy, the sacrum (including the SIJ) was removed
and fixed in 10% neutral buffered formalin, followed by decalcifica-
tion. The SIJ was then sectioned transversely and analysed using
hematoxylin and eosin (H&E) stain.
Results
All treatments resulted in non-perfused regions surrounding the SIJ
medial surface visible on CE-MR (Fig. 122a-c) and CT 48-hour follow-
up images (Fig. 122d-e). Continuous non-perfused regions of ablation
were achieved along the SIJ in animals 2 and 3 (Fig. 122a-c). In the
first experiment, continuous muscle necrosis extended from the SIJ
to the skin (Fig. 122e) and skin discoloration consistent with the burn
approximately 10 mm in diameter was found. There were no skin
burns or unwanted muscle necrosis in the other two animals. Gross
pathology analysis showed discoloration of muscle and the surface
layer of adjacent bone, as is associated with hemorrhage (Fig. 123a).
Histological analysis (Fig. 123b-c) confirmed necrosis of muscle and
adjacent bone, and thermal destruction of the nerves manifested as
hyperemia of endoneurial vessels, and loss of axons associated with
dilation of the myelin sheath. Neither superficial nor deep pain, nor
changes in animals’ ambulation nor behaviour were reported by the
veterinary stuff.
Conclusions
The present study shows that the lateral branch nerves innervating
the SIJ can be successfully ablated using MRgHIFU by creating a con-
tinuous thermal lesion along the SIJs. Due to the overall short dis-
tance separating the surface of the sacral and iliac bones from the
skin, and the previously reported slower cooling of tissue adjacent to
cortical bone [4], sufficient cooling time needs to be allowed be-
tween the sonications to minimize excessive damage of adjacent
muscle. Additionally, due to the “double-oblique” surface of the SIJ
and the necessary angulation of the beam in right-left and superior-
inferior planes, thermal imaging in the sagittal plane may better cap-
ture the largest temperature rise during a sonication compared to
the axial plane imaging. In conclusion, this study provides prelimin-
ary evidence of feasibility of a novel, and potentially more effective,
treatment technique for denervation of the SIJ in humans. Further
study is needed to accurately determine if pain improvement can be
achieved clinically.
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bone metastasis. ISMRM; 2015; Toronto.Fig. 123 (abstract O86). a Example of gross pathology section of
the SIJ showing discoloration of muscle and bone tissue consistent
with thermal changes. b Low magnification H&E histology of a
boxed section in (a). Muscle, adjacent bone tissue, and two nerves
(black arrows), show changes consistent with thermal necrosis. 1 mm
scalebar. (c) High magnification H&E histology image of the nerve
showing hemorrhage (asterisk), and loss of axons associated with
dilation of the myelin sheath (arrow). 100 um scalebar
Fig. 122 (abstract O86). Example of CE-MR images obtained
immediately following MR-HIFU treatment and follow-up CE-CT
images. Lack of contrast uptake indicates the ablated regions (arrows).
a Coronal image showing the continuous regions of ablation along
the SIJs. b-c Axial CE-MR images of the most superior and inferior slices
of the bilateral lesions. Axial CE-CT images showing a successful ablation
confined to the SIJ and adjacent tissue (d), and unwanted necrosis of
a large volume of muscle and skin (asterisk), which resulted from
potentially insufficient cooling time between consecutive sonications (e)
Fig. 121 (abstract O86). Example of planning MR images showing
the SIJ in coronal and axial planes. a Green and magenta lines indicate
the most superior (green) and inferior (magenta) slices where the
sonications were prescribed as shown in (b) and (c). White arrow
points out the short distance between the bone and the skinO87
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Objectives
Treating liver tumours using FUS poses a great challenge due to the
breathing motion of the target and the occlusion of the anatomical lo-
cation of the malignancy by the rib cage. To perform safe, effective and
efficient ablation of tumours, a thorough planning as well as precisely
conducting of the treatment is essential. The EU projects FUSIMO
(2011–2015) and TRANS-FUSIMO (www.trans-fusimo.eu) aim at the de-
velopment and clinical translation of a sophisticated software system
that supports the exploration of the full potential of extracorporeal FUS
in the planning and execution stage of the treatment.
Methods
The enabling technology of the TRANS-FUSIMO software system is a
set of dynamic organ models for the physical and biophysical pro-
cesses involved in FUS treatment: (i) an abdominal motion model
simulates the patient specific deformation of the organ and relevant
anatomical structures during breathing; (ii) a patient specific tissue
model represents the ultrasound propagation, the energy deposition
as well as the tissue heating and cooling; (iii) an organ/tumour model
captures the patient specific tissue’s response to the therapy. These
model components are parameterized with patient specific data that
is extracted from patient specific pre-interventional imaging data like
MRI and/or US imaging data. Moreover, in TRANS-FUSIMO, the ab-
dominal motion model is used with real-time MR and/or US data to
track the motion of the target and steer the FUS beam accordingly.
Results
The model components are capable of simulating the patient specific
motion of the organ under breathing, as well as the propagation of
ultrasound, the diffusion of heat and the influence of blood perfusion
in the FUSIMO planning system. The treatment system using the ab-
dominal motion model and the other model components are being
validated in phantom and ex vivo experiments as well as in Thiel soft
embalmed human cadavers. Furthermore, in TRANS-FUSIMO, the
safety, efficacy and efficiency of the software assistant will be evalu-
ated in an in-vivo animal study. Moreover, a two-arm study (neoadju-
vant TRANS-FUSIMO MRgFUS + resection, TRANS-FUSIMO MRgFUS
only) for human patients with metastases or HCC will show the feasi-
bility of the TRANS-FUSIMO treatment system for the clinical setting.
The talk will give an update on the current progress of the project.
Conclusions
The FUSIMO software demonstrator comprises patient specific mo-
dels for the simulation of FUS application in moving organs. It sup-
ports the assessment of the feasibility of the intervention, predicting
and optimizing the outcome, detecting potential risks and avoiding
them, as well as monitoring the progress and tracking deviations
from the planned procedure. Our ex-vivo experiments show that the
FUSIMO system is capable of compensating organ motion through
real-time motion detection, motion modelling and real-time beam
steering. In TRANS-FUSIMO a fully integrated system is being devel-
oped for which in-vivo animal studies and first patient study shall
show that MRgFUS in moving organs can be performed safely, effica-
ciously and effectively.
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Objectives
Prostate cancer is the most frequently diagnosed non-skin cancer in
the United States and the third leading cause of cancer deaths. Re-
cent progresses in the diagnosis of prostate cancer open the gate to
focal therapy. New HIFU devices have been specifically designed for
that purpose. They combine the necessary tools to visualize, target,
treat and validate the focal treatment. The goal of the presentation is
to describe some of these developments made for improving the
cancer diagnosis, the guidance of the treatment and the assessment
of its efficacy.
Methods
A computer-assisted diagnosis (CAD) system was developed for de-
termining a likelihood measure of prostate cancer presence in the
peripheral zone (PZ) based on multiparametric magnetic resonance
(MR) imaging. The evaluation database consisted of 30 sets of multi-
parametric MR images acquired from radical prostatectomy patients.
Both cancer and non-malignant (but suspicious) tissues were
annotated in consensus on all MR images by four experts. Histologic
sections were considered as the gold standard.
Focal treatments by HIFU were performed with Focal One®
(EDAP-TMS, Lyon France). The process can be divided in 4 steps:
treatment preparation with import of MR images and fusion with
the real-time ultrasound volume, focal target definition, HIFU de-
livery and validation of effectively de-vascularized volume with
contrast-enhanced ultrasound (CEUS). Pretreatment MR images
with contoured prostate and annotated suspect ROI can be
imported in the HIFU device. The urologist contours similarly the
prostate on the live ultrasound images acquired with the trans-
rectal probe. The software automatically registers the two vol-
umes and proceeds to an “elastic fusion”. For treatment
guidance, the same 3D elastic transformation is applied to the
ROIs initially indicated on the MR image so they appear at the
adequate position on the ultrasound Image.
For monitoring purpose and assessing the treated volume, a system-
atic CEUS with SonoVue TM is performed at the end of the proced-
ure. A treatment completion can be performed if necessary in the
same HIFU session.
Results
For the CAD, a restrictive set of about 15 highly informative fea-
tures coming from all MR sequences was discriminated, thus con-
firming the validity of the multiparametric approach. Quantitative
evaluation of the diagnostic performance yielded a maximal area
under the ROC curve (AUC) of 0.89 (0.81-0.94) for the discrimin-
ation of the malignant versus nonmalignant tissues and 0.82
(0.73-0.90) for the discrimination of the malignant versus suspi-
cious tissues.
A feasibility study was performed on 10 patients focally treated with
Focal One to evaluate the precision and the efficacy of the focal ther-
apy. Concerning the precision of the treatment, control CEUS-guided
biopsies inside and around the necrotic zone at one month showed
100% negative biopsies in the treated area and viable tissue immedi-
ately around the treated area. For the monitoring, this feasibility
study demonstrated that the post-operative necrosis observed onearly MRI (2–7 days after HIFU) corresponded to the devascularized
area observed on CEUS at the end of the HIFU procedure. Urinary
continence and erectile function were fully preserved for the 10
patients.
Conclusions
Last generation of transrectal HIFU represents an interesting option
for focal treatment of prostate cancer, combining imaging tech-
niques, treatment preciseness and treatment validation. The cancer
must be localized precisely and CAD based on multiparametric mag-
netic resonance (MR) imaging can be helpful. The developed CAD as-
sists both non-experts and expert uro-radiologists in the detection of
aggressive cancerous foci in the PZ. This development is particularly
interesting in the context of overtreatment of prostate cancer. The
MRI/US fusion facilitates the targeting of the localized prostate can-
cer and allows a precise and efficient focal treatment. Post-HIFU
CEUS is demonstrated to be a good method for evaluating the qual-
ity of the treatment.
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Objectives
Harmonic Motion Imaging for Focused Ultrasound (HMIFU) has been
shown to image and monitor HIFU ablation based on the stiffness
change of the tissue. In this study, the feasibility of HMI for real-time
monitoring and the formation of the lesion during HIFU treatment is
explored.
Methods
The HMIFU setup consists of a 93-element, 4.5-MHz HIFU transducer
confocally aligned with a 64-element 2.5-MHz phased array to trans-
mit and receive through a 4-board VDAS system. All HIFU channels
were synchronously excited by a 50 Hz amplitude modulation to vi-
brate the tissue at 100 Hz. In vitro experiments were performed on 9
canine liver specimens. The acoustic power and ablation duration
was 20 W and 90 s respectively. Peak-to-peak HMI displacement map
were calculated. The displacement map at 1s was used as a reference
frame to subtract the following frames during ablation. The last
frame of ablation subtracted from the reference frame was used to
quantify the size of HMIFU lesion. The dimension of HMIFU lesions
were compared to the gross pathology. Both depth and width of the
lesions were compared between lesion-segmented images obtained
for both techniques.
Results
The average peak-to-peak displacement in the ROI of canine liver
before ablation was found to equal 16.32±3.02 μm. After ablation,
the average displacement of canine liver after ablation was de-
creased to 3.84±1.94 μm. The figure shows representative HMI
displacement contrast maps in canine liver during ablation and a
photography of the gross pathology section after ablation. Yellow
indicates the area where displacement decreasing during abla-
tion. The depth and width of the 5 lesions’ measured by HMI
were equal to 10.9 ±3.4 mm and 8.4 ±2.9 mm respectively while
depth of 11.5 ±2.4 mm and width of 9.8 ±1.5 mm was found in
gross pathology. Good agreement between the lesion’s depths
and widths determined with gross pathology and HMI. HMIFU
can successfully monitor thermal lesions development in in vitro
canine liver specimens.
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HMIFU can successfully monitor thermal lesions development in
in vitro canine liver specimens.
Supported by R01EB014496-01.Fig. 125 (abstract O90). HMIFU results in a murine pancreatic
tumour model. The tumour is delineated on the Bmode image (a)
with the FUS focal shown in red. The mean HMI displacement in the
tumour during ablation is shown in (b). Corresponding HMI maps
during with values relative to the baseline at t = 0 are shown for
t = 4 s, 32 s and 60 s (c). The decrease reflects the progressive
stiffening of the ablated tissue
Fig. 124 (abstract O89). HMI displacement contrast maps in canine
liver during ablation and a photography of the gross pathology
section after ablation (down right)O90
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Objectives
Harmonic Motion Imaging (HMI) assesses tissue mechanical proper-
ties by inducing localized oscillation resulting from a periodic acous-
tic radiation force. The amplitude of the induced displacement is
directly related to the underlying tissue stiffness. The sonication can
be short for imaging (HMI) or prolonged for simultaneous HMI and
HIFU treatment (Harmonic Motion Imaging for Focused Ultrasound
or HMIFU).
The objective of this study was to assess a murine pancreatic tumour
model during its growth in terms of elasticity with HMI, then treat it
using HMIFU. HMI measurements are then resumed to monitor the
mechanical changes resulting from the treatment.
Methods
A 4.5-MHz focused ultrasound transducer (FUS) generated an
amplitude-modulated beam resulting in harmonic tissue oscillations
at its focus. Axial tissue displacement was estimated using 1D cross-
correlation of RF signals acquired with a confocally aligned, 7.8-MHzdiagnostic transducer (P12-5, ATL) using a plane-wave beam se-
quence at a framerate of 1 kHz. Pancreatic tumour growth was moni-
tored using HMI in a transgenic mouse model to acquire elasticity
maps with 0.2 s sonication for each scan position. When the tumour
reached a size of approximately 5 mm, HMIFU was performed over a
period up to 120 s, which was shown to generate a lesion in this
model according to previous work by our group (Chen et al., IEEE
TUFFC, 2015). The success of the treatment was assessed by measur-
ing both the tumour area and its elasticity up to 14 days with regular
histological measurements.
Results
HMI demonstrated its capability to provide reproducible elasticity
measurements in murine pancreatic tumours. Measurements show
that stiffening occurs progressively during pancreatic tumour growth
from the very early stages. When plotting the HMI displacement
against the tumour size, an exponential trend was fitted to the data
with R2 > 0.7. During ablation with HMIFU, the tumour was shown to
stiffen (Fig. 125). After 60 s of treatment, a 51.4% decrease in HMI
displacement was observed compared to baseline value at t = 0
(Fig. 125b and c). The lesion was confirmed by histology. The follow-
up of the HMIFU treatment is performed with HMI to assess long-
term tissue mechanical changes after treatment.
Conclusions
This work shows that the HMI technique can provide elasticity mea-
surements in the murine pancreatic tumour during its growth with
HMI as well as treat the tumour with simultaneous monitoring using
HMIFU. The follow-up was performed with HMI to assess post-
treatment mechanical changes. This study underlines the potential of
HMI for monitoring tumour growth, treatment and follow-up
changes in elasticity.
Fig. 126 (abstract O91). a and b show displacement maps after
MR-ARFI at 450W and 1000W, respectively. c and d show temperature
maps af ablations at 450W and 1000W. All images are overlayed on
anatomical T1-weighted MR images. ARFI-maps and temperature maps
coincide when equivalent power levels are used. Note the spacial shift
between the 450W and 1000W experiments
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Objectives
The precision of MRI based interventional guidance of High-
Intensity Focused Ultrasound relies i.a. on the stereotactic corres-
pondence between the MR-image and the location of the HIFU
ablation area. However, incongruities between the planned focal
point location and the actual focal position of the HIFU beam
are routinely observed, predominantly due to acoustic wave-
front aberrations induced by dissimilarities of the acoustic im-
pedance in the beam propagation path. The current solution in
clinical practice is to employ a “low power test shot” before the
start of the ablation of particular region to provide a 3D correc-
tion of the precise focus location. The low power generally al-
lows observing a distinct temperature elevation without causing
irreversible tissue damage. In spite of being safe and accurate in
low perfused target tissues such as uterine fibroids, the high
heat extraction rate renders this approach of limited value in
high-perfused organs such as liver or kidney. Moreover, further
discrepancy is added between a linear test shot and a thera-
peutic sonication for therapeutic HIFU sonications in the non-
linear pressure range [1].
Recently, MR-acoustic radiation force imaging (MR-ARFI) has been
proposed as an alternative method to locate the focal point non-
invasively without giving rise to non-desired tissue damage [2–5].
MR-ARFI evidences the tissue displacement due to the acoustic radi-
ation force of the HIFU beam instead of the temperature. However,
since MR-ARFI employs a highly motion sensitized sequence and dis-
plays limited sensitivity, it is challenging in abdominal organs and
in vivo experience with this type of this approach is currently limited
to the liver.
The first aim of this study was to investigate the feasibility of
respiratory-gated MR-ARFI on clinical HIFU equipment for the exact
beam localization in the kidney. Of particular interest was hereby po-
tential interference with other motion sources, such as cardiac pulsa-
tions in the vicinity of larger vessels such as the renal artery. The
second goal was to validate if MR-ARFI can perform this task for both
linear and non-linear acoustic energy delivery.
Methods
A porcine model (85 kg) was chosen for its similarities in size and
perfusion of the kidney to the human kidney. The local animal wel-
fare committee approved the study The pig was anesthetized and
mechanically ventilated at a frequency of 13/min. A clinical Philips
Sonalleve MR-HIFU therapy system (Philips Healthcare, Finland) inte-
grated with a 1.5T Achieva MRI (Philips Healthcare, The Netherlands)
with minor modifications was used for MR-HIFU. An MR-HIFU treat-
ment cell was positioned at 4.5cm from the skin in the cortex of the
kidney. A gradient-recalled echo planar imaging 2D dynamic scan
(TR 100ms, TE 30ms, flip angle 20°, FOV 168x168mm2, matrix
112x108, voxel size 1.51x1.51mm2, slice thickness 7mm) was per-
formed to visualize displacement due to the acoustic radiation force
similar to [2]. Thermometry data was obtained using a gradient echo
with echo planar imaging (TR 100ms, TE 15ms, flip angle 20°, matrix
160x160, FOV 400x400mm2, voxel size 2.5x2.5mm2, slice thickness
5mm). All MR sequences, including anatomical images, and theacoustic energy delivery were respiratory gated based on pencil
beam navigator images along the transition of the contralateral
kidney to the perinephric fatty tissue. For comparison of linear
and non-linear effects, four experiments at two different power
levels were performed: Two thermal ablations with 450 W con-
tinuous wave and 1000 W pulsed (30% duty cycle, tone-burst of
10500 cycles), and two MR-ARFI experiments at equivalent acous-
tic intensity (tone-burst of 2400 cycles, bipolar MR-ARFI gradient
20mT/m, 3ms).
Results
Displacements due to the radiation force could be reproducibly mea-
sured for both acoustic intensities and coincided with the location of
the temperature elevation of the equivalent 450W and 1000W abla-
tions, respectively (Fig. 126). No interference/artifacts with the cardiac
cycle were observed during MR-ARFI. The focal point of the beam
cone was evidenced more posteriorly than planned for the 1000 W,
most likely due to shock-wave formation and non-linear absorption.
No significant heating was observed during the MR-ARFI experiments
(<2°C).
Conclusions
The employed respiratory gated MR-ARFI sequence in combin-
ation with a 450 W excitation tone-burst of 2400 cycles is sensi-
tive enough to exceed the noise level and to clearly display the
focal point of the HIFU beam at a fraction of the energy com-
pared to the 450W thermal ablation. Both at 450W and at 1000W
the displacement due to the radiation force coincided with the
location of the temperature rise due to thermal ablation at
equivalent power. Hence, radiation force in combination with a
pencil beam navigator to compensate for respiratory motion is a
reliable indicator of the location of the thermal lesion and might
be an alternative to the low power thermal test shot in highly
perfused organs such as the kidney.
Fig. 127 (abstract O92). Left: acoustic transmission factor, in pressure,
of the rats’ skull as a function of animal weight. Measurement done at
1.5 MHz and at the three positions: back (green), middle (blue), front
(red), as drawn with red circles on the skull. Right: the three positions
on the skulls
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Objectives
When performing transcranial focused ultrasound procedures, the
knowledge of the in situ acoustic pressure is key in order to ensure
both efficacy and safety. This is particularly true for blood–brain bar-
rier (BBB) disruption studies where only a narrow range of peak
negative pressure (PNP) is acceptable, sufficient stable cavitation of
the microbubbles without reaching inertial cavitation responsible for
irreversible damages.
More specifically, the literature is missing data on rat transmission fac-
tors [O’Reilly et al. Ultrasound Med Biol. 2012] while this animal model is
widely used for HIFU in brain [Dervishi et al. Int. J. Hyperthermia. 2013].
The transmission factor seems to depend on both age and skull loca-
tion. This makes it difficult to compare studies performed on rats of dif-
ferent weights and - more concerning - it could bias some of the PNP
values published in the literature. It is therefore useful to provide more
ex vivo data. However, the real grail would be to be able to measure
this transmission factor (or directly the PNP) in vivo. To do so, magnetic
resonance acoustic radiation force imaging seems a promising tech-
nique [Larrat et al. Phys Med Biol. 2010] since it is based on the MR en-
coding of displacements induced by the ultrasound beam at focus
which are quantitatively related to acoustic intensity.
In this work, we present new in vitro measurements through rat
skulls that go beyond already available data and we introduce a way
to use MR-ARFI for in situ acoustic calibration in the rat brain. Firstly,
this coefficient was measured ex vivo, in a water tank, for rats of dif-
ferent ages and for different positions of the focal acoustic spot in
the skull and different frequency. Secondly, the transmission factor
was estimated in vivo, under MRI, thanks to an Acoustic Radiation
Force Imaging (ARFI) sequence.
Methods
Prior to all studies, an 8 channels concave annular array transducer
(Imasonic) was first calibrated in open field in a water tank. A calibrated
hydrophone was used to measure the peak negative pressure of the
transducer at focus as well as to measure the size of the focal spot.
Then, in a first study, the ultrasonic transmission factors through rat
skulls were measured as a function of animal weight and ultrasound
frequency. These measurements were performed with the ultrasound
beam intersecting the skulls at three different locations in the head-
foot direction: front, middle and back, for differrent frequencies: 1,
1.25, 1.5, 1.5 and 2 MHz. The skulls of 11 Sprague–Dawley rats
(Janvier, France) of different weights (100–500 g) were used. The acous-
tic transmission factor was then measured as the ratio between the
PNP at the focal spot in the presence and in the absence of skull.
In a second study, 4 rats were installed in our motorized MR guided trans-
cranial focused ultrasound system (Image Guided Therapy and Bruker)
using the same transducer as previously. MR-ARFI signals are acquired at
38 different locations in the brain separated by 1 mm so that to cover one
whole skull hemisphere. Under our imaging conditions, the ARFI phase dif-
ference between the center of the focal spot and the background can be
assumed to be proportional to the acoustic intensity. Therefore, the rela-
tive transmission factor through the skull is proportional to the square root
of the ARFI phase difference. After sacrifice of the animals, the transmission
factors through the same hemisphere were mapped in a water tank at
high spatial resolution (millimeter by millimeter).
Results
The main result of the first study is the almost linear dependence of
the transmission factors on the animal weights (see Fig. 127) at allfrequencies. This is explained by the fact that the heavier animals
are older and have thicker skulls. Our measurements also show that
the skull is not homogeneous in the head-foot direction, the front
and middle parts transmitting less than the back. Finally, as ex-
pected, the transmission factors decrease with increasing ultra-
sound frequency.
The full mapping of left skull hemispheres (see Fig. 128) confirms the
strong variations in the head-foot direction but it also shows that the
transmission factor dramatically drops on the sides of the skulls.
The best way to remove background phase on the ARFI images was
proved to be the following: mask the brain excluding the focal spot,
find the best 2D polynomial (order 5 in x and y directions) surface that
fits the background and then remove this modelled background. Quali-
tatively, the ARFI signals (see Fig. 129) is in agreement with the one in
the water tank: the transmission factor is maximum in the middle and
falls on skull sides. The encoded displacement of the media due to the
radiation force depends on the viscoelastic behavior of this media, so
for a given PNP, ARFI signals will differ between two regions if the
viscoelastic response is too different. This is particularly true in ventri-
cles where water can flow easily. To take this into account, a more re-
fined data analysis was developed. High resolution T2w images are
segmented into 3 compartments of known elasticity and viscosity: grey
matter, white matter and cerebro-spinal fluid. The Green function and
the MR-ARFI encoding are simulated at each ARFI location to recover
the estimated acoustic pressure [Larrat et al. Phys Med Biol. 2010,
Bercoff et al. IEEE Trans UFFC. 2004]. This new analysis is still on going.
Conclusions
Those results are very interesting in order to gain control in the trans-
cranial FUS experiments in rats. The transmission factor varies a lot be-
tween small and big rats. The power delivered to the transducer has to
be tuned to take this into account. This is particularly relevant in longi-
tudinal studies where the animals can grow significantly.
The “high resolution” mapping of acoustic transmission shows a
strong dependence on the part of skull that is intersected by the
beam. This knowledge allows to correct the power to ensure uniform
pressure distribution along motorized trajectory such as the one per-
formed for our BBB openings protocols. More power has to be deliv-
ered to the back and lateral parts of the brain.
The ARFI in vivo estimation technique is promising in order to cali-
brate the beam in situ. However, from our preliminary results, it is
clear that one has to take viscoelasticity into account to get reliable
quantitative pressure estimations.
Fig. 129 (abstract O92). Example ARFI images for three positions of
the transducer on top of the head showing that the transmission
factor decreases on the back and on the sides
Fig. 128 (abstract O92). Acoustic transmission factor mapping, in
pressure, of the left half skull of a 320 g rat. The corresponding
region is drawn as a black rectangle on Fig. 127
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Objectives
The acoustic intensity needs to be very well known to efficiently
open the Blood–brain Barrier (BBB) since it is mainly ruled by the
mechanical index [1]. Previous studies have shown that a narrow
range of peak negative pressure (PNP) is acceptable, corresponding
to sufficient stable cavitation of injected microbubbles without reach-
ing inertial cavitation responsible for irreversible damages. Within
this range, only few data are available about how the pressure affects
the strength of BBB disruption that is to say the amount of delivered
drugs.
We propose two new methods to evidence the opening threshold
in vivo and measure this relationship after a MRI controlled protocol
of the BBB opening: 1) Several different pressures are used at several
brain locations during the same BBB opening session 2) A single
point focal opening is performed and the brain uptake of contrast
agent is correlated in each voxel with the pressure estimated from a
MR-acoustic radiation force image [2].
Methods
We use our previously introduced motorized MR-compatible FUS sys-
tem [3] (Image Guided Therapy, France). An 8 channel annular arraytransducer operating at 1.5MHz (Imasonic, France) was calibrated in
a water tank and acoustic transmission factors through rat skulls
were measured in another study. This ability to shrewdly control the
pressure we deliver in vivo in the brain is crucial for the two pro-
posed methods. Fisher F344 rats (n=5, body weight=220g) were
shaved and installed in the MRI bed of a 7T MRI scanner (Bruker)
under isoflurane anesthesia. The transducer was coupled to the head
with echographic gel.
In a first experiment, after intravenous injection of microbubbles
(Sonovue), a square trajectory was played with the transducer con-
tinuously shooting. 4 different pressures (0.25 0.35 0.45 0.55 MPa)
were applied on the 4 sides of the square. The transducer was mov-
ing at 10 mm/s, the size of the square was 5 mm and the trajectory
was played 60 times. Then a 200μL Gadolinium based MRI contrast
agent (Dotarem, Guerbet, France) was intravenously injected, at dif-
ferent time after the opening (10 minutes, 4 hours and 24 hours),
and its uptake into the brain was quantitatively measured thank to
T1 maps.
In a second experiment, the BBB was focally open with 0.6 MPa peak
negative pressure at focus. Before the opening session, an Acoustic
Radiation Force Image was acquired in order to estimate in vivo the
pressure applied in each voxel during the BBB opening. After the
opening, Dotarem was intravenously injected and the contrast agent
concentration was measured in each voxel by acquiring T1 maps [4].
The concentration in each voxel is then correlated to the pressure
which has been used in this voxel to open the BBB.
Results
The first experiment with the square trajectory gives a rough estima-
tion of the pressure threshold. Indeed it appears clearly (see Fig. 130)
that the BBB is not open on the 0.25 and 0.35 MPa sides while it is
open on the 0.45 and 0.55 MPa sides. The acoustic threshold must
be between 0.35 and 0.45 MPa. With the second injection, we also
found that the BBB was already close as soon as 4 hours after the
opening even for the 0.55 MPa region.
The second experiment gives a more accurate estimation of the pres-
sure threshold. By plotting the concentrations in contrast agent in
the voxel versus the pressure used in these voxel to open the BBB
(see Fig. 131), two trends are observables. In a first pressure range,
from 0 to 0.4 MPa, the pressure is not sufficient to open the BBB so
the concentration is not significant. In a higher pressure range, from
0.4 MPa to 0.6MPa, the pressure is sufficient to open the BBB and
the concentration increases as the pressure increases in a roughly lin-
ear way. With this experiment the found pressure threshold is about
0.4 MPa.
A third way of determining the opening threshold is to study the
width of the opening on the sides [LB1] of the square of the first ex-
periment. Indeed it is possible to plot the concentration profile
across the lines of the opening and to compare it to the Gaussian
profile of the pressure which has been studied in water tank. It
appeared that the width where the BBB is open matches with
the width on the Gaussian profile where the pressure is higher
than 0.4 MPa.
Conclusions
The two different methods proposed for the study of the depend-
ency of drug uptake after BBB disruption with acoustic pressure give
consistent results. We find an acoustic pressure threshold for the BBB
opening of 0.4 MPa, for a 1.5 MHz working frequency. This result is
in good accordance with the literature [5].
By acquiring T2 weighted images after those experiments, we are
confident we caused no damages up to 0.6 MPa. This pressure is
close to the one for which adverse effects started to appear in our
previous studies thought. As a consequence, the pressure window
for a safe and efficient BBB opening is quite narrow which highlights
that the pressure in vivo has to be very well controlled. [LB1] Above
the opening threshold, the relationship between drug uptake and
acoustic pressure is linear. The knowledge of this relationship is key
in order to predict drug pharmacokinetics after BBB disruption.
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Objectives
Histotripsy is a non-invasive ablation surgery which uses high inten-
sity acoustic pulses to stimulate a cavitation cloud and homogenize
a tissue target. Magnetic resonance imaging (MRI) is a useful tool for
assessing lesions made by this therapy. MR contrast parameters such
as R2 and the apparent diffusion coefficient (ADC) are sensitive tostructural properties of cellular tissue. Changes to these properties,
such as homogenization by histotripsy, should induce changes in MR
image contrast. In this study we estimate R2 and the ADC of histo-
tripsy lesions made in ex vivo brain, liver, kidney, muscle, blood clot,
and various red blood cell (RBC) phantoms commonly used in histo-
tripsy studies.
Methods
A 500 kHz, electronically steered, focused transducer (256 elements,
f#: 0.5, focal distance: 15 cm, focal length: 3.5 mm, focal width:
1.5mm, PRF: 10 Hz) generated histotripsy bubble clouds in in vitro
samples of porcine liver, kidney, bovine liver, brain, and blood clot as
well as agar gels mixed with 3, 6, and 16%/wt red blood cells (RBC’s).
Lesions were made by electronically steering the focal zone through
a grid of points spaced 0.66 mm apart. For each steering point, the
transducer emitted a single, two-cycle acoustic pulse (~5 us long)
with a peak negative pressure that exceeded 35 MPa. This treatment
pattern was repeated until 1, 3, 30, 100, 300, or 1000 pulses were de-
posited per grid point. A total of 4 lesions for each pulse number
were formed in each tissue sample.
After treatment, each sample was placed in the bore of a 7-Tesla
small animal MR scanner (Agilent Technologies, Walnut Creek, CA)
and imaged using spin-echo sequences with various echo-times and
diffusion-weighting b-values. Contrast parameters R2, and ADC were
estimated from the resulting images by selecting a region of interest
(ROI) within each lesion and performing a non-linear, least-squares fit
of the mean signal within the ROI.
Results
Example R2 and diffusion-weighted (DW) images of lesions made in
porcine liver and bovine brain are displayed in Fig. 132. The R2 and
ADC parameters measured in each tissue type are plotted as a func-
tion of pulse number in Fig. 133. In liver, kidney, muscle, blood clot,
and the red blood cell phantoms, homogenization induced measur-
able decreases in the R2 rate. However, R2 did not change appre-
ciably in brain with treatment. In the red blood cell phantoms, the
magnitude of change of the R2 rate decreases with decreasing RBC
concentration. In Fig. 134, tissue iron concentrations published in the
literature [1–7] are plotted alongside the average maximum change
in R2 observed in each tissue type. The total change in R2 appears to
decrease with tissue iron concentration. The ADC for all samples in-
creased measurably with treatment.
Conclusions
For most samples, the R2 relaxation rate and the ADC changed appre-
ciably with increasing pulse numbers. Both contrast parameters asymp-
totically approach a final value such that further pulses cause marginal
changes in the contrast parameters. Histotripsy induced changes in R2
appear to decrease with decreasing tissue iron concentration. R2
weighted imaging may be a good indicator of homogenization in sam-
ples with high iron content such as liver and RBC phantom.
The ADC appears to change with pulse number in all materials re-
ported here, likely because homogenization removes cellular mem-
branes. These results suggest that diffusion-weighted imaging is a
good assessment tool for histotripsy therapy. However, R2-weighted
imaging may suffice for histotripsy therapy in the body, where tis-
sues contain more iron content and respiratory motion makes
diffusion-weighted imaging difficult.
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tissues of livestock and poultry. J. AOAC Int. 1992.Fig. 132 (abstract O94). Example images of histotripsy lesions
made in in vitro liver (a-b) and brain (c-d). Enhanced contrast
indicating lesions made in liver can be observed in T2-weighted (a)
and diffusion-weighted (b) images with identical slice plans. Lesions
made in brain tissue are difficult to find in a T2-weighted image (c)
but are readily observed in a diffusion-weighted image (d) with an
identical slice plan
Fig. 133 (abstract O94). Estimated R2 rates and ADC’s of histotripsy
lesions made in various tissues and phantoms plotted against the
number of pulses applied to each lesion. The R2 rate decreases with
pulse number for all samples except for brain. The ADC increases
with pulse number for all samples. Note that the y-axis on the
bottom left frame is on a logarithmic scale
Fig. 134 (abstract O94). The mean and standard deviation of tissue
iron concentrations published in Refs [1–7] as a function of tissue
type. Also plotted are the mean and standard deviations of the total
change in R2 observed in histotripsy lesions made in each tissue type.
The change in R2 appears to correlate with tissue iron concentrationO95
Monitoring of non-cavitational HIFU thermal ablation in ex-vivo ox
liver using passive acoustic mapping
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Objectives
Passive Acoustic Mapping (PAM) is a novel technique that enables
spatiotemporal monitoring of sources of nonlinear acoustic emissions
received by a multi-element array during ultrasound therapies. So
far, it has primarily been used as a method of passive cavitation im-
aging, either by reconstructing broadband emissions attributable to
inertial cavitation [1] or harmonic emissions due to boiling [2] or
stable cavitation in the presence of ultrasound contrast agents. In
the present work, PAM is used for the first time to spatially map
sources of narrowband (harmonic) emissions arising purely due to
nonlinear propagation and scattering of the incident ultrasound field,
in order to enable real-time monitoring of non-cavitational HIFU ther-
mal ablation. A key advantage of PAM over conventional B-mode im-
aging is that it enables much higher spectral resolution, making it
potentially possible to detect subtle changes in the frequency re-
sponse of tissue during thermal ablation.
Methods
A single-element HIFU transducer (H102, Sonic Concepts, 64 mm ac-
tive diameter, 63 mm focal length) was driven at 3.3MHz , and used
to expose degassed ox liver to a range of peak positive pressures
leading to varying heating regimes, from hyperthermia to boiling. A
linear ultrasound array (L11-4v, Verasonics Inc., 128 elements,
6.25MHz central frequency) was positioned co-axially with the HIFU
transducer through a central rectangular cutout, and used for B-
mode ultrasound imaging and PAM during HIFU exposure (Fig. 135).
The passively recorded acoustic emissions were filtered using a
newly developed Sum-Of-Harmonics (SOH) data-adaptive parametric
model [3] to accurately isolate the emissions corresponding to the
2nd harmonic (6MHz) and 3rd harmonic (9MHz), and then beam-
formed [4] to provide PAM maps of sources of nonlinear scattering.
Results
During HIFU exposure the spectrum of the passively recorded signals
mainly comprises the first three harmonics of the HIFU transmitting
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):15 Page 81 of 114frequency. No noticeable changes in the broadband component of the
signal were observed for any of the exposure conditions, suggesting
that inertial cavitation did not occur at 3.3 MHz over the range of pres-
sures used here. In the case of over-treatment (i,e, treating until sus-
tained boiling occurred), the boiling was successfully detected by both
active B-mode imaging and PAM. However, for the vast majority of
cases, a lesion was successfully created without any observable hypere-
cho on B-mode images, yet PAM evidenced a measurable change in
the amplitude of the 2nd and 3rd harmonic that coincided spatially
and temporally with the appearance of a lesion.
Conclusions
PAM has considerable potential as a tool for low-cost, real-time, non-
invasive ultrasound-based lesion detection, even in the absence of
any measurable cavitation activity. This study paves the way for PAM
to be used as a safety tool to prevent both overtreatment due to
boiling, and to achieve more efficacious tissue ablation.
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beamforming in ultrasound therapy.Fig. 135 (abstract O95). Experimental setup involving an ox liver
tissue sample placed at the focus of a HIFU transducer driven at
3.3MHz. The HIFU transducer is co-aligned with a 4-11MHz array for
B-mode imaging and passive recording of acoustic emissions. These
emissions are filtered, isolating the 2nd and 3rd harmonic of the
HIFU transmitting frequency, which are then processed using PAM
Fig. 136 (abstract O96). The propagation process of shear-wave in
porcine skinO96
Diagnosis and treatment monitoring of skin cancer using phase
sensitive optical coherence tomography (PHS-OCT) and
high-intensity focused ultrasound (HIFU) induced shear wave
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Objectives
Clinical diagnosis of skin cancer relies on the visual examination and
palpation by a trained surgeon. It is low in accuracy since it is largely
depends on individual experiences. Mechanical properties are import-
ant tissue parameters of skin that are useful for understanding skin
patho-physiology, and aiding disease diagnosis and treatment, espe-
cially in skin cancer diagnosis. To meet this requirement, a sensitive,
non-destructive and non-invasive method that is capable of assessing
the skin mechanical properties as well as geometry information, in
diagnosis and treatment procedures, is needed. Optical coherence elas-
tography (OCE) using phase sensitive optical coherence tomography(PhS-OCT) system has the advantages of a high spatial resolution to re-
solve skin problems. High intensity focused ultrasound (HIFU) is a well-
known non-contact method and non-invasive method for shear wave
inducer and cancer treatment. The objective of this study is to 1) com-
bine PhS-OCT and HIFU, and 2) recover the elasticity map of skin from
this new combination for diagnosis.
Methods
This system consists of shear wave generation part and detection
part. Shear wave generation part includes miniature HIFU transducer,
signal generator, power amplifier and impedance matching trans-
former. The miniature HIFU transducer (1.89 MHz, 20mm diameter,
16mm radius, and 12.5mm focal length) is produced in-house,
pressure-field and calibrated. The driven signal for HIFU transducer
was 1 volt burst sine-wave signal with 20 cycles/pulse at 2.091MHz,
which was triggered by 125Hz external TTL. The acoustic power out-
put by the HIFU transducer was 3.72w. For shear wave detection the
system employs a PhS-OCT system. It performs a 46.8 kHz sampling
rate with axial resolution of 0.5 μm, resulting in sampling the
complete data with the format of 1024 depth x 256 frames x 256
scan-lines in approximately 2 seconds. Each frame was processed
with respect to the previous one to determine the phase shift.
This study begun with the ex-vivo experiment on porcine abdomen
skin, which was embedded in 2% agar phantom and put under the
PhS-OCT for observation. There were 2 sets of experiments on 3 dif-
ferent samples to investigate the propagation process of shear-wave
in different position; each was repeated three times.
Results
The propagation process of shear wave in porcine skin is shown in
Fig. 136. The figure contains 2D maps of phase differences between
each consecutive frame at 46.8 kHz with respect to the time after the
first synchronized signal, at the shear-wave source (HIFU focus,
2.091MHz, 20 cycles/pulse at 3.72W acoustic power).
The elasticity map of porcine skin is shown in Fig. 137. The elasticity
of porcine skin was calculated according to the map of phase differ-
ences. The recoverable electricity area was annotated by the white
dashed line in the figure.
The Young’s modulus of each set of experiment was also calculated
according to the map of phase differences. The Young’s modulus of
the first sample is 1.314±0.017 MPa, followed by 0.932±0.0171 MPa
and 1.5815±0.2264 MPa for the second and the third sample respect-
ively. This agrees well with the finding of Ankerson et al. 1999.
Conclusions
Our work combines PhS-OCT and HIFU for the diagnosis and treatment
monitoring of skin cancer. This study demonstrates the feasibility of
elasticity measurement on ex-vivo porcine skin using the proposed
setup. The initial results are in agreement with the previous study on
porcine skin. However, HIFU-induced shear-wave is required to have a
large bandwidth (sharp pulse) in order to utilise PhS-OCT running at
micron resolution. This requirement needs to be compensated for a
high attenuation coefficient of high frequency shear-wave component.
Fig. 137 (abstract O96). the elasticity map of porcine skin
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Objectives
Recently, in the treatment of diseases such as cancer, non-
invasive or low invasive modality such as high-intensity focused
ultrasound (HIFU) has been put into practice as an alternative to
open surgery. HIFU induces thermal ablation of target tissue to
be treated. To improve the efficiency of HIFU, we have proposed
a "triggered-HIFU" technique, which uses the combination of a
short-duration, high-voltage transmission and a long-duration,
medium-voltage transmission. In this method, the transmission
device has to endure the high peak voltage for the former and
the high time average power for the latter. The triggered-HIFU
sequence requires electronical scanning of HIFU focus to
maximize its thermal efficiency. Therefore, the transmission device
has to drive an array transducer with number of elements in the
order of a hundred or more, which requires that each part of the
device to drive each element has to be compact. The purpose of
this presentation is to propose and construct such a transmission
device by improving the staircase drive circuit, which we previ-
ously proposed. In the previous staircase HIFU drive circuit using
MOSFETs, there is a risk of device damage due to the excess
heating of the MOSFETs and the spike noise exceeding the de-
vice rating. The objective of this presentation here is to realizean HIFU transmission circuit suitable for “triggered HIFU” mode
by:
1) suppressing the heating of MOSFET transmission circuit,
inhibition of spike noise exceeding the device rating,
2) reducing the odd harmonic components of output voltage for
preventing unwanted nearfield tissue heating.
Methods
If the load of the MOSFET has inductance components, such as cable
inductance or PCB wiring, flyback voltage would be generated at the
time of turn off the switching operation, which cause the spike noise
exceeding the supply voltage. On the other hand, if it is a capacitive
load as a HIFU transducer, the fall of the positive voltage or the rise of
negative voltage, it is not possible to discharge the electric charge ap-
plied to the transducer. These phenomena bring the excessive heat
generation of the MOSFETs, and the transmission waveform would be
a rectangular shape. To solve these problems, we developed a new cir-
cuit for feeding back charges exceeding the supply voltage, to the
power supply circuit. As a result, for the HIFU system, MOSFET damage
and power supply, MOSFET and diode damage should be avoided, it is
possible to build a HIFU transmission system with safety.
Results
In the proposed circuit, MOSFET maximum temperature rise reached
16.4°C, and total power consumption is 2.4W at 1.01MHz transmission.
This result shows a 26.7% power consumption reduction and a MOSFET
maximum temperature rise of 14.5°C less than the previous circuit. Fur-
thermore, at 1.01 MHz transmission, the third and fifth harmonic at-
tenuation rates of the fundamental wave were −30.0 dB and −62.0 dB
respectively. As a result, in the transmission waveform, ringing and
spikes exceeding the power supply voltage has been extremely sup-
pressed. In spite of not only the inductance load of the cable, but also
the capacitive load by the transducer. We got a prospect of significantly
reduces the circuit temperature rise, and power consumption in the
heating-mode by these results. Therefore, the possibility of MOSFET
damage due to excessive heat was alleviated. As these results, our new
proposed circuit should be safe and suitable for HIFU transmission dur-
ing heating-mode, because the possibility of damage to the MOSFET
was alleviated than the previous circuit.
Conclusions
We proposed a HIFU transmission circuit suitable for triggered-HIFU
mode. The proposed circuit is effective for reducing power consump-
tion, temperature rise suppression, odd harmonic reduction, help to
HIFU transmitter circuit safety, during the heating-mode. Meanwhile,
the proposed circuit utility of in trigger-mode was not disclosed on
the basis of the experimental results. We will show the effectiveness
of the proposed circuit in trigger-mode, construct a prototype system
more than 100 channels using the proposed method, and deal with
the ablation studies using array HIFU probe.
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Objectives
In this paper an MRI-guided focused ultrasound (MRgFUS) robotic
system was developed that can be used for conducting experiments
in animals. The robotic system is capable to scan the ultrasound
transducer for performing MR-guided focused ultrasound experi-
ments in in any size of animals.
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A single element spherically focused transducer of 3 cm diameter, fo-
cusing at 10 cm and operating at 1 MHz was used. The positioning
device incorporates only MRI compatible materials such as piezoelec-
tric motors, Acrylonitrile Butadiene Styrene (ABS) plastic, brass
screws, and brass rods. The propagation of ultrasound is a bottom to
top approach.
Results
The system was tested successfully in freshly excised tissues from an-
imals for various tasks (creation of single lesions, creation of overlap-
ping lesions, accuracy, and MR compatibility).
Conclusions
A simple, cost effective, portable positioning device has been devel-
oped which can be used in virtually any clinical MRI scanner since it
can be sited on the scanner's table. The system was proven accurate,
reliable, safe and functional. This system has the potential to be mar-
keted as a cost effective solution for performing experiments in small
and large animals.
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Objectives
Magnetic resonance guided high-intensity focused ultrasound
(MR-HIFU) has been used for the treatment of a variety of dis-
eases and conditions. Clinically, these procedures are performed
by commercial MR-HIFU platforms designed for particular anatom-
ical targets: uterine fibroids for the InSighTec ExAblate 2000/2100
and the Philips Sonalleve; the brain for the InSighTec ExAblate
4000. The former class uses a transducer array with a robotic po-
sitioning system integrated with a MRI bed with limited mechan-
ical translation and electronic steering. The latter is mechanically
fixed but has a larger number of elements for electronic distor-
tion correction and steering.
Liberating the transducer from the mechanical confines of the exist-
ing clinical systems may allow for easier access to more anatomical
targets. The goal of this study is to develop an anatomically adaptive
MR-HIFU system using a transducer mounted on a robotic arm that
can be positioned within the MRI bore with a large range of motion
and a versatile mechanism for acoustic coupling. As a precursor to
an adaptive clinical system, this study discusses the capabilities and
results of a preclinical system built on the Philips Sonalleve MR-HIFU
software platform. The objectives are:
1. Integrate a preclinical-specific, multi-element transducer [1]
with a novel MR-Safe robotic manipulation technology [2–3]
for adaptable focused ultrasound in preclinical animal
models.
2. Implement graphical overlays and sonication controls of this
ultrasound system with the Philips Sonalleve clinical MR-HIFU
treatment planning platform to plan the ultrasound focus prior
to sonication and to monitor therapy in real-time using
automatically-oriented MR-thermometry.
3. Assess the ability of the transducer to remain acoustically
coupled to the target during movement and quantify
sonication targeting accuracy.Methods
A 5 cm, 3 MHz, f-number 1 transducer with 8 elements in a
sector-vortex arrangement was selected for this study. A flexible
polyethylene membrane was affixed to the transducer shell that
could be inflated or deflated with degassed water to maintain
acoustic coupling while changing the focal depth in the target
tissue. The frequency used was desirable as it allowed higher at-
tenuation than would be achieved at frequencies typically used
clinically (1–1.5 MHz) so as to avoid far-field structures. The
sector-vortex array design allowed for tight focusing (mode 0, all
elements in phase) or more diffuse focusing (modes 1–3, with
the phase difference (phase) between adjacent elements of 180°,
90°, and 45°, respectively) to emulate the focal size of clinical sys-
tems [1].
The Sonalleve software platform (Philips, Vantaa, Finland) was
modified to interface with the transducer. First, a virtual model of
the transducer was designed that could be positioned arbitrarily
in the MR image space. By aligning the model with markers on
the transducer using the therapy planning software, the ultra-
sound focus could be identified and MR-thermometry slices posi-
tioned automatically, both parallel and perpendicular to the
ultrasound beam. Second, the software pipeline was modified to
send power, phase, start, and stop commands to the amplifiers
via a serial connection.
The feasibility of using an existing MR-safe robot [4–6] to move
the transducer accurately and maintain acoustic coupling was
assessed in vitro and ex vivo. An acrylamide-based tissue-
mimicking gel phantom containing silica particles (1.0% w/v) and
bovine serum albumin (BSA, 3% w/v) was sonicated (3 MHz,
mode 0) at room temperature (22°C) in a regular grid pattern (15
mm spacing) at electrical powers of 4, 8, 16, and 32 W, for dura-
tions of 30, 60, and 90 s. A fresh, excised pig leg (27°C) was
shaved and treated with a depilatory agent to remove all hair.
Nine locations in the pig leg were sonicated with electrical pow-
ers ranging between 32 and 64 W for durations of 30 to 90 s.
MRI T2 maps were acquired to identify volumes of protein de-
naturation, and the overlying tissue in the pig leg was dissected
to observe volumes of visible thermal damage.
Results
Screenshots showing the transducer overlay and sonication location
are shown in Figs. 138 and 139. Through the use of added graphical
overlays, it was possible to predict the location of peak heating to
within 1.8 mm, based on the location of visible fiducial markers on
the transducer case.
The flexible membrane was used to couple the transducer to the
phantom and leg specimen, shown together with the robot in
Fig. 140. The measured spatial error between the centre of the
observed T2 decrease due to protein coagulation and the desired
sonication locations was found to be 0.3 ± 0.1 mm in the phan-
tom. A T2 map from one phantom experiment is shown in
Fig. 141. The coupling layer was suitable for multiple sonications
in the pig leg despite its curvature without any other interven-
tion, demonstrating the feasibility of using this method for ro-
botic surgery.
Conclusions
The initial integration of a preclinical HIFU transducer with the MR-
safe robot and clinical MR-HIFU planning and control software was
successful, though further integration is desirable to facilitate
image-guided treatments. The transducer and robot are suitable for
accurate sonication at depths relevant for many preclinical
applications.
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[6] Stoianovici, D., et al. (2007). MITAT, 16(4), 241–8.Fig. 140 (abstract P3). MR-safe robot with attached transducer
coupled to an ex-vivo pig leg
Fig. 139 (abstract P3). Heating profile produced by driving
the transducer in mode 3 (phase=45°) for 60 seconds at
16 W electric
Fig. 141 (abstract P3). Map of post-sonication T2 values of the
phantom with an overlaid grid indicating the duration and power
used at that location. Lower T2 values (ms) indicate a greater degree
of protein denaturation, visible only for longer durations (60 s, 90 s)
and higher powers (8 – 32 W)
Fig. 138 (abstract P3). MR image showing transducer overlay
(gold colour, left) and anticipated focal profile (contained with
dark-coloured lines) along with the resulting temperature increase
visualized using the parallel MR-thermometry slice, centred on the
ultrasound focus. The transducer was driven in mode 1 (phase=180°)
for 60 seconds at 16 W (electric)P4
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Fig. 143 (abstract P4). See text for description
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Cavitation microbubbles are known to enhance therapeutic effects of
ultrasound. They can be incepted in a controlled manner by short
ultrasonic pulses with highly negative pressure. Such highly negative
pressure exceeding the cavitation threshold is difficult to produce
simply by focusing because of nonlinear propagation followed by
focal phase shift. Superimposing the second harmonic to fundamen-
tal can significantly reduce the problem, but the conventional design
of thickness mode transducer is not suitable to generate both the
second harmonic and fundamental at the same time. The objective
of this study is to overcome this problem.
Methods
We propose an approach of a high acoustic impedance matching
layer. Unlike a conventional matching layer, the acoustic impedance
is chosen nearly as high as that of the piezo-composite. Numerical
simulation was performed using a code, PZFlex, to optimize the
acoustic impedance and the thickness of the matching layer so that
an air backed transducer, as schematically shown in Fig. 142, can
produce both the second harmonic (2 MHz) and fundamental (1
MHz) at a similarly high efficiency. Here, the efficiency was defined
as the produced acoustic power divided by the square of the drive
voltage. Then, a prototype transducer was constructed based on the
simulation result. The real and imaginary electrical admittance of a
transducer element was measured, and the acoustic power from
seven transducer elements was measured by radiation force.
Results
The simulation and experimental results shown in Fig. 143 emphasize
that the transducer with a heavy matching layer demonstrate to be
able to practically produce both the fundamental and second har-
monic at high efficiency. They also illustrate the efficacy of the afore-
mentioned concept. The phase of electrical admittance at 1 and 2
MHz were designed near to zero so that the high power can be
transferred with a maximum power factor. The fundamental and sec-
ond harmonic peaks in efficiency from simulation were around 1.01
and 1.98 MHz while the measurements were around 1.1 and 2.1
MHz.
Further studies are needed to explain the relatively large difference
in amplitude between the simulation and measurement.
Conclusions
Implementing a transducer with a high impedance matching
layer with an appropriate thickness on piezocomposite was dem-
onstrated to be able to produce both the fundamental and sec-
ond harmonic at high efficiency, while the conventional air back
transducer cannot. Even though there is significant difference in
amplitude between the simulation and measurement results, the
result produced from both simulation and measurement shows
the capability of transducer with a high impedance matching
layer to produce both the fundamental and second harmonic at
the same time.Fig. 142 (abstract P4). See text for descriptionP5
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Objectives
Magnetic resonance (MR) is the most widely used for focus targeting
and temperature monitoring in focused ultrasound surgery (FUS).
The aim of this study is to demonstrate the feasibility and the effect-
iveness of the two parameters, SNR and B0 homogeneities for com-
patibility evaluation.
Methods
In this study, we investigated the influence of ultrasonic probes on
the MR imaging from SNR and B0 homogeneities. The SNR of images
can be used to evaluate the level of electromagnetic interference
from the ultrasonic probes. The images were acquired on the condi-
tions that the ultrasonic probes worked on four different voltages,
and the calculated SNRs were compared with the original SNR with-
out power. For more scientific, each image was segmented to five
sub-regions and the SNR of each part was calculated respectively.
The B0 homogeneities can be used to guarantee the accuracy of
thermometry. The effect of B0 inhomogeneities caused by the ultra-
sonic probes was estimated from B0 field mappings with and without
the ultrasonic probes in the magnetic field. For more accurate, the B0
field mappings were measured from three slices near the ultrasonic
probes and three slices away from the ultrasonic probes.
Results
Here, the SNR values of each same sub-region in different working-
voltage images were smaller than that in no-power image. Mean-
while, the B0 field mappings of all slices exhibited that the B0 field
transformed near the ultrasonic probes. However, the B0 field away
from the ultrasonic probes almost did not change.
Conclusions
The two indicators, SNR of images and B0 homogeneities, are proved
to be effective on the compatibility evaluation between MR and
ultrasonic probes.
Fig. 144 (abstract P7). T2-weighted FSE image of the endoluminal
ultrasound applicator (white arrow) positioned in the stomach lumen
of an in vivo porcine model for treatment of adjacent pancreatic
tissue (red arrow)
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Objectives
The objective of this work is to examine problems and opportunities
of immersing MRI surface coils in water. We will look at issues of fre-
quency shift and induced RF losses. The work examines the inter-
action of electric fields and water. We will discuss number design
techniques to overcome these interactions and ways to minimize
performance problems due to coils being under water. We will also
discuss safety electrical issues involving connections to the MRI sys-
tem in or around water used with therapeutic ultrasound.
Methods
We used very conventional methods of reducing local electric fields
in MRI coils by choosing the number of capacitor breaks and looking
at the value of each capacitor used in the design. We evaluated sev-
eral coils with varying number of capacitors which in turn determines
the value of each capacitor. We examined the centre frequency and
Q of various coils with different numbers of capacitor breaks as well
as several coatings for the coils. We derived equivalent circuit models
to compare frequency shift on resistive losses due to the interaction
of electric fields and water.
Results
We found that increasing the number of capacitor breaks increased
the resistive losses slightly but significantly reduced the frequency
shift induced by the presence of water. Almost all coating decreased
frequency shift by a small amount and did not significantly increase
losses.
Conclusions
When surface coils are immersed in water, the high permittivity of
water can induce very large tuning shifts in MRI coils. This can be
mitigates by increasing the number of capacitor breaks in the coil
design. The water itself does add some resistive losses to the coil but
not by a large amount. Several coatings were effective at reducing
corrosion of copper from water. None of the coating did introduce a
small shift in centre frequency.
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Objectives
Pancreatic lesions created during ablations, were examined histologi-
cally to determine the extent of tissue/cell death, in lesions created
in the in vivo pigs. This current study used applicators positioned in
the stomach via the oesophagus, with HIU delivered through the
stomach wall to the pancreas. Our histopathologic analyses will help
the interventional radiologists optimize applicator placement and
thermal dose delivery necessary to ablate normal pancreatic tissue
with the ultimate goal of ablating pancreatic cancer in human
patients.Methods
In vivo experiments: All ablation in vivo studies were performed in
anesthetized pigs that were euthanized following post-treatment
imaging. All animal studies were approved by Stanford’s Institutional
Animal Use and Care Committee in accordance with the Guide for the
Care and Use of Laboratory Animals. Three pigs were treated with an
applicator introduced in to the stomach via the oesophagus (Fig. 144).
HFU was directed through the stomach wall into the pancreas, a six mi-
nute treatment with approximate average intensity of 4 W/cm2 was
performed to ablate the tissue. Following euthanasia, the pancreata
and associated tissues (gastric wall) were removed and examined
grossly, then incubated in TTC for better visualization of ablation le-
sions. Affected tissues were then fixed in 10% BNF, routinely processed
for histology and H&E staining of microscopic slides, and examined
under a light microscope by a board certified veterinary pathologist.
Results
HIU ablation lesions in all pancreata treatments were visible grossly
post-TTC incubation as non-stained (white) regions within normal red-
stained pancreatic tissue (Fig. 145a). Histologically, lesions consisted of
a central area of coagulative necrosis (CN), characterized by a “ghosted”
appearance of cells and nuclear dissolution (karyorrhexis and karyolysis)
(Fig. 145d). Surrounding the central necrotic lesions was a thin zone of
capillary congestion, scattered haemorrhages, and acinar fragmentation
in the transition zone (TZ) where the normal architecture of the organ
was disrupted, but individual cells were less severely affected.
Conclusions
Pig pancreata were successfully ablated in regions targeted by the
endo-luminal HIU applicator. Via MR-guidance, HIU ablation resulted
in discrete zones of coagulation necrosis in the pancreas with min-
imal damage to surrounding tissues. Continued studies using this
model will help further optimize MR-imaging and detection of abla-
tion lesions in vivo, and provide a minimally invasive treatment with
improved outcome for patients with pancreatic cancer.
Fig. 145 (abstract P7). HIU ablation of pig pancreas. a Post treatment
excised pancreas stained with TTC shows viable tissue red and ablated
tissue as tan (blue arrow) b - d) Histology of treated pancreas (b)
depiction of 3 regions, untreated (UT), transition zone (TZ), and
coagulation necrosis (CN) 25x. c Untreated 200x, D) Coagulation
necrosis of treated pancreas 200x. Slides are stained with H&E
Fig. 146 (abstract P8). Combinational therapeutic treatment device
Fig. 147 (abstract P8). Vacuum cap
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Objectives
Systems and methods for performing a surgical, therapeutic or aes-
thetic medical procedure in target tissues of patient’s body by using
HIFU are well known in the art. Recently, the HIFU systems were pro-
posed for body aesthetic therapy by adipose tissue lysis. The main
disadvantage of HIFU application for treatment of large volumes of
tissues is small treated volume in lateral direction. Other disadvan-
tage of conventional HIFU treatment of superficial tissues is a re-
stricted number of body areas suitable for the procedure. Therefore,
the need exists for new methods and devices aimed at treatment of
large volumes of tissue, as for example in the case of removing sig-
nificant amounts of adipose tissue from arbitrary body parts. The
need also exists for devices and methods for treating the skin and
subcutaneous adipose tissue region using ultrasound energy,
wherein the energy is applied in a more efficient, safe and effective
manner. The paper introduces an innovative combinational treat-
ment method for non-invasive surgical, therapeutic, lipolytic or cos-
metic treatment of tissues including subcutaneous adipose tissue,
cellulite or skin on arbitrary body part of patient.
Methods
The method is based on simultaneous or successive applying of con-
structively interfering physically and biologically sensed influences:
ultrasonic standing waves (USW), radio-frequency (RF) heating, vac-
uum massage, and transdermal drags delivery.
Unlike all existing HIFU and non-focused systems, ultrasound energy
in USW directed parallel to the body surface and fully localized in
treated body region. Resulting USW efficiency is comparable with
HIFU at huge increase of treated tissue volume. Continuous cyclic
changes of the nodal pattern of USW with proper repetition rates
corresponding to a specific resonant or relaxation times of living cells
or tissue components provide effective dynamical influence of USW
on tissues. Synergetic combination of USW with RF therapeutic heat-
ing and vacuum massage lowering cavitation threshold and intensi-
fying a blood flow and clearance of disrupted cell debris along with
inherent treatment process control and diagnostic possibilities offers
a great future for the technology. The technology provides also an
opportunity to use phonophoresis as an option for transdermal drags
delivery using drug-loaded microcapsules.
Results
The paper provides the basic physical principles of USW as well as
critical comparison of USW and HIFU therapeutic treatment methods.
The results of finite-elements and finite-difference modelling of USW
formation in tissues are presented. Therapeutic head design compris-
ing USW and RF transducers, and vacuum system, as well as original
ex vivo experiments on tissues are described. Physical and biologicaleffects of USW - tissue interaction and synergetic aspects of USW, RF,
and vacuum massage combinational influences are shown. The diag-
nostic capabilities of the USW and RF methods, as well as the possi-
bility of transdermal drags delivery using developed therapeutic
head are also demonstrated changes of the nodal pattern of USW
with proper repetition rates corresponding to a specific resonant or
relaxation times of living cells or tissue components provide effective
dynamical influence of USW on tissues. Synergetic combination of
USW with RF therapeutic heating and vacuum massage lowering
cavitation threshold and intensifying a blood flow and clearance of
disrupted cell debris along with inherent treatment process control
and diagnostic possibilities offers a great future for the technology.
The technology provides also an opportunity to use phonophoresis
as an option for transdermal drags delivery using drug-loaded
microcapsules.
Conclusions
Synergetic combination of USW influence, RF therapeutic heating,
phonophoresis, and vacuum massage along with inherent thera-
peutic treatment process control and diagnostic possibilities offers a
great future for the technology.
Fig. 148 (abstract P8). Therapeutic head
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):15 Page 88 of 114P9
Ultrasound hyperthermia can improve sensitivity to
chemotherapeutics in TCA8113 cells
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Objectives
To explore the influence of chemosensitivity of Tca8113 (a human
tongue squamous carcinoma cell line) cells by modified MTT assay
after the animal models of Tca8113 were treated by the ultrasound
hyperthermia system.
Methods
To heat the tumours in Tca8113 nude mice (BALB/C) models by the
ultrasound hyperthermia system in different heating temperature(39°C
to 44oC, 30min) and different heating time(42°C, 15min to 75min)
respectively(each group has 3 nude mice).Then to obtain the treated
tumour specimen and prepare tumour cell suspension cultivated with
9 kinds of chemotherapeutics (CDDP, MTX, PTX, BLM, VCR, THP, 5-FU,
HCPT, VM-26,to use the 0.9% saline as control drug). To detect the aver-
age suppression rate of the treated cells in each group by the MTT
assay, which reflects the sensitivity to the chemotherapeutics. Last to
analysis the differences between the treated group and control group
by SAS6.12 statistics software.
Results
There were no significant differences in the chemosensitivity to the 9
kinds of drugs between the Tca8113 cells in the control group and
the 39°C-treated group, or among the 41 to 44°C-treated groups, but
existing significant difference between the 40°C-treated group and
the 41or 42°C-treated group. In the heating-time grads test, there
were no significant differences in the chemosensitivity to the 9 kinds
of drugs between these three pairs of group (the control group and
the 15min-treated group, the 30min-treated and the 45min-treated
group, the 60min-treated and the 75min-treated group), but there
were significant differences between the 30min-treated or the
45min-treated group and the 60min-treated or the 75min-treated
group.
Conclusions
Ultrasound hyperthermia performed in 40~44°C for 30min or in 42°C
for 30 ~ 45 minutes can improve the chemosensitivity of Tca8113
cells significantly, which confirms the rationale of synchronous com-
bination of hyperthermia and chemotherapy from a chemosensitivity
point of view.P10
Focused ultrasound-induced blood–brain barrier opening to
stimulate gene expression and treatment as a therapeutic strategy
in Parkinson's disease model
Chung-Yin Lin, Han-Yi Hsieh, Kuo-Chen Wei, Hao-Li Liu
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Objectives
Parkinson’s disease (PD) is a common neurodegenerative disorder
with selected loss of middle brain dopaminergic neurons, however,
blood–brain barrier (BBB) is the major drawback encountered for ef-
fectively delivering drugs/genes to the brain. In this study, we
propose a reliable strategy to synergistically apply FUS-BBB opening
for the non-invasive and targeted delivery of non-viral genes into the
PD mouse model for therapeutic purpose.
Methods
In this study, we studied a novel gene-liposome system, in which the
biotin-conjugated liposomes are designed to carry plasmid DNA (pDNA,
containing both green fluorescent protein (GFP) reporter gene and glial
cell-derived neurotrophic factor (GDNF) therapeutic gene) and avidin-
conjugated targeting microbubbles (MBs) to form a liposomal-plasmid
DNA microbubbles (LP-MBs). Eight-week-old Balb/c male mice, each
weighing about 25 g, were used for all experiments. Mice (n=15 per
group) received the intraperitoneal injection of MTPT-HCl (40 mg/kg in
saline once a day for 15 days at 3 weeks interval, and were killed at se-
lected times 0–21 days after the last injection. Control mice received sa-
line only. Pulsed FUS exposure was delivered to induce BBB opening
(500 kHz, burst length = 10 ms, 1% duty cycle, PRF = 1 Hz). The longitu-
dinal expression of GFP and GDNF were quantitated via an Elisa protein
Assay Kit. The gene expression level was confirmed via immunoblot-
ting, and histological staining was used to identify transfected cells via
fluorescent microscopy.
Results
Animals with FUS treatment showed significant promotion of pDNA re-
lease into the striatum and demonstrated enhanced expression of
genes upon sonication with FUS-BBB opening, while both the GFP and
GDNF protein expression were successfully measured via Western blot-
ting and Elisa Assay Kits. The transfection efficiency was higher pay-
loads of pDNA resulted in a higher transfection rate via FUS-BBB
opening. The treatment was higher efficacy than carrier only, FUS only.
Immunoblotting and histological staining confirmed the expression of
reporter genes and therapeutic genes in neuronal cells.
Conclusions
This novel gene delivery system promises to provide more effective ultra-
sonic therapy and neurodegenerative treatment and has the potential to
achieve non-invasive gene delivery for treatment of Parkinson's disease.
P11
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signature
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Objectives
Epithelial ovarian cancers (EOC) are still today among the most aggres-
sive tumours, making them the fifth causes of cancer death in women in
western countries. In the perspective of better stratifying patients and
deciphering the mechanisms that govern tumour progression and treat-
ment failure, the "Stress and Cancer" laboratory recently discovered a
dual molecular signature, associated to "Oxidative Stress Response" and
"Fibrosis" processes. In all datasets studied so far, this signature predicts
a partial debulking, a bad response to chemotherapy, and a poor
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):15 Page 89 of 114survival for Fibrosis EOC patients (Mateescu, Nature Medicine, 2011:
Batista, IJBCB, 2013). In this context, we aim at characterizing the
mechano-molecular properties involved in the aggressive development
of the "Fibrosis" tumours.
Methods
– GSEA analysis on patient transcriptomic datasets;
– Shear Wave Elastography on Patient-Derived-Xenografted
mouse models;
– Immunohistological analysis (mono and tri-colorations);
– RNA and protein tumour extracts for qPCR and Western Blotting;
– Cell culture in vitro (spheroids or monolayers) on matrices
recapitulating the tumour stiffness range.
Results
– By GSEA analysis on 3 patient transcriptomic datasets, we found
in "Fibrosis" tumours, an activation signature of YAP and TAZ, two
major mechano-transducers, suggesting that mechanical inputs
such as stiffening can occur in Fibrosis EOC.
– In order to assess the tumour stiffness in vivo, we then applied
a recent and innovative technic, called Shear Wave
Elastography, on "Fibrosis" PDX (patient-derived xenografted)
mouse models. We found a high correlation between tumour
size and tumour stiffness (varying from 10kPa up to 70kPa).
– In addition, immunohistological analysis revealed that the
advanced stiff tumours are characterized by a global stromal
accumulation and collagen enrichment at the periphery,
creating a fibrillar ring.
– To characterize the molecular pathways impacted by the tumour
stiffening, we further performed RNA and protein extracts from
soft versus stiff tumours. The YAP/TAZ target genes were found
up-regulated by stiffness, and we also observed a specific
activation of the MEK pathway in stiff conditions.
– We confirmed these data in vitro in a system recapitulating the
tumour stiffness range.
Conclusions
In conclusion, our results suggest that the "Fibrosis" signature identi-
fies one subgroup of EOC tumours that is highly sensitive to stiffness
variations, as detected by Shear Wave Elastography, through the
YAP/TAZ and MEK pathway. Moreover, the stromal organization and
more precisely, the collagen deposition could be an important driver
of the tumour stiffening. That paves the way to a better understand-
ing of mechano-transduction processes in "Fibrosis" ovarian patients,
which is essential for expanding possible therapeutic options.Fig. 149 (abstract P11). See text for descriptionP12
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therapy
Navid Farr1, Ari Partanen2, Ayele H. Negussie1, Andrew Mikhail1,
Reza Seifabadi1, Emmanuel Wilson3, Avinash Eranki3, Peter Kim3,
Bradford Wood1
1National Institutes of Health, Bethesda, MD, UAS, 2Clinical Science MR
Therapy, Philips, Andover, MA, USA, 3Children's National Medical Center,
Washington, DC, USA
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):P12
Objectives
High intensity focused ultrasound (HIFU) enables highly localized,
non-invasive thermoablation of various solid tumours. In the treat-
ment of hepatic tumours the transmission of sufficient energy
through the ribcage, while minimizing heating of the ribs and adja-
cent tissues, remains a problem. Several research groups have inves-
tigated the theoretical and experimental feasibility of transcostal
HIFU ablation. Validation of theoretical models in controlled experi-
ments using materials with similar shape and boundaries to human
ribs may aid in clinical translation of HIFU for the treatment of upper
abdominal tumours. The objective of this study was to develop and
produce a tissue-mimicking gel phantom with embedded, 3D-
printed rib mimics for the evaluation of heating in bone and adja-
cent tissues following transcostal HIFU.
Methods
A 3D-printable ribcage model was designed based on volume
rendering of ribs from computed tomography (CT) scans of an adult
male. The rib mimic was manufactured using a 3D printer (Connex
500, Stratasys Ltd., Eden Prairie, MN, USA) and a UV-curing
photopolymer (VeroWhite Plus®, Stratasys Ltd.) with similar acoustic
impedance and attenuation to human ribs (a = 3.0 dB/cm @ 1 MHz,
c = 2370 m/s, rho = 1170 kg/m3). The section of rib was selected
based on its relevance to MR-HIFU liver therapy. The 3D-printed rib
mimic was fixed in a custom holder within a cylindrical plastic mold
of 14 cm in diameter. Tissue-mimicking polyacrylamide gel contain-
ing thermochromic ink (color change temperature threshold of 60 °C),
silica particles, and bovine serum albumin (BSA) was poured to
fill the plastic mould, and let to solidify around the ribs at 4°C.
Subsequently, the phantom was positioned on a clinical HIFU
table (Sonalleve V2, Philips, Finland), maintained at 37 °C using a
heated water bath, while acoustic coupling was achieved using
degassed water. Sonications at 1.2 MHz frequency and 80W
acoustic power for 60 seconds were performed under Magnetic
Resonance Imaging (Achieva 1.5T, Philips, Best, the Netherlands)
guidance. Prior to sonication, the rib mimic was visualized on T2-
weighted MRI as a hypointense region, and manually segmented.
8 mm target locations 3 cm behind the ribs were sonicated with all ele-
ments enabled and the resulting temperature elevation within the tar-
get region and on the rib mimic measured. Then, the ribs were
projected onto the transducer surface by ray tracing from the focal
point. Power for the transducer elements in the “shadow” of the ribs
were set to zero, while power for the other, remaining elements was
compensated accordingly. MRI magnitude and phase images during
sonications were acquired in 3 slices automatically placed at the focus
in coronal and sagittal planes and one slice coincident at the rib-mimic
plane, and temperature elevations were calculated using the proton
resonance frequency shift (PRFS). Moreover, the thermochromic phan-
tom enabled monitoring of the distribution of temperature changes in
the area surrounding ribs and target location.
Results
Real time temperature changes in the area surrounding rib-mimic
and target location were monitored successfully using MRI. Qualita-
tive and quantitative assessment of temperature rise on those loca-
tions was obtained by colour change. The overall temperature rise in
the area surrounding the 3D printed ribs was reduced as a result of
selective deactivation of transducer elements whilst maintaining
equivalent focus quality.
Conclusions
A 3D printed rib phantom embedded in thermochromic gel with
realistic rib array location was developed and validated for use in
Fig. 150 (abstract P13). HIFU setup and signal path diagram
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ing the temperature rises on the surface of the rib-mimics during
trans-costal sonication can be demonstrated by observation of heat-
ing patterns in the phantom. This phantom may be useful for ther-
mal therapy characterization, and in comparison of numerical models
with experimental data.
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Objectives
Besides acoustic radiation force during HIFU treatment, the detection
of cavitation is a possible candidate for non-thermal dose standard
of focused ultrasound setups. The detection and quantification of
cavitation currently involves custom-made devices which often re-
quire complex setups or special measurement chambers and limit
the detection of cavitation to laboratory environments. As the occur-
rence of cavitation is expected to cause changes in MR susceptibility,
we propose here a method for passive and non-invasive detection of
cavitation by using a multi-contrast segmented EPI sequence and
evaluating the changes in T2* decay in MR images in the focal spot
during high intensity ultrasound pulses. The aim of this study is to
evaluate the possibilities for cavitation detection in a standard clinical
MRI scanner.
Methods
HIFU setup: A MR-compatible fixed focus HIFU setup (Siemens, 1.7
MHz, 60 mm Ø, f = 68 mm) with a calibrated signal chain (function
generator, amplifier and adaptation (see Fig. 150)) and a dedicated
basin to hold both the transducer and the phantom is used to gener-
ate series of varying short high intensity HIFU bursts (between 10 μs
and 10 ms). According to calibration data, the maximum positive
peak pressure is approximately 32 MPa. A real-time spectrum ana-
lyser is used as a passive detector to capture the occurrence of har-
monics of the base frequency in the reflected signal.
Sample preparation: Three different phantoms made of gelatine and
evaporated milk have been used as sonication targets [2]. The gels
were made with distilled but non-degassed water to increase the
probability for cavitation.
Multi-contrast EPI sequence with external trigger signal: A segmented
EPI sequence has been modified to allow the acquisition of multiple
contrasts per image. Acquisition of up to 12 contrasts is possible de-
pending on TE and EPI factor. As a trade-off between acquisition
time, duty-cycle, echo time and in-plane resolution the following ac-
quisition parameters have been used: FOV: 140x140 mm, FA: 80°, TR:
5000 ms, TE: 16 ms, Matrix: 128x128, Voxel size: 1.1x1.1x2.5 mm, EPI-
factor: 16, 10 contrasts per acquisition. The long repetition time TR
has been chosen to avoid heating of the phantom in the focal spot
due to subsequent sonications. The sequence contains functionality
to submit a trigger signal of 10 μs at the beginning of an arbitrary
contrast ADC to allow precise triggering of the HIFU bursts (see
Fig. 151). Shifting the trigger signal to different contrasts is expected
to also shift the time of the expected change in susceptibility due to
cavitation or other HIFU effects. Experiments were executed on a Sie-
mens Skyra 3T MRI scanner (Siemens Healthcare AG, Germany).
To ensure proper placement of the multi-contrast EPI slice, a gradient
echo thermometry measurement is executed in transversal and cor-
onal orientation to locate the focal spot during a continuous 10 s
sonication. A single transversal slice intersecting the centre of the
focal spot is used for the multi-contrast EPI sequence with the same
FOV and matrix size as for the transversal thermometry to use the
same ROI of the focal spot for analysis.
A baseline approach is used to compare the effects that occur during
sonication to a reference state. A new reference image was acquiredafter each fifth image with sonication. Sonication took place in two
different focal spots per phantom.
For comparability, the HIFU burst was triggered at varying contrasts
to test the influence of MR signal strength and to validate that the
effects only occur during the HIFU bursts.
Multiple sonication strategies have been tested: a) continuous sonic-
ation over 1-10ms per TR and b) short pulses of 10 μs length with at
least 490 μs pause between each pulse to avoid heating of the phan-
tom. The number of HIFU pulses was set such that the series of
pulses was only active during the selected contrast.
Results
Evaluation has been done by calculating the T2* fit over a 3x3 and
1x1 ROI in the focal spot for both the reference images and those
with sonication. While the input values for the fitting show clear dif-
ferences for certain contrasts, only a subtle change in the T2* fit is
visible. For better visibility of the effect, a windowed fitting over cer-
tain intervals has been chosen which shows a more significant de-
crease in T2* only during the HIFU bursts.
Sonications with more than 30 MPa pressure show visible echoes
and harmonics in the spectrum analysis for all sonication strategies.
Visible effects in the MR images could only be reproduced when
using continuous sonications of at least 5 ms rather than the series
of 10 μs pulses (see Fig. 152). The change in T2* decay could only be
observed after playing the HIFU burst. All visible effects were fully re-
versible. No permanent change in the phantom could be detected
when comparing subsequent reference images after multiple
sonications.
While the input values for the fit show a clear difference for the ROI
between reference and sonication, the fitted T2* values were only
marginally different unless using the segmented fitting approach.
Due to the microscopic extent of cavitation, evaluating the 1x1 ROI
yields more distinct results. Best results could be obtained using an
EPI factor 16 and 128x128 matrix size, short TE and 10 contrasts.
Conclusions
While all sonication strategies with a peak pressure above 30 MPa
showed visible echoes and harmonics in the spectrum analysis, vis-
ible effects in the MR images only occurred with continuous sonica-
tions >= 5 ms. This may be caused by the rather limited power of
the HIFU transducer used in the experiments. This also confirms the
cavitation threshold described in [1]. Taking into account that cavita-
tion only exists for microseconds within a very limited space, redu-
cing the voxel size will help to achieve more unambiguous results
and to avoid partial volume effects. We have successfully shown the
detectability of the effects of short HIFU bursts in MR images using a
multi-contrast EPI sequence. Despite the limited power of the HIFU
transducer used, magnetic susceptibility is reduced only during the
HIFU pulses and can be seen in the T2* fit (see Fig. 153). Further ex-
periments will be executed with another transducer (Imasonic,
France) with lower frequency and more power to exceed the cavita-
tion threshold.
Fig. 151 (abstract P13). Multi-contrast EPI sequence diagram
(4 contrasts with long HIFU burst)
Fig. 152 (abstract P13). Visible HIFU effects after contrast 5
Fig. 153 (abstract P13). T2* evaluation with fit for reference and
sonication over multiple segments shows visible T2* reduction
for sonication
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Objectives
We present the results of a study to compare MR thermometry mea-
surements using a calibrated HIFU setup with simulation results
based on the free-field parameters that were assessed during the
calibration process. The aim of this study is to demonstrate the co-
herence between measurements and simulation in order to validate
the outcome of thermometry measurements through simulation. Fur-
ther applications can be established in the process of HIFU dosimetry
when using standardized methods for HIFU setup and gel calibration
in order to predict expected measurement results from simulation.
Another potential benefit of the simulation is to correct possible par-
tial volume effects that can occur during MR thermometry due to im-
perfect slice orientation.
Methods
HIFU setup: A MR-compatible fixed focus HIFU setup (Siemens 1.7
MHz, 60 mm Ø, f = 68 mm) with a calibrated signal chain (function
generator, amplifier and adaptation) and a dedicated basin to hold
both the transducer and the phantom are used to sonicate custom
made gelatine and agar based phantoms at varying power levels (be-
tween 6 and 20 W acoustic power) and sonication times (between 5
s and 20 s). State of the art calibration of the system includes acous-
tic power for continuous sonication, free-field line-scans for peak
pressure and 2D near-field maps that allow to simulate sound
propagation.
Sample preparation: Phantoms made of agar/gelatine (bloom value
225) and evaporated milk (50%) were used as sonication targets [1].
The gels are made with distilled and degassed water. The advantage
of the gelatine phantoms is better homogeneity whereas the agar
based gels have a higher melting point and allow longer sonications
at higher power levels.
EPI thermometry sequence and measurement protocol: To achieve
high temporal resolution a proton resonance frequency sensitive
(PRF) EPI gradient echo MRI sequence is used for the MR thermom-
etry measurements, allowing acquisition times of 110 ms per slice.
The following parameters are used for image acquisition: TR: 15 ms,
TE: 7.5 ms, Flip Angle: 12°, FOV: 140x140 mm, Matrix Size: 128x128,
Slice Thickness: 2.5 mm, Voxel Size: 0.9 x 0.9 x 2.5 mm, EPI factor: 13.
Thermometry measurements are executed with different numbers of
slices and varying slice orientations to investigate reproducibility and
partial volume effects. A single measurement consists of acquisition
of at least 8 reference images (until a magnetic steady state is estab-
lished) and subsequent acquisition of up to 500 images capturing
the heating and cool-down in the focal spot. Sonication duration is
varied from 5 to 20 s. Since in the transversal slices the extent of the
focal spot cannot be determined, additional measurements with
three coronal slices in parallel orientation to the sound direction
were executed to obtain results (with possible partial volume effects)
that can be compared to the simulation as discussed in the next
chapter.
HIFU simulation methods: The HIFU simulation is based on the geo-
metric arrangement of the transducer and phantoms, which is ob-
tained from MR images. The simulation is performed in two steps.
First, the pressure field is computed based on the acoustic power of
the transducer and the known acoustic parameters of water as well
as the phantom using the hybrid angular spectrum method. Second,
the temperature field is computed by solving Pennes bioheat equa-
tion using the known thermal material parameters for the phantom
(attenuation = 0.53 dB/cm/MHz, thermal conductivity = 0.55 J/
(m*s*K)). Finally, the high resolution temperature grid is resampled
Fig. 155 (abstract P14). Reproducibility test: Three subsequent
sonications and cool-down (same voxel used for evaluation for
each session)
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voxel to allow for comparison of the data.
Results
MR thermometry results: Best results could be obtained with a single
transversal slice orthogonal to the direction of sound, intersecting
the focal point in its center. This also minimizes the influence of par-
tial volume effects and reliably provides reproducible results over
multiple measurements. Evaluation of the phase images obtained
from PRF evaluated MR thermometry shows reproducible results over
multiple measurements (see Figs. 154 and 155). Stepwise rotation of
the thermometry slice from transversal to coronal orientation (in 30°
steps) shows visible irregularities and lower maximum temperature
(see Fig. 156) over time that might be caused by partial volume
effects.
Comparison of MR thermometry and simulation results: Fig. 157
shows the comparison of the MR measurements (red) and the simu-
lation (blue) at two cuts (left: transversal, right: coronal) through the
focal point at different time points of a sonication during heating
and cooling phase. It can be seen that in both cutting planes, the
temperature profiles match quite well. It is worth noting that the
maximal temperature in the focal spot is higher, but due to the lim-
ited spatial and temporal resolution of the MR thermometry the
temperature does not show up in the measurements.
Conclusions
In this study we have shown the coherence of MR thermometry and
HIFU simulation by using as input only the free-field parameters of
the HIFU setup and the known parameters of the phantom material.
The simulation methods provide a good approximation of the mea-
surements with the additional benefit of being immune to partial
volume effects that can occur with imperfect MR slice orientation.
Using standardized phantoms with known acoustic and thermal pa-
rameters, the HIFU simulation could serve in the process of HIFU dos-
imetry and calibration.
Our method is an effective means to present highly resolved
temperature data from the simulation that are in accordance with
the (coarse) measurements and can even capture regions where no
thermometry slices have been measured (prediction). With proper as-
sessment of the temperature deviation depending on the slice orien-
tation it should be possible to derive a correction method to
compensate for the influence of partial volume effects. The quantifi-
cation of the temperature difference depending on the slice align-
ment is left as future work.
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European Union.Fig. 154 (abstract P14). Transversal slice intersecting the focal spot
(three sonications). Figure 155: Reproducibility test: Three subsequent
sonications and cool-down (same voxel used for evaluation for
each session)
Fig. 156 (abstract P14). Possible influence of partial volume effects
with imperfect slice orientation (top image shows the different slice
orientations, bottom image shows temperature development in the
same colors as the slices used above, voxel with maximum
temperature shown)
Fig. 157 (abstract P14). Comparison of MR thermometry
measurements and simulation results over the heating and cooling
phase of a sonication. a Geometrical setting of readout lines along and
across the focus position, b temperature plots at different time-points
comparing MR thermometry measurements (red) and simulated
temperature (blue). For each time-point the left plot shows the data
readout along the focus, respectively the right plot shows the data
across the focus
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Objectives
High intensity focused ultrasound (HIFU) is a non-invasive thera-
peutic technique used traditionally to destroy tissue via thermo-
coagulation. Alternate HIFU methods of boiling and cavitation
histotripsy have been developed with the goal of mechanically
disrupting tissue without inducing substantial thermal effects.
Boiling histotripsy (BH) generates a millimetre-size boiling bubble,
causing instantaneous tissue emulsification within the focal re-
gion. BH tissue emulsification is aided by waveform non-linearity
at high acoustic pressures leading to a shock wave formation
within the focal zone. This results in rapid boiling of tissue in a
few milliseconds at the focal zone. The BH mechanism differs
from traditional HIFU ablation techniques, since it causes little or
no thermal damage outside the focal zone. Thus, nearby critical
structures may be spared, potentially increasing the clinical ap-
plicability or safety of HIFU, especially when heat-sensitive critical
structures are close to target region. This work characterized the
effect of BH sonication parameters on the resulting volumetric le-
sions in a tissue-mimicking phantom. This initial study explores a
wide range of sonication parameters, such as peak acoustic
power, total sonication time, pulse width, and pulse repetition
frequency (PRF) in gel phantoms. The study thus provides a refer-
ence point for future BH studies in tissue-mimicking phantoms,
as well as for ex vivo and in vivo studies. This work also utilizes
a clinical MR-HIFU system and can thus easily be translated and
repeated at different research sites and in the clinic.
Methods
Sonications were performed on a clinical MR-HIFU system (Sonalleve
V2, Philips, Vantaa, Finland) with a 256-element, phased-array trans-
ducer (focal length = 14 cm, frequency 1.2 MHz). Polyacrylamide gel
phantoms (7% w/w) were prepared using deionized and degassed
water. Phantoms were placed in a custom 3D-printed holder within a
water bath (Fig. 158a). MR imaging was used to obtain images of the
phantom and to plan the sonications. Locations 30mm deep withinthe phantom were sonicated to produce a pattern consisting of 27
lesions separated by 1mm, in a 3 x 3 x 3 matrix. To relate the experi-
ments conducted at room temperature to in vivo studies, reference
temperature for MR-thermometry was set to 37.5°C, and temperature
was calculated as a relative change. Temperature elevation and
morphology of BH lesions were characterized across varied sonic-
ation parameters: peak acoustic power (500 to 650 W in steps of 50
W), pulse length (10,000-20,000 cycles/pulse in steps of 2000 cycles/
pulse), total sonication time (136 to 820 s in increments of 137 s),
and PRF (0.5 to 5 Hz in 0.5 Hz increments). For lesions made with
varying peak acoustic power, the PRF was constant at 1Hz and pulse
length at 15000cycles/pulse. Similarly, when the number of cycles/
pulse varied, the peak acoustic power was kept constant at 600 W at
1 Hz PRF. While the PRF was varied, the peak acoustic power was set
to 600 W and number of cycles/pulse was constant at 16000. Real-
time MR thermometry was performed during sonication using an
FFE-EPI sequence with three coronal slices centred on the target re-
gion. Parameters were: FOV=160x121 mm, voxel size=2.5x2.5x6 mm,
EPI factor=5, TE=16 ms, TR=25 ms, flip angle=20°, dynamic scan
time=1.8 s. Post-sonication, the lesions were individually scanned
using a clinical diagnostic ultrasound system (iU22, Philips, Bothell,
WA, USA) equipped with a 3D transducer (X6-1). Lesion volumes
were computed following semi-automatic segmentation (TurtleSeg,
The University of British Columbia, Canada). Sonications were per-
formed in two independent sets of measurements (n=2). Temperature
quantification was performed using a region of interest (ROI) within the
centre MR thermometry slice, centred on the BH lesion. The maximum
temperature value in each ROI (as a function of time) was plotted to
observe and quantify differences between test parameters.
Results
Boiling histotripsy sonications produced ‘tadpole’ –shaped lesions
in the gel phantoms with all tested parameters (Fig. 158b). In-
creasing the peak acoustic power from 500 to 650 W slightly in-
creased the lesion volumes from 1025 to 1335 mm3. Interestingly,
the lesion volumes increased substantially from 930 to 1762 mm3
by changing the number of cycles per pulse from 10000 to
20000 (Fig. 158d), while other parameters were kept constant as
described in the methods section. A similar change in lesion vol-
umes was observed when sonication time increased, with lesion
volumes increasing from 934 to 1760 mm3. However, varying PRF
from 0.5 to 5 Hz resulted in only a slight increase in volume
from 1571 to 1838 mm3. Lesion shapes also varied from being
27 independent point lesions to a completely connected, single
large lesion for different sonication parameters. For example, son-
ication time of 137 s yielded a lesion that consisted of 27 separ-
ate sub-lesions, while 820 s produced a contiguous single, large
lesion. These differences could potentially have very different bio-
effects in-vivo and therapeutically. Maximum temperature within
each ROI increased until the end of the sonication. Peak relative
temperature increases were higher for increasing powers and PRF
(Fig. 158c), with temperatures increasing from 47 to 96°C, when
the PRF was adjusted from 0.5 to 5 Hz with an exponential in-
crease during the sonication period.
Conclusions
In this preliminary work a HIFU method to induce mechanical
damage in tissue is examined in vitro. It was shown that BH can
produce mechanical damage in a tissue mimicking phantom with
varying degrees of temperature elevation, depending on the son-
ication parameters. While all the lesions had sharp boundaries,
some sonication parameters produced one large lesion and
others produced several independent lesions with the same son-
ication protocol. This could have profound effects in-vivo, espe-
cially while studying immune effects due to BH. Boiling
histotripsy lesions in phantoms were repeatable in terms of their
location and volumes. In some applications, BH could be better
than traditional HIFU ablation due to its ability to produce lesions
with sharp boundaries while limiting temperature elevations. The
use of a commercial, clinical HIFU system to produce BH lesions
may aid in clinical translation of this methodology compared to
custom built, preclinical HIFU systems.
Fig. 158 (abstract P15). a MR-guided histotripsy experimental
setup. The setup consisted of a polyacrylamide gel placed in a
3D-printed holder in a degassed water bath (white tank). This
entire setup was placed over the HIFU transducer. b typical boiling
histotripsy lesion produced using the clinical MR-HIFU system with
600 W, 1 Hz PRF and 15000 cycles/pulse. The lesion has a characteristic
tadpole-looking shape. c maximum temperature value in each ROI was
plotted as function of time for all different PRFs. An exponential
temperature increase, but the time constants and decays are different
between 0.5 Hz (cyan curve) and 5 Hz (dark blue curve) PRF. d Lesion
volumes were somewhat reproducible and showed some consistency
between the two repetitions. Lesion volumes substantially increased
between 10000 cycles/pulse and 20000 cycles/pulse
Fig. 159 (abstract P16). See text for description
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Objectives
Ultrasound has become an efficient approach for non-invasive brain
stimulation. Currently low frequency ultrasound (<1 MHz) are prefera-
ble as its low ultrasonic attenuation when pass through the human
skull. However, the stimulated area in the brain is hard to be specific
located since the focal zone is relatively large when using low fre-
quency ultrasound. It is important especially in mouse study due to
small brain size. According to the principle of ultrasound engineering
technique, higher ultrasound frequency has the ability to support
smaller focal zone, which ultimately minimize the stimulation area.
This study examines the feasibility of using higher frequency, i.e. 5
MHz, focused pulsed ultrasound to evoke motor responses of mouse.
Methods
5 BALB/c mice, 8 weeks old, 20 g (+/−25%) in weight were used.
Mouse was anesthetized by intraperitoneal injection of chloral hy-
drate and fixed on a mouse stereotax (68028, RWD Life Science Co.).
5MHz ultrasonic pulses (80 circles/pulse, pulse repetition frequency
of 1.2 kHz, 100 pulses) were excited every 1s, 3s, and 5s, by a single
element transducer (5 MHz centre frequency, IL0506HP, Valpey
Fisher), two function generators (AFG3102, Tektronix), and a RF
power amplifier (AR150A100B, Amplifier Research). The transducer
could be moved above the skull of mouse with 0.1 mm steps in
three dimensional. The motor movements of mice were captured by
camera (HD1080P, Aoni Ltd., Shenzhen). Electromyography (EMG) re-
sponses collected from the tail and forelimbs muscles were used to
monitor the motor potentials evoked by motor cortices. Ultrasonic
attenuation coefficients of skulls in high frequency were measured
and calculated using 3D acoustic intensity measurement system
(SN2010, Precision Acoustics).Results
Our results indicate that 5MHz focused ultrasound can efficiently
penetrate through skull of mouse and stimulate motor cortex to
evoke motor potentials and movement responses, thus allow for
more precise stimulation on brain of mouse. Attached picture shows
the motion response of a mouse tail and the EMG signal acquired
from the tail. The compensated acoustic intensities are similar (differ-
ence <5%) between 1 MHz and 5 MHz ultrasound. The peak EMG
amplitude increases gradually when increasing the acoustic intensity
with 5 MHz ultrasound. The acoustic intensities range from 130 mW/
cm2 to 230 mW/cm2. The equivalent diameter of ultrasound stimulus
with 5 MHz (0.29±0.08 mm) is significantly smaller than that of 1
MHz (0.83±0.11 mm). The quantity of successfully evoked waveforms
of 1 MHz ultrasound is larger than that evoked by 5 MHz. Moreover,
the EMG response latency of 1 MHz ultrasound is greatly larger than
that of 5 MHz.
Conclusions
This study examined the feasibility and effectiveness of using higher
frequency (5 MHz) ultrasound to evoke motor responses of mice. The
results show that 5 MHz ultrasound can efficiently penetrate through
mouse skull and stimulate brain to evoke motor potentials and
movement responses. It provides a reduced focal region, which thus
offers an improved anatomical specificity in neuro-stimulation in a
non-invasive manner.P17
Neuro-navigation-guided focused ultrasound-induced blood–brain
barrier opening: feasibility in penetrating through human skull
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Objectives
Focused ultrasound (FUS) exposure with the presence of microbub-
bles has shown its promise in temporally and targeted open the
blood–brain barrier (BBB), and brings potential in delivering thera-
peutic agents into the brain for CNS disease treatment. Feasibility in
using neuronavigation system to guide the FUS-BBB procedure in
large animals has been demonstrated successfully, and the guidance
precision has been measured to be acceptably low. However, it is still
unknown whether same precision and power compensation strategy
is valid when FUS beam is intend to penetrate the human skull. The
purpose of this study is to verify that using neuronavigation system
combined with a prior treatment plan can successfully guide FUS-
BBB opening with the consideration of involvement of human skull.
Methods
A human cadaver was employed to perform CT scan, and a treat-
ment planning software was developed to simulate focal beam redis-
tribution and pressure decay when transcranial FUS exposure were
performed. During experiment, 4 groups of animals (n = 22) were
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):15 Page 95 of 114conducted to verify the success of BBB-opening when incorporating
with the in-prior treatment plan.
Results
The developed algorithm provides can well reconstruct the 3D hu-
man skull structure and perform reliable skull-insert pressure loss
prediction. Data comparison shows that focal beam distortion and
shifting can be well predicted. In animal experiments, we showed
that success rate in inducing BBB opening in animal brain at the tar-
get position can be increased to 87% when compared to 0% in un-
corrected experimental groups.
Conclusions
Neuronavigation guided FUS-BBB opening has the added advantage
of not limiting neurosurgical intervention by MRI chamber space or
non-magnetic properties. Combining neuronavigation guidance with
the prior treatment planning information is feasible to precisely
guide the FUS-BBB opening procedure.Fig. 160 (abstract P17). a Experimental setup of the neuronavigation-
guided FUS-induced BBB opening in small animals when considering
human skull cadaver insertion. b Representative comparisons of the
FUS-induced BBB regions identified by post mortem observation of EB
extravasations (upper: frontal view; middle: sectional view) as well as
the real-time guided view via neuronavigation system during FUS
exposure. (left) No skull; (middle) Skull insertion; (right) Skull insertion with
compensation. Yellow = FUS energy target positionsP18
The impact of skull temperature on focusing in transcranial
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Objectives
To measure the change in the speed of sound of skull bone in a pig
model as a function of temperature and to use these values in simu-
lation to predict if changes in speed of sound as a function of
temperature could negatively impact treatment outcomes.
Methods
A holesaw was used to acquire a 0.5 inch diameter core from a dried,
ex-vivo pig skull. The core was then cut and sanded further to re-
move trabecular bone and leave a smooth edge. The Fragment was
attached to an aluminium plate that was fastened to an ultrasound
transducer at the focal spot (Olympus, 500 KHz, 1 inch diameter, 1.25
inch focal length). Fig. 161a shows a schematic of the setup.
Acoustic measurements were acquired with a needle hydrophone
(HNR-0500 Onda, Sunnyvale, CA), which was connected to an oscillo-
scope that digitized the data and passed it to a PC. Internalaveraging in the oscilloscope was set such that each measurement
was made 16 times and averaged.
Temperature was controlled using water heated in a separate water
bath and circulated through the measurement tank. Measurements
were performed at each temperature with and without the bone
present. Temperature in the water was measured with an optical
thermal probe and the temperature was allowed to equilibrate for
one hour before measurements were taken.
Velocity measurements were repeated five times at each
temperature. Each measurement was performed by acquiring acous-
tic recordings with the bone in place, removing the bone without
disturbing the hydrophone, and then repeating the recordings with-
out the bone.
Data Analysis: Phase velocity measurements were obtained by com-
paring the phases of the Fourier transform component nearest to
500 kHz as done by Fry and Barger [1]. The phase change is given by
Φ = 2πω(d/cw-d/cb), where ω is the radial frequency, d is the width
of the bone fragment, cw is the sound velocity in water, and cb is
the sound velocity in the bone fragment. Solving for cb gives cb = 1/
(1+Φcw/(2πdω)). Figure 161b shows example hydrophone measure-
ments in the time domain and the phase difference, Φ, at frequen-
cies surrounding 500 kHz.
Simulation: A CT of two patients (one “easy” and one “hard” as de-
fined by the ratio of the temperature rise of the first sonication to
the power of the first sonication) was segmented into water, skull,
and brain. The skull was further segmented using the Hounsfield Unit
Value and speed of sound and scattering values were assigned ac-
cording to Vyas et al. [2].
Temperature simulation was done using a finite difference time do-
main implementation of the Pennes’ bioheat equation [3]. The beam
pattern was recalculated once every second during the simulated
sonication based on temperature changes reported by the bioheat
simulation. In each skull, the acoustic power was set such that the
temperature rise, assuming no variation in acoustic velocity, was
60°C.
All voxels in the skull were assumed to have the same absolute
change in velocity with temperature as was measured in this frag-
ment. This assumption should lead to an estimate of the worst-case
scenario because, in the temperature range of interest, the velocity
of sound in water and bone trend in opposite directions as a func-
tion of temperature. Therefore, in voxels composed primarily of tra-
becular bone, the overall change in velocity will be small compared
to voxels composed primarily of cortical bone. Therefore assuming
that all voxels segmented as bone change in the same way as cor-
tical bone should overestimate the affect.
Results
Figure 162a shows the measured speed of sound as a function of
temperature. Error bars represent the standard deviation of the five
measurements acquired at each temperature. Fitting the data yields
a slope of −9.5 m/s/C, a relatively small change.
Figure 162b shows results from simulation. The plot compares cuts
along the z-axis of the absorbed power at the beginning of the son-
ication, before any skull heating has occurred, to the same cut at the
end of the sonication. There is no appreciable change in the beam
pattern or the power at the focal spot in either skull.
Conclusions
While the speed of sound in bone does have some dependence on
temperature, this work provides evidence that it is not enough to
significantly alter the focal spot during a sonication.
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Datasets. Submitted, 2015. 1, no. 2, pp. 93–122, 1948.Fig. 162 (abstract P18). a Measured speed of sound as a function
of temperature. Error bars represent standard deviation of the five
measurements done at each temperature. b Change to the
simulated focal spot shape and the simulated efficiency as a result
of changes in the speed of sound in the skull. The plot shows a cut
through the beam along the z-axis at the beginning and end of
the sonication
Fig. 163 (abstract P19). Reconstructed fornix models in a live and
b post-mortem porcine subjects. c Fornix sub-regions of the columns,
body, and crura are identified. Three regions of interest are indicated in
the anterior (red), middle (blue), and posterior (green) body of the fornix
Fig. 161 (abstract P18). a Schematic of experimental setup.
b Sample of measured signal as recorded by the hydrophone in the
time domain (top) and the difference in phase (water – bone) as a
function of frequency (bottom)P19
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Objectives
Diffusion tensor imaging (DTI) is a valuable tool for localizing white
matter fibres and measure metrics of diffusivity. Tractography algo-
rithms can be used to visually reconstruct white matter fibres in
order to delineate focused ultrasound (FUS) targets of interest. Ani-
mal models are useful in pre-clinical investigation stages of FUS ap-
plication. However, in vivo studies can be logistically and financially
challenging. Where possible, it would be desirable to use post-
mortem animals prior to clinical testing of FUS in animals. Wecompared the imaging and diffusivity metrics of the body of the for-
nix in a young pig model. Specifically, we aimed to demonstrate that
visualization of tracts post-mortem was feasible and compared to see
which metrics of diffusivity were altered between in vivo and ex vivo
models.
Methods
Six piglets were studied: three live, three post mortem (<24 hr), aver-
age weight 5.2 kg. T1 anatomical and diffusion-weighted imaging
(DWI) scans were acquired. The DWI scanning parameters included
128 diffusion directions, 1.6mm isotropic voxel resolution, and diffu-
sion weighting of b=800 s/mm2. Eddy current, motion, and field map
corrections were performed. A one-direction reverse phase-encoded
sequence was also incorporated for correcting diffusion gradient-
associated image distortions. The T1 and DWI scans were co-
registered for accurate anatomical localization. The fornix was chosen
as a model white matter structure due to its central position within
the brain and ease of visualization. Single-tensor tractography of the
fornix was performed using 3D Slicer (version 4.4) using the following
parameters in both living and post-mortem subjects: stopping frac-
tional anisotropy (FA) value 0.05; step size 0.4 mm; seed spacing 0.2;
stopping curvature 0.7. A region of interest (ROI) based analysis was
performed in order to measure scalar diffusion metrics of fractional
anisotropy (FA), radial (RD), axial (AD), and mean (MD) diffusivities.
Three ROIs (3.2x3.2x3.2 mm3) were placed along the body of the for-
nix (designated anterior, middle, and posterior) to mimic potential
FUS sonication target position and size. Comparisons were per-
formed across subjects for each individual ROI placement as well as
in a group, effectively covering the complete segment of the fornix
body.
Results
The tracts of the fornix were successfully imaged in both settings,
and included the anterior, middle, and posterior sub-regions of the
fornix body. Measurement of ROI diffusivities demonstrated that,
across all comparisons, the post-mortem subjects showed signifi-
cantly decreased mean, axial, and radial diffusivity (p<0.0005). FA,
however, was unaltered between both groups (p value), suggesting
that the overall balance of diffusivities and directionality remains
unchanged.
Conclusions
We observed a consistent and significant pattern in the diffusivities
between in vivo and post mortem piglets. Post mortem subjects ex-
hibited decreased MD, AD, and RD in the fornix compared to living
subjects but showed no significant change in FA. The post-mortem
decrease in diffusivity is indicative of a number of factors including
lack of blood circulation, lack of cerebral spinal fluid, and decreased
tissue temperature. Unaltered measures of FA exhibits that diffusion
directionality remains consistent and that similar tractography algo-
rithms and parameters may be readily applied to both groups. This
shows that post mortem animal models may be sufficient for meth-
odological development in DTI and FUS research. DTI is also shown
to be an effective tool for visualizing white matter structures and
extracting diffusion metrics which are useful measures for the assess-
ment of focused ultrasound treatment.
Fig. 164 (abstract P20). a Graph shows the protein expressions of
BDNF in the hippocampus. b Graph shows the change of body
weight in the LIPUS-treated BCCAO rats. *, #, and † denote significant
differences compared to Sham, LIPUS, and BCCAO groups rats,
respectively. (*,#,†, p<0.05)
Fig. 165 (abstract P20). H&E staining shows the effects of LIPUS on
brain damage in the hippocampus. The scale bar is 100 mm in
amplified regions
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Objectives
The decreased cerebral blood flow is a prominent risk factor for cog-
nitive dysfunction. Numerous clinical studies have indicated that the
reduction of cerebral blood flow is often observed in patients with
vascular dementia (VaD). Therapeutic drugs against VaD have faced
many challenges, as it has no effective treatment with existing drugs.
Thus, the development of proper strategies for treatment of VaD
would be highly desirable. The aim of this study was to investigate
the effects of ultrasound on VaD rats.
Methods
Low-intensity pulsed ultrasound (LIPUS) was generated by a 1-
MHz focused piezoelectric transducer at a 5% duty cycle and a
repetition frequency of 1 Hz. The focused transducer was posi-
tioned using the stereotaxic apparatus in order to direct the
acoustic beam to the desired region (3.0 mm posterior and 2.5
mm lateral to the bregma) of the brain. A function generator
was connected to a power amplifier to create the US excitation
signal. The spatial-peak temporal-average intensity over the fo-
cused transducer head was 528 mW/cm2, and was measured in
degassed water. LIPUS was transmitted from the top of the rat
brain. Each rat hemisphere was treated by LIPUS with triple son-
ications. The duration of each sonicaton was 5 min and there
was an interval of 5 min between each sonication.
All procedures involving animals were in accordance with the
guidelines for the Care and Use of Laboratory Animals. Male
Sprague–Dawley rats weighing from 160 to 170 g were used in this
study Before bilateral common carotid artery occlusion(BCCAO) oper-
ation, each animal was anesthetized in the prone position by inhal-
ation of 2% isoflurane in 2 l/min oxygen, and the body temperature
was maintained at 37 °C using a heating pad. Two-vessel occlusion
was produced in rats with permanent BCCAO. The bilateral common
carotid arteries were ligated with 5–0 type surgical silk suture in
BCCAO rats. The rat heads were mounted on a stereotaxic apparatus,
and the top of the cranium was shaved for LIPUS stimulation. The an-
imals were randomized into four groups (Sham, LIPUS, BCCAO, and
BCCAO+LIPUS) for biochemical analysis and histological observation.
The normal rats served as sham group. Animals in group of LIPUS
were treated with LIPUS daily for 14 days. In BCCAO group, animals
received BCCAO surgery. Two weeks after BCCAO, the BCCAO rats
treated with LIPUS daily for 14 days were assessed in group of
BCCAO+LIPUS.
Results
To further confirm the effect of LIPUS on the protein levels of
BDNF in the brain, bilateral rat hemispheres were exposed to
multiple LIPUS stimulations. Western blot analysis was used to
examine the endogenous protein expressions 24 h after the last
LIPUS stimulation. The protein expressions of BDNF in the stimu-
lated normal brains were significantly enhanced compared with
the sham rats (Fig. 164a). There was a significant decrease of
BDNF level in BCCAO rats as compared to the sham rats. How-
ever, no significant differences were found for the protein expres-
sions of BDNF in the sonicated BCCAO rats as compared with
sham rats. Figure 164b shows the change of body weight in
BCCAO rats after LIPUS treatment. The body weight of BCCAO
rats reached a plateau at day 7 after surgery. The body weight ofLIPUS-treated BCCAO rats was significantly increased at two week
after LIPUS treatment. Besides, no significant differences were
found in the LIPUS-treated rats as compared to the sham group.
Figure 165 shows H&E staining of neurons in the hippocampus of
the four groups. The surviving cells of the hippocampus band in the
dorsal hippocampus were observed. The hippocampal neurons in
sham rats were arranged neatly, cell morphology was intact, and cell
outlines were distinct. No significant difference was found in the cell
morphology of neurons in the hippocampal region between sham
rats and LIPUS rats. By contrast, hippocampal cells of BCCAO rats
were indistinct and loosely arranged.
Conclusions
LIPUS plays the beneficial effects in the restoration treatment of
VaD, which may be related to the mechanism that LIPUS can
promote the protein levels of BDNF and affect the synaptic
plasticity in the hippocampus of brain. However, further in-
vestigations are needed for the elucidation of the detailed
mechanisms.
Fig. 167 (abstract P21). See text for description
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Objectives
Magnetic Resonance Acoustic Radiation Force Imaging (MR ARFI) is a
promising imaging modality that combines MR Imaging and Focused
Ultrasound. The modality allows localizing the acoustic spot applying
very low energy. This ability is especially beneficial for transcranial
MRgFUS there intensity based measurements can be translated to
phase delay for skull aberration correction (Hertzberg et al., Marsc
et al.). Recently several new methods for focusing improvement were
suggested that reduce the amount of needed samples – keyhole ac-
celeration (Paquin et al.) and the use of full MR ARFI image instead
of a single pixel for the auto-focusing (Grissom et al.). The new
methods underline the need for MR ARFI that is not prone to geo-
metrical distortions as the echo planar imaging from one hand but
will allow same low amount of applied acoustic energy for single
image generation.
The suggested method allows generating a full MR ARFI image using
4 ultrasonic pulses and significantly reduces the geometrical distor-
tions of the image.
Methods
Fast Spin Echo Pulse sequence that is depicted in Fig. 166 was used
on MR 1.5T (GE). ExAblate Neuro (InSighTec) system was the source
of the ultrasonic pulses. Ultrasound compatible 2 channel head coil
(InSighTec) was used for the imaging. In-house built gel phantom
was used for displacement generation.
Results
MR-ARFI displacement image in perpendicular to the ultrasonic beam
direction is presented on Fig. 167. The Fast Spin Echo scan is not af-
fected by B0 inhomogeneity, producing symmetric displacement
map in parallel to the beam direction, as can be seen on Fig. 167.
Conclusions
The new fast spin echo based sequence significantly reduced geo-
metrical distortions, while improving the signal to noise ratio. The en-
ergy needed for single MR ARFI image generation is currently 2
times higher than for the EPI based sequence, however it can be fur-
ther reduced using reduced field of view and parallel imaging tech-
niques. The TE time is not ARFI pulse time depended, which allows
higher image quality for different tissues.Fig. 166 (abstract P21). Fast Spin Echo based MR ARFI pulse
sequence diagramP22
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Objectives
Using transcranial focused ultrasound for the modulation of brain ac-
tivity has been identified as a possible non-invasive means of treat-
ing neurological disorders. Most studies involving sedate rodents use
frequencies in the kilohertz range, which allow for optimal transmis-
sion of acoustic power through the skull. The trade-off of using lower
frequencies involves a lack of target specificity. Higher frequencies
must be used in order to modulate activity in a more highly-
specified manner. This study demonstrates that focused ultrasound
in the megahertz range can be used to evoke motor- and cognitive-
related responses in mice under deep anaesthesia by targeting spe-
cific brain structures. Contralateral-paired hind limb movements were
observed when stimulating cortical regions, demonstrating the ability
of MHz-range FUS to stimulate activity in highly-localized brain re-
gions. Additionally, pupil dilation was observed when deep-seated
anxiety-related structures were targeted, demonstrating the ability of
FUS to modulate cognitive activity in a highly-specified manner.
Methods
For this study, wild-type adult male mice were anesthetized with in-
traperitoneal injections of sodium pentobarbital (65 mg/kg) and fixed
in a stereotaxic frame. A single-element FUS transducer with funda-
mental frequency of 1.94 MHz was fixed to a 3D positioning system
for accurate navigation through the brain. A 6x6 mm grid centred +2
mm rostral of the lambda skull suture was sonicated in a random
order using a centre frequency of 1.9 MHz, pulse repetition fre-
quency of 1 kHz, 50% duty cycle, 1 second pulse duration, 1 second
inter-pulse interval for a total of 10 pulse repetitions. The acoustic
pressure applied was varied in order to evaluate thresholds for elicit-
ing physiological responses like motor movement, eye movement, or
pupil dilation. Motor movements were validated using video record-
ings and electromyography via needle electrodes implanted into the
Fig. 168 (abstract P23). See text for description
Fig. 169 (abstract P23). See text for description
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high-resolution camera focused at the right eye and processed to
measure eye movements or changes in pupil size.
Results
The minimum acoustic pressure required to elicit motor movements
was 1.45 MPa when targeting the somatosensory cortex, calibrated
using an excised mouse skull. Higher pressures increased the success
rate from 20% (at the 1.45 MPa threshold) to 70% (1.79 MPa). Target-
ing eye-motor and anxiety related regions of the brain elicited eye
movements and pupil dilations up to 20%. Sonicating the superior
colliculus resulted in both eye movement and pupil dilation at a
lower threshold pressure (1.20 MPa) than the hippocampus and locus
coeruleus which required pressures greater than 1.80 MPa.
Conclusions
This study successfully demonstrated that MHz-range transcranial fo-
cused ultrasound can be used to elicit motor- and cognitive-related
physiological responses with high specificity in mice in vivo. It was
also shown that the success rate of stimulation increased with acous-
tic pressure for motor movements associated with cortical activity
modulation but highly depends on the region of the brain targeted.
These findings emphasize the complex and yet to be determined
mechanism of action involved in ultrasonic neuromodulation.
P23
Pre-clinical in-vivo MR ARFI evaluation
Alexander Volovick1, Javier Grinfeld1, David Castel2
1InSighTec, Tirat Carmel, Israel; 2Sheba Medical Center, Ramat Gan, Israel
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):P23
Objectives
Transcranial Magnetic Resonance guided Focused Ultrasound Surgery
(MRgFUS) is a novel non-invasive therapeutic alternative that is gain-
ing interest both with physicians and patients. One of the remaining
challenges for transcranial MRgFUS is skull aberration correction. Be-
cause of skull variance between patients the amount of acoustic
power reaching the focal point and the focus quality are hard to es-
tablish. MR Acoustic Radiation Force Imaging (ARFI) is the potential
imaging modality that will allow such measurements. MR ARFI mea-
sures the displacement of tissue, which is proportional to the acoustic
intensity. Based on the displacement we will be able to determine the
amount of acoustic power reaching the focal point (skull attenuation)
and the focus quality (skull aberration). In order to determine the cali-
bration slope for the power and displacement area, in-vivo experiments
on brainy tissue for large animal model were performed.
Methods
Nine subjects underwent wide craniotomy procedure. MR ARFI was
performed for each animal at 3 different locations using different
acoustic powers. MR ARFI sequence was Echo Planar Imaging (EPI)
based and the experiments were performed using ExAblate Neuro
mid frequency system (InSighTec), 1.5T MRI (GE). The imaging was
performed using integrated 2 channels Head Coil, by InSighTec.
Results
Linear dependence of displacement at applied acoustic power is pre-
sented on Fig. 168. Typical displacement map is presented on
Fig. 169. The shape of the spot is not symmetric because of EPI sensi-
tivity to B0 field inhomogeneity. Spot diameter was observed to be
8.69±1.36 mm, almost 3 times higher than the acoustic intensity spot
diameter.
Conclusions
As expected the displacement is linearly proportional to the applied
acoustic power (intensity). The displacement diameter is higher than
the acoustic intensity spot diameter because of the elastic properties
of the brainy tissue. Spot diameter can be used as the focus quality
measure. Taking into account expected skull attenuation and aberra-
tions in patients; we expect the acoustic powers reaching the focus
to be lower than 35W (which is 8 W/mm2 or 2.3MPa). Such know-
ledge can be a measure of safety for determining the proximity to
cavitation threshold in the focus.P25
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Objectives
One of the major challenges of liver or kidney tumour ablation with
HIFU (High Intensity focused ultrasound) or FUS (Focused ultrasound
surgery) is organ motion caused by respiration. A prerequisite for
gapless and confluent tumour destruction is real-time knowledge of
the target position. Diagnostic Ultrasound (US) and Magnetic
Resonance Imaging (MRI) are suitable image guiding methods to pro-
vide nearly real-time position information. For several years, we have
been developing and improving US-based motion tracking for
MRgFUS (MR-guided FUS). The aim of the present study was to ex-
tend this approach to an MR-based motion tracking. Further goals
were the automated instantiation of tracking features and the assess-
ment of feature quality of a current tracking routine on US and MR,
respectively.
Fig. 170 (abstract P26). a Axial, sagittal and coronal localizer
images for patient 2 showing the transducer, gel pad and cooling
water bag; b coronal T2 maps of two slices acquired during the
treatment over time (ROI shown in black on slice 2); c plot of T2
values within the ROI over time
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For motion tracking, image streams are analyzed in real-time to track
predefined structures (“features”). Basis for tracking are 2D/3D US or
fast MR-EPI (Echo Planar Imaging) images of moving structures. In
the first step, pronounced contours (e.g. diaphragm) or landmarks
(e.g. vessels) are defined manually or automatically. A Particle Filter-
based algorithm evaluates state hypotheses of local affine transfor-
mations to track these single positions through the image stream.
With each position, an associated quality measure based on the
probability distribution is provided. Tracking data is then sent to the
treatment unit, e.g. MRgFUS/HIFU system. Based on this position
data, real-time beam steering can be performed to compensate the
motion. If the motion exceeds predefined limits, the therapy proced-
ure can be interrupted immediately.
Results
The tracking algorithm was evaluated on liver US and MR data from
volunteers. Automated detection of blood vessels as tracking feature
on MR-EPI images yielded satisfying results. Computing time for
tracking on MR-EPI image data was about 1ms per frame. A mean
tracking error of 1.7 mm was achieved. Feature position estimation
on US image streams was possible in less than 2 ms per frame with
an averaged position error of 1.5 mm. Automated estimation of fea-
ture quality proved to be not always sufficient.
Conclusions
Real time liver motion tracking on 2D/3D US- or MR-data streams
with sufficient spatial and temporal resolution for precise MRgFUS is
possible. Further refinements for automated estimation of tracking
feature quality are necessary. In the future, an automated replace-
ment of insufficient tracking features will be implemented.
Acknowledgements
Parts of the research leading to these results has received funding from the
European Union's Seventh Framework Programme (FP7/2007-2013) under grant
agreement no. 611889 (TRANS-FUSIMO).
P26
T2-mapping as a predictor for non-perfused volume in mrgfus
treatments of desmoid tumours
Eugene Ozhinsky, Matthew D. Bucknor, Viola Rieke
Radiology and Biomedical Imaging, University of California San
Francisco, San Francisco, CA, USA
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):P26
Objectives
MR-guided focused ultrasound (MRgFUS) is a non-invasive ablation
technique that has been successfully used for the treatment of uter-
ine fibroids and bone metastases. More recently, focused ultrasound
has been investigated for novel indications such as treatment of es-
sential tremor, focal breast lesions, osteoid osteomas, and desmoid
tumours.
Desmoid tumours are benign but locally aggressive soft tissue tumours
that arise from fibroblast cells. Conventional therapies include surgical
resection, radiation and chemotherapy. Despite these treatments, the tu-
mours have a high recurrence rate of up to 50% in 5 years (Peng PD,
et al. Ann Surg Oncol, 2012). As an alternative treatment, focused ultra-
sound has shown promising results in reduction of tumour volume with-
out significant side effects (Wang Y, et al. Int J Hyperthermia, 2011).
Visualization of the ablated volume remains a large problem in focused
ultrasound therapy. Thermal dose maps are used during the treatment
to visualize the treated volume, but fail to reliably predict the extent of
ablation. Post-treatment contrast enhanced MR imaging allows assess-
ment of the non-perfused volume (NPV), the gold standard assessment
of the quantity of tumour ablation. However, safety concerns regarding
heating of tissue after gadolinium injection prevent further treatment
following the NPV assessment.
In this study we investigated rapid T2 mapping as a way to visualize tissue
changes during MRgFUS treatment of patients with desmoid tumours.
Methods
MR-guided focused ultrasound ablation was performed in two pa-
tients with paediatric desmoid tumours in lower extremities using anExAblate 2100 system (InSighTec, Haifa, Israel) integrated with a 3.0
Tesla MR scanner (GE Healthcare, Waukesha, WI, USA). Sonications
were performed with duration of 20–30 sec and acoustic power be-
tween 49 and 107 W.
The patients received 68 (patient 1) and 65 (patient 2) treatment sonica-
tions with 2–4 verifications sonications over the course of about 3 hours.
Over the course of the treatment 4 (pt. 1) and 6 (pt. 2) double echo
Fast Spin Echo images were acquired (TE = 35/186 ms, TR = 1500
ms, echo train length = 40, FOV = 24–28 cm, 128 x 128 matrix size,
BW = 15.6 kHz, 10 mm slice thickness, 1–2 slices, 15 s acquisition
time) before, during and after the treatment. T2 maps were gener-
ated with an exponential fit for two data points. At the end of the
treatment pre- and post-contrast 3D FSPGR images were acquired.
T2-maps were compared to post-contrast images.
Results
Our results in Figs. 170 and 171 show that T2 mapping could be
used to visualize the changes in tissue during focused ultrasound
treatments of desmoid tumours. The areas of T2 elevation showed
an excellent agreement with the non-perfused volumes in the post-
contrast images. T2 values of tissues such as muscle and fat have
been shown to increase with temperature (Graham SJ, et al. Magn
Reson Med, 1998; Ozhinsky E, et al. J Ther Ultrasound, 2015). Al-
though some of the observed T2 elevation could be caused by the
heat from the previous sonications, the elevated T2 values were ob-
served throughout the interior of the tumour. Future work will study
the T2 values in the tumour after it returned to the baseline
temperature.
Conclusions
We have shown that T2 mapping can be used to visualize the extent
of ablation with focused ultrasound and be used as a predictor of
NPV without the need for contrast injections. This could be used by
physicians to ensure complete ablation of the tissue within the re-
gion of treatment.
Fig. 171 (abstract P26). Comparison between T2 maps (a) and
post-contrast images (b) for the same location for patient 2. The
non-perfused volume (NPV) appears dark on the post-contrast
images. Arrows show gaps in the NPV, which correspond to areas
with low T2 in the T2 maps
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Objectives
X-ray CT offers a commonly available imaging modality, with high
spatial and temporal resolution. CT is substantially less expensive
than MRI and provides images which quality is superior to ultra-
sound. In addition, CT does not impose any restrictions on the equip-
ment located in its vicinity as MRI does and unlike ultrasound can
scan the in-vivo brain. The objective of this study was to examine
the feasibility of using CT for non-invasive monitoring of high inten-
sity focused ultrasound (HIFU) thermal ablation.
Methods
Ex-vivo tissue samples which included porcine fat and bovine liver
were heated by HIFU while positioned within a CT scanner (Philips
Healthcare). A thermocouple (Omega Engineering) which was
inserted into the HIFU focal spot was used to register the
temperature as a function of time during the HIFU heating and cooling
processes. After the specimen was sufficiently cold, the thermocouple
probe was removed to avoid image artefacts. Then, while using the
same experimental setup and the same tissue, the HIFU was aimed at
an untreated spot located several centimetres away from the previously
treated area. The HIFU was activated again, this time while acquiring CT
images at very short intervals during both heating and cooling stages.
The set of scanned slices were positioned at and around the focal zone.
The images were registered, time stamped and transferred to an exter-
nal computer for further analysis. From the obtained data, the CT
Hounsfield Units (HU) vs. temperature curves were plotted.Results
The results have shown that the HU change in a nonlinear manner
during the heating stage. Contrary to that, a linear relation of the
HU-Temperature curve was observed during the cooling stage. This
formed a hysteresis phenomenon [1] which may be attributed to irre-
versible changes in the tissue resulting from the thermal ablation.
Furthermore, while the HU- Temperature loop obtained during heat-
ing and cooling for liver tissue progressed along the clockwise direc-
tion, the HU-Temperature loop progressed along the counter
clockwise direction for fat [2]. Moreover, for fat, a clear nadir point
was observed at about 44.5°C [2].
Conclusions
X-ray CT HU are sensitive to thermal changes, indicating their poten-
tial to serve as a tool for thermal monitoring. However, the HU-
Temperature relation is nonlinear and its characteristics are different
for different tissue types. This may pose a challenge when treating
an organ which comprises of several tissue types. Another challenge
stems from the need for a high rate of image acquisition. This may
be currently associated with a high radiation dose. In conclusion, as-
suming that radiation dose can be reduced to an acceptable level, X-
ray CT may be a valuable modality for non-invasive monitoring of
HIFU thermal procedures.
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Objectives
High intensity focused ultrasound (HIFU) causes selective tissue ne-
crosis in a very well defined volume. Tissue necrosis is created at a
variable distance from the transducer through heating and cavita-
tion. Over the past decade, the use of HIFU has been investigated in
many clinical settings with the most prominent applications in pros-
tate cancer and more recently for the treatment of liver tumours,
uterine fibroids and brain disorders, amongst others. Today, the only
reliable technique allowing measuring the temperature during a
HIFU treatment is Magnetic Resonance Imaging (MRI). The spatial
resolution of MR images during thermometry is about a millimetre
and the temporal resolution is about half a second. Recent work has
also demonstrated that temperature monitoring using MRI is possible
during breathing. Nevertheless, MRI requires a complex and expen-
sive apparatus with limited availability. MR monitoring also implies a
trade-off between frame rate versus spatial resolution and monitor-
ing accuracy. Moreover, HIFU boiling can happen rapidly causing er-
rors and artefacts. Finally it requires MR-compatible electronics and
transducers. Otherwise, ultrasound imaging allows fast, cheap and
portable devices. Temporal and spatial resolutions of ultrasound im-
ages are high but the contrast is low and all organs cannot be im-
aged (for example, brain and lungs). Today reliable temperature
monitoring, specifically for temperature higher than 55°C, is not pos-
sible using ultrasound imaging. Many studies have suggested using
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cently variations in the shear modulus to estimate temperature. The
main limit of ultrasound based methods is that the range of measur-
able temperature is often limited by cell lysis threshold, which is
around 50°C. However, many other acoustic parameters of tissues
can be measured such as the backscattered energy or the backscat-
ter coefficient that can be combined to the attenuation or the speed
of sound to enable temperature measurement at higher values. In
this work the relationship between changes in ultrasound backscat-
tered power and temperature during HIFU treatments was studied.
Methods
A flat pulse-echo transducer working at 2.25 MHz (bandwidth: 1.4 –
2.9 MHz) was used. The active diameter of the pulse-echo transduc-
ers was 10 mm. A high intensity ultrasound transducer working at 3
MHz was used to create lesions in in vitro liver samples. The active
diameter of this transducer was 4 cm. Experiments were conducted
in a tank filled with degassed water at 37°C. The acoustic axis of the
pulse-echo transducer was placed perpendicularly to the acoustic
axis of the HIFU probe. An acoustic mirror was placed parallel to the
surface of the pulse-echo transducer. The electrical power was deliv-
ered to the high intensity transducer in continuous mode via a
power amplifier driven by a sinusoidal wave generator. A power
meter was inserted between the amplifier output and the high inten-
sity ultrasound transducer. The pulse-echo transducer was driven by
a pulse-echo generator connected to an oscilloscope to acquire
signals.
First a pulse was emitted by the pulse-echo transducer only in water.
This pulse wave was reflected on the acoustical mirror and used as a
reference for the total energy emitted by the transducer. Then a liver
sample was placed in a holder between the pulse-echo transducer
and the acoustic mirror. Liver tissues were warmed up to 37°C and
then high intensity exposures were created to increase the
temperature in liver samples. Temperature was recorded using a thin
thermocouple placed on the heated zone in the liver. Long exposure
time (30 minutes) was used to observe smooth temperature increase
from 37 to 70°C. Pulse-echo acquisitions were performed every mi-
nute during heating. Four experiments were conducted to observe
the reproducibility of the measurements. Acoustical signals were re-
corded using an oscilloscope and analysed using software specifically
developed on MATLAB. From this signal, the attenuation of the liver,
the energy of the backscattered signal, the backscatter coefficient,
and the speed of sound were computed.
Results
The attenuation coefficient increases only when a coagulation necro-
sis is created in liver tissues. Its initial value for an untreated liver is
about 0.08 Np.cm-1.MHz-1, and increases suddenly to 0.35 Np.cm-
1.MHz-1 when necrosis is created (around 60°C). The speed of sound
increases from an initial value of about 1478 m.s-1 to 1505 m.s-1 at
50°C and then decreases to its initial value. During heating, the en-
ergy of the backscattered signal increases roughly linearly with
temperature. A linear increase of 3 dB was measured in ultrasound
backscattered power during experiments. The tissue temperature in-
crease estimated using backscattered energy correlated well (r=0.79)
with temperature measurements performed using thermocouples.
This linear relationship between changes in the backscattered energy
and actual temperature was observed up to 70°C.
Conclusions
Other parameters such as acoustical impedance of the tissue, size
and density of the scatterers, could also be correlated to these mea-
surements in order to increase the accuracy of temperature estima-
tion. Successful temperature estimation may allow creating 2D
temperature maps during HIFU treatments using ultrasound imaging.P29
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Objectives
The use of pulsed focused ultrasound (pFUS) has been demonstrated
as a non-invasive regenerative medicine to enhance homing perme-
ability and retention (EHPR) of intravenously (i.v.) infused mesenchy-
mal stem cells (MSCs) to target tissues [1–3]. The purpose of this
study was to examine the effects of a non-invasive MR-guided pFUS
on cardiac responses in a rat model.
Methods
Eight to ten week old female Sprague Dawley rats were imaged on a
3T clinical MR scanner (Achieva, Philips Healthcare, USA) and T2-
weighted MR images were acquired with 8.9ms repetition time (TR),
4.5ms echo time (TE) in 1mm slice thickness (Fig. 172a).
The images were used as guidance for pFUS to target the rat cardiac
tissue (1 MHz; 0 to 8 MPa; 10 ms bursts; 0.7 Hz PRF; RK-100, FUS In-
struments, CAN). The levels of cardiac troponin I (cTnI), a cardiac in-
jury marker (Rat cTnI ELISA kit, LSBio, USA), and brain natriuretic
peptide (BNP), a cardiac muscle stretch marker (BNP Enzyme Im-
munoassay kit, RayBio, USA), in blood plasma were evaluated after
pFUS exposure at 0 to 8MPa with 100 pulses per 9 targets. In order
to determine the accurate location of pFUS targeted region in hearts,
the hearts were harvested after euthanasia to examine the immuno-
pathologic changes using 7T MR microimaging system (Bruker, USA)
with 7000 ms TR and 50 ms TE in 250 μm slice thickness.
Results
pFUS exposure resulted in histological changes in targeted region of
hearts. Myocardial oedema in pFUS targeted region was also found
in 7T MR images (Fig. 172b) while there was no difference with the
SHAM group. Immunohistochemical (IHC) analysis confirmed that
serum albumin was present in pFUS treated regions (Fig. 172d) while
little was found in SHAM group (Fig. 172c). No significant changes of
cTnI levels were found in pFUS groups compared to SHAM; however,
mean BNP levels were slightly increased by pFUS (Fig. 172). Qualita-
tively there was no tissue damage in pFUS exposed groups by
haematoxylin and eosin stain (data not shown). IHC analysis shows
that intercellular adhesion molecules (ICAM) were considerably en-
hanced by pFUS (Fig. 173a & c) compared to SHAM (Fig. 173b).
Conclusions
It has been previously demonstrated that pFUS exposure enhanced
i.v. infused MSCs homing toward pFUS-targeted tissue. Combination
of pFUS exposure and MSCs infusion has already proven to be effect-
ive in rescuing mice from cisplatin-induced acute kidney injury (AKI)
by modulating anti-inflammatory immune cell profile [1–3]. We inves-
tigated the mechanical and histological effects of pFUS exposure on
rat cardiac tissue in this study. Our data demonstrate that pFUS treat-
ment can be non-invasively applied to cardiac tissue as mechanical
stimuli without damages in order for triggering biologic responses. In
conclusion, pFUS has potentials to be used as a non-invasive regen-
erative medicine for cardiac diseases in combination of MSCs by
modulating anti-inflammatory responses.
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injury in mice. Stem Cells. 2015 Apr;33(4): pp. 1241–53.Fig. 173 (abstract P29). pFUS exposure to the hearts resulted in
slightly increased BNP level in blood plasma. No correlation of pFUS
pressure-dependent BNP levels was found between groups
Fig. 174 (abstract P29). ICAM expression in pFUS exposed regions.
Enhanced ICAM in pFUS treated regions were found by IHC analysis
(a). Compared to SHAM (b), considerably higher ICAM stained
regions were found in pFUS exposure groups (c). Bar = 100 μm
Fig. 172 (abstract P29). Myocardial oedema found in pFUS treated
region. a An axial MR image that used as guidance for pFUS to
target the rat cardiac tissue. b pFUS exposure resulted in myocardial
oedema that found in 7T MR images. IHC analysis confirmed that
significantly increased albumin was present in pFUS treated region
(d) while little was found in SHAM (c). Red arrows represent the
pFUS targeting regions. Bar = 100 μmP30
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Objectives
High-intensity focused ultrasound (HIFU) has been emerged as non-
invasive and effective modality of cancer/tumour ablation utilizing its
thermal effect. In the HIFU field, the high rarefactional pressure could
also generate significant cavitation effect, which may lead to material
erosion. The effects of pHIFU on the erosion of soft and hard material
are studied to understand the underlying mechanisms.
Methods
Various ultrasound parameters were tried in the experiment. Cavita-
tion signals were measured during pHIFU exposure by passive cavita-
tion detection (PCD) approach. The volume and area of erosion at
the interface of material and water were quantitatively assessed.
High speed photography was carried out to capture the images of
material erosion and bubble cavitation.
Results
The material erosion increases with the delivered acoustic power and
pulse duration. At the same acoustic energy and duty cycle, low
pulse repetition frequency (i.e., PRF=1 Hz) leads to more significant
erosion (more than 10 folds) than that high PRF (i.e., 100~1000 Hz as
histotripsy). It suggests that acoustic radiation force plays an import-
ant role in material erosion as well as bubble cavitation at the inter-
face. Similar results were found in ex vivo experiments.
Conclusions
Ultrasound parameters could be optimized for the best material ero-
sion using the same energy. Acoustic radiation force could push the
ultrasound-induced bubble towards the interface for effective and
Fig. 175 (abstract P32). Lesion size versus ARF field during thermal
ablation at 65°C
Fig. 176 (abstract P32). FEM mesh used in the modelling of ARF
induced displacements
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associated mechanisms appropriately could improve the outcome of
ultrasound.
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Objectives
In other study of our group, combination treatment of focused ultra-
sound (FUS) and gemcitabine (GEM) has shown that mechanical ef-
fects of FUS more effectively control the growth of pancreatic cancer
in animal model. This study was designed to evaluate therapeutic ef-
fects of FUS+GEM treatment using the similar clinical protocol.
Methods
Human pancreatic cancer cells (CFPAC-1) were inoculated in BALB/c
nude mouse as a pancreatic xenograft model. Animals were divided
into two groups: GEM only, and FUS+GEM. For FUS+GEM group, ani-
mals were sonicated for 20 sec at 1 MHz in burst mode (acoustic
power = 80.5 W, duty cycle = 5%). GEM was administered in IV im-
mediately after sonication. One treatment cycle consisted of three
weekly treatments and one week monitoring. The treatment cycle
was repeated four times.
Results
For both treatment groups, tumour size reduced during the weekly
treatments in each cycle and increased again during the monitoring
period. Tumour in both groups showed similar growth pattern for
each treatment cycle. However, the re-growth rate of tumour after
the weekly treatments got higher as the treatment cycle repeated.
Although pancreatic cancer treated by GEM combined with FUS
showed reduction of the size, the efficacy of combination treatment
became lower as the treatment cycle repeated.
Conclusions
In conclusion, chemotherapy combined with FUS shows feasibility of
controlling pancreatic cancer growth. However, thorough studies for
treatment efficacy and effective treatment protocol are required prior
to clinical application.
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Objectives
Acoustic radiation force (ARF) is dependent on tissue attenuation
and sound speed, both of which are also known to change with
temperature. Furthermore, the viscoelastic properties of tissue are
also temperature dependent, which affect the displacements induced
by ARF. The objective of this study is therefore to quantify the
temperature dependent acoustic and viscoelastic changes in liver
and measure their effect on ARF induced displacements both experi-
mentally and with simulations.
Methods
The temperature dependent acoustic attenuation for liver was ob-
tained from the literature and fit to a fourth order polynomial func-
tion. The temperature dependent viscoelastic properties of liver were
experimentally measured and Zener-model of viscoelasticity was
used to fit the data. The effect on ARF induced displacements was
measured by using harmonic motion imaging (HMI) in ex vivo liver
during high-intensity focused ultrasound (HIFU) thermal ablation. Themeasured displacements were then compared to finite element
method (FEM) simulations with temperature effects incorporated.
Results
The measured peak-to-peak displacements initially decreased as tis-
sue warmed, then reached a peak when the lesion was similar in size
to the focal spot and in the end decreased as the lesion grew be-
yond the size of the focal spot. The characteristics experimental HMI
data were captured well in the simulations. Based on the results a
method for estimating lesion size based on this data was presented.
Conclusions
These results show that the displacement induced in ARF is
dependent on both the acoustic and elastic properties of tissue and
so any imaging modality exploiting these displacements needs to ac-
count for variations in both the acoustic and elastic properties of the
tissue. The findings of this study benefit the research of ultrasound
elasticity imaging modalities which are used in monitoring HIFU and
other thermal ablation therapies.
Fig. 177 (abstract P34). Thermochromic DQA phantom
colour-change resulting from HIFU sonication
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Objectives
Errors in power output ranging from −100% to +210% have been re-
ported in a multitude of physiotherapy transducers. Differences in
power output can arise even after careful calibration on an annual or
bi-annual schedule, which in the case of HIFU treatments can either
result in harm to the patient or non-effective treatment. Many ultra-
sound phantoms require complex set-ups, with large water tanks
and imaging systems to produce accurate data. Simpler phantoms
have been developed for use in benchtop settings but still rely on
complicated image analysis. We propose a simple, low cost and easy
to use DQA phantom which allows the user to assess the power out-
put of the focused ultrasound transducer, and determine if it has
changed significantly after calibration. The proposed phantom will
be a product with which the end-user can visually assess a transduc-
er’s gross functionality without resorting to complicated image
analysis.
Methods
The phantom is a highly attenuating ultrasound absorber with a sur-
face layer of thermochromic liquid crystals (TLC) that change colour
in response to heating. The acoustic absorber used was 3mm-thick
AptFlex F28 (Precision Acoustics Ltd, Dorchester, Dorset, UK) and the
TLC used was Hallcrest R35C5B (LCR Hallcrest, Glenview, IL, USA). Ex-
perimental results were generated by sonicating the absorbing sur-
face of the phantom through a 35mm non-absorbing coupling
gelatine layer using a 1.1 MHz single-element transducer with a fixed
23mm focus (Model XDR058, Sonic Concepts, Bothel, WA, USA). A
custom-designed 3D printed jig was used to hold the transducer and
phantom in known positions.
The phantom absorption and heating were modelled using a three-
dimensional time-domain bioheat transfer simulation written in
Matlab (Mathworks, Natick, MA, USA). Transducer output was mea-
sured with a needle hydrophone (Onda Corp., Sunnyvale, CA, USA) in
a single plane parallel to the axis of acoustic propagation in order to
provide an axisymmetric pressure field to the acoustic solver. The
simulation was validated against experimental measurements of time
to first colour change across four equivalent phantoms. The phan-
toms were allowed to cool for 8 minutes to return to a baseline rest-
ing temperature. Measurements were conducted with a 1.1 Mhz
input with amplitude 57V and were repeated four times per phan-
tom for each of three distinct sessions over the course of two weeks
to test for consistency across distinct experimental sessions. Measure-
ments were also collected input amplitudes of 74V and 142V for
each phantom during a single experimental session to generate pres-
sure dependent time-to-heating curves for the fabricated phantoms.
Results
Simulations were shown to be accurate within 15% of measured
heating times. The phantoms demonstrated time to first colour
change of 18s at the 57V amplitude excitation, 13s at the 74V ampli-
tude excitation, and 8s at the 142V amplitude excitation, The individ-
ual phantoms had mean heating times of 17.4s (+/− 6%), 11.8s (+/−
5%), and 13.2s (+/− 7%) over all measurements and experimental
sessions.
Conclusions
The phantom was shown to demonstrate the expected dependence
on input voltage amplitude, with time-to-first-colour-change decreas-
ing with increasing voltage. While there was noticeable phantom-to-
phantom variability, each of the three phantoms was shown to per-
form consistently over time. It is hoped that further independent
measurement of the absorbing material used will help explain the
inter-phantom variability.P35
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Objectives
Cavitation – bubbles oscillation and potential rupture is gaining a
growing interest in therapeutic ultrasound, mainly for targeted drug
delivery and blood brain barrier opening. The main challenges of
cavitation based therapy are its localization and control. The
localization problem is especially challenging for brain applications,
there skull and inhomogeneous brainy tissue become both cloaking
and unwanted cavitation generating factors. Recently, passive cavita-
tion mapping was proposed (Miklós Gyöngy and Constantin-C.
Coussios) and successfully integrated into clinical transcranial
MRgFUS system (Arvanitis and McDannold). However the method re-
quires large amount of passive receivers and in its current implemen-
tation allows only 2 dimensional monitoring.
Room acoustics analysis is a well-established field of research that al-
lows localizing multiple speakers in highly reverberating environment
(Nadiri and Rafaeli). In the presented work we suggest to utilize the
methods studied in room acoustics analysis for cavitation
localization.
Methods
ExAblate Neuro mid frequency (InSighTec) system was used for cavi-
tation generation. Multiple 2 seconds continuous sonications were
performed in degassed water (1 ppm level) using different acoustic
powers at multiple locations. The acoustic data was recorded by 7
hydrophones and underwent localization using room acoustics
analysis.
Results
The cavitation was successfully localized with precision of up to 3
millimetres in the worst case using four receiving elements. X-Y plots
of the cost function with the maximum at the identified position are
presented for one of the sonications in Fig. 178. The localization re-
sults were sensitive to the choice of time segments inside each son-
ication changing during the sonication. This shows that the
cavitation location in water can change during sonication.
Conclusions
The use of room acoustics analysis has proved to be accurate and
consistent for cavitation localization. The use of significantly smaller
amount of receivers for the localization is the biggest advantage rela-
tive to the existing methods. The cavitation cloud behaviour that
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the method can be used both for localization and for characteristics.Fig. 178 (abstract P35). X-Y cost function for sonication at location
of X=10, Y=10, Z=150P36
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Objectives
The model of intra-membrane cavitation, which is denoted here as
Bilayer Sonophore (BLS), based on ultrasound (US) induces pulsating
gas pockets in the intra-membrane space between the two lipid leaf-
lets. Resultantly, the acoustic energy is transformed into distortions
and strains in the cellular structure. Moreover, the BLS may poten-
tially explain both cavitational and non-cavitational US-induced bio-
effects.
Methods
In order to validate the sonophore model and to study the response
of cell membrane subjected to acoustic stimulation, a wide-field
digital interferometry (WFDI) technique is used. WFDI is a label-free
holographic technique that captures the complex wave front (phase
and amplitude) of the sample field, containing the quantitative phase
profile of the sample and gives a three-dimensional cell morphology
map. A piezoelectric tube transducer of 1MHz frequency is used and
acoustic pressure amplitudes in the range of 150kPa are quantified.
The sonication time is ten minutes. Reconstructed images are ob-
tained by an efficient digital process. We use the resulted images to
quantify the cell morphological change. Three dimensional represen-
tations of the cell thickness are obtained. A quantitative analysis of
the cross sectional area of the cell was performed.
Results
During the US transmission a morphological change of the examined
endothelial cells (ECs) was observed. The measured cell thickness,
based on phase profiles, was significantly increased in the nucleus re-
gion (9%± 2%). Consequently the cross-sectional area of cells be-
came significantly smaller compared to their initial area.
Conclusions
Two mechanisms of force transmission between US and cells were
considered as might be responsible for the morphological change:
the tension force, formed in the membrane due to sonophore gener-
ation, and the radiation force. We predict that the geometrical
change is attributed to the tension force formed in the membraneaccording to an estimated forces value, which might result in two
elementary mechanisms: changing the membrane curvature due to
tension, and changing the membrane curvature due to the detach-
ment of focal adhesion (FA) contacts. However, we presume that
most of the changes occur in the lower part interface, the surface be-
tween the cell and the plate, owing to the rearrangement (gener-
ation and detachment) of the FA points. Accordingly, the change in
the cross-sectional area may be explained relying on the detachment
of the FA contacts that led to higher values of cell thickness and to a
more spherical shape.
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Objectives
A possible mechanism of gas bubbles interactions with the acoustic
field (cavitation) was explored using backscatter signal observations.
The “Bilayer Sonophore” model (BLS model) suggests intramembrane
cavitation as a unifying mechanism for US induced cavitation related
bioeffects. It hypothesizes that the hydrophobic intramembrane
space between the two bilayer leaflets of membranes is capable of
inflating and deflating under an ultrasonic field thus creating cavita-
tion nuclei of gas.
Methods
Using a focused US transducer (0.5MHz, λ=3mm) a sample (Bovine
Aortic Endothelial Cells - BAEC or growth medium) was sonicated
using a pulsatile regimen consisting of 15 cycles at a pulse repetition
frequency (PRF) of 0.1 and 1 Hz and the backscatter signal was re-
corded as a function of time. As BAECs are significantly smaller than
the US wavelength used, they constitute a very small scatterer. Com-
bined with their fluidic consistency, the backscatter signal received
from the BAEC is negligible and so it was hypothesized that any
backscatter signal detected can only be the result of bubbles pulsa-
tion in the ultrasonic field, or more accurately, a bubble cluster. As
more bubbles are formed, a higher backscatter signal which will be
received and vice versa.
Results
The results showed a steady increase of the backscatter signal over
time for BAEC in ~80% of cases (mean percent of change of 2.61%
for 0.1Hz PRF and 4.69% for 1Hz PRF. The percent of change is calcu-
lated only for the cases showing increase of signal), with a decrease
of the signal for control experiments using medium in 80% of cases
for 0.1Hz PRF and 100% for 1Hz PRF (mean percent of change of
−2.38% for 0.1Hz PRF and −11.72% for 1Hz PRF. The percent of
change is calculated only for the cases showing decrease of signal).
This was found to be statistically significant.
Conclusions
It is believed in this work that the decrease of the backscatter
signal in the medium control case is the result of a mild degas-
sing effect, in which free bubbles are expelled from the focal
area due to the US pulse and thus less bubbles are available for
pulsation, which resulted in backscatter signal decrease. Further-
more, it is believed that the increase of the backscatter signal in
the BAEC case is possibly the result of sonophore formation in
the intramembrane space thus creating stable encapsulated gas
bubbles available for pulsation in the focal area, which resulted
in the backscatter signal increase.
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The goal of the proposed study was the development of a bone
phantom that can be used for the evaluation of focused ultrasound
protocols under magnetic resonance imaging (MRI) guidance.
Methods
High resolution CT images were used to segment femur bone. The
segmented model was manufactured with (Acrylonitrile Butadiene
Styrene) ABS plastic using a 3-D printer. The surrounding skeletal
muscle tissue was mimicked using an agar-silica-evaporation milk
gel.
Results
MR thermometry of focused ultrasound exposures were acquired
using the bone phantom at a plane parallel and a plane perpendicu-
lar to the ultrasound beam.
Conclusions
Due to growing interest in using Focused ultrasound for pain palli-
ation of bone cancer patients, the proposed phantom is considered
as a very useful tool for evaluating ultrasonic exposures, thus minim-
izing the need for animal experiments.
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Objectives
The biological effects of High intensity focused ultrasound (HIFU) are
often associated with the induction of high temperatures in target
tissue. Traditional 2D cell culture models are not suitable for the in-
vestigation of HIFU’s thermal effects due to their lack of energy ab-
sorption. In contrast, 3D matrices could offer a tissue-mimicking
biologically-compatible medium in which to demonstrate the ther-
mal effects of HIFU. These gels can be designed to contain
physiologically-relevant concentrations of extracellular matrix constit-
uents including collagen. In this study colon cancer cells were cul-
tured in 3D compressed collagen-based matrices. The effect of HIFU
on cell viability was then investigated.
Methods
The human colon cancer cell line HT29 was used to form non-
adherent cell spheroids, which enabled the cells to be contained in
the narrow focus of the HIFU beam. These spheroids were embed-
ded in 3D collagen gel matrices developed using Type I collagen
from rat tail mixed with concentrated Minimum Essential Medium.
The gel was allowed to set in a 2.5 cm wide cylindrical mold for 35
minutes. To increase collagen concentration a metallic plunger
weighing 195 g compressed the gel twice. An ultrasound chamber
was developed to allow exposure of the gel. The exposure system
consisted of a 1.66 MHz HIFU transducer with a beam focal diameter
of 1 mm and a focal length of 10 mm. Cavitation was detected using
a passive cavitation detection sensor located in the central aperture
of the HIFU transducer and connected to a data acquisition card.
Cavitation data was processed using Matlab. The HIFU transducer
was connected to an automated gantry which allowed computer
controlled movement in 3D. The HIFU transducer targeted the wells
of a purpose built, 3D printed 6-well acoustic plate. Wells were
sealed at both ends with 19 mm thick Melinex films. The plate was
held at the edge of a large water tank, and was connected to a fibre
optic probe to record temperature. The compressed 3D collagen gel
was placed in the middle of the well, fixed in place by two hydrogels
on either side. A fibre optic probe was placed next to the cell spher-
oid. The gel was exposed to HIFU, transferred to a well of a 24-well
plate and covered in medium. Cell viability was determined 1 and 4
days after exposure using the Cell Titer Luminescence assay.
Results
HT29 cells grew as spheroids in 2D medium and in 3D collagen
matrices without a significant loss of viability for up to 7 days. Expos-
ure of cells to heating these 3D matrices using a thermal cyclerresulted in a reduction of cell viability that was dependent on ap-
plied thermal dose and on time elapsed after treatment. However
those cells still viable after heat exposure did not retain their prolifer-
ative capacity. The 3D collagen gel matrices withstood HIFU expo-
sures up to Isp 1580 W/cm
2. Pilot experiments showed that the
viability of cells cultured in these matrices was reduced relative to
sham exposed cells. Viability of cells in 2D medium was not signifi-
cantly affected at these intensities. A full set of data will be
presented.
Conclusions
A biologically and HIFU-compatible tissue-mimicking matrix has been
created which allows investigation of the thermal effects of HIFU
in vitro. Preliminary results suggest that HIFU exposure reduces the
viability of cells cultured in this model.
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Objectives
MRI-guided high-intensity focused ultrasound (HIFU) is a novel tech-
nology that is revolutionizing the concept of neurosurgery HIFU can
potentially be used in many neurological and psychiatric disorders
such as Parkinson’s disease, neuropathic pain or obsessive compul-
sive disorder among others. So far, one of the most successful appli-
cations arises for the treatment of Essential Tremor (ET). Several
centres around the world have performed ablation of the ventral
intermediate nucleus (VIM) of the thalamus for drug refractory ET.
The Centre for Integrative Neuroscience (CINAC) in Hospital Puerta
del Sur, Móstoles, has recently joined the HIFU community. This ab-
stract summarizes our experience in the first five VIM ablation
procedures.
Methods
Five patients, four with ET and one with tremor-dominant Parkinson’s
disease (PD) were considered candidates for ablative thalamotomy
after neurological evaluation. Pre-treatment evaluation included a
general neurological exam and the clinical rating scale for tremor
(CRST). MRI was performed in a 3T MR GE Discovery 750w. The im-
aging protocol consisted of 3D-T1w FSPGR, T2w TSE, T2 FLAIR and
T2*. Pre-treatment radiological exam did not reveal any counter-
indication for the procedure. Head CT was acquired in an Aquilion
PRIME system (Toshiba) and Skull Density Ratios (SDR) were esti-
mated. All patients presented a suitable skull density (see Table 6).
VIM ablations were performed with the clinical ExAblate 4000 system
(InSighTec) fully compatible with the MR scanner. The ExAblate 4000
contains a hemispheric 1024 elements phased array transducer. The
day of the procedure, the patients’ head was shaved and a stereotac-
tic frame was attached using local anaesthesia. A flexible membrane
was placed around the head, and was attached to the transducer,
creating a close space, posteriorly filled with degassed water, which
was circulating for cooling. 3D-T2w FIESTA images were acquired to
define our target for ablation. VIM was localized in relation to anter-
ior commissure and posterior commissure coordinates. Then the nat-
ural focus of the transducer was manually aligned to our target.
Several low-power sonications (1500-2000J) were performed to con-
firm alignment between hot-spot and target. Once alignment was
confirmed, energy administration was gradually raised in order to in-
crease temperature in the target. Patients were awake during the
procedure, and neurological examination was carried out after each
sonication in order to evaluate tremor remission, and detect any pos-
sible side-effects, such as paraesthesias, ataxia or pyramidal features.
After procedure, patients were monitored at the ICU for 12h. The day
after, post-treatment cranial MR was performed, using the same
protocol as in the pre-treatment session. Clinical follow-up
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week, and one month.
Results
Tremor remitted in all five patients after the focused ultrasound pro-
cedure. One week later tremor evaluation showed a reduction in
CRST of 63% for patient 1, 50% for patient 2, 76% for patient 4 and
53% for patient 5. Patient 3 was evaluated not on the whole CRST
but just in the dominant hand, and showed full remission of tremor.
One month after evaluation has been just carried in three of five pa-
tients, and CRST scores are stable with a maximum variation with re-
spect to baseline of 6% (see Table 6).
The procedure lasted in average 4.06 hours, 20.6 total sonications on
average, and 2.8 average sonications exceeding an average on-target
temperature of 55° (see Table 7). Side effects after the procedure in-
cluded mild ataxia (patients 1 and 2), mild paresis (patient 3 and 5)
and perioral paraesthesia (patient 4). Figure 179 shows different MR
contrasts of the lesion 24 hours after the procedure in all the five
patients.
Conclusions
Based in our experience, HIFU is a safe and effective treatment for
tremor control in patients with ET. All patients showed marked im-
provement in their tremor that, while awaiting for a longer follow-
up, was maintained for more than one month. Side-effects were tran-
sient and related to the ablative procedure.Table 7 (abstract P40). Skull density ratios (SDR) and procedure related
parameters, including procedure duration, number of sonications, total






















01 0.41 3.5 h 945
(343 cm2)
16 13 8 4 66850 J 88.42 105.36
02 0.43 4.3 h 885
(326 cm2)
24 14 9 3 237200 J 262.36 332.31
0 0.34 3.6 h 875
(294 cm2)
16 14 8 3 96850 J 100.06 117.69
04 0.51 5.3 h 926
(354 cm2)
33 31 21 2 138250 J 225.99 274.07
05 0.34 3.6 h 916
(349 cm2)
14 12 7 2 101000 J 98.39 115.84
Fig. 179 (abstract P40). Axial view of MR images confirming the
VIM ablation. Rows are sorted to MR contrasts, T1w, T2w, T2 FLAIR,
and T2*. Columns are sorted according to patients’ ID
Table 6 (abstract P40). Patients’ demography and clinical rating scale
for tremor before and after the VIM ablative procedure
CRST Baseline CRST 1 Week CRST 1 Month
ID Gender Age Diagnose YoD Laterality A B C T A B C T A B C T
01 F 74 ET 10 L 24 13 18 55 15 5 0 20 17 5 0 22
02 F 74 ET 15 L 9 11 14 34 5 7 5 17 5 7 3 15




04 M 64 ET 11 L 12 17 17 46 2 7 2 11 2 8 2 12
05 M 87 ET 25 L 28 36 27 91 18 18 6 42 P41
Tissue-mimicking phantom for HIFU lesion characterization by
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Objectives
Polyacrylamide gel with bovine serum albumin (PAG-BSA) was pro-
posed as a tissue-mimicking phantom for following thermal lesion
during HIFU treatment (Lafon 2005). Indeed, the protein contained in
the transparent phantom denatures and becomes opaque when
heated. The aim of the present study was to assess if elastography
can be used for monitoring HIFU lesions in PAG-BSA.
Methods
Guntur (2014) proposed a PAG-BSA phantom with glass beads (40-
80μm) used as scatterers. BSA concentration was set to 18% (w/v) in
order to improve thermal lesion contrast
Mechanical properties changes with thermal dose
Once polymerized, compression tests were performed on cylindrical
samples of the gel (ø33x5mm) in order to measure the change of
the Young modulus as a function of the thermal dose. Eighteen sam-
ples were heated in a 95°C water bath. Heating time ranged from
10s to 10 min.
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A block of PAG-BSA (dimensions) was immersed in a water tank at a
temperature of 37°C. Thermal lesions were generated with a 3.25
MHz focused transducer (50mm diameter and focal length). The focal
spot was positioned 10 mm deep in the phantom. A focal intensity
of 4000 W/cm2 (in water) was delivered for 15 s. The elasticity was
measured with a 5MHz abdominal probe by two methods: passive
elastography - PE - (Catheline 2013) performed with a Vantage 256
Verasonics system and transient elastography - SSI - (Bercoff 2004)
with a clinical Aixplorer. B-mode, elastography and microscopy im-
aging were performed and compared just after sonications and 24h
later.
Results
Compression test: Young modulus of the non-coagulated sample
was 8.4 ± 1 kPa. Young modulus increased linearly with respect to
heating time until it reached a steady-state of 24 kPa after 120s of
heating.
Imaging: Shear waves propagated in the gel at a speed of 2.3 m/s ac-
cording to PE and 1.8 m/s according to SSI. Just after sonication, le-
sions could be observed with all imaging methods. The lesions
showed a tadpole shape in the sagittal plane of the block. Lesions
were visible by SSI and PE. The surfaces of the lesion on the trans-
verse focal plane were 21.7 mm2 and 23.9 mm2 for PE and SSI re-
spectively. Shear waves propagation velocities in the lesion were 3.5
m/s with PE and 3.3 m/s with SSI. At 24h, the surface of the lesion
decreased to 20.6 mm2 with PE. The shear wave’s speed was still 3.5
m/s with PE at 24h. One hour after HIFU exposure, microscopy evi-
denced, in the core of the lesions, the systematic presence of bub-
bles whose diameters ranged from 150 to 250 um. These dimensions
are much larger than the glass beads. At 24 hours, no bubbles were
detected except in the centre of the lesions.
Conclusions
Stiffness of the gel increased by a maximum factor of 2.8 with the
coagulation of the BSA protein. Thermal lesions were visible in the
PAG-BSA with both elastography methods tested in these experi-
ments even when B-mode was no longer able to detect it. HIFU le-
sions increased the local stiffness of the PAG-BSA, at least by a factor
of 2.2. The presence of bubbles did not disrupt the elastographic
image.
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B-mode and PE maps. HIFU lesions were well-visible during 24h,
even when B-mode did not show hyper-echoic signalsP42
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Objectives
To report the results of the robotic high-intensity focused ultrasound
(rHIFU) treatment for the prostate cancer and failure after external
beam radiotherapy (EBRT) and radical prostatectomy (RPE), stratified
by tumour recurrence risk according to D'Amico risk classification.
Methods
1150 patients were treated in our centre between Sep 2007 – No-
vember 2015: 339 with low risk progression, 355 with intermediate
risk progression, 409 with high risk progression, 47 – after the EBRT
and RPE failure. 925 patients underwent TURP+HIFU, 225 only HIFU
(volume prostate < 40 cc). Mean follow-up is 62 months (range 3–
98). The mean age of the whole group of patients was 69.2 (52–89)
years.
Results
Median PSA level 12 months after rHIFU treatment were 0.03 (0.0-
2.4) ng/ml – low risk group, 0.04 (0.1-4.2) ng/ml – intermediate risk
group, high risk group - 0.5 (0–18.4) ng/ml, with failure after EBRT –
0.5 (0–3.2) ng/ml; 72 months after rHIFU treatment were 0.5 (0.0-3.6)
ng/ml – low risk group, 1.04 (0.2-6.3) ng/ml – intermediate risk
group, for high risk group – 3.2 (0–21.3) ng/ml, with failure after EBRT
and RPE – 1.7 (0.0-9.8) ng/ml. Patients with low risk had 6.3% of pro-
gression, with intermediate risk had 8.2% of progression, with high
risk PC – 37.4%, with failure after EBRT – 20.8%. Kaplan-Meir analyses
of the total group indicated that the risk of progression after 8 year
follow-up was 84.9% for all patients. Complications: incontinence I –
18.1%, incontinence II – 7.5%, stricture – 17.8%, fistula – 0.1%.
Conclusions
rHIFU ablation is a safe, minimally invasive treatment for localized
and locally advanced prostate cancer, effective in 84.9% of cases with
mild and transient side effects; rHIFU-therapy can also be successfully
performed in patients with local recurrence after RPE and EBRT.P43
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Objectives
In biological systems, episodic release of bioactive compounds may
elicit different effects from constant rate of release. For example,
once-daily administration of pharmacological doses of parathyroid
hormone has a bone anabolic effect, while continuous administration
is detrimental for the skeleton due to stimulation of bone resorption.
Conventional drug delivery systems allow approximate spatial
localization of cues depending on polymer degradation and passive
diffusion, but are unable to control release rates temporarily. In con-
trast, “on-demand” release systems which based on polymers or ma-
terials activated by external stimuli may provide such temporal
flexibility and are beginning to be applied in the clinical setting. The
current study aims at exploring the accelerating release rate of bo-
vine serum albumin (BSA) embedded in the N-isopropylacrylamide
(NIPAM) -based hydrogel in response to temperature rise provided
by ultrasound (US) exposure with energy in therapeutic ranges.
Fig. 182 (abstract P43). BSA release at different temperature in
water bath or after US exposure
Fig. 181 (abstract P43). BSA release at different MBAm amount in
water bath or after US exposure
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The NIPAM-based reusable hydrogel phantoms were fabricated by
crosslinking copolymerization of NIAPM and N,N'-methylenebisacryla-
mide (MBAm) with the addition of acrylic acid (AAc) to adjust the
cloud point so that it fell in the temperature range of biological sig-
nificance (37oC in this study). Hydrogels, before set, were mixed with
BSA and added into a 6-well culture plate before heating by either
water bath or US (1 MHz, 30% duty cycle, 3 W/cm2) for a certain
period of time. The ability of BSA release from hydrogels was tested
in various conditions including (1) different NIAPM (1, 2 and 3 g) and
MBAm (0.02 to 0.10 g) compositions, (2) different target temperature
from 25 to 45oC, and (3) water bath heating or ultrasound exposure
(both thermal and mechanic effects). Moreover, the microstructure of
the hydrogel below and above the cloud point was examined by
electronic microscopy.
Results
With the same MBAm amount, release of BSA reduced when NIPAM
increased. With the same NIAPM amount, release of BSA increased
with the increase of MBAm (Fig. 181). Both water bath heating and
US exposure induced BSA release and is temperature dependent, but
significantly more release was induced by US exposure (Fig. 182). At
temperature below the cloud point, the hydrogel (NIPAM/MBAm=1
g/ 0.02 g) is transparent in colour and shows dense microstructure
with small pores. When heated above the cloud point, the whitish
hydrogel shows pores of increased sizes.
Conclusions
In this study, an ultrasound and temperature dual-responsive hydro-
gel suitable for controlled release is described. In certain formula of
the NIPAM-based hydrogel, the ratio of BSA release between
ultrasound-triggered release and release from diffusion could reach
32 folds. In another formula, transparent hydrogel became whitish
when release from the hydrogel increased. By simply adjusting con-
tents of NIPAM and MBAm, the ratio of BSA release between
ultrasound-triggered release and release from diffusion can be ad-
justed according to clinical needs.
Ultrasound-triggered release has only been reported in few studies.
By combing microbubbles, liposomes and the hydrogel, ultrasound-
trigger release was demonstrated in this complicated system. The sys-
tem would be structurally destructed by ultrasound exposure. Using a
reversibly cross-linked alginate-based hydrogel, ultrasound induced a
10-fold increase in drug release. (PNAS 2014) In another study, using
gold nanoparticles coupled with poly(ethylene glycol) incorporated in
the alginate-based hydrogel, ultrasound stimulated the release rate by
110 folds. In this study, the ultrasound and temperature dual-responsive
NIPAM-based hydrogel directly contained BSA without incorporating li-
posomes and nanoparticles and reached an increasing release rate by
about 32 folds. Furthermore, the ratio of BSA release between
ultrasound-triggered release and release from diffusion ranged from 1.5
folds to 32 folds by modifying contents of NIPAM and MBAm.
The mechanism of increased release responsive to temperature may
be, at least partly, associated alteration of the hydrogel microstruc-
ture. Under SEM, sizes of the pores in the hydrogel increased when
temperature increased to above the LCST. In such circumstance, the
hydrogel became whitish, possibly due to light scattering; increased
of BSA also increased possibly due to enlarged pores. However in
the current study, even at the same temperature, release rate was
much higher using ultrasound stimulation than using water bath.
Such difference may be related to non-thermal effects of ultrasound,
such as streaming or cavitation.
One possible clinical application of this dual-responsive hydrogel is
that, after implantation into the body, there will be a two-step con-
trolled release. The first step is achieved by heating the hydrogel. If a
higher release is needed, applying ultrasound stimulation will
achieve the second-step release. Another possible clinical application
of the discolouring hydrogel associated with increased release is for
designing a wound dressing material. One of the problems in treat-
ing poorly-healed wound is to determine the timing of changing
wound dressing. Using this discolouring hydrogel as a medication-
containing dressing, the healthcare-provider can change the dressing
when it becomes whitish, because at this timing most medication
has been released.P44
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Objectives
In the context of ultrasound enhanced drug delivery, our aim was to as-
sess the impact of sonication and inertial cavitation on the penetration
of fluorescent probes into tumour cells. We also wanted to estimate
the impact of parameters such as the peak negative pressure gener-
ated at focus, the timing of sonication, and its duration.
Methods
Female nude mice (Charles River, Saint-Germain-sur-l'Arbresle,
France) were used for a subcutaneous implantation of WM-266-4 hu-
man metastatic melanoma xenografts. Tumours were exposed to
ultrasound about 20 days after cell implantation when solid tumours
Fig. 184 (abstract P44). See text for description
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either 30 minutes after (protocol 1) or 10 minutes before (protocol 2)
the injection of 100 μL of fluorescent probe AngioSense 680 EX
(PerkinElmer, Waltham, MA) at a concentration of 4 nMol/100 μL.
The ultrasound system used for sonicating the animals and generat-
ing unseeded inertial cavitation inside the tumour consists of a two
confocal transducers transmitting 40-μs long sinusoidal pulses at 1
MHz centre frequency every 4 ms. The transducer assembly is
immersed in a tank filled with degassed water and can be positioned
with motors ensuring translation in the three directions (see Fig. 183).
This allows sonication of a predefined volume that includes the
tumour using raster scans in stacked horizontal planes.
To estimate the penetration of fluorescent probes inside the tumour
cells the animals were sacrificed and the tumours harvested. We
used a cytometric analysis to quantify the fluorescence intensity of
the non-necrotic cells due to the presence of fluorescent probes and
compared the sonicated groups to the reference groups.
In the first series of tests, peak negative pressure was varied between
16 MPa, 19 MPa, and 21 MPa rarefactional pressures. In the second
series of tests, protocols 1 and 2 were compared to assess if penetra-
tion was greater when probes were injected before or after sonic-
ation. In the last series of tests, the speed of the raster scan was
increased from 1 mm/s to 2 mm/s and 4 mm/s to estimate the im-
pact in probe penetration when reducing the sonication duration.
Results
The first series of tests showed that ultrasound generated inertial cavita-
tion had a significant effect on the penetration of probes into tumour
cells with a maximum improvement of 47%. The peak negative pressure
level that gave the largest improvement was 19 MPa (see Fig. 184). At
this pressure, macroscopic observation showed minor skin damages
such as point like petechiae that disappeared a few days post-treatment.
In the second series of tests, both protocols showed a significant dif-
ference in probe penetration compared to the control group but
protocol 1 where sonication was applied in the presence of the
probes showed a much larger improvement than protocol 2 (68% vs.
20%, see Fig. 184).
The last series of tests showed that increasing the raster scan speed
and decreasing the duration of sonication by a factor 4 did not have
a significant impact (see Fig. 184). This means that the treatment
time could be significantly reduced without reducing its efficiency.
Conclusions
We have presented an ultrasound device that generates a significant
improvement in the penetration of fluorescent probes into in vivo
tumour cells. The hypothesized mechanism at play is ultrasound-
induced inertial cavitation. Our parametric study showed that ultra-
sound exposure improved the uptake of fluorescent probes. The op-
timal pressure level generated an improvement in probe penetration
up to 68% with only minor damages on the skin. For best efficiency,
the ultrasound should be applied in presence of the probes. The
raster scan speed could be set up to 4 mm/s without adverse
consequences.Fig. 183 (abstract P44). See text for descriptionP45
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Objectives
Sonoporation process, at the origin of ultrasound cell transfection, is
ruled by the interaction between cells and cavitating bubbles. Due to
the stochastic behaviour of acoustic cavitation, there exists a need in
ensuring a stable and reproducible state of cavitation within a
medium during cell transfection to enhance transfection efficiency
and to control mortality. In this study is described how stochastic the
cavitation activity could be by describing a classical nonlinear effect
(hysteresis effect), before the characterization of a controlled-
cavitation device dedicated to the real-time monitoring, control and
stabilization of inertial cavitation activity during cell sonication. The
induced ultrasound strategy for sonication is discussed through the
quantification of sonoporation efficiency for suspended cells or ad-
herent cell monolayer, as well as the need of employing an initial dis-
tribution of gas nuclei thanks to ultrasound contrast agents in order
to initiate cavitation process.
Methods
A specific ultrasound sonoporation chamber has been designed by
mounting ultrasound transducers (frequency around 450 kHz) on a
culture well located within a microscopic stage allowing real-time
visualization of bubble activity atop an adherent cell monolayer dur-
ing a sonication experiment. A needle hydrophone allows listening
the cavitation broadband noise in order to quantify inertial cavitation
activity. The hydrophone signal is then digitized and sent to a FPGA
(Field Programmable Gate Array) that synthetizes the output signal
feeding the ultrasound transducers, and modulate the applied acous-
tic intensity to the transducer to reach and maintain a fixed inertial
cavitation activity during the experiment. For cell sonoporation ex-
periments, HT29 adherent cells (human colorectal adenocarcinoma
cell lines) were plated in the well at 2.10^6 cells/well, with 2 mL of
RPMI 1640 completed media. Sonoporation experiments consisted in
the internalization of siRNA coupled to the fluorochrome AlexaFluor-
488 before analysis with a flow cytometer.
Results
First, when applying successive ultrasound shots for increasing and
decreasing fixed acoustic intensity, it is shown that inertial cavitation
activity exhibits hysteretical behaviour related to the fluctuation of
the bubble size distribution. Besides its fundamental interest in non-
linear physics, this hysteretic effect finds applications in the design of
appropriate control of the cavitation activity by taking advantage of
the jump of the phenomenon from a metastable state to another.
This strategy is applied thanks to FPGA programming allowing a per-
manent modulation of the applied signal amplitude to the trans-
ducer in an ultrafast regulation loop (smaller than 300μs). When
using such real-time control, the inertial cavitation activity reveals
Fig. 185 (abstract P46). See text for description
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controlling cavitation activity in pulsed wave from a pulse to another,
and even within a single pulse. When studying cell transfection with
or without regulation process, it is shown that transfection rate is
more reproducible when using the cavitation-controlled device, even
without attaining much higher transfection rate. This increase in re-
producibility has been observed for both suspended and adherent
cells experiments. Because the real-time cavitation control demon-
strated its potential for maintaining a stable cavitation state during
an ultrasound shot, the question arises of the interest of using ultra-
sound contrast agents as cavitation nuclei. It is shown in-vitro that,
when using the cavitation-controlled device superimposed to the in-
jection of ultrasound contrast agents, the reproducibility of inertial
cavitation activity is even enhanced. Interestingly, when ultrasound
contrast agents quickly collapse during sonication, the regulated-
cavitation device can counterbalance their destruction to sustain a
stable cavitation state. The interest of combining UCAs and cavitation
control is then demonstrated for in-vitro cell transfection.
Conclusions
Lowering applied acoustic intensities while increasing the induced
biological effects is of great importance for the growth of
ultrasound-based drug delivery applications without increase of cell
mortality. Such objective can be attained by the real-time monitoring
and control of cavitation state during medium sonication, in-vitro
and even in-vivo. In this study, the interest of using a cavitation-
controlled sonoporation device is demonstrated by enhancing cell
transfection reproducibility, as well as the possibility of counterbalan-
cing the use of ultrasound contrast agents in vitro.
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Objectives
The combination of imaging and treatment is the prerogative of a
new scientific concept called theranostic (contraction of therapeutic
and diagnostic). While conventional imaging provides anatomical
visualization of organs and tissues for the purpose of detecting and
tracking the evolution of the disease, the future of imaging is ex-
pected to predict the efficacy of treatment and monitor the evolu-
tion of its activities throughout the disease for early detection of
phenomena of resistance and to consider a rapid change from the
first signs of relapse. Moreover it will have to deliver drugs only to
the pathological site allowing increasing efficacy while reducing side
effects. Progress of new therapeutic will therefore be done in con-
junction with new imaging methods more sensitive, more specific,
less invasive and less expensive, to allow an early and reliable diag-
nosis of the response related to the drug's action and active target-
ing with localized, effective, and safe new drug delivery platform.
Micro-nanoparticulate vectors are particularly advantageous from this
point of view as they allow to encapsulate in a single particle the
contrast agent and the drug and hence to follow the action thereof
in real time while limiting the number injections.
Our work will be to develop novel nanoparticle systems with both
contrast agents for medical imaging properties and active drug deliv-
ery by high intensity focus ultrasound. We seek to design a theranos-
tic agent for targeting tumours and with the ability of being
observed by fluorine magnetic resonance imaging (19F MRI). Thisintravenously injectable agent with encapsulated drugs, should allow
to visualize tumours. Then focused ultrasound will induce release of
the encapsulated drug in order to achieve a local chemotherapy.
Methods
We have developed theranostic nanocapsules combining a diagnostic
moiety to improve tumour detection and a therapeutic moiety to treat
them. These nanocapsules are composed of a polymer shell of PLGA-
PEG and a core of a perfluorocarbon namely perfluorooctyl bromide
(PFOB) in which a cytotoxic drug (paclitaxel) is encapsulated. The goal
is to use these capsules to select patients exhibiting the enhanced per-
meation and retention effect for further treatments with nanomedi-
cines. In our case, PFOB has the interesting properties to respond to
19F MRI to allow early detection of the tumour, diagnosis of accumula-
tion of EPR effect and follow up of the response to treatment. This li-
quid perfluocarbon is also responsive to ultrasound allowing an active
targeting by high intensity focused ultrasound to actively deliver cyto-
toxic drug to tumours. Paclitaxel, an antimitotic drug, was encapsulated
in an attempt to reduce side-effects associated with excipients such as
Cremophor® used in the commercial formulation (Taxol®).
Results
We optimized the encapsulation of paclitaxel into nanocapsules by
varying formulation parameters, focusing in particular in preventing
or limiting paclitaxel recrystallization and nanocapsule aggregation.
The optimized formulation was tested in vitro on CT-26 colon cancer
cells and showed similar cytotoxicity as compared with Taxol®. Pacli-
taxel pharmacokinetics and biodistribution were evaluated in nude
mice bearing CT-26 xenografted tumours comparing nanocapsules
with Taxol®. For nanocapsules, pharmacokinetic parameters are im-
proved leading to a longer circulation and resulting in an enhanced
accumulation in tumours, as confirmed by 19F-MRI. In term of effi-
cacy, this enhanced passive targeting allows a slower tumour growth
in animals treated with paclitaxel-loaded nanocapsules compared to
PBS and Taxol®. Ultrasounds were also used to further improve
tumour targeting. In collaboration with Benoit Larrat’s team at CEA,
we studied the influence of ultrasound on our nanoparticles to deter-
mine the most suitable ultrasonic sequences for our system. We
showed that when applying a safe ultrasound sequence inducing
mild hyperthermia, tumour growth was slower on our tumour model.
In vitro studies showed that this decreased growth is due to mild
hyperthermia favouring tumour perfusion and vascular leakage lead-
ing in an enhance accumulation of drugs inside the tumour.
Conclusions
Finally we showed that it is possible to combine within the same
nanoparticles the diagnostic properties of a 19F MRI contrast agent
and an active drug targeting mediated by High intensity focus ultra-
sound. The theranostic agent allows a better diagnosis and a higher
anti-tumoural efficacy compared to available therapies.
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Objectives
To develop a novel bubble formulation for ultrasound (US) imaging
and therapy with small particle size and a good stability and test the
formulation as US contrast agent and for gene delivery in vitro and
in vivo.
Methods
Lipid-stabilized bubbles were prepared by homogenization of lipid
dispersion in the presence of perfluoropropane gas. Different
phospholipid compositions were tested and evaluated. After bubble
formation the bubbles were freeze-dried so that a dry cake contain-
ing bubbles was formed. After reconstitution of the samples they
were analysed for size, gas content and US signal intensity and lon-
gevity. The bubbles were also evaluated as US contrast agents
in vivo, and for US activated gene delivery of luciferase encoding
pDNA in vitro on cell culture and in vivo in mice.
Results
Bubbles were in the size range 500–800 nm and could be preserved
by freeze-drying and re-constituted by simple addition of water to
the dry sample. Changes in the lipid composition had a big impact
on the properties of the bubbles produced. A mixture of three differ-
ent lipids in the stabilizing layer resulted in the most stable bubbles.
In vivo imaging of B16BL6 tumours in mice, using the most stable
bubbles showed half-lives substantially longer than for the commer-
cial bubble Sonazoid. Also, the bubbles were well suited for
visualization of tumour neovasculature. Bubbles together with pDNA
and US exposure increased the luciferase activity by about 300 times
in vitro and 2000 times in vivo, respectively, compared to only pDNA
+US.
Conclusions
We believe this new formulation shows great promise for both diag-
nostic and therapeutic applications thanks to its good stability, rela-
tively small bubble size and the simplicity of handling.
Acknowledgements
This work was supported by MEXT-Supported Program for the Strategic
Research Foundation at Private.
P48
Ultrasonic potentiation of doxorubicin-induced cell death in 4K1
cells in vitro
Cécile Fant, Maxime Lafond, Bernadette Rogez, Jacqueline Ngo,
Cyril Lafon, Jean-Louis Mestas
LabTAU, INSERM U1032, Lyon, France
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):P48
Objectives
Ultrasonic cavitation has been shown to be a promising strategy to
potentiate chemotherapy drugs. In the case of doxorubicin (DOX), a
potent drug routinely used in clinic, it can address to a twofold prob-
lem: severe side effects and acquired drug resistance. Under certain
settings, the onset of ultrasonic cavitation entails profound physical
and chemical changes on cell structure. These alterations can be
exploited to improve the delivery of chemotherapy drugs, enhance
their effects and overcome drug resistance in tumour cells. The aim
of this study was first to evaluate the potentiation of DOX by stable
cavitation in murine 4T1 mammary tumour cells in vitro. The mech-
anism of potentiation was also investigated.
Methods
An ultrasonic setup based on confocal ultrasound (US) beams sepa-
rated by an angle of 90° was used. It operated at a frequency of 1.1
MHz The apparatus was able to generate stable cavitation (gener-
ation and oscillation of bubble without collapse) without adding cavi-
tation nuclei such as ultrasound contrast agents. High-pressurepulses of 6600 cycles (6.7 MPa peak negative pressure – PNP at a
pulse repetition frequency of 25 Hz) produced a cavitation cloud in
the sample while lower pressure pulses (2.95 MPa PNP, PRF 25Hz)
maintained a stable cavitation activity. Monitoring of cavitation activ-
ity based on the measurement of the subharmonic emergence at
550 kHz with an integrated PVDF hydrophone permitted to switch
between the two pressure regimens. Four groups were used: control,
DOX alone, US alone and DOX/US combination. The cell growth
index (number of viable cells relatively to the number of viable cells
at 1h post-US) is measured at 72h post-US. Flow cytometry measure-
ments at 1h post-US were also performed to assess the DOX internal-
ization. In a second time, the same experiment was reproduced
adding radical scavenger (histidine and mannitol) to evaluate the
role of radical oxygen species (ROS) in the potentiation.
Results
Measurements showed that stable cavitation was obtained with a
high reproducibility, being 12.5±2.4 dB. At 72h, the cell growth in-
dexes were 6.4±2.2 and 5.4±1.3 for US group and controls respect-
ively and not statistically different. The DOX dosage chosen for this
study lead to a cell growth index of 0.54±0.17 while DOX+US permit-
ted to reduce the index to 0.31±0.092. No increase of DOX uptake
could be observed at 1h post-US, discarding the hypothesis of sono-
poration. Moreover, radical scavengers did not prevent the reduction
of proliferation, excluding the role of the radical oxygen species pro-
duced by cavitation in the observed synergetic effect.
Conclusions
Unseeded stable cavitation was initiated and maintained using con-
focal ultrasound, an acoustic strategy based on two pressure levels
and a passive cavitation detector for monitoring. The created cavita-
tion was shown to act synergistically with doxorubicin in order to re-
duce the tumour cell proliferation. However neither sonoporation
nor an action of free radicals could be evidenced as an underlying
mechanism.
P49
Effect of acoustic radiation force on the distribution of
nanoparticles in solid tumours
Mercy Afadzi1, Ola Finneng Myhre2, Siri Vea2, Astrid Bjørkøy1,
Petros Tesfamichael Yemane 1, Annemieke van Wamel1, Sigrid Berg3, 2,
Rune Hansen3, 2, Bjørn Angelsen2, Catharina Davies1
1Physics, Norwegian Univeristy of Science and Techonlogy, Trondhiem,
Norway; 2Circulation and Medical Imaging, Norwegian Univeristy of
Science and Techonlogy, Trondhiem, Norway; 3SINTEF Technology and
Society, Trondhiem, Norway
Journal of Therapeutic Ultrasound 2017, 5(Suppl 1):P49
Objectives
Encapsulating cytotoxic drugs in a particulate carrier such as lipo-
somes, micelle or other nanoparticles (NPs) may reduce toxicity to
normal tissues by delivering NPs selectively to tumour tissues. How-
ever, due to the heterogeneous fenestration of the tumour blood
vessel and the poor penetration through the extracellular matrix
(ECM), large areas of the tumour are not reached by the drug/NPs.
To overcome these challenges in drug delivery, development of new
and effective treatments is of great need. In recent years, there have
been considerable efforts to develop therapeutic use of focused
ultrasound (FUS) and it has shown significant potential in cancer
therapy. Ultrasound –mediated mechanism such as cavitation and
acoustic radiation force (ARF, transfer of momentum from US beam
to the attenuating media) may enhance both extravasation of NPs
across the capillaries and penetration of NPs through the ECM. The
study aims to investigate the effect of ARF on the transport of NPs
across the capillary wall and through the ECM.
Methods
Silica NP (70 nm) with half-life of 2h was injected intravenously into
mice bearing subcutaneous prostate xenografts. The tumours were
exposed to various FUS exposure parameters (5 or 10MHz frequency,
0.5 or 1μs pulse length and 1 5 66 kHz pulse repetition frequency)
immediately or 4h after the injection of the NP Using a stepping
robot the tumour was scanned (3×3 points) in the lateral plane for
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focal width of the US probe. Total scanned areas were 1.8 × 1.8 mm
and 0.9 ×0.9 mm for the 5 MHz and 1 0MHz respectively. Fluorescent
labelled lectin was injected immediately after US treatment and
allowed to circulate for 5mins to stain the blood vessels. Tumours
were surgically removed and frozen sections were analysed by con-
focal laser scanning microscope. Confocal microscopy images were
then analysed quantitatively using ImageJ and Matlab. The experi-
mental work was supported by simulation of ARF on tissues using
the exposure parameters of the experimental work.Results
Preliminary results indicate an enhanced extravasation and improved
microdistribution of NPs in the US exposed animals compared with
non-exposed animals. Thus, tumours exposed to US showed increase
mean distances between NPs and microvessels than non-exposed
tumours.
Conclusions
The results demonstrate the potential of FUS to improve cancer ther-
apy, and that ARF can be an important mechanism for improved de-
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